# EDGAR Filing Document

**Accession Number:** 0000877860
**File Stem:** 0000877860-26-000053
**Filing Date:** 2026-2
**Character Count:** 642109
**Document Hash:** c45f63fb19e058e885055fc434a4f027
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000877860-26-000053.hdr.sgml**: 20260226

**ACCESSION NUMBER**: 0000877860-26-000053

**CONFORMED SUBMISSION TYPE**: 10-K

**PUBLIC DOCUMENT COUNT**: 120

**CONFORMED PERIOD OF REPORT**: 20251231

**FILED AS OF DATE**: 20260226

**DATE AS OF CHANGE**: 20260226

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** NATIONAL HEALTH INVESTORS INC
- **CENTRAL INDEX KEY:** 0000877860
- **STANDARD INDUSTRIAL CLASSIFICATION:** REAL ESTATE INVESTMENT TRUSTS [6798]
- **ORGANIZATION NAME:** 05 Real Estate & Construction
- **EIN:** 621470956
- **STATE OF INCORPORATION:** MD
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-10822
- **FILM NUMBER:** 26688138

**BUSINESS ADDRESS:**
- **STREET 1:** 222 ROBERT ROSE DRIVE
- **CITY:** MURFREESBORO
- **STATE:** TN
- **ZIP:** 37129
- **BUSINESS PHONE:** 6158909100

**MAIL ADDRESS:**
- **STREET 1:** 222 ROBERT ROSE DRIVE
- **CITY:** MURFREESBORO
- **STATE:** TN
- **ZIP:** 37129

?xml version='1.0' encoding='ASCII'? nhi-20251231

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

WASHINGTON, D.C. 20549

**FORM 10-K**

---

| | | | | |
|:---|:---|:---|:---|:---|
| (Mark One) | (Mark One) |  |  |  |
| ☒ | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| For the fiscal year ended | For the fiscal year ended | December 31, 2025 | December 31, 2025 | December 31, 2025 |
| ☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|  | For the transition period from | _____________ | to | _____________ |

---

Commission File Number 001-10822

**<u>National Health Investors, Inc.</u>**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| Maryland | Maryland | 62-1470956 |
| (State or other jurisdiction of incorporation or organization) | (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
| 222 Robert Rose Drive | 222 Robert Rose Drive |  |
| Murfreesboro | Tennessee | 37129 |
| (Address of principal executive offices) | (Address of principal executive offices) | (Zip Code) |

---

(615) 890-9100 <br> (Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each Class | Trading Symbol(s) | Name of each exchange on which registered |
| Common Stock, $0.01 par value | NHI | New York Stock Exchange |

---

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer", "accelerated filer", "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| Large Accelerated Filer | ☒ | Accelerated filer | ☐ | Emerging growth company | ☐ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ | | |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☒

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to Section 240.10D-1(b). ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

The aggregate market value of shares of common stock held by non-affiliates on June 30, 2025 (based on the closing price of these shares on the New York Stock Exchange) was approximately $2.9 billion.

As of February 20, 2026, the registrant had 48,392,384 shares of common stock outstanding.

**DOCUMENTS INCORPORATED BY REFERENCE**

Portions of the registrant's definitive proxy statement for its 2026 annual meeting of stockholders are incorporated by reference into Part III, Items 10, 11, 12, 13, and 14 of this Annual Report on Form 10-K.

------

**NATIONAL HEALTH INVESTORS, INC.**

**TABLE OF CONTENTS**

---

| | |
|:---|:---|
| | <u>Page</u> |
| <u>[Part I.](#i5eab276dbf9543dcafb4a7f5846ad360_10)</u> | |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Cautionary Statement Regarding Forward Looking Statements](#i5eab276dbf9543dcafb4a7f5846ad360_13)</u> | <u>[2](#i5eab276dbf9543dcafb4a7f5846ad360_13)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Summary Risk Factors](#i5eab276dbf9543dcafb4a7f5846ad360_16)</u> | <u>[2](#i5eab276dbf9543dcafb4a7f5846ad360_16)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 1. Business](#i5eab276dbf9543dcafb4a7f5846ad360_19)</u> | <u>[5](#i5eab276dbf9543dcafb4a7f5846ad360_19)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 1A. Risk Factors](#i5eab276dbf9543dcafb4a7f5846ad360_64)</u> | <u>[20](#i5eab276dbf9543dcafb4a7f5846ad360_64)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 1B. Unresolved Staff Comments](#i5eab276dbf9543dcafb4a7f5846ad360_70)</u> | <u>[34](#i5eab276dbf9543dcafb4a7f5846ad360_70)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 1C. Cybersecurity](#i5eab276dbf9543dcafb4a7f5846ad360_76)</u> | <u>[34](#i5eab276dbf9543dcafb4a7f5846ad360_76)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 2. Properties](#i5eab276dbf9543dcafb4a7f5846ad360_79)</u> | <u>[36](#i5eab276dbf9543dcafb4a7f5846ad360_79)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 3. Legal Proceedings](#i5eab276dbf9543dcafb4a7f5846ad360_91)</u> | <u>[38](#i5eab276dbf9543dcafb4a7f5846ad360_91)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 4. Mine Safety Disclosures](#i5eab276dbf9543dcafb4a7f5846ad360_97)</u> | <u>[38](#i5eab276dbf9543dcafb4a7f5846ad360_97)</u> |
| <u>[Part II.](#i5eab276dbf9543dcafb4a7f5846ad360_277)</u> | |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities](#i5eab276dbf9543dcafb4a7f5846ad360_103)</u> | <u>[39](#i5eab276dbf9543dcafb4a7f5846ad360_103)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 6. Reserved](#i5eab276dbf9543dcafb4a7f5846ad360_112)</u> | <u>[40](#i5eab276dbf9543dcafb4a7f5846ad360_112)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations](#i5eab276dbf9543dcafb4a7f5846ad360_118)</u> | <u>[41](#i5eab276dbf9543dcafb4a7f5846ad360_118)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 7A. Quantitative and Qualitative Disclosures About Market Risk](#i5eab276dbf9543dcafb4a7f5846ad360_160)</u> | <u>[62](#i5eab276dbf9543dcafb4a7f5846ad360_160)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 8. Financial Statements and Supplementary Data](#i5eab276dbf9543dcafb4a7f5846ad360_175)</u> | <u>[71](#i5eab276dbf9543dcafb4a7f5846ad360_175)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure](#i5eab276dbf9543dcafb4a7f5846ad360_256)</u> | <u>[113](#i5eab276dbf9543dcafb4a7f5846ad360_256)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 9A. Controls and Procedures](#i5eab276dbf9543dcafb4a7f5846ad360_259)</u> | <u>[113](#i5eab276dbf9543dcafb4a7f5846ad360_259)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 9B. Other Information](#i5eab276dbf9543dcafb4a7f5846ad360_271)</u> | <u>[117](#i5eab276dbf9543dcafb4a7f5846ad360_271)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;I<u>[tem 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections](#i5eab276dbf9543dcafb4a7f5846ad360_274)</u> | <u>[117](#i5eab276dbf9543dcafb4a7f5846ad360_271)</u> |
| <u>[Part III.](#i5eab276dbf9543dcafb4a7f5846ad360_277)</u> | |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 10. Directors, Executive Officers and Corporate Governance](#i5eab276dbf9543dcafb4a7f5846ad360_280)</u> | <u>[118](#i5eab276dbf9543dcafb4a7f5846ad360_280)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 11. Executive Compensation](#i5eab276dbf9543dcafb4a7f5846ad360_283)</u> | <u>[118](#i5eab276dbf9543dcafb4a7f5846ad360_283)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters](#i5eab276dbf9543dcafb4a7f5846ad360_286)</u> | <u>[118](#i5eab276dbf9543dcafb4a7f5846ad360_286)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 13. Certain Relationships and Related Transactions](#i5eab276dbf9543dcafb4a7f5846ad360_289)[, and Director Independence](#i5eab276dbf9543dcafb4a7f5846ad360_289)</u> | <u>[118](#i5eab276dbf9543dcafb4a7f5846ad360_289)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 14. Principal Accountant Fees and Services](#i5eab276dbf9543dcafb4a7f5846ad360_292)</u> | <u>[118](#i5eab276dbf9543dcafb4a7f5846ad360_292)</u> |
| <u>[Part IV.](#i5eab276dbf9543dcafb4a7f5846ad360_295)</u> | |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 15. Exhibits and Financial Statement Schedules](#i5eab276dbf9543dcafb4a7f5846ad360_298)</u> | <u>[119](#i5eab276dbf9543dcafb4a7f5846ad360_298)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Exhibit Index](#i5eab276dbf9543dcafb4a7f5846ad360_301)</u> | <u>[120](#i5eab276dbf9543dcafb4a7f5846ad360_301)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 16. Summary](#i5eab276dbf9543dcafb4a7f5846ad360_304)</u> | <u>[123](#i5eab276dbf9543dcafb4a7f5846ad360_304)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Signatures](#i5eab276dbf9543dcafb4a7f5846ad360_307)</u> | <u>[124](#i5eab276dbf9543dcafb4a7f5846ad360_307)</u> |

---

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

**PART I.**

Unless the context otherwise requires, references throughout this document to "NHI" or the "Company" include National Health Investors, Inc., and its consolidated subsidiaries. In accordance with the Securities and Exchange Commission's "Plain English" guidelines, this Annual Report on Form 10-K ("Annual Report") has been written in the first person. In this document, the words "we", "our", "ours" and "us" refer only to National Health Investors, Inc. and its consolidated subsidiaries and not any other person.

**Cautionary Statement Regarding Forward-Looking Statements**

This Annual Report and other materials we have filed or may file with the Securities and Exchange Commission ("SEC"), as well as information included in oral statements made, or to be made, by our senior management contain certain "forward-looking" statements as that term is defined by the Private Securities Litigation Reform Act of 1995. All statements regarding our expected future financial position, results of operations, cash flows, funds from operations, continued performance improvements, ability to service and refinance our debt obligations, ability to finance growth opportunities and similar statements including, without limitation, those containing words such as "may", "will", "should", "would", "believes", "anticipates", "expects", "intends", "estimates", "plans", "likely" and other similar expressions are forward-looking statements.

Forward-looking statements involve known and unknown risks and uncertainties that may cause our actual results in future periods to differ materially from those projected or contemplated in the forward-looking statements. For a discussion of some of the risks and uncertainties, although not all risks and uncertainties, which could cause our actual results to differ materially from those presented in our forward-looking statements, reference the risks identified in "Summary Risk Factors" below. In addition, reference "Part I, Item 1. Business", "Part I, Item 1A. Risk Factors" and the notes to the consolidated financial statements in "Part II, Item 8. Financial Statements and Supplementary Data" in this Annual Report for a further discussion of factors that could cause our future results to differ materially from any forward-looking statements. You should carefully consider these risks before making any investment decisions in us. These risks and uncertainties are not the only ones facing us. There may be additional risks that we do not presently know of or that we currently deem immaterial. If any of the risks actually occur, our business, financial condition, results of operations, or cash flows could be materially and adversely affected. In that case, the trading price of our common stock could decline, and you may lose part or all of your investment. Our forward-looking statements speak only as of the date made and we expressly disclaim any responsibility to update our forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. Given these risks and uncertainties, we can give no assurance that these forward-looking statements will, in fact, occur and, therefore, caution investors not to place undue reliance on them.

**Summary Risk Factors**

Our business is subject to significant risks and uncertainties that make an investment in us speculative and risky. We provide a summary below of what we believe are our principal risk factors, but these risks are not the only ones we face, and you should carefully review and consider the full discussion of our risk factors in "Part I, Item 1A. Risk Factors" in this Annual Report, together with the other information in this Annual Report. If any of the following risks, or any other risks and uncertainties that are not addressed below or elsewhere in this Annual Report or that we have not yet identified, actually occur, our business, financial condition and results of operations could be materially adversely affected, and the value of our securities could decline.

*Risks Related to Our Business and Operations*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We depend on the operating success of our tenants, managers and borrowers and if their financial condition or business prospects deteriorate, our business, financial condition and results of operations could be adversely affected;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our tenants, managers and borrowers may become subject to bankruptcy or insolvency proceedings;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• A small number of tenants in our portfolio account for a significant percentage of the rental income we expect to generate from our portfolio, and the failure of any of these tenants to meet their obligations to us could materially and adversely affect our business, financial condition and results of operations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We may be unable to replace managers if our management agreements are terminated or not renewed;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Actual or perceived risks associated with pandemics, epidemics or outbreaks have had, and may in the future, have a material adverse effect on our operators' businesses and results of operations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• A member of our board of directors ("Board of Directors") is also the chairperson of the board of directors of National HealthCare Corporation ("NHC"), and his interests may differ from those of our stockholders;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We are exposed to risks related to government regulations and payors, principally Medicare and Medicaid, and the effect of changes to laws, regulations and reimbursement rates on the businesses of our tenants, managers and borrowers;

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The cash flows of our tenants, managers and borrowers may be adversely affected by increased liability claims and liability insurance costs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Significant legal or regulatory proceedings could adversely affect the liquidity, financial condition and results of operations of our tenants, managers and borrowers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We may not be fully indemnified by our tenants, managers and borrowers against future litigation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We depend on the success of property development and construction activities, which may fail to achieve the operating results we expect;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The illiquidity of real estate investments could impede our ability to respond to adverse changes in the performance of our properties;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our investments are concentrated in healthcare properties;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We are subject to risks related to our investment with Life Care Services for Timber Ridge, an entrance fee continuing care retirement community ("CCRC"), associated with Type A benefits offered to the residents of the CCRC and the related accounting requirements;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Risks related to our joint venture investments could adversely affect our financial condition and results of operations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Inflation and increased interest rates may adversely affect our business, financial condition and results of operations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Adverse developments affecting the financial services industry, including events or concerns involving liquidity, defaults or non-performance by financial institutions, could adversely affect our business, financial condition, results of operations or prospects;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Adverse geopolitical developments could have a material adverse impact on our business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We are exposed to operational risks with respect to our senior housing operating portfolio ("SHOP") structured communities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• A cybersecurity incident or other form of data breach involving Company information could cause a loss of confidential consumer and other personal information, give rise to remediation and other expenses, expose us to liability under privacy and security and consumer protection laws, subject us to federal and state governmental inquiries, damage our reputation, and otherwise be disruptive to our business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We are exposed to risks related to environmental laws and the costs associated with liabilities related to hazardous substances;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We are subject to risks of damage from catastrophic weather and other natural or man-made disasters and the physical effects of climate change;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We depend on the success of our future acquisitions and investments;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We depend on our ability to reinvest cash in real estate investments in a timely manner and on acceptable terms;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Competition for acquisitions may result in increased prices for properties;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We depend on our ability to retain our management team and other personnel and attract suitable replacements should any such personnel leave;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We are exposed to the risk that our assets may be subject to impairment charges;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Stockholder activism efforts could cause us to incur substantial costs, divert management's attention and have an adverse effect on our business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our ability to raise capital through equity sales is dependent, in part, on the market price of our common stock, and our failure to meet market expectations with respect to our business, or other factors we do not control, could negatively impact such market price and availability of equity capital;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The United States ("U.S.") federal income tax treatment of the cash that we might receive from cash settlement of our forward equity sales agreements is unclear and could jeopardize our ability to meet the real estate investment trust ("REIT") qualification requirements;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our use of artificial intelligence ("AI") could expose us to various risks;

*Risks Related to Our Debt*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We may need to refinance existing debt or incur additional debt in the future, which may not be available on terms acceptable to us;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We have covenants related to our indebtedness which impose certain operational limitations, and a breach of those covenants could materially adversely affect our financial condition and results of operations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Downgrades in our credit ratings could have a material adverse effect on our cost and availability of capital;

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We rely on external sources of capital to fund future capital needs, and if we encounter difficulty in obtaining such capital, we may not be able to make future investments necessary to grow our business or meet maturing commitments;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We depend on revenues derived mainly from fixed rate investments in real estate assets, while a portion of our debt used to finance those investments bears interest at variable rates, which subjects us to interest rate risk;

*Risks Related to Our Status as a REIT*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We depend on the ability to continue to qualify for taxation as a REIT for U.S. federal income tax purposes;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• There are no assurances of our ability to pay dividends in the future;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Complying with REIT requirements may cause us to forego otherwise attractive acquisition opportunities or liquidate otherwise attractive investments, which could materially hinder our performance;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our ownership of and relationship with any taxable REIT subsidiaries ("TRS") that we have formed or will form will be limited and a failure to comply with the limits would jeopardize our REIT status and may result in the application of a 100% excise tax;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Legislative, regulatory, or administrative tax changes could adversely affect us or our security holders;

*Risks Related to Our Organizational Structure*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We have ownership limits in our charter with respect to our common stock and other classes of capital stock which may delay, defer or prevent a transaction or a change of control that might involve a premium price for our common stock or might otherwise be in the best interests of our stockholders; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We are subject to certain provisions of Maryland law and our charter and bylaws that could hinder, delay or prevent a change in control transaction, even if the transaction involves a premium price for our common stock or our stockholders believe such transaction to be otherwise in their best interests.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

**ITEM 1. BUSINESS**

**General**

National Health Investors, Inc. ("NHI", the "Company", "we", "us" or "our"), established in 1991 as a Maryland corporation, is a self-managed real estate investment trust ("REIT"). We own, lease, operate and finance the development of high-quality real estate properties, focusing on senior housing communities and medical facilities. We operate through two reportable segments, Real Estate Investments and Senior Housing Operating Portfolio ("SHOP").

Our investments in senior housing communities, also referred to as senior housing properties ("SHO"), include independent living facilities ("ILF"), assisted living facilities ("ALF"), entrance fee communities ("EFC") and senior living campuses ("SLC"). Our investments in medical facilities include skilled nursing facilities ("SNF") and hospitals ("HOSP"). Our financing arrangements consist of mortgages, construction loans, mezzanine loans and revolving lines of credit extended to our tenants, operators, or affiliates of our tenants and operators, and other third parties.

As of December 31, 2025, our Real Estate Investments segment consisted of gross real estate investments of $2.7 billion in 176 properties, excluding one property classified as assets held for sale, which are located in 32 states and leased pursuant primarily to triple-net leases to 31 tenants. These investments included 110 SHOs, 65 SNFs and one HOSP. Additionally, our investments included $218.7 million in principal amounts of mortgage and other notes receivable, excluding $15.4 million of credit loss reserves.

As of December 31, 2025, our SHOP segment consisted of gross real estate investments of $634.3 million in 26 senior housing communities located in 13 states and comprised of 17 ILFs, six SLCs and three ALFs with a combined total of 3,009 units. We outsource the operations at these properties to third-party managers and pay a management fee for these services. As of December 31, 2025, 16 of our senior housing communities were held in consolidated partnerships in which the noncontrolling common equity interests are owned by affiliates of the respective managers.

**Sources of Revenues**

In our Real Estate Investments segment, our revenues primarily relate to triple-net leases with third-party operators at our properties. Additionally, we recognize interest income from financing arrangements we provide to our tenants, operators, or affiliates of our tenants and operators, and other third parties primarily for construction, renovation and expansion projects, funding of working capital or corporate needs and the acquisition of real estate properties. Our SHOP segment is comprised of senior housing communities from which we generate revenues from resident fees and services on each unit. We utilize third-party managers to operate these properties on our behalf and pay a management fee for their services.

We fund our real estate investments primarily through: (1) operating cash flows, (2) debt offerings, including revolving lines of credit and term debt that are both unsecured and secured, and (3) sales of equity securities. Our investments in real estate and the real estate properties that secure our mortgage loans are located within the United States. Information about our revenues from tenant leases, resident fees and services, and loans and information on our financial condition, results of operations and cash flows can be found in "Part II, Item 8. Financial Statements and Supplementary Data" of this Annual Report.

For the year ended December 31, 2025, our total revenues were $375.6 million, an increase of 12.1% over the prior year, consisting of $271.6 million of rental income, $80.1 million of resident fees and services and $24.0 million of interest and other income. Rental income, resident fees and services and interest and other income represented 72.3%, 21.3% and 6.4%, respectively, of our total revenues for the year ended December 31, 2025. Our revenues depend on the operating success of our tenants, managers and borrowers whose sources and amounts of revenues are determined by factors including, but not limited to (i) the number of licensed beds or units at each facility, (ii) occupancy rates, (iii) the extent to which services are utilized by the residents and patients, (iv) the mix of private pay, Medicare and Medicaid patients and (v) the rates paid by private health insurance, Medicare and Medicaid programs.

**Investment Portfolios**

As of December 31, 2025, our investments comprising the Real Estate Investments segment included real estate properties and financing arrangements involving 189 properties located in 32 states, excluding one property classified as assets held for sale. The aggregate gross carrying value of the owned properties was $2.7 billion, which included 110 SHOs, 65 SNFs and one HOSP leased to 31 tenants. The aggregate gross carrying value of our mortgage and other notes receivable was $218.7 million, excluding $15.4 million of credit loss reserves.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

As of December 31, 2025, our investments included in the SHOP segment consisted of 17 ILFs, six SLCs and three ALFs located in 13 states with a combined total of 3,009 units. The aggregate gross carrying value of these properties was $634.3 million. We have structured the operations at these senior housing communities to comply with the requirements of the REIT Investment Diversification and Empowerment Act of 2007 ("RIDEA") and to utilize our taxable REIT subsidiaries ("TRS") for activities that would otherwise be non-qualifying for REIT purposes.

**Types of Real Estate Properties**

We classify our investments in real estate properties as either SHOs or medical facilities and further classify our SHOs as either need-driven or discretionary properties based on the differing credit risk profiles represented by the underlying revenue sources.

A summary of information related to these classifications follows:

*Need-Driven Senior Housing*

*Assisted Living Facilities -* As of December 31, 2025, our Real Estate Investments segment included 86 ALFs leased to third-party operators and six ALFs secured by mortgage loans with us. In our SHOP segment, we had three ALFs as of December 31, 2025 which are operated by third-party managers on our behalf. ALFs are free-standing facilities that provide basic room and board functions for elderly residents. As residents typically receive assistance with activities of daily living, such as bathing, grooming, administering medication and memory care services, we consider these facilities to be need-driven senior housing. On-site staff personnel at these facilities are available to assist with minor medical needs on an as-needed basis. Operators of ALFs are typically paid from private payor sources without government assistance through the Medicare and Medicaid programs. ALFs may be licensed and regulated in some states, but generally do not require the issuance of a Certificate of Need ("CON") as is often required for SNFs.

*Senior Living Campuses -* As of December 31, 2025, our Real Estate Investments segment included nine SLCs leased to third-party operators and two SLCs secured by mortgage loans with us. In our SHOP segment, we had six SLCs as of December 31, 2025 which are operated by third-party managers on our behalf. SLCs generally have one or more buildings and typically include a higher acuity level of care for residents. For example, an SLC may offer skilled nursing beds in combination with independent or assisted living accommodations providing basic room and board functions to elderly residents. They may also provide assistance to residents with activities of daily living, such as bathing, grooming, administering medication and memory care services. On-site staff personnel are available to assist with minor medical needs on an as-needed basis. As the decision to transition to a SLC is typically more than a lifestyle choice and is usually driven by a resident's need for some moderate level of care, we consider these types of SHOs to be need-driven. Operators of SLCs are typically paid through private payor sources and when skilled nursing care is involved, they may also be paid from government assistance programs, including Medicare and Medicaid. SLCs may be licensed and regulated as nursing homes in some states and may also require a CON.

*Discretionary Senior Housing Properties*

*Independent Living Facilities -* As of December 31, 2025, our Real Estate Investments segment included three ILFs leased to third-party operators and one ILF secured by a mortgage loan with us. In our SHOP segment, we had 17 ILFs as of December 31, 2025 which are operated by third-party managers on our behalf. ILFs offer specially designed residential units for active senior adults and provide various ancillary services for their residents including restaurants, activity rooms and social areas. Services provided by ILF operators are generally paid from private payor sources without government assistance through the Medicare and Medicaid programs. ILFs are generally, but not always, unlicensed facilities and do not require the issuance of a CON as required for SNFs. As ILFs typically do not provide assistance with the activities of daily living, we consider the decision of a senior adult to transition to an ILF to be discretionary.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

*Entrance Fee Communities -* As of December 31, 2025, our Real Estate Investments segment included 12 EFCs leased to third-party operators. EFCs, frequently referred to as CCRC, typically include a combination of detached cottages, an ILF, an ALF and an SNF on one campus. These communities appeal to senior adults because there is no need to relocate when health and medical needs change. EFC licensure is state-specific, but generally skilled nursing beds included in our EFC portfolio are subject to state licensure and regulation. Certain services may also require a CON. As the decision to transition to an EFC is typically made as a lifestyle choice and not as the result of a pressing medical concern, we consider the decision of a senior adult to transition to an EFC to be discretionary. Accordingly, the predominant source of revenue for operators of EFCs is from private payor sources. EFCs are classified as Type A, B or C depending upon the amount of healthcare benefits included in the entrance fee contract. Type A EFCs, also referred to as lifecare communities, include substantially all future healthcare costs in the payment of an entrance fee and thereafter payments of a set monthly service fee upon residency. The entrance fee is divided into refundable and non-refundable portions specific to each residential contract. The monthly service fee is determined upon taking residency into an independent living unit and is subject to certain inflationary adjustments regardless of the resident's future care needs. A resident is required to move into an independent living unit initially and must have a level of independence to not require care services at this stage. Thereafter, the resident's care requirements upon transitioning to an assisted living unit or a skilled nursing unit are covered under the terms of the contract. Type B EFCs are communities providing a modified healthcare contract offering access to skilled nursing care that is subject to a maximum number of days allowable under the individual contract terms. Type C EFCs are fee-for-service communities which do not provide any healthcare benefits and correspondingly have the lowest entrance fees. The monthly service fees may be higher at Type C EFCs to reflect the current costs of healthcare services delivered to each resident. As of December 31, 2025, we had 28.0% Type A EFCs, 8.0% Type B EFCs and 64.0% Type C EFCs in our Real Estate Investments segment.

*Medical Facilities*

*Skilled Nursing Facilities -* As of December 31, 2025, our Real Estate Investments segment included 65 SNFs leased to third-party operators and three SNFs secured by mortgage loans with us. SNFs provide residents with some combination of skilled and intermediate nursing and rehabilitative care, including speech, physical and occupational therapy. The operators of SNFs typically receive payment from a combination of private payor sources and government assistance programs, including Medicare and Medicaid. SNFs are required to obtain state licenses and are highly regulated at the federal, state and local levels. The operators in nine of the 11 states in which we own SNFs must obtain a CON from the state before opening or expanding their facilities. Some SNFs have assisted living beds available to residents. As the decision to utilize the services of an SNF is typically made as the result of a pressing medical concern, we consider these properties to be need-driven medical facilities.

*Hospitals -* As of December 31, 2025, our Real Estate Investments segment included one HOSP leased to a third party operator and one HOSP secured by a mortgage loan with us. HOSPs provide a wide range of inpatient and outpatient services, which may include acute psychiatric, behavioral and rehabilitation services, and are subject to extensive federal, state and local legislation and regulation. HOSPs undergo periodic inspections regarding standards of medical care, equipment and hygiene as a condition of licensure. Services provided by HOSPs are generally paid for by a combination of private payor sources and government assistance programs, including Medicare and Medicaid. As the decision to utilize the services of a HOSP is typically made as the result of a pressing medical concern, we consider these properties to be need-driven medical facilities.

**Types of Investments**

Our investments include asset acquisitions structured as purchase-leaseback transactions, asset acquisitions from other real estate investors, tenant leases, financing arrangements and operating senior housing communities.

*Tenant Leases*

Our tenant leases on owned properties in our Real Estate Investments segment generally have initial leasehold terms of 10 to 15 years with one or more five-year extension options. The leases are "triple-net leases" under which the tenant is responsible for the payment of all taxes, utilities, insurance premiums, repairs and other charges relating to the operations of the properties, including required levels of capital expenditures each year. The tenant is obligated at its expense to keep all improvements, fixtures and other components of the properties covered by "all risk" insurance in an amount equal to at least the full replacement cost thereof, and to maintain specified minimum personal injury and property damage insurance, protecting us as well as the tenant. The leases also require the tenant to indemnify and hold us harmless from all claims resulting from the use, occupancy and related activities of each property and to indemnify us against all costs related to any release, discovery, clean-up and removal of hazardous substances or materials, or other environmental responsibilities with respect to each facility.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

Most of our existing leases contain annual escalators in rent payments. For financial statement purposes, rental income is recognized on a straight-line basis over the term of the lease when the lease contains fixed rent escalators. Certain of our tenants hold purchase options allowing them to acquire properties they currently lease from us. When present, tenant purchase options generally give the tenant an option to purchase the underlying property for consideration that would not be less than our net investment basis.

Some of the obligations under our tenant leases are guaranteed by the parent corporation of the tenant, if any, or affiliates or individual principals of the tenant. For some leases, third parties or affiliated entities will also guarantee some portion of the lease obligations. Some obligations are backed further by other collateral, such as security deposits, trade receivables, equipment, furnishings and other personal property.

We monitor our triple-net lease tenant credit quality and identify any material changes by performing the following activities:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• obtaining financial statements on a monthly, quarterly and annual basis to assess the operational trends of our tenants and the financial position and capability of those tenants;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• calculating the operating cash flows of our tenants;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• calculating the lease service coverage ratio and other ratios pertinent to our tenants;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• obtaining property-level occupancy rates for our tenants;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• verifying the payment of real estate taxes by our tenants;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• obtaining certificates of insurance for our tenants;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• obtaining reviewed or audited financial statements of our tenant corporate guarantors on an annual basis, if applicable;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• conducting a periodic inspection of our properties to ascertain proper maintenance, repair and upkeep; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• monitoring those tenants with indications of continuing and material deteriorating credit quality through discussions with our executive management and Board of Directors.

*Mortgage Loans*

In our Real Estate Investments segment, we have mortgage loans with original maturities, generally five years or less, with varying amortization schedules from interest-only to fully amortizing. Most of the loans are at a fixed interest rate; however, some interest rates increase based on a fixed schedule. In most cases, the owner of the facility is committed to make minimum annual capital expenditures for the purpose of maintaining or upgrading its respective facility. Additionally, most of our loans are collateralized by first or second mortgage liens and corporate or personal guarantees. As of December 31, 2025, we had 11 mortgage loans bearing annual interest rates ranging from 7.3% to 12.0%.

*Mezzanine Loans*

In our Real Estate Investments segment, we provide mezzanine loans to our tenants, operators, or affiliates of our tenants and operators, and other third parties in situations in which the borrower needs temporary financing and/or the borrower has in-place lending arrangements that prohibit a mortgage security agreement. In some instances, we include a purchase option for the respective property in the loan agreement. As of December 31, 2025, we had nine mezzanine loans bearing annual interest rates ranging from 6.0% to 10.0%.

*Construction Loans*

In our Real Estate Investments segment, we provide construction loans that become mortgage loans upon the completion of the construction period for a property. We may also obtain a purchase option to acquire the property at a future date and, if purchased, may lease the property back to the borrower. During the term of the construction loan, funds are usually advanced pursuant to draw requests made by the borrower in accordance with the terms and conditions of the loan agreement. Interest is typically assessed on our construction loans at an interest rate that is equivalent to the eventual mortgage interest rate upon conversion. In addition to the security of a lien against the property, we will generally require additional security and collateral from the borrower in the form of either payment and performance completion bonds or completion guarantees by the borrower's parent, affiliates of the borrower or one or more of the individuals who control the borrower. As of December 31, 2025, we had four construction loans bearing annual interest rates ranging from 8.5% to 9.0%.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

*Other Notes Receivable*

In our Real Estate Investments segment, we provide revolving lines of credit to our tenants, operators, affiliates of our tenants and operators and other third parties to fund their acquisitions, construction projects and working capital needs. Our revolving lines of credit typically require the borrower to provide a personal or business guarantee or to pledge assets as security for the loan. As of December 31, 2025, we had three revolving lines of credit bearing annual interest rates ranging from 8.0% to 9.2%.

*RIDEA Transactions*

Our arrangement with an affiliate of Life Care Services, which we completed in January 2020, is structured to be compliant with the provisions of RIDEA and permits us to receive rent payments through a triple-net lease between a consolidated real estate entity in which we own 80.0% and an unconsolidated operating company which is 25.0% owned by our TRS. Our investments in ALFs in our SHOP segment are also structured to be compliant with the provisions of RIDEA. These arrangements give us the opportunity to capture additional value on the performance of the operating companies through distributions to the TRS. Additionally, this organizational structure allows the TRS to engage in a broad range of activities and share in revenues that would otherwise be non-qualifying income under the REIT gross income tests. The TRS is subject to both federal and state income taxes.

*Operating Activities in the SHOP Segment*

The senior housing communities included in our SHOP segment are operated on our behalf by third-party managers in exchange for a management fee from us. As a result, we are not directly exposed to the credit risk of the managers in the same manner or to the same extent as we are related to our triple-net tenant leases. However, we rely on the managers' personnel, expertise, technical resources and information systems, proprietary information, good faith and judgment to manage our communities efficiently and effectively. We also rely on the managers to set appropriate resident fees and to operate our communities in compliance with the terms of our management agreements and all applicable laws and regulations. Our management agreements typically have fixed terms and are subject to renewal under certain conditions. These agreements may include provisions for termination under specific circumstances, with or without the payment of a fee. The managers may also be entitled to receive an annual management fee, which is calculated based on various annual performance measures, such as revenues and net operating income ("NOI"). Additionally, our managers may be entitled to receive other incentive fees if specified performance targets are met.

**Competition and Market Conditions**

We compete primarily with other REITs, private equity funds, healthcare providers, banks and insurance companies in the acquisition, leasing and financing of healthcare real estate properties.

Operators of our properties compete on a local and regional basis with operators of other facilities that provide comparable services. Operators compete for residents, patients and staff based on quality of care, reputation, location and physical appearance of facilities, services offered, family preference, physicians, staff and price. We compete with other operators and companies that manage multiple healthcare facilities, some of which are substantially larger and have greater resources than the operators of our facilities. Some of these facilities are operated for profit while others are owned by government agencies or tax-exempt not-for-profit entities.

The operators of our properties, including the managers in our SHOP segment, generally rely on the ability of private-pay residents and patients to meet their contractual obligations and may be negatively impacted in an economic downturn. In addition, the success of the operators of our properties is also impacted by the degree of existence of comparable and competing facilities in our local markets.

**Commitments and Contingencies**

In the normal course of business, we enter into a variety of commitments, typically consisting of funding mortgage notes, construction loans, mezzanine loans and revolving lines of credit with our tenants, operators, or affiliates of our tenants and operators, and other third parties. In our leasing operations, we may offer our tenants and the sellers of properties we acquire certain inducements that originate contractually as contingencies, but which may become commitments upon the satisfaction of the contingent event. Any contingent payments made by us are included in the respective lease base when funded.

As of December 31, 2025, we had loan commitments with nine operators or borrowers totaling $151.6 million of which we had funded $115.7 million toward these commitments. As of December 31, 2025, $33.9 million of the remaining funding obligations were payable within 12 months.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

As of December 31, 2025, we had development commitments with seven tenants totaling $23.6 million of which we had funded $12.1 million toward these commitments with the remainder payable within one to three years.

As of December 31, 2025, we had remaining contingency commitments of $15.7 million, which included lease inducement contingencies with three tenants and contingent consideration related to an acquisition in our SHOP segment. Each of these contingency commitments is based on the respective facility operating performance over a specified period.

**Corporate Sustainability**

We believe that integrating environmental initiatives into our strategic business objectives will contribute to our long-term success. Additional information on these initiatives can be found in our Corporate Sustainability Report which is available on our website at www.nhireit.com.

Our corporate sustainability goals include:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• inventorying and reporting our Scope 1, 2 and 3 greenhouse gas emissions in accordance with the Greenhouse Gas Protocol;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• improving our emissions data every year with a longer-term goal to establish an emissions reduction strategy in accordance with science-based targets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• measuring and reporting our annual water usage related to our corporate headquarters and real estate properties in the SHOP segment; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• identifying and evaluating our material sustainability-related risks and opportunities utilizing the Task Force on Climate- Related Financial Disclosure framework.

We have established an Environmental, Social and Governance ("ESG") Committee comprised of management, including our Chief Financial Officer, the Vice President of Finance and Investor Relations and our Vice President of Human Resources, Benefits and Compliance. The ESG Committee is tasked with overseeing our strategies on social impact and environmental sustainability. We established the ESG Committee with the goal of increasing our accountability, sharpening our focus and maximizing our efforts with respect to the ESG impact we have on our tenants, managers, employees and real estate properties. In addition, the ESG Committee measures our company-wide progress on these ESG initiatives and priorities, adding an element of accountability, which should also increase our effectiveness. The ESG Committee meets at least quarterly with the Chair of the Nominating and Corporate Governance Committee of our Board of Directors. Through our sustainability efforts, we seek to incentivize positive change and create value for our stakeholders.

A summary of certain of our corporate environmental sustainability efforts has been provided below:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;We make significant capital expenditures at the real estate properties in our SHOP segment, including adding energy efficient improvements like LED lighting and low emission carpeting and recycled materials.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;We obtain Phase I environmental reports and, if warranted, Phase II environmental reports as part of our due diligence procedures when acquiring properties and attempt to avoid buying real estate with known environmental contamination.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• &nbsp;&nbsp;&nbsp;&nbsp;Our document retention practices strive to reduce paper usage and encourage electronic file sharing.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;We strive for efficiency and sustainability in our corporate headquarters, participate in a recycling program and encourage our employees to reduce, reuse and recycle waste.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• &nbsp;&nbsp;&nbsp;&nbsp;We purchase carbon offsets to help offset our primary sources of emissions, which include energy use, travel and commuting, to compensate for any emissions we cannot eliminate directly by investing in projects that reduce, avoid, or remove emissions elsewhere.

**Human Capital**

We employ individuals who possess a broad range of experiences, background and skills. We believe that to continue to deliver long-term value to our stockholders, we must provide and maintain a work environment that attracts, develops and retains top talent, and affords our employees an engaging work experience that allows for career development and opportunities. Along with a competitive compensation program including incentive bonuses and a stock incentive plan, we provide a 401(k) plan with a safe harbor contribution limit, paid employee health insurance coverage, parental leave and tuition reimbursement.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

As of December 31, 2025, we had 32 full-time employees, consisting of 26 employees located in our Murfreesboro, Tennessee corporate office, with one employee in each of Georgia, North Carolina, Oregon and Texas and two employees in Florida. The tenure of our current employees includes six employees who have been with us for over five years (but less than 10 years), three employees who have been with us over 10 years (but less than 20 years) and two employees who have been with us over 20 years. None of our employees are subject to a collective bargaining agreement. We empower our employees and reinforce our corporate culture through onboarding, training and team-building events. We actively support charitable organizations within our local communities that promote health education and social well-being, and we encourage our employees to personally volunteer with organizations that are meaningful to them. We consider our employee relations to be good.

Certain of our essential services, such as internal audit, tax compliance, information technology and legal services, are outsourced to third-party professional firms.

**Government Regulations**

*Overview*

Our tenants, managers and borrowers are subject to extensive and complex federal, state and local healthcare laws and regulations, including those relating to Medicare and Medicaid reimbursement, fraud and abuse, relationships with referral sources and referral recipients, licensure and certification, building codes, privacy and security of health information and other personal data, CON, appropriateness and classification of care, qualifications of medical and support personnel, distribution, maintenance and dispensing of pharmaceuticals, communications with patients and consumers and the operation of healthcare facilities. In addition, many of our tenants, managers and borrowers that operate ILFs may be subject to state licensing, and all of our properties are subject to environmental regulations related to real estate. In our SHOP segment, these laws and regulations typically apply directly to us and our senior housing communities, where we generally hold the applicable healthcare licenses. Applicable laws and regulations are wide-ranging, vary across jurisdictions, and are administered by several government agencies. Further, these laws and regulations are subject to change, enforcement practices may evolve, and it is difficult to predict the impact of new laws and regulations. We expect that the healthcare industry, in general, will continue to face increased regulation. Our tenants, managers and borrowers may find it increasingly difficult and costly to operate within this complex and evolving regulatory environment. Noncompliance with applicable laws and regulations may result in the imposition of civil and criminal penalties that could adversely affect the operations and financial condition of tenants, managers or borrowers, which in turn may adversely affect us. The following is a brief discussion of certain laws and regulations applicable to certain of our tenants, managers and borrowers and, in some cases, to us.

*Licensure and Certifications*

Various licenses, certifications and permits are required to operate SNFs, ALFs, EFCs, HOSPs and, to a lesser degree, ILFs, to dispense narcotics, to handle radioactive materials and to operate equipment, among other regulated actions. Licensure, certification and enrollment with government programs may be conditioned on requirements related to, among other things, the quality of medical care provided, qualifications of the operator's administrative personnel and clinical staff, disclosure of ownership and related information, adequacy of the physical plant and equipment, staff-to-patient or resident ratios, capital and other expenditures, record keeping, dietary services, infection prevention and control, and patient rights. For example, a final rule issued by the Centers for Medicare and Medicaid Services ("CMS") in November 2023 requires Medicare-enrolled SNFs and Medicaid-enrolled nursing homes to disclose additional information about owners, operators and management, which will be publicly available. To increase transparency with regard to direct and indirect owning and managing entities, the rule establishes definitions of REIT and private equity companies for purposes of Medicare enrollment and requires providers to disclose whether an owner or manager is a REIT or private equity company. Licensed facilities are generally subject to periodic inspections by regulators to determine compliance with applicable licensure and certification standards. Further, some types of licensed facilities must comply with federal and/or state requirements related to staffing and facilities.

Sanctions for failure to comply with applicable laws and regulations include (but are not limited to) loss of licensure and ability to participate in the Medicare, Medicaid and other government healthcare programs, suspension of or non-payment for new admissions and fines, as well as potential criminal penalties. The failure of any tenant, manager or borrower to comply with such laws and regulations could affect its ability to operate its facility or facilities and could adversely affect any such tenant's or borrower's ability to make lease or debt payments to us. In addition, if we have to replace a tenant, we may experience difficulties in finding a replacement because our ability to replace the tenant may be affected by federal and state laws governing changes in control and ownership.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

The healthcare facilities in which we invest may be subject to state CON or similar laws, which require government approval prior to the construction or establishment of new facilities, the expansion of existing facilities, the addition of beds to existing facilities, the addition of services or certain capital expenditures. CON requirements are not uniform throughout the United States and are subject to change. We cannot predict the impact of regulatory changes with respect to CONs on the operations of our tenants, managers and borrowers.

*Medicare and Medicaid Reimbursements*

A significant portion of the revenues of our SNF tenants and borrowers is derived from government-funded reimbursement programs, primarily Medicare and Medicaid. The Medicare and Medicaid programs are highly regulated and subject to frequent and substantial changes resulting from legislation, regulations and administrative and judicial interpretations of existing law.

Medicare is a federal health insurance program for persons aged 65 and over, some disabled persons and persons with end-stage renal disease or Lou Gehrig's disease/amyotrophic lateral sclerosis. Medicare generally covers SNF services for beneficiaries who require skilled nursing or therapy services after a qualifying hospital stay. Medicare Part A generally pays a per diem rate for each beneficiary. The reimbursement rates are set forth under a prospective payment system ("PPS"), an acuity-based classification system that uses nursing and therapy indexes, adjusted by additional factors such as geographic differences in wage rates, to calculate per diem rates for each Medicare beneficiary. Medicare Part A payment rates cover most services provided to a beneficiary for a limited benefit period, including room and board, skilled nursing care, therapy and medications. CMS updates Medicare payment rates annually. For fiscal year 2026, which started October 1, 2025, CMS estimates that payments to SNFs under the SNF PPS will increase by approximately $1.2 billion, or 3.2%, compared to fiscal year 2025.

CMS has implemented policies intended to shift Medicare towards value-based payment methodologies that link reimbursement to the quality of care provided rather than the quantity of services rendered. For example, CMS uses the Patient Driven Payment Model ("PDPM") payment methodology for SNF services, which classifies beneficiaries into payment groups based on clinical factors using diagnosis codes rather than by volume of services. In addition, under the SNF Quality Reporting Program, CMS requires SNFs to report certain quality data and SNFs that fail to do so are subject to payment reductions. Under the SNF Value-Based Purchasing Program, CMS withholds 2% of SNF PPS payments, and redistributes between 50% and 70% of these funds to SNFs as incentive payments based on quality measure performance.

Medicaid is a medical assistance program for eligible low-income persons that is funded jointly by federal and state governments. Medicaid programs are operated by state agencies under plans approved by the federal government. Reimbursement methodologies, eligibility requirements and covered services vary from state to state. In many instances, revenues from Medicaid programs are insufficient to cover the actual costs incurred in providing care to patients, particularly in nursing facilities. The federal government and many states are using or considering various strategies to reduce Medicaid expenditures. Outside of the government response to the COVID-19 pandemic, budgetary pressures have, in recent years, resulted in decreased spending, or decreased spending growth, for Medicaid programs in many states. Budgetary pressures are expected to continue in the future, and many states are actively seeking ways to reduce Medicaid spending, including for nursing home and assisted living care, by methods such as capitated payments, reductions in reimbursement rates and/or coverage, and increased enrollment in managed Medicaid plans. Some states use, or have applied to use, waivers granted by CMS to make these changes, implement Medicaid expansion under the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010, or otherwise implement programs that vary from federal standards. Some states in which we have investments and managed care plans are pursuing alternatives to institutional care, such as home and community-based services actively seeking to reduce or slow increases in Medicaid spending for care in nursing homes and other institutional settings. Changes in federal policy and funding are an additional source of uncertainty. Further, on July 4, 2025, the One Big Beautiful Bill Act (the "OBBBA") was signed into law. The OBBBA is projected to decrease federal health care spending by approximately $1.0 trillion by reducing Medicaid spending and enrollment and making changes to federal Medicare spending. We have not determined the impact of these changes on our business, but the reductions in the number of Medicaid enrollees and in Medicare and Medicaid spending may negatively impact the businesses of our tenants, managers and borrowers.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

In addition to reimbursement pressures and changes in governmental healthcare programs, healthcare facilities are experiencing increasing pressure from private payors attempting to control healthcare costs. In some cases, private payors rely on governmental reimbursement systems to determine reimbursement rates and policies. Changes to Medicare and Medicaid that reduce payments under these programs or negatively affect utilization of services may negatively impact payments from private payors. We cannot make any assessment as to the timing or the effect that any such changes may have on the costs to our tenants, managers and borrowers of doing business and on the amount of reimbursement by government and other third-party payors. There can be no assurance that future payment rates for either government or private payors will be sufficient to cover the cost of providing services to patients, including any cost increases. Any changes in government or private payor reimbursement policies that reduce payments to levels that are insufficient to cover the cost of providing patient care or significant decreases in enrollment or coverage under the Medicare and Medicaid programs could adversely affect the operating revenues of tenants, managers and borrowers in our properties that rely on such payments, and thereby adversely affect their ability to make their lease or debt payments to us.

*Fraud and Abuse*

Participants in the healthcare industry are subject to various complex federal and state civil and criminal laws and regulations governing a wide array of healthcare provider referrals, relationships and arrangements. These laws include but are not limited to (i) federal and state false claims acts, including the federal civil False Claims Act, which prohibits any person from knowingly presenting, or causing to be presented, a false or fraudulent claim for payment of federal funds or knowingly making, or causing to be made, a false record or statement to get a false claim paid, (ii) federal and state anti-kickback and fee-splitting statutes, including the federal Anti-Kickback Statute, which prohibits knowingly and willfully offering, paying, soliciting or receiving anything of value to induce, or in return for, items or services reimbursed by federal health care programs or the referral of Medicare and Medicaid patients, (iii) federal and state physician self-referral laws, including the federal prohibition commonly referred to as the Stark Law, which generally prohibits physicians from referring Medicare and Medicaid patients for designated health services, which include hospital inpatient and outpatient services and some of the services provided in SNFs, to entities with which the physician or an immediate family member has a financial relationship, (iv) the healthcare fraud provisions under the Health Insurance Portability and Accountability Act of 1996 ("HIPAA"), which impose criminal liability for, among other things, knowingly and willfully executing, or attempting to execute, a scheme to defraud any health care benefit program, including private third-party payors, or falsifying or covering up a material fact or making any materially false or fraudulent statement in connection with the delivery of or payment for health care benefits, items or services and (v) the federal Civil Monetary Penalties Law, which authorizes the imposition of civil monetary penalties, assessments and program exclusions for a wide range of conduct, including the submission of improper claims, the offering or receipt of remuneration that may influence the provision of federally reimbursable services, failures to meet certain Medicare or Medicaid program requirements and other forms of fraudulent, abusive, or non-compliant activity. Violations of these laws and regulations may result in criminal, civil and administrative penalties, fines and damages, including exclusion from participation in federal healthcare programs like Medicare and Medicaid and denial of Medicare and Medicaid payments. The laws are enforced by a variety of federal, state and local agencies. Federal and state false claims act laws also permit a private individual acting as a "whistleblower" to bring actions on behalf of themselves and the government alleging violations of the statute and to share in any monetary recovery. In recent years, both federal and state governments have significantly increased investigation and enforcement activity to detect and punish wrongdoers.

It is anticipated that the trend toward increased investigation and enforcement activity will continue. In the event that any tenant, manager or borrower were to be found in violation of any of these laws and regulations, the ability of that tenant, manager or borrower to operate the facility could be jeopardized, which could also adversely affect the ability of the tenants or borrowers to make lease or debt payments to us and could thereby adversely affect us.

*Privacy and Security and Data Interoperability*

Privacy and security regulations issued pursuant to HIPPA restrict the use and disclosure of individually identifiable health information ("protected health information"), provide for individual rights, require safeguards for protected health information and require notification of breaches of unsecure protected health information. Entities subject to HIPAA include health plans, healthcare clearinghouses, and most healthcare providers (including some of our tenants, managers and borrowers). Business associates of these entities who create, receive, maintain or transmit protected health information are also subject to certain HIPAA provisions. Covered entities must report breaches involving unsecured protected health information to the affected individuals, the U.S. Department of Health and Human Services and, in large breaches, the media. Violations of HIPAA may result in substantial civil and/or criminal fines and penalties.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

There are several other laws and legislative and regulatory initiatives and proposals at the federal and state levels addressing privacy and security of personal data that may not be preempted by HIPAA and that impact on our business or the businesses of our tenants, managers and borrowers. For example, several states have enacted comprehensive consumer data privacy laws providing residents of those states with additional or expanded rights with respect to their personal information, such as a right to know what personal information is collected and how it is used, a right to opt out of certain processing activities for sensitive data and a right to a portable copy of their personal information. For example, the California Consumer Privacy Act, as amended by the California Privacy Rights Act ("CCPA"), includes certain transparency and other requirements to protect personal data and grants California consumers with certain rights regarding their personal data. In addition, California consumers have the right to bring a private right of action in connection with data security incidents involving certain elements of personal data. Additionally, other jurisdictions, such as Virginia, Colorado, Utah and Connecticut, have enacted similar legislation and/or regulations. Consumer data privacy laws also require subject businesses to conduct affirmative data protection impact assessments for certain personal information processing activities. State privacy laws typically provide for civil penalties for violations, and some states provide a private right of action for data breaches, which may increase data breach litigation. In addition, the Federal Trade Commission ("FTC") continues to pursue privacy as an enforcement priority, including addressing unfair or deceptive practices relating to privacy policies, consumer data collection and processing consent, and digital advertising practices. Health-specific consumer privacy laws were also passed in multiple states, including Washington and Nevada. These laws and regulations are constantly evolving and may impose limitations on our business activities.

Federal and state legislative and regulatory bodies, including at the executive level, continue to signal increased scrutiny and to propose or enact legislation and regulations addressing the creation, adoption and leveraging of AI and/or machine learning based or enhanced tools, systems and functions. The shifting regulatory and enforcement landscape in this space may require additional disclosures, risk assessments or adjustments to our operations and systems that may leverage such technologies. The FTC expects a company's data privacy and security measures to be reasonable and appropriate in light of the sensitivity and volume of consumer information it holds, the size and complexity of its business, and the cost of available tools to improve security and reduce vulnerabilities. Failure to meet these standards may constitute unfair or deceptive acts or practices in violation of Section 5 of the Federal Trade Commission Act of 1914 ("FTC Act"). The FTC also has the power to enforce the Health Breach Notification Rule which imposes notification obligations on companies for breaches of certain health information contained in personal health records. Enforcement by the FTC under the FTC Act and Health Breach Notification Rule can result in civil penalties or enforcement actions.

Marketing and patient engagement activities that we may engage in are subject to communications laws, such as the Telephone Consumer Protection Act ("TCPA") and the Controlling the Assault of Non-Solicited Pornography and Marketing Act ("CAN-SPAM"). A determination by a court or regulatory agency that we and/or our tenants, managers and borrowers engaged in communication or marketing practices that violate the TCPA or CAN-SPAM could subject us to civil penalties and result in negative publicity.

The costs to the business or, for an operator of a healthcare property, associated with developing and maintaining programs and systems to comply with shifting data privacy and security laws, defending against privacy and security related claims or enforcement actions and paying any assessed fines can be substantial. Many of these privacy laws and regulations and related interpretations are subject to uncertain application, interpretation or enforcement standards that could result in claims against us and/or our tenants, managers and borrowers, extensive changes to our business practices, systems and operational processes, including our data processing and security systems, penalties, increased operating costs or other impacts on our businesses. New or expanding privacy and security laws could require substantial further investment in resources to comply with regulatory changes as privacy and security laws impose additional obligations.

In addition, healthcare providers and industry participants are subject to a growing number of requirements intended to promote the interoperability and exchange of patient information. Noncompliance may result in penalties or other disincentives.

*Americans with Disabilities Act*

Our properties generally must comply with the Americans with Disabilities Act (the "ADA") and any similar state or local laws to the extent that such properties are public accommodations as defined in those statutes. The ADA may require removal of barriers to access by persons with disabilities in certain public areas of our properties where such removal is readily achievable. While under our triple-net lease structure, our tenants would generally be responsible for additional costs that may be required to make our facilities ADA-compliant, should barriers to access by persons with disabilities be discovered, we may be indirectly responsible for additional costs that may be required to make facilities ADA-compliant. Non-compliance with the ADA could result in the imposition of fines or an award of damages to private litigants. Our commitment to make readily achievable accommodations pursuant to the ADA is ongoing, and we continue to assess our properties and make modifications as appropriate in this respect.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

*Environmental Regulations*

As an owner of real property, we are subject to various federal, state and local laws and regulations regarding environmental, health and safety matters. These laws and regulations address, among other things, asbestos, polychlorinated biphenyls, fuel, oil management, wastewater discharges, air emissions, radioactive materials, medical wastes and hazardous wastes, and in certain cases, the costs of complying with these laws and regulations and the penalties for non-compliance can be substantial. We may be held primarily or jointly and severally liable for costs relating to the investigation and clean-up of any property that we own from which there is or has been an actual or threatened release of a regulated material and any other affected properties, regardless of whether we knew of or caused the release. Such costs typically are not limited by law or regulation and could exceed the property's value. In addition, we may be liable for certain other costs, such as governmental fines and injuries to persons, property or natural resources, as a result of any such actual or threatened release. Under the terms of our triple-net leases, we generally have a right to indemnification by our tenants for any contamination caused by them. However, we cannot assure you that our tenants will have the financial capability or willingness to satisfy their respective indemnification obligations to us, and any such inability or unwillingness to do so may require us to satisfy the underlying environmental claims.

**Income Tax Regulations**

We have elected to be taxed as a REIT under Sections 856 through 860 of the Internal Revenue Code of 1986, as amended (the "Internal Revenue Code"), and since our formation, have filed our U.S. federal income tax return as a REIT. We believe that we have met the requirements for qualification as a REIT since our initial REIT election in 1991, and we expect to qualify as such for each of our taxable years. Our qualification and taxation as a REIT depend upon our ability to meet on a continuing basis, through actual annual operating results, the various qualification tests and organizational requirements imposed under the Internal Revenue Code, including qualification tests based on NHI's assets, income, distributions and stock ownership. Provided we qualify for taxation as a REIT, we generally will not be required to pay U.S. federal corporate income taxes on our REIT taxable income (computed without regard to the dividends-paid deduction or our net capital gain or loss) that is currently distributed to our stockholders. This treatment substantially eliminates the "double taxation" that ordinarily results from investment in a C corporation. We will, however, be required to pay U.S. federal income tax in certain circumstances.

The sections of the Internal Revenue Code relating to qualification and operation as a REIT, and the U.S. federal income taxation of a REIT and its stockholders, are highly technical and complex. Some of the requirements depend upon actual operating results, distribution levels, diversity of stock ownership, asset composition, source of income and record keeping. Accordingly, while we intend to continue to qualify to be taxed as a REIT, the actual results of our operations for any particular year might not satisfy these requirements for qualification and taxation as a REIT. Accordingly, no assurance can be given that the actual results of our operations for any particular taxable year will satisfy such requirements. Further, the anticipated U.S. federal income tax treatment may be changed, perhaps retroactively, by legislative, administrative or judicial action at any time.

To qualify as a REIT, we must elect to be treated as a REIT, and we must meet various (a) organizational requirements, (b) gross income tests, (c) asset tests and (d) annual dividend requirements.

*Organizational Requirements*

The Internal Revenue Code defines a REIT as a corporation, trust or association with the following characteristics:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• it is managed by one or more trustees or directors;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the beneficial ownership is evidenced by transferable shares, or by transferable certificates of beneficial interest;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• it would otherwise be taxable as a domestic corporation, except for the exclusions that apply under Sections 856 through 859 of the Internal Revenue Code;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• it is neither a financial institution nor an insurance company to which certain provisions of the Internal Revenue Code apply;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the beneficial ownership is held by 100 or more persons;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• during the last half of each taxable year, not more than 50% in market value of its outstanding stock is owned, directly or constructively, by five or fewer individuals, as defined in the Internal Revenue Code to also include certain entities; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• certain other tests regarding the nature of its income and assets are met.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

We believe that we have been organized and have operated in a manner that has allowed us, and will continue to allow us, to satisfy the conditions above during the relevant time periods, and we intend to continue to be organized and to operate in this manner. However, qualification and taxation as a REIT depend upon our ability to meet the various qualification tests imposed under the Internal Revenue Code, including through actual operating results, asset composition, distribution levels and diversity of stock ownership. Accordingly, no assurance can be given that we will be able to continue to operate in a manner so as to qualify or remain qualified as a REIT.

*Gross Income Tests*

We must satisfy two gross income tests annually to maintain our qualification as a REIT.

First, at least 75% of our gross income for each taxable year (excluding gross income from prohibited transactions) must consist of defined types of income that we derive, directly or indirectly, from investments relating to real property or mortgages on real property or qualified temporary investment income.

Qualifying income for purposes of the 75% gross income test generally includes:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• rents from real property;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• interest on debt secured by mortgages on real property, or on interests in real property (including interest on an obligation secured by a mortgage on both real property and personal property if the fair market value of the personal property does not exceed 15% of the total fair market value of all the property securing the obligation);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• dividends or other distributions on, and gains from the sale of, shares in other REITs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• gains from the sale of real estate assets; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• income derived from the temporary investment of new capital that is attributable to the issuance of our shares of beneficial interest or a public offering of our debt with a maturity date of at least five years that we receive during the one-year period beginning on the date on which we received such new capital.

Second, in general, at least 95% of our gross income for each taxable year (excluding gross income from prohibited transactions) must consist of income that is qualifying income for purposes of the 75% gross income test, other types of interest and dividends, gains from the sale or disposition of stock or securities or any combination of these.

*Asset Tests*

To maintain our qualification as a REIT, we also must satisfy the following asset tests at the end of each quarter of each taxable year:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• First, at least 75% of the value of our total assets must consist of (a) cash or cash items, including certain receivables, (b) government securities, (c) real estate assets, including interests in real property, leaseholds and options to acquire real property and leaseholds, (d) interests in mortgages on real property (including an interest in an obligation secured by a mortgage on both real property and personal property if the fair market value of the personal property does not exceed 15% of the total fair market value of all the property securing the obligation) or on interests in real property, (e) stock in other REITs, (f) debt instruments issued by publicly offered REITs (*i.e*., REITs which are required to file annual and periodic reports with the SEC under the Securities Exchange Act of 1934, as amended (the "Exchange Act")), (g) personal property leased in connection with real property to the extent that rents attributable to such personal property do not exceed 15% of the total rent received under the lease and are treated as "rents from real property"; and (h) investments in stock or debt instruments during the one-year period following our receipt of new capital that we raise through equity offerings or offerings of debt with at least a five year term;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Second, of our investments not included in the 75% asset class, the value of our interest in any one issuer's securities may not exceed 5% of the value of our total assets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Third, we may not own more than 10% of the voting power or value of any one issuer's outstanding securities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fourth, no more than 20% (25% commencing in 2026) of the value of our total assets may consist of the securities of one or more TRSs;

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fifth, no more than 25% of the value of our total assets may consist of the securities of TRSs and other non-TRS taxable subsidiaries and other assets that are not qualifying assets for purposes of the 75% asset test; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Sixth, no more than 25% of our total assets may consist of debt instruments issued by publicly offered REITs that qualify as "real estate assets" only because of the express inclusion of "debt instruments issued by publicly offered REITs" in the definition of "real estate assets".

*Distribution Requirements*

Each taxable year, we must distribute dividends, other than capital gain dividends, to our stockholders in an aggregate amount not less than the sum of (a) 90% of our "REIT taxable income", computed without regard to the dividends-paid deduction or our net capital gain or loss, and (b) 90% of our after-tax net income, if any, from foreclosure property, minus the sum of certain items of non-cash income.

*Taxable REIT Subsidiary*

A REIT may directly or indirectly own stock in a TRS. A TRS may be any corporation in which we directly or indirectly own stock and where both NHI and the subsidiary make a joint election to treat the corporation as a TRS, in which case it is treated separately from us and will be subject to U.S. federal corporate income taxation. Our stock, if any, of a TRS is not subject to the 10% or 5% asset tests. Instead, the value of all TRSs owned by us cannot exceed 20% (25% commencing in 2026) of the value of our assets. We currently own all of the membership interests of NHI-SS TRS, LLC. We and our Subsidiary REIT, as defined below, hold 99% and 1%, respectively, of NHI-Discovery I TRS, LLC. We may form additional TRSs in the future.

We also lease "qualified healthcare properties" on an arm's-length basis to a TRS (or subsidiary thereof) and the property is operated on behalf of such subsidiary by a person who qualifies as an "independent contractor" and who is, or is related to a person who is, actively engaged in the trade or business of operating healthcare facilities for any person unrelated to us or our TRS. Generally, the rent that we receive from our TRS in such structures will be treated as "rents from real property."

*Subsidiary REITs*.

We currently own all of the common interests in NHI PropCo Member LLC, an entity that has elected to be taxed as a REIT under Sections 856 through 860 of the Internal Revenue Code (the "Subsidiary REIT"), and we may own and acquire direct or indirect interests in additional subsidiary REITs in the future. We believe that the Subsidiary REIT is organized and operates in a manner that permits it to qualify for taxation as a REIT for U.S. federal income tax purposes. However, if the Subsidiary REIT were to fail to qualify as a REIT, then (i) the Subsidiary REIT would become subject to regular U.S. corporate income tax and (ii) our equity interest in the Subsidiary REIT would cease to be a qualifying real estate asset for purposes of the 75% asset test and could become subject to the 5% asset test, the 10% voting share asset test, and the 10% value asset test generally applicable to our ownership in corporations other than REITs, qualified REIT subsidiaries and TRSs. If the Subsidiary REIT were to fail to qualify as a REIT and if we were not able to treat the Subsidiary REIT as a TRS of ours pursuant to certain prophylactic elections we have made, it is possible that we would not meet the 10% voting share test and the 10% value test with respect to our interest in the Subsidiary REIT, in which event we could fail to qualify as a REIT unless we could avail ourselves of certain relief provisions.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

*Failure to Qualify*

If we lose our status as a REIT (currently or with respect to any tax years for which the statute of limitations has not expired), we will face serious tax consequences that will substantially reduce the funds available to satisfy our obligations, to implement our business strategy and to make distributions to our stockholders for each of the years involved because:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• we would be subject to U.S. federal income tax at the regular corporate rate applicable to regular C corporations on our taxable income, determined without reduction for amounts distributed to stockholders;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• for tax years beginning after December 31, 2022, we would possibly be subject to certain taxes enacted by the Inflation Reduction Act of 2022 that are applicable to non-REIT corporations, including the nondeductible 1% excise tax on certain stock repurchases;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• we would not be required to make any distributions to stockholders, and any dividends to stockholders would be taxable as ordinary income to the extent of our current and accumulated earnings and profits (which may be subject to tax at preferential rates to individual stockholders); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• unless we are entitled to relief under statutory provisions, we could not elect to be subject to tax as a REIT for four taxable years following the year during which we were disqualified.

In the event we are no longer required to pay dividends to maintain REIT status, this could adversely affect the value of our common stock. Reference "Part I, Item 1A. Risk Factors - Risks Related to Our Status as a REIT" in this Annual Report.

**Investment Policies**

Our investment objectives are to (i) provide consistent and growing current income for distribution to our stockholders through investments primarily in healthcare-related facilities or in the operations thereof through independent third-party managers, (ii) provide the opportunity to realize capital growth resulting from appreciation, if any, in the residual value of our portfolio properties and (iii) preserve and protect stockholders' capital through a balance of diversity, flexibility and liquidity. There can be no assurance that these objectives will be realized. Our investment policies include making investments in real estate, mortgage and other notes receivable, and joint ventures structured to comply with the provisions of RIDEA. We consider the creditworthiness of our tenants and borrowers to be an important factor in underwriting a lease or loan investment, and we generally have the right to approve any changes in tenants.

During the year ended December 31, 2025, we completed $325.6 million of new real estate investments and funded $71.1 million of new mortgage and other notes investments. In making new investments, we consider factors, such as (i) the geographic area and type of property, (ii) the location, construction quality, condition and design of the property, (iii) the current and anticipated cash flow and its adequacy to meet operational needs, and for lease or mortgage obligations to provide a competitive income return to our investors, (iv) the growth, tax and regulatory environments of the communities in which the properties are located, (v) occupancy and demand for similar facilities in the same or nearby communities, (vi) the quality, experience and creditworthiness of the manager operating the facility located on the property and (vii) the mix of private and government-sponsored residents. There can be no assurances that investments meeting our standards regarding these attributes will be found or closed. Our intention is to make investments in properties with substantial, long-term potential. However, we may choose to sell properties if they no longer meet our investment objectives.

We will not, without the approval or ratification of the Audit Committee or a majority of our disinterested Board of Directors, enter into any agreement with any of our directors, officers, or employees, or any affiliate thereof, to (i) enter into any joint venture or other partnership relationships or (ii) acquire from or sell any of our real estate properties or other assets.

The Board of Directors, without the approval of our stockholders, may alter our investment policies if it determines that such a change is in our best interests and our stockholders' best interests. The methods of implementing our investment policies may vary as new investment and financing techniques are developed or for other reasons. Management may recommend changes in investment criteria from time to time.

Our investments in healthcare-related facilities may utilize borrowed funds or the issuance of equity. We may negotiate lines of credit or arrange for other short or long-term borrowings from lenders. We may arrange for long-term borrowings from institutional investors or through public offerings. We have previously invested, and may in the future invest, in properties subject to existing loans or secured by mortgages, deeds of trust or similar liens with favorable terms or in mortgage investment pools.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

**Investor Information**

We publish our Annual Report, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to such reports on our website at www.nhireit.com. We have a policy of publishing these on the website as soon as reasonably practicable after filing them with, or furnishing them to, the SEC. Information contained on our website is not incorporated by reference into this Annual Report. The SEC also maintains reports, proxy statements, information statements, and other information regarding registrants that file electronically at http://www.sec.gov.

The following information is available on our website and documents may also be obtained free of charge by an interested party upon receipt of a written request:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the NHI Code of Business Conduct and Ethics, which applies to our employees, officers and directors;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the NHI EthicsPoint program, which allows interested parties to communicate directly or anonymously with our executive officers and independent directors;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the NHI Audit Committee Charter;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the NHI Compensation Committee Charter;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the NHI Nominating and Corporate Governance Committee Charter;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the NHI Corporate Governance Guidelines; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the NHI Inside Information and Insider Trading Policy.

Contact information for our Investor Relations Department follows:

National Health Investors, Inc.

222 Robert Rose Drive

Murfreesboro, TN 37129

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(615) 890-9100

investorrelations@nhireit.com

Our transfer agent is Computershare. Computershare will assist registered owners with the NHI Dividend Reinvestment Plan, a change of address, a transfer of ownership, payment of dividends, or replacement of lost checks or stock certificates. Computershare's contact information is: Computershare Trust Company, N.A., P.O. Box 43078, Providence, RI 02940-3078. The toll free number is 800-568-3476 and the website is www.computershare.com.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

**ITEM 1A. RISK FACTORS**

There are many significant factors that could materially adversely impact our financial condition, results of operations, cash flows, distributions and stock price. The following are risks we believe are material to our stockholders. There may be additional risks and uncertainties that we have not presently identified or have not deemed material. Some of the following risk factors constitute forward-looking statements. Please refer to "Cautionary Statement Regarding Forward-Looking Statements" at the beginning of this Annual Report.

**Risks Related to Our Business and Operations** 

***We depend on the operating success of our tenants, managers and borrowers and if their financial condition or business prospects deteriorate, our business, financial condition and results of operations could be adversely affected.***

We rely on our tenants, managers and borrowers and their ability to perform their obligations to us under leases, management agreements and loan arrangements. Any of our tenants, managers or borrowers may experience a weakening in their overall financial condition as a result of deteriorating operating performance, changes in industry or market conditions, such as rising or elevated interest rates or inflation, increases in operating and borrowing costs, including labor costs, or other factors. If the financial condition of any of our tenants, managers or borrowers deteriorates, they may be unable or unwilling to make payments or perform their obligations to us in a timely manner, if at all.

Our operators' revenues are also driven by occupancy rates. Periods of weak economic growth in the U.S. that affect housing sales, investment returns and personal incomes, as well as with an oversupply of senior housing real estate, may adversely affect senior housing occupancy rates. In addition, our operators are experiencing increasing cost pressures. Labor and other operating costs have continued to rise, and historically low unemployment levels have contributed to significant wage pressure.

To the extent any decrease in revenues and/or any increase in operating expenses of our operators results in a property not generating enough cash to make scheduled payments to us, our revenues, net income and funds from operations would be adversely affected. Such events and circumstances would cause us to evaluate whether there was an impairment of the real estate or mortgage loan that should be charged to earnings. Such impairment would be measured as the amount by which the carrying amount of the asset exceeded its fair value. Consequently, we might be unable to maintain or increase our current dividends and the market price of our stock may decline.

***We are exposed to the risk that our tenants, managers and borrowers may become subject to bankruptcy or insolvency proceedings.***

The insolvency or bankruptcy of our tenants, managers and borrowers may adversely affect our business, results of operations and financial condition. Although our lease agreements provide us the right to evict a tenant/operator and demand immediate payment of rent and exercise other remedies, and our mortgage loans provide us the right to terminate any funding obligations, demand immediate repayment of principal and unpaid interest, foreclose on the collateral and exercise other remedies, in the event our counterparty has filed for bankruptcy or reorganization, the bankruptcy laws afford certain rights to a party that has filed for bankruptcy or reorganization. A tenant or borrower in bankruptcy may be able to limit or delay our ability to collect unpaid rent in the case of a lease or to receive unpaid principal and/or interest in the case of a mortgage loan and to exercise other rights and remedies. For example, a tenant may reject its lease with us in a bankruptcy proceeding. In such a case, our claim against the tenant for unpaid and future rents would be limited by the statutory cap of the U.S. Bankruptcy Code. This statutory cap could be substantially less than the remaining rent owed under the lease, and any claim we have for unpaid rent might not be paid in full. In addition, a tenant may assert in a bankruptcy proceeding that its lease should be re-characterized as a financing agreement. If such a claim is successful, our rights and remedies as a lender, compared to a landlord, are generally more limited. We may be required to fund certain expenses, such as real estate taxes, maintenance and capital improvements, to preserve the value of a property, avoid the imposition of liens on a property and/or transition a property to a new tenant or borrower. In some instances, we have terminated our lease with a tenant and leased the facility to another tenant. In certain of those situations, we provided working capital loans to, and limited indemnification of, the new tenant. If we cannot transition a leased facility to a new tenant, we may take possession of that property, which may expose us to certain successor liabilities. Should such events occur, our revenues and operating cash flows may be adversely affected.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

***A small number of tenants in our portfolio account for a significant percentage of the rental income we expect to generate from our portfolio, and the failure of any of these tenants to meet their obligations to us could materially and adversely affect our business, financial condition and results of operations and our ability to make distributions to our stockholders.***

Successful performance of our real estate investments is materially dependent on the financial stability of our tenants and operators. For the year ended December 31, 2025, approximately 36.9% of our total revenues were generated from three tenants, including 14.7% from Senior Living Communities, LLC ("Senior Living"), 11.5% from Bickford Senior Living ("Bickford") and 10.7% from National HealthCare Corporation ("NHC"). We have been recognizing rental income from Bickford using the cash basis of accounting for revenue recognition since 2022 based upon information obtained from Bickford regarding its financial condition. Payment or other tenant defaults, the failure of tenants to meet their other obligations to us or a decline in the operating performance by any of these tenants or other tenants and operators could materially and adversely affect our business, financial condition and results of operations, and our ability to pay expected dividends to our stockholders. In the event of a tenant default, we may experience delays in enforcing our rights as landlord and may incur substantial costs in protecting our investment and re-leasing of the related property. Further, we may not be able to re-lease the property for the rent for a similar rental rate, or at all, or lease terminations may cause us to sell the property at a loss. The realization of any of the foregoing risks could have a material adverse effect on our business and financial condition.

***We have rights to terminate our management agreements with managers, in whole or with respect to specific properties under certain circumstances, and we may be unable to replace managers if our management agreements are terminated or not renewed.***

We are a party to the management agreements with the managers utilized in our SHOP segment pursuant to which the managers operate the properties providing comprehensive property management, accounting and other services at the respective properties. Although we have the right to terminate any of our management agreements, whether upon the occurrence of certain events or for no cause, there is no assurance that we would be able to timely source a replacement or that any replacement manager would be effective. Any transition to a new manager may require regulatory approval and potentially the approval of the holders of any liens on the property. The failure to replace a manager on a timely or successful basis, as well as the failure to receive required approvals, could have an adverse effect on the properties and our revenue.

***Actual or perceived risks associated with pandemics, epidemics or outbreaks have had, and may in the future, have a material adverse effect on our operators' business and results of operations.***

The business and results of operations of the operators of our properties and our business and results of operations are subject to health and economic effects of public health conditions. If a pandemic, epidemic, outbreak of infectious disease or other public health crisis were to affect the markets in which our properties are located, our business could be adversely affected. Revenues for the tenants and operators of our properties are significantly impacted by occupancy rates. A public health crisis may diminish the public trust in senior housing properties or medical facilities, especially those that have treated or house consumers affected by contagious diseases, which may result in a decline in consumers seeking services offered through our properties. Consumer volumes and occupancy rates may also decline as a result of economic circumstances surrounding a public health crisis, particularly if the volume of uninsured and underinsured consumers increases. The business of the operators of our properties and our business may be more vulnerable to the effects of a public health crisis because most of our properties are designed for elderly consumers, a population that may experience complex medical conditions or socioeconomic factors. Due to the physical proximity required to offer many of the services provided by the operators of our properties, our operators may encounter difficulties attending to consumers due to social distancing policies or infection control protocols and face heightened workforce challenges. In addition, actions our operators take to address contagious diseases may materially increase their operating costs, including those related to enhanced health and safety precautions and increased retention and recruitment labor costs, among other measures. A decrease in occupancy rates or increase in costs is likely to have a material adverse effect on the ability of our tenants and operators to meet their financial and other contractual obligations to us, including the payment of rent, as well as on our results of operations. In some cases, we have had to, and we may in the future have to, write off unpaid rental payments, incur lease accounting charges due to uncollectible rental payments and/or restructure our tenants' long-term rent obligations. Furthermore, infections of contagious diseases at our facilities could lead to material increases in litigation costs for which our operators, or possibly we, may be liable.

The measures that federal, state and local governments, agencies and health authorities implement to address an epidemic, pandemic, outbreak of infectious disease or other public health crisis may be insufficient to offset any downturn in business of our tenants and operators, may increase operating costs for our tenants, managers and borrowers or may otherwise disrupt or affect the operation of our properties. The rapid development, fluid nature and other factors related to an epidemic, pandemic, outbreak of infectious disease or other public health crisis make it difficult to predict the potential impact of such a crisis on NHI or its operators. Nevertheless, a public health crisis, and the public and government responses to such future public health crisis, could have a material, adverse effect on our business.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

***A member of our Board of Directors is also the chairman of the board of directors of NHC, and his interests may differ from those of our stockholders.***

One of the members of our Board of Directors is also the chairperson of NHC's board of directors. This director may have conflicting interests with holders of our common stock with respect to the NHC properties. During the year ended December 31, 2025, our revenues from NHC represented 10.7% of our total revenues. With respect to all decisions by our Board of Directors related to the NHC properties, the director who is also a member of NHC's board of directors is recused and does not participate in our board discussions or vote related to such matters. Such director has announced his resignation to be effective as of our 2026 annual meeting of stockholders. However, this relationship could influence our Board of Directors' decisions with respect to the properties leased to and operated by NHC. As of December 31, 2025, NHC owned 1,630,642 shares of our common stock.

***We are exposed to risks related to government regulations and payors, principally Medicare and Medicaid, and the effect of changes to laws, regulations and reimbursement rates on the businesses of our tenants, managers and borrowers.***

Our tenants, managers and borrowers are subject to complex federal, state and local laws and regulations relating to governmental healthcare programs. Reference "Part I, Item 1. Business - Government Regulations" in this Annual Report. Regulation of the healthcare industry generally has intensified over time both in the number and type of regulations and in the efforts to enforce those regulations. Federal, state and local laws and regulations affecting the healthcare industry include those relating to, among other things, licensure; certification and enrollment with government programs; facility operations; addition or expansion of services or facilities; services and equipment; allowable costs; the preparation and filing of cost reports; privacy and security of health-related and other personal information; prices for services; quality of medical equipment and services; necessity and adequacy of medical care; patient rights; billing and coding for services and properly handling overpayments; maintenance of adequate records; relationships with physicians and other referral sources and referral recipients; debt collection; communications with patients and consumers; interoperability; and information blocking. If our tenants, managers or borrowers fail to comply with applicable laws and regulations, they may be subject to liabilities and other consequences including civil penalties, loss of facility licensure, exclusion from participation in the Medicare, Medicaid and other government healthcare programs, civil lawsuits and criminal penalties. We generally hold the applicable healthcare licenses and enroll in applicable government healthcare programs on behalf of the RIDEA properties in our SHOP segment, and that subjects us to potential liability under some healthcare laws and regulations. In addition, different interpretations or enforcement of, or changes to, applicable laws and regulations in the future could subject current or past practices to allegations of illegality or impropriety or could require our tenants, managers and borrowers to make changes to their facilities, equipment, personnel, services, and operating expenses. If the operations, cash flows or financial condition of our tenants, operators, or affiliates of our tenants and operators, and our borrowers are materially adversely impacted by current or future government regulation, our revenues and operations may be adversely affected as well. In addition, if an operator, borrower or tenant defaults on its lease or loan with us, our ability to replace the operator or tenant may be delayed by federal, state, or local approval processes.

The businesses of our tenants, managers and borrowers are also affected by government and private payor reimbursement rates and policies. Payments from government programs and private payors are subject to statutory and regulatory changes, retroactive rate adjustments, recovery of program overpayments or set-offs, administrative rulings, policy interpretations, payment or other delays by fiscal intermediaries, government funding restrictions (at a program level or with respect to specific facilities) and interruption or delays in payments due to delays or issues implementing reimbursement-related rules and any ongoing governmental investigations and audits at specific facilities. In recent years, legislative and regulatory changes have resulted in limitations and reductions in payments for certain services under government programs. For example, the Budget Control Act of 2011 requires automatic spending reductions to reduce the federal deficit, resulting in a uniform payment reduction across all Medicare programs of 2% per fiscal year that extends through the first seven months of 2032. State budgetary pressures have resulted, and will likely continue to result, in reduced spending or reduced spending growth for Medicaid programs in many states, including measures such as tightening patient eligibility requirements, reducing coverage, and enrolling Medicaid recipients in managed care programs. In addition, legislation and administrative actions at the federal level may impact the funding for, or structure of, Medicaid programs and may shape administration of Medicaid programs at the state level. CMS may implement or oversee changes affecting reimbursement, including through new or modified demonstration projects, such as those authorized pursuant to waivers under the Social Security Act.

Any reductions in Medicare or Medicaid reimbursement could have an adverse effect on the financial operations of our tenants, managers and borrowers who operate SNFs. Further, reductions in payments under government healthcare programs may negatively impact payments from private payors, as some private payors rely on government payment systems to determine payment rates. There can be no assurance that adequate reimbursement levels will continue to be available for services provided by any facility operator, whether the facility receives reimbursement from Medicare, Medicaid or private payor sources. Significant limits on the scope of services reimbursed and on reimbursement rates and fees could have a material adverse effect on an operator's liquidity, financial condition and results of operations, which could adversely affect the ability of an operator to meet its obligations to us.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

More generally, the legislative and regulatory environment for healthcare products and services is dynamic, and Congress and certain state legislatures have considered or enacted a large number of laws and regulations intended to make major changes in the healthcare system, including laws that affect how healthcare services are delivered and reimbursed. Recent government initiatives and proposals relevant to our properties include those focused on transparency of SNF ownership. For example, a final rule issued by CMS in November 2023 requires Medicare-enrolled SNFs and Medicaid-enrolled nursing homes to disclose additional information about owners, operators, and management, including whether they are a REIT or private equity company. This information will be publicly available. This rule may result in increased scrutiny of REITs, private equity companies, and similar entities involved in owning or operating SNFs and nursing homes. Other industry participants, such as private payors, may also introduce financial or delivery system reforms. There is uncertainty with regard to whether, when and what health reform initiatives will be adopted in the future and the impact of such reform efforts on providers and other healthcare industry participants, including our tenants, managers and borrowers.

***We are exposed to the risk that the cash flows of our tenants, managers and borrowers may be adversely affected by increased liability claims and liability insurance costs.***

ALF and SNF operators have experienced substantial increases in both the number and size of patient care liability claims in recent years. As a result, general and professional liability costs have increased and may continue to increase. Nationwide, long-term care liability insurance rates are increasing because of large jury awards in states like Texas and Florida. Both Texas and Florida have adopted SNF liability laws that modify or limit tort damages. Despite some of these reforms, the long-term care industry overall continues to experience very high general and professional liability costs. Insurance companies have responded to this claims crisis by severely restricting their capacity to write long-term care general and professional liability policies. No assurance can be given that the climate for long-term care general and professional liability insurance will improve in either of the foregoing states or any other states where the facilities operators conduct business. Insurance companies may continue to reduce or stop writing general and professional liability policies for ALFs and SNFs. Thus, general and professional liability insurance coverage may be restricted, very costly or not available. Increased general and professional liability costs may adversely affect our tenants' or operators' future operations, cash flows and financial condition and may have a material adverse effect on the tenants' or operators' ability to meet their obligations to us.

***Significant legal or regulatory proceedings could adversely affect the liquidity, financial condition and results of operations of our tenants, managers and borrowers.***

From time to time, we or our tenants, managers or borrowers may be subject to lawsuits, investigations, claims and other legal or regulatory proceedings arising out of our or their alleged actions or inactions. These claims may include, among other things, professional liability and general liability claims, commercial liability claims, unfair business practices claims, class action claims, employment-related claims, as well as regulatory proceedings, including proceedings related to our SHOP segment, where we are typically the holder of the applicable healthcare license.

In our SHOP segment, we are generally responsible for all liabilities of the properties, other than those arising out of certain limited actions by our managers, such as those caused by gross negligence, fraud or willful misconduct. As a result, we are exposed to professional and general liability claims, employment-related claims, and the costs of defending and resolving such matters, some of which may not be insured or may only be partially insured due to limited coverage or cost constraints. If a manager within our SHOP segment fails to comply with applicable laws or regulations, we could be held responsible, which could subject us to civil, criminal and administrative penalties.

In our Real Estate Investments segment, our tenants and borrowers generally operate the facilities and are responsible for all related liabilities, including those arising from professional, general, or employment-related claims. Under the terms of our leases and loan agreements, these tenants and borrowers are obligated to indemnify and defend us against liabilities related to their operations.

We cannot assure you that any contractual obligations to indemnify, defend and hold us harmless from the liabilities described above will be satisfied by third parties, or that any amounts held in escrow for such purpose will be sufficient.

An unfavorable resolution of any such lawsuit, investigation, claim or other legal or regulatory proceeding could materially and adversely affect our or our tenants', managers' or borrowers' liquidity, financial condition and results of operations, and may not be protected by sufficient or any insurance coverage.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

***We are exposed to the risk that we may not be fully indemnified by our tenants, managers and borrowers against future litigation.***

Our facility leases and loans require that the tenants, managers or borrowers that are a party to the respective agreement name us as an additional insured party on their insurance policies covering professional liability or personal injury claims. We also require our tenants and borrowers to indemnify and hold us harmless for all claims arising from or incidental to the occupancy and use of our properties. However, claims could exceed the applicable policy limits, the insurance company could fail or other coverage may not be available. We cannot give any assurance that these protective measures will eliminate any risk to us related to future litigation, the costs of which could have a material adverse impact on us.

***We depend on the success of property development and construction activities, which may fail to achieve the operating results we expect.***

When we decide to invest in the renovation of an existing property or in the development of a new property, we make assumptions about the future potential cash flows of that property. We estimate our return based on expected occupancy rates, rental rates and future capital costs. If our projections prove to be inaccurate due to increased capital costs, lower occupancy rates or other factors, our investment in that property may not generate the cash flow we expected. Construction and development projects involve risks such as (i) development of a project could be abandoned after expending significant resources resulting in loss of deposits or failure to recover expenses already incurred; (ii) development and construction costs of a project could exceed original estimates due to increased interest rates and higher material costs; (iii) project delays could result in increases in construction costs and debt service expenses as a result of a variety of factors that are beyond our control, including natural disasters, labor conditions, material shortages, and regulatory hurdles; and (iv) financing for a project could be unavailable on favorable terms or at all. Recently developed properties may take longer than expected to achieve stabilized operating levels, if ever. In addition, international trade disputes, including threatened or implemented tariffs imposed by the U.S. and threatened or implemented tariffs imposed by foreign countries in retaliation, could result in inflationary pressures that directly impact costs, such as costs for steel, lumber and other materials applicable to our development and construction projects. Trade disputes could also adversely impact global supply chains which could further increase costs or delay delivery of key inventories and supplies. Tariffs and trade restrictions can be announced with little or no advance notice, and we may not be able to effectively mitigate all adverse impacts from such measures. To the extent such facilities experience such increases in cost or delays in construction or financing, or otherwise fail to reach stabilized operating levels or achieve stabilization later than expected, it could materially adversely affect our tenants' abilities to make payments to us under their leases and thus adversely affect our business and results of operations.

***We are exposed to the risk that the illiquidity of real estate investments could impede our ability to respond to adverse changes in the performance of our properties.***

Real estate investments are relatively illiquid and, therefore, our ability to quickly sell or exchange any of our properties in response to changes in economic and other conditions, including rising interest rates, may be limited. All of our properties are "special purpose" properties that cannot be readily converted to general residential, retail or office use. Facilities that participate in Medicare or Medicaid must meet extensive program requirements, including physical plant and operational requirements. Transfers of operations of these facilities are subject to regulatory approvals not required for transfers of other types of real estate. Thus, if the operation of any of our properties becomes unprofitable due to competition, age of improvements or other factors such that our tenant or borrower becomes unable to meet its obligations on the lease or mortgage loan, the liquidation value of the property may be less than the net carrying value or the amount owed on any related mortgage loan, because the property may not be readily adaptable to other uses. The sale of the property or the replacement of an operator that has defaulted on its lease or mortgage loan could also be delayed by the approval process of any federal, state or local agency necessary for the transfer of the property or the replacement of the operator with a new operator licensed to manage the facility. No assurances can be given that we will recognize full value for any property that we are required to sell for liquidity reasons. Should such events occur, our results of operations and cash flows could be adversely affected.

***Our investments are concentrated in healthcare properties***.

We acquire, develop, and make investments in healthcare real estate. In addition, we selectively make investments in healthcare operators. A downturn in the healthcare property sector could have a greater adverse effect on our business and financial condition than if we had investments in multiple industries and sectors. A downturn in the healthcare property sector also could adversely impact the ability of our operators to meet their obligations to us and maintain residents and occupancy rates. Additionally, a downturn in the healthcare property sector could adversely affect the value of our properties and our ability to sell properties at prices or on terms acceptable to us.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

***We are subject to risks related to our investment with Life Care Services for Timber Ridge, an entrance fee CCRC, associated with Type A benefits offered to the residents of the CCRC and related accounting requirements.***

In January 2020, we entered into an investment with Life Care Services ("LCS") which consists of two parts, NHI-LCS JV I, LLC ("Timber Ridge PropCo"), which owns the real estate and is owned 80.0% by NHI and 20.0% by LCS, and Timber Ridge OpCo, LLC ("Timber Ridge OpCo"), which operates the property and is owned 25.0% by NHI's TRS and 75.0% by LCS.

As part of acquisition of the real estate in January 2020, Timber Ridge PropCo accepted the property subject to trust liens previously granted to residents of Timber Ridge. These liens secure certain mortgage loans previously made by residents of Timber Ridge to prior owner-operators pursuant to a deed of trust and indenture (the "Deed and Indenture"). This practice was discontinued at Timber Ridge in 2008, prior to our investment. However, certain resident loans remain outstanding and continue to be secured by a lien on the property. The trustee for all of the residents who made "old" loans in accordance with the resident agreements entered into a subordination agreement concurrent with Timber Ridge PropCo's acquisition of the property, pursuant to which the trustee acknowledged and confirmed that the security interests created under the Deed and Indenture were subordinate to any security interests granted in connection with the loan made by NHI to Timber Ridge PropCo. As a result of periodic settlements of resident loans in the ordinary course of operations, the balance secured by the Deed and Indenture as of December 31, 2025 was $7.7 million. By terms of the resident loan assumption agreement, during the term of the lease (seven years with two five-year renewal options), Timber Ridge OpCo is to indemnify Timber Ridge PropCo for any repayment by Timber Ridge PropCo of these liabilities under the guarantee. We cannot give any assurance that these protective measures will eliminate any risk to us related to claims under the Deed and Indenture.

As a result of the RIDEA structure, we have an investment in the operations of Timber Ridge, which is a Class A quality, Type A CCRC. As a Type A CCRC, the entrance fee is divided into a refundable and non-refundable portion depending upon the resident's chosen contract program. The refundable portion of the upfront entrance fee is recorded as a liability on the financial statements of Timber Ridge OpCo. The non-refundable portion of the upfront entrance fee is recorded as deferred revenue and amortized over the actuarial life of the resident. We believe the structure of our investment does not require that Timber Ridge OpCo's financial statements be consolidated into NHI, but if we are unable to properly maintain that structure or become required for any reason to consolidate Timber Ridge OpCo's financial statements into ours, the results would have a material adverse impact on our financial results.

***Risks related to our joint venture investments could adversely affect our financial condition and results of operations.***

We have entered into, and may in the future enter into, joint ventures and similar arrangements with third parties, including investments in unconsolidated entities. These investments involve risks that may not be present with wholly owned investments, including our lack of exclusive control over major decisions, reliance on our partners' financial condition and performance, and the potential for disputes with our partners.

In some of our joint ventures, including our investment in Timber Ridge OpCo, certain major decisions regarding management, financing, capital expenditures or disposition of assets may require partner approval. Our partners may have interests, objectives or financial constraints that differ from ours, which could delay or prevent actions we believe are in our best interests. In addition, our partners may become insolvent, fail to fund required capital contributions or otherwise fail to meet their obligations, which could limit the joint venture's ability to operate effectively and may require us to contribute additional capital or expose us to liabilities under guarantees or other commitments.

Disputes with joint venture partners could result in litigation or arbitration, increased expenses, management distraction and disruptions to operations. Certain joint venture arrangements may also include buy-sell provisions, put or call rights or forced sale mechanisms that could require us to sell our interest, acquire our partner's interest or sell the underlying asset at a time or on terms that are unfavorable to us, and our ability to fund or transfer such interests may be limited.

In addition, we may be exposed to operational risks that may increase our costs or adversely affect our ability to increase revenues. For example, our investment in Timber Ridge OpCo is subject to risks applicable to operating healthcare businesses, including fluctuations in resident occupancy rates, operating expenses, and economic conditions; competition; certification and inspection laws, regulations, and standards; the availability and increases in cost of general and professional liability insurance coverage; litigation; federal, state and local taxes and regulations; costs associated with government investigations and enforcement actions; the availability and increases in cost of labor; and other risks applicable to any operating business. Any one or a combination of these factors could adversely affect the performance of a joint venture and our results of operations.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

***Inflation and increased interest rates may adversely affect our business, financial condition and results of operations.***

Inflation and interest rates continue to remain at elevated levels compared to years prior to 2022. In addition, President Trump's administration has announced various policies which may impact inflation, including the implementation of tariffs on U.S. imports and immigration enforcement, as well as other policies, which could increase inflation. High inflation and interest rates could have an adverse impact on our variable rate debt, our ability to borrow money, and general and administrative expenses, as these costs could increase at a rate higher than our rental income and other revenue. Increases in the costs of owning and operating our properties due to inflation could reduce our net operating income and the value of an investment in us to the extent such increases are not reimbursed or paid by our tenants. If we are materially impacted by increasing inflation because, for example, inflationary increases in costs are not sufficiently offset by the contractual rent increases and operating expense reimbursement provisions or escalations in the leases with our tenants, our results of operations could be adversely affected. In addition, due to high interest rates, we may experience restrictions in our liquidity based on certain financial covenant requirements, our inability to refinance maturing debt in part or in full as it comes due and higher debt service costs and reduced yields relative to cost of debt. If we are unable to find alternative credit arrangements or other funding in a high interest environment, our financial results may be negatively impacted.

In addition, inflation, both real and anticipated, as well as any resulting governmental policies, have affected and could continue to adversely affect the costs of labor, goods and services for our operators. Increased operating costs could have an adverse impact on our operators and the operating results of our SHOP segment if increases in operating expenses exceed increases in revenue, which may adversely affect our operators' ability to pay rent and make loan payments to us. An increase in our operators' expenses and a failure of their revenues to increase at least with inflation could adversely affect our operators' and our financial condition and our results of operations.

***Adverse developments affecting the financial services industry, including events or concerns involving liquidity, defaults, or non-performance by financial institutions, could adversely affect our business, financial condition, results of operations or our prospects.***

The funds in our accounts are held in banks or other financial institutions. Our cash held in non-interest bearing and interest-bearing accounts may periodically exceed any applicable Federal Deposit Insurance Corporation ("FDIC") insurance limits. Should events, including limited liquidity, defaults, non-performance or other adverse developments occur with respect to the banks or other financial institutions that hold our funds, or that affect financial institutions or the financial services industry generally, or concerns or rumors about any events of these kinds or other similar risks, our liquidity may be adversely affected.

In addition, investor concerns regarding the U.S. or international financial systems could result in less favorable commercial financing terms, including higher interest rates or costs and tighter financial and operating covenants, or systemic limitations on access to credit and liquidity sources, thereby making it more difficult for us to acquire financing on terms favorable to us in connection with a potential business combination, or at all, and could have material adverse impacts on our business, financial condition, results of operations or our prospects.

***Adverse geopolitical developments could have a material adverse impact on our business.***

Currently, there are several geopolitical concerns that could, indirectly, have an adverse impact on our business, such as armed conflicts in various regions of the world, including, but not limited to, the Russia/Ukraine conflict and the conflicts in the Middle East. The conditions, and the responses thereto, such as sanctions imposed by the United States and other western democracies, and any expansion thereof is likely to have unpredictable and wide-ranging effects on the domestic and global financial markets, which could have an adverse effect on our business and results of operations. Already, these conditions have led to market volatility and an increasing number and frequency of cybersecurity threats. So far, we have not experienced any direct impact from the conflict and, as our business is conducted exclusively in the United States, we are less vulnerable than companies with international operations. We will continue to monitor the situation carefully and, if necessary, take action to protect our business, operations, and financial condition.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

***We are exposed to operational risks with respect to our SHOP structured communities.***

Our SHOP structured communities expose us to various operational risks that may increase our costs or adversely affect our ability to generate revenues. As the owner of a property under a SHOP structure, we are ultimately responsible for all operational risks and other liabilities of the property, other than those arising out of certain actions by our manager, such as gross negligence or willful misconduct. Operational risks include, and our revenues therefore depend on, among other things (i) occupancy rates; (ii) rental rates charged to residents; (iii) our operators' reputations and ability to attract and retain residents; (iv) general economic conditions and market factors that impact seniors including those exacerbated by public health conditions; (v) competition from other senior housing providers; (vi) compliance with federal, state, and local laws and regulations and industry standards, including but not limited to licensure requirements, where applicable; (vii) litigation involving our properties or residents; (viii) the availability and cost of general and professional liability insurance coverage or increases in insurance policy deductibles; and (ix) the ability to control operating expenses, which have increased, and may continue to increase. In addition, the success of our SHOP structured communities will depend largely on our ability to establish and maintain good relationships with our managers. Although the SHOP structure gives us certain oversight approval rights (*e.g*., budgets, material contracts, etc.) and the right to review operational and financial reporting information, we have outsourced to our third-party managers the day-to-day operations of the communities. Therefore, we depend on our managers to operate these communities in a manner that complies with applicable law, minimizes legal risk and maximizes the value of our investment. Failure by our managers to adequately manage these risks could have a material adverse effect on our business, results of operations and financial condition.

From time to time, disputes may arise between us and our managers regarding their performance or compliance with the terms of the agreements we have entered into with them, which in turn could adversely affect our results of operations. We will generally attempt to resolve any such disputes through discussions and negotiations; however, if we are unable to reach satisfactory results through discussions and negotiations, we may choose to terminate the applicable agreement, litigate the dispute or submit the matter to third-party dispute resolution, the outcome of which may be unfavorable to us.

***A cybersecurity incident or other form of data breach involving Company information could cause a loss of confidential consumer and other personal information, give rise to remediation and other expenses, expose us to liability under privacy and security and consumer protection laws, subject us to federal and state governmental inquiries, damage our reputation, and otherwise be disruptive to our business.***

Our business, like that of other REITs, involves the receipt, storage and transmission of information about our Company, our tenants, managers and borrowers, and our employees, some of which is entrusted to third-party service providers and vendors. We also work with third-party service providers and vendors to provide technology, systems and services that we use in connection with the receipt, storage and transmission of this information. As a matter of course, we may store or process the personal data of employees and other persons as required to provide our services and such personal data or other data may be hosted or exchanged with our partners and other third-party providers. The secure maintenance of this information and technology is critical to our business operations.

As with all companies that utilize information systems, our information systems, and those of our third-party service providers and vendors, may be vulnerable to continually evolving cybersecurity risks. We employ industry standard administrative, technical and physical safeguards designed to protect the integrity and security of personal data we collect or process. We have implemented and regularly review and update processes and procedures designed to protect against unauthorized access to or use of secured data and to prevent data loss. Unauthorized parties may attempt to gain access to these systems or our information through fraud or deception of our associates, ransomware, malware, and other malicious software, third-party service providers or vendors. Hardware, software or applications we obtain from third parties may contain defects in design or manufacture or other problems that could unexpectedly compromise information security. The methods used to obtain unauthorized access, disable, misappropriate, manipulate, or degrade service or sabotage systems are also constantly changing and evolving and may be difficult to anticipate or detect for long periods of time. The ever-evolving threats mean we and our third-party service providers and vendors must continually evaluate and adapt our respective systems and processes, and there is no guarantee that these systems and processes will be adequate to safeguard against all data security breaches or misuses of data. Furthermore, because threat actors may leverage new and evolving technologies, including AI, which may not be immediately recognized, we may experience security or data breaches that remain undetected for an extended time. Despite the security measures we have in place, and any additional measures we may implement in the future, our facilities and systems, and those of our third-party service providers and vendors, could be vulnerable to damage and service interruptions from a variety of sources including telecommunications or network failures, cyber attacks and security breaches and incidents (including data theft, computer viruses, ransomware and other malicious software), human error, fires, natural disasters, power losses, fraud, military or political conflicts, terrorist attacks and other geopolitical unrest.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

In addition, as the regulatory environment related to information security, data collection and use, and privacy becomes increasingly rigorous at the federal and state levels, with new and constantly changing requirements applicable to our business, compliance with those requirements could also result in significant additional costs.

***We are exposed to risks related to environmental laws and the costs associated with liabilities related to hazardous substances.***

Under various federal and state laws, owners or operators of real property may be required to respond to the release of hazardous substances on the property and may be held liable for property damage, personal injuries or penalties that result from environmental contamination of currently or formerly owned real estate, often regardless of knowledge of or responsibility for the contamination. These laws also expose us to the possibility that we may become liable to reimburse the government for damages and costs it incurs in connection with the contamination. Generally, such liability attaches to a person based on the person's relationship to the property. Although our tenants and operators are primarily responsible for the condition of the property they occupy, we also could be held liable to a governmental authority or to third parties for property damage, personal injuries, and investigation and clean-up costs incurred in connection with the contamination or we could be required to incur additional costs to change how the property is constructed or operated due to presence of such substances. However, we review environmental site assessments of the properties that we purchase or encumber prior to taking an interest in them. Those assessments are designed to meet the "all appropriate inquiry" standard, which qualifies us for the innocent purchaser defense if environmental liabilities arise. Notwithstanding these assessments, however, environmental liabilities, including mold, may be present in our properties and we may incur costs to remediate contamination, which could have a material adverse effect on our business or financial condition. In addition, the presence of hazardous substances or a failure to properly remediate any resulting contamination could adversely affect our ability to lease, mortgage, or sell an affected property.

***We are subject to risks of damage from catastrophic weather and other natural or man-made disasters and the physical effects of climate change.***

Natural and man-made disasters, including terrorist attacks and acts of nature, such as hurricanes, tornados, earthquakes, flooding and wildfires, may cause damage to our properties or business disruption to our tenants, managers and borrowers. These adverse weather and natural or man-made events could cause substantial damage or loss to our properties which could exceed applicable property insurance coverage. Such events could also have a material adverse impact on our tenants', managers' and borrowers' operations and ability to meet their obligations to us. In the event of a loss in excess of insured limits, we could lose our capital invested in the affected property, as well as anticipated future revenue from that property. Any such loss could materially and adversely affect our business and our financial condition and results of operations.

Climate change may also have indirect effects on our business by increasing the cost of (or making unavailable) property insurance on terms we find acceptable. To the extent that significant changes in the climate occur in areas where our properties are located, we may experience more frequent extreme weather events which may result in physical damage to, or a decrease in demand for, properties located in these areas or affected by these conditions. In addition, changes in federal and state legislation and regulation on climate change could result in increased capital expenditures to improve the energy efficiency of our existing properties and could also require us to spend more on our new development properties without a corresponding increase in revenue. Should the impact of climate change be material in nature, including destruction of our properties, or occur for lengthy periods of time, our financial condition or results of operations may be adversely affected.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

***We depend on the success of our future acquisitions and investments.***

We are exposed to the risk that our future acquisitions may not prove to be successful. We could encounter unanticipated difficulties and expenditures relating to any acquired properties, including contingent liabilities, and newly acquired properties might require significant attention of our management that would otherwise be devoted to our existing business. If we agree to provide construction funding to a borrower and the project is not completed, we may need to take steps to ensure completion of the project. Moreover, if we issue equity securities or incur additional debt, or both, to finance future acquisitions, it may reduce our per share financial results.

***We depend on our ability to reinvest cash in real estate investments in a timely manner and on acceptable terms.***

From time to time, we will have cash available from principal payments on our mortgage and other notes receivable and the sale of properties, including tenant purchase option exercises, under the terms of master leases or similar financial support arrangements. We must reinvest these proceeds, on a timely basis, in new investments or in qualified short-term investments. We compete for real estate investments with a broad variety of potential investors. This competition for attractive investments may negatively affect our ability to make timely investments on terms acceptable to us. Delays in reinvesting our cash may negatively impact revenues and the amount of distributions to stockholders.

***Competition for acquisitions may result in increased prices for properties.***

We may face increased competition for acquisition opportunities from other well-capitalized investors, including publicly traded and privately held REITs, private real estate funds, partnerships and others. This may mean that we are unsuccessful in a potential acquisition of a desired property at an acceptable price, or even if we are able to acquire a desired property, competition from other real estate investors may significantly increase the purchase price.

***We depend on our ability to retain our management team and other personnel and attract suitable replacements should any such personnel leave.***

The management and governance of our business depend on the services of certain key personnel, including senior management. The departure of any key personnel could have an adverse effect on us and adversely affect our financial condition and results of operations. Our senior management team possesses substantial experience and expertise and has strong business relationships with our tenants and operators and other members of the business communities and industries in which we operate. As a result, the loss of these personnel could jeopardize our relationships and operations. We cannot predict the impact that any such departures could have on our ability to achieve our objectives. Furthermore, such a loss could be negatively perceived in the capital markets. Other than Mr. Mendelsohn, our Chief Executive Officer, we do not have employment agreements with any of our management team. In addition, we do not have key man insurance on any of our key employees. Our failure to retain and motivate our management team and other personnel and attract suitable replacements should any such personnel leave, could have a significant impact on our financial condition and results of operations.

***We are exposed to the risk that our assets may be subject to impairment charges.***

As a REIT, a significant percentage of our assets is invested in real estate. We regularly evaluate our real estate investments and other assets for impairment indicators. The judgment regarding the existence of impairment indicators is based on factors such as market conditions, operator performance and legal structure. If we determine that a significant impairment has occurred, we would be required to make an adjustment to the net carrying value of the asset, which could have a material adverse effect on our reported results of operations in the period in which the impairment charge occurs. Such impairment charges may make it more difficult for us to meet the financial ratios in our indebtedness and may reduce the borrowing base, which may reduce the amounts of cash we would otherwise have available to pay expenses, make dividend distributions, service other indebtedness and operate our business. During the year ended December 31, 2025, we did not recognize any impairment charges.

***Stockholder activism efforts could cause us to incur substantial costs, divert management's attention and have an adverse effect on our business.***

Activist investors have engaged, and may in the future engage, in proxy solicitations, advance shareholder proposals or may otherwise attempt to affect changes or acquire control over us. Responding to such investor activism can be costly and time consuming, and can divert the attention of our Board of Directors and management from the management of our business and the pursuit of our business strategies. In addition to incurring costs, perceived uncertainties as to our future direction may result in the loss of potential business opportunities, damage to our reputation and may make it more difficult to attract and retain qualified directors, personnel and business partners. These actions could also cause our stock price to experience periods of volatility.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

***Our ability to raise capital through equity sales is dependent, in part, on the market price of our common stock, and our failure to meet market expectations with respect to our business, or other factors we do not control, could negatively impact such market price and availability of equity capital.***

As of December 31, 2025, we had the potential to access $480.0 million through the issuance of common stock under our at-the-market ("ATM") equity program. In addition, we maintain an effective automatic shelf registration statement through which capital could be raised via the issuance of equity securities. Similar to other publicly traded companies, the availability of equity capital will depend, in part, on the market price of our common stock which, in turn, will depend upon various market conditions and other factors, some of which we cannot control, that may change from time to time including:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the extent of investor interest;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the general reputation of REITs and the attractiveness of their equity securities in comparison to other equity securities, including securities issued by other real estate-based companies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the financial performance of us and our tenants, managers and borrowers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• investment and tenant concentrations in our investment portfolio;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• concerns about our operators', tenants' and borrowers' financial condition due to uncertainty regarding reimbursement from governmental and other third-party payor programs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our credit ratings and analyst reports on us and the REIT industry in general, including recommendations, and our ability to meet our guidance estimates or analysts' estimates;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• general economic, global and market conditions, including changes in interest rates on fixed income securities, which may lead prospective purchasers of our common stock to demand a higher annual yield from future distributions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our failure to maintain or increase our dividend, which is dependent, to a large part, on the increase in funds from operations, which in turn depends upon increased revenues from additional investments and rental increases; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• other factors, such as governmental regulatory action and changes in REIT tax laws as well as changes in litigation and regulatory proceedings.

The market value of the equity securities of a REIT is generally based upon the market's perception of the REIT's growth potential and its current and potential future earnings and cash distributions. Our failure to meet the market's expectation with regard to future earnings and cash distributions would likely adversely affect the market price of our common stock and, as a result, the availability of equity capital to us.

***The U.S. federal income tax treatment of the cash that we might receive from cash settlement of the forward equity sales agreements is unclear and could jeopardize our ability to meet the REIT qualification requirements.***

We enter into forward sales agreements from time to time and, subject to certain conditions, we have the right to elect physical, cash or net share settlement under these agreements at any time and from time to time, in part or in full. In the event that we elect to settle any forward sales agreements for cash and the settlement price is below the applicable forward sale price, we would be entitled to receive a cash payment from the relevant forward purchaser. Under Section 1032 of the Internal Revenue Code, generally, no gains and losses are recognized by a corporation in dealing in its own shares, including pursuant to a "securities futures contract", as defined in the Internal Revenue Code by reference to the Exchange Act. Although we believe that any amount received by us in exchange for our shares of our common stock would qualify for the exemption under Section 1032 of the Internal Revenue Code, because it is not entirely clear whether a forward sales agreement qualifies as a "securities futures contract", the U.S. federal income tax treatment of any cash settlement payment we receive is uncertain. In the event that we recognize a significant gain from the cash settlement of a forward sales agreement, we might not be able to satisfy the gross income requirements applicable to REITs under the Internal Revenue Code. In that case, we may be able to rely upon the relief provisions under the Internal Revenue Code in order to avoid the loss of our REIT status. Even if the relief provisions apply, we will be subject to a 100% tax based upon the amount by which we fail to satisfy the particular gross income test. In the event that these relief provisions were inapplicable, we could lose our REIT status under the Internal Revenue Code.

***Our use of artificial intelligence could expose us to various risks.***

We may use AI tools in our operations, including machine learning technology and generative and agentic AI technologies. The current and potential future applications of these AI tools are rapidly evolving, as are the legal and regulatory frameworks that govern them. AI could significantly disrupt the markets in which we operate and subject us to increased competition, legal and regulatory risks and compliance costs, which could have a material adverse effect on our business, financial condition and results of operations.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

**Risks Related to Our Debt** 

***We may need to refinance existing debt or incur additional debt in the future, which may not be available on terms acceptable to us.***

We operate with a policy of incurring debt when, in the opinion of our Board of Directors, it is advisable. Currently, we believe that our current liquidity, availability under our unsecured credit facility, potential proceeds from our ATM equity program and our capacity to service additional debt will enable us to meet our obligations, including dividends, and continue to make investments in healthcare real estate. We have a $700.0 million unsecured revolving credit facility (the "Credit Facility") that matures in October 2028, which may be further extended by us pursuant to (i) one or both of the two six-month extension options or (ii) one 12-month extension option. In June 2023, we entered into a two-year term loan agreement providing for a $200.0 million term loan (the "Bank Term Loan") bearing interest at a variable rate which is Secured Overnight Financing Rate ("SOFR") based with a margin determined according to our credit ratings. We may incur additional debt by borrowing under our Credit Facility, mortgaging properties we own and/or issuing debt securities in a public offering or in a private transaction. As of January 31, 2026, we had $1.3 billion in outstanding indebtedness and $356.0 million available to draw under the Credit Facility. Our ability to raise reasonably priced capital is not guaranteed. We may be unable to raise reasonably priced capital because of reasons related to our business or for reasons beyond our control, such as market conditions and rising interest rates. If our access to capital becomes limited, it could have an impact on our ability to refinance our debt obligations, fund dividend payments and acquire properties.

***We have covenants related to our indebtedness which impose certain operational limitations and a breach of those covenants could materially adversely affect our financial condition and results of operations.***

The terms of our current indebtedness are, and debt instruments that we may enter into in the future may be, subject to customary financial and operational covenants. Among other things, these provisions require us to maintain certain financial ratios and minimum net worth and impose certain limits on our ability to incur indebtedness, create liens and make investments or acquisitions. Our continued ability to incur debt and operate our business is subject to compliance with these covenants, which limit operational flexibility. Breaches of these covenants could result in a default under applicable debt instruments, even if payment obligations are satisfied. Financial and other covenants that limit our operational flexibility, as well as defaults resulting from a breach of any of these covenants in our debt instruments, could have a material adverse effect on our financial condition and results of operations.

***Downgrades in our credit ratings could have a material adverse effect on our cost and availability of capital.***

We plan to manage and to maintain a capital structure consistent with our current profile, but there can be no assurance that we will be able to maintain our current credit ratings. Any downgrades of ratings or changes to outlooks by any or all of the rating agencies could have a material adverse effect on our cost and availability of capital, which could in turn have a material adverse effect on our results of operations, liquidity, cash flows, the trading/redemption price of our securities and our ability to satisfy our debt service obligations and to pay dividends and distributions to our equity holders.

***We rely on external sources of capital to fund future capital needs, and if we encounter difficulty in obtaining such capital, we may not be able to make future investments necessary to grow our business or meet maturing commitments.***

As a REIT under the Internal Revenue Code, we are required to, among other things, distribute at least 90% of our REIT taxable income (computed without regard to the dividends-paid deduction or our net capital gain or loss) each year to our stockholders. Because of this distribution requirement, we may not be able to fund, from cash retained from operations, all future capital needs, including capital needed to make investments and to satisfy or refinance maturing commitments. As a result, we rely on external sources of capital, including debt and equity financing. If we are unable to obtain necessary capital at all or only on unfavorable terms from these sources, we might not be able to make the investments needed to grow our business, or to meet our obligations and commitments as they mature, which could negatively affect the ratings of our debt and even, in extreme circumstances, affect our ability to continue operations. We may not be in a position to take advantage of future investment opportunities in the event that we are unable to access the capital markets on a timely basis or we are only able to obtain financing on unfavorable terms.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

***We depend on revenues derived mainly from fixed rate investments in real estate assets, while a portion of our debt used to finance those investments bears interest at variable rates, which subjects us to interest rate risk.***

Our business model assumes that we can earn a spread between the returns earned from our investments in real estate as compared to our cost of debt and/or equity capital. Interest rates remain above levels prior to 2022. We are exposed to interest rate risk in the potential for a narrowing of our spread and profitability if interest rates increase in the future. Certain of our debt obligations are floating rate obligations with interest rates that vary with the movement of the SOFR or other indexes. Our revenues are derived mainly from fixed rate investments in real estate assets. Although our leases generally contain escalating rent clauses that provide a partial hedge against interest rate fluctuations, if interest rates rise, our interest costs for our existing floating rate debt and any new debt we incur would also increase. This increasing cost of debt could reduce our profitability by increasing the cost of financing our existing portfolio and our investment activity. Rising interest rates could limit our ability to refinance existing debt upon maturity or cause us to pay higher rates upon refinancing. We manage a portion of our exposure to interest rate risk by accessing debt with staggered maturities and through the use of derivative instruments, such as interest rate swap agreements with major financial institutions. Increased interest rates may also negatively affect the market price of our common stock and increase the cost of new equity capital.

**Risks Related to Our Status as a REIT**

***We depend on the ability to continue to qualify for taxation as a REIT for U.S. federal income tax purposes.***

We intend to operate as a REIT under the Internal Revenue Code and believe we have and will continue to operate in such a manner. In addition, we currently hold an interest in a Subsidiary REIT, and may in the future own or acquire additional interests in Subsidiary REITs. Since REIT qualification requires us to meet a number of complex requirements, it is possible that we, or our Subsidiary REIT, may fail to fulfill them.

If we, or our Subsidiary REIT fail to qualify as a REIT:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• we, or our Subsidiary REIT, will not be allowed a deduction for distributions to our stockholders in computing taxable income;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• we, or our Subsidiary REIT, will be subject to corporate-level income tax on taxable income at regular corporate rates;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• we, or our Subsidiary REIT, could be subject to increased state and local income taxes;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• we, or our Subsidiary REIT, would possibly be subject to certain taxes enacted by the Inflation Reduction Act of 2022 that are applicable to non-REIT corporations, including the nondeductible 1% excise tax on certain stock repurchases; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• unless we, or our Subsidiary REIT, are entitled to relief under relevant statutory provisions, we, or our Subsidiary REIT as applicable, will be disqualified from taxation as a REIT for the four taxable years following the year during which we, or our Subsidiary REIT as applicable, fail to qualify as a REIT.

Because of all these factors, our, or our Subsidiary REIT's, failure to qualify as a REIT could also impair our ability to expand our business and could materially adversely affect the value of our common stock. The present federal income tax treatment of REITs may be modified, possibly with retroactive effect, by legislative, judicial or administrative action at any time, which could affect the federal income tax treatment of an investment in us. The federal income tax rules dealing with REITs are constantly under review by persons involved in the legislative process, the U.S. Internal Revenue Service and the U.S. Treasury Department, which results in statutory changes as well as frequent revisions to regulations and interpretations. Revisions in federal tax laws and interpretations thereof could affect or cause us to change our investments and commitments and affect the tax considerations of an investment in us.

***There are no assurances of our ability to pay dividends in the future.***

Our ability to pay dividends may be adversely affected upon the occurrence of any of the risks described herein. Our payment of dividends is subject to compliance with restrictions contained in our credit agreements, notes and any preferred stock that our Board of Directors may from time to time designate and authorize for issuance. All dividends will be paid at the discretion of our Board of Directors and will depend upon our earnings, our financial condition, maintenance of our REIT status and such other factors as our Board of Directors may deem relevant from time to time. There are no assurances of our ability to pay dividends in the future. In addition, our dividends in the past have included, and may in the future include a return of capital.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

***Complying with the REIT requirements may cause us to forego otherwise attractive acquisition opportunities or liquidate otherwise attractive investments, which could materially hinder our performance.***

To qualify as a REIT for U.S. federal income tax purposes, we (and any Subsidiary REIT of ours) must continually satisfy certain tests, including tests concerning the sources of our income, the nature and diversification of our assets, the amounts we distribute to our stockholders and the ownership of our stock. To meet these tests, we may be required to forgo investments or acquisitions we might otherwise make. Thus, compliance with the REIT requirements may materially hinder our performance.

We believe that the ownership and management of assets in our SHOP structures is in compliance with the REIT requirements; however, application of the REIT rules to such assets is complex, fact dependent and subject to interpretation. There can be no assurances that the Internal Revenue Service will agree with our characterization of these assets and if the Internal Revenue Service were to successfully contend that our SHOP structures do not meet the REIT requirements, all or a portion of the rent that we receive under these structures could be non-qualifying income for purposes of the REIT gross income tests. In such event, we may be required to rely on the REIT savings provisions under the Internal Revenue Code, reorganize our SHOP structures, or take such other steps to avoid incurring non-qualifying income, any of which could be at a significant financial cost.

***Our ownership of and relationship with any TRS that we have formed or will form will be limited, and a failure to comply with the limits would jeopardize our REIT status and may result in the application of a 100% excise tax.***

A REIT may own up to 100% of the stock of one or more TRSs. A TRS may earn income that would not be qualifying income if earned directly by its parent REIT. Both the subsidiary and the REIT must jointly elect to treat the subsidiary as a TRS. A corporation (other than a REIT) of which a TRS directly or indirectly owns securities possessing more than 35% of the total voting power or total value of the outstanding securities of such corporation will automatically be treated as a TRS. Overall, no more than 20% (25% commencing in 2026) of the value of a REIT's total assets may consist of stock or securities of one or more TRSs.

Rents received from a TRS in a RIDEA structure are treated as qualifying rents from real property for REIT tax purposes only if (i) they are paid pursuant to a lease of a "qualified healthcare property" and (ii) the operator qualifies as an "eligible independent contractor", as defined in the Internal Revenue Code. If either of these requirements is not satisfied, then the rents will not be qualifying rents. The Internal Revenue Code also imposes a 100% excise tax on certain transactions between a TRS and its parent REIT that are not conducted on an arm's length basis. Any domestic TRS that we form will pay U.S. federal, state and local income tax on its taxable income, and its after-tax net income will be available for distribution to us but is not required to be distributed to us unless necessary to maintain our REIT qualification.

***Legislative, regulatory, or administrative tax changes could adversely affect us or our security holders.***

The tax laws or regulations governing REITs or the administrative interpretations thereof may be amended at any time. We cannot predict if or when any new or amended law, regulation, or administrative interpretation will be adopted, promulgated, or become effective, and any such change may apply retroactively. Changes to the U.S. federal income tax laws, including the possibility of major tax legislation, could have a material and adverse effect on us or our security holders.

In connection with the passing of the OBBBA on July 4, 2025, certain changes to U.S. tax laws were approved that impact us and our shareholders. Among other changes, this legislation (i) permanently extended the 20% deduction for "qualified REIT dividends" for individuals and other non-corporate taxpayers under Section 199A of the Internal Revenue Code, (ii) increased the percentage limit under the REIT asset test applicable to TRSs from 20% to 25% for taxable years beginning after December 31, 2025 and (iii) increased the basis on which the 30% interest deduction limit under Section 163(j) of the Internal Revenue Code applies by excluding depreciation, amortization and depletion from the definition of "Adjusted Taxable Income" for taxable years beginning after December 31, 2024.

Investors are urged to consult with their tax advisors with respect to the status of any tax legislation and any other regulatory or administrative developments and proposals and their potential effect on investment in our securities.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

**Risks Related to Our Organizational Structure**

***We have ownership limits in our charter with respect to our common stock and other classes of capital stock which may delay, defer or prevent a transaction or a change of control that might involve a premium price for our common stock or might otherwise be in the best interests of our stockholders.***

Our charter, subject to certain exceptions, contains restrictions on the ownership and transfer of our common stock and preferred stock that are intended to assist us in preserving our qualification as a REIT. Our charter provides that any transfer that would cause NHI to be beneficially owned by fewer than 100 persons or would cause NHI to be "closely held" under the Internal Revenue Code would be void, which, subject to certain exceptions, results in no person or entity being allowed to own, actually or constructively, more than 9.9% of the outstanding shares of our stock. Our Board of Directors, in its sole discretion, may exempt a proposed transferee from the ownership limit. Our charter gives our Board of Directors broad powers to prohibit and rescind any attempted transfer in violation of the ownership limits. These ownership limits may delay, defer or prevent a transaction or a change of control that might involve a premium price for our common stock or might otherwise be in the best interests of our stockholders.

***We are subject to certain provisions of Maryland law and our charter and bylaws that could hinder, delay or prevent a change in control transaction, even if the transaction involves a premium price for our common stock or our stockholders believe such transaction to be otherwise in their best interests.***

The Maryland Business Combination Act provides that, unless exempted, a Maryland corporation may not engage in business combinations, including mergers, dispositions of 10% or more of its assets, issuances of shares of stock and other specified transactions with an "interested stockholder" or an affiliate of an interested stockholder for five years after the most recent date on which the interested stockholder became an interested stockholder, and thereafter, unless specified criteria are met. An interested stockholder is generally a person owning or controlling, directly or indirectly, 10% or more of the voting power of the outstanding stock of a Maryland corporation. Unless our Board of Directors takes action to exempt us, generally or with respect to certain transactions, from this statute in the future, the Maryland Business Combination Act will be applicable to business combinations between us and other persons. Our charter and bylaws also contain certain provisions that could have the effect of making it more difficult for a third party to acquire, or discouraging a third party from attempting to acquire, control of us. These provisions include blank check preferred stock and the application of Maryland corporate law provisions on business combinations and control shares. Such provisions could limit the price that certain investors might be willing to pay in the future for the common stock. The foregoing matters may, together or separately, have the effect of discouraging or making more difficult an acquisition or change of control of us.

**ITEM 1B. UNRESOLVED STAFF COMMENTS**

None

**ITEM 1C. CYBERSECURITY**

**Risk Management and Strategy**

The Board of Directors recognizes the importance of maintaining the trust and confidence of our tenants, managers, borrowers and employees to safeguard sensitive information and the integrity of our information systems. We have systems in place to assess, identify and manage cybersecurity incidents and we invest in technology and third-party support to identify, mitigate, and quickly respond to cybersecurity incidents. We have maintained a strong focus on consistently reviewing our cybersecurity practices. We also conduct periodic information security and awareness training to ensure that employees are aware of information security risks and to enable them to take steps to mitigate those risks. As part of this program, we also take steps designed to provide appropriate guidance regarding security to our executive management and employees, including any employee who may come into possession of confidential financial information.

We have engaged the services of various third-party service providers to, among other things, review and evaluate our processes and procedures designed to control access to our information systems, perform penetration testing on our cybersecurity systems on a biannual basis, and perform regular information technology reviews based upon the National Institute of Standards and Technology ("NIST") Cybersecurity Framework. In addition, we contracted with a third-party managed detection and response security company ("MDR") to test for cyber vulnerabilities on a continual basis.

In order to identify and mitigate cybersecurity threats related to our use of material third-party vendors, we conduct periodic reviews of internal controls of certain third-party service providers to assess their procedures to mitigate material security risks.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

**Board of Directors and Management Responsibilities**

We formed an Information Technology Steering Committee which is comprised of employees across multiple departments in our business, including our Chief Executive Officer ("CEO"), Chief Financial Officer, Chief Accounting Officer, the Vice President and Controller, the Vice President of Finance and Investor Relations, the Vice President of Portfolio Management, and the Vice President of Human Resources, Benefits and Compliance and our Information Security Officer ("ISO"), to more effectively prevent, detect and respond to information security threats. The ISO has served in various roles in corporate compliance for over 20 years and reports directly to our CEO. To enhance our cybersecurity capabilities, we actively collaborate with third-party vendors. Notably, we engage a Managed Service Provider ("MSP") and an MDR provider who specializes in cybersecurity issues. Our MSP plays a critical role in supporting our IT infrastructure, offering expertise and resources that complement our in-house capabilities. The MDR provides advanced cybersecurity solutions, including continuous monitoring and threat detection services, which are integral to our cybersecurity program.

The ISO is responsible for overseeing a company-wide information security strategy, including policy, standards, architecture, and processes, and managing many of the security services that run on personal computers and servers. The Audit Committee of our Board of Directors meets with the ISO at least annually to review and discuss our cyber risks and threats, incident responses, technology, the status of projects to strengthen our information security systems, assessments of our security program and the emerging threat landscape.

In the event of an incident that jeopardizes the confidentiality, integrity, or availability of the information technology systems we use, we utilize a regularly updated information security incident response plan ("IRP"). The IRP is overseen by the Information Technology Steering Committee and sets forth the processes for containment, review, escalation, recovery from and remediation of any cybersecurity incidents identified by us. Pursuant to our IRP and its escalation protocols, designated personnel are responsible for assessing the severity of the incident and associated threat, containing the threat, remediating the threat, including recovery of data and access to systems, analyzing the reporting obligations associated with the incident, and performing post-incident analysis and program improvements. The IRP also specifies the approach to reporting findings and keeping senior management and other key stakeholders, including the Audit Committee and the Board of Directors for certain incidents, informed and involved as appropriate and specifies the use of third-party experts for legal advice, consulting and cyber incident response.

We periodically conducts cybersecurity "tabletop" exercises administered by an independent third-party in which members of a cross-functional team and relevant third-party vendors engage in simulated cybersecurity incident scenarios. These exercises are intended to provide hands-on training for the participants and assist us in assessing our processes and capabilities in addressing cybersecurity threats.

As of December 31, 2025, we have not had any known instances of material cybersecurity incidents, including third-party incidents, during any of the prior three fiscal years. We also maintain cyber liability insurance to help mitigate potential liabilities resulting from cyber issues. However, there can be no assurance that our cyber risk insurance coverage will be sufficient to cover incurred losses in the event of a cyber attack.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

**ITEM 2. PROPERTIES**

A summary of information related to our owned real estate properties as of and for the year ended December 31, 2025 follows *($ in thousands)*:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | | | | | | Gross |
| | Number of Properties<sup>1</sup> | Number of Properties<sup>1</sup> | Number of Properties<sup>1</sup> | Number of Properties<sup>1</sup> | | Carrying |
| Location | SHOs | SNFs | HOSPs | SHOP | NOI | Amount<sup>2</sup> |
| Alabama | 2 | 2 |  |  | $3453 | $24297 |
| Arizona |  | 1 |  |  | 930 | 7131 |
| Arkansas |  |  |  | 2 | 2008 | 53931 |
| California | 1 |  |  | 5 | 4672 | 130774 |
| Colorado | 2 |  |  |  | 2402 | 28800 |
| Connecticut | 3 |  |  |  | 13561 | 139719 |
| Florida | 2 | 10 |  | 1 | 23972 | 223665 |
| Georgia | 3 |  |  | 2 | 7790 | 108612 |
| Idaho | 1 |  |  |  | 1066 | 9673 |
| Illinois | 13 |  |  |  | 15449 | 197528 |
| Indiana | 5 |  |  | 3 | 4123 | 92117 |
| Iowa | 7 |  |  |  | 5585 | 41384 |
| Kentucky |  | 1 |  |  | 1568 | 2143 |
| Louisiana | 2 |  |  |  | 1183 | 10241 |
| Maryland | 1 |  |  | 1 | 2656 | 66081 |
| Massachusetts | 1 |  |  |  | 3536 | 52108 |
| Michigan | 5 |  |  |  | 3605 | 44138 |
| Minnesota | 5 |  |  |  | 2414 | 31144 |
| Missouri | 1 | 5 |  |  | 3279 | 27695 |
| Nebraska | 9 |  |  |  | 7716 | 92933 |
| Nevada | 1 |  |  |  | 1640 | 18136 |
| New Jersey | 1 |  |  | 1 | 4058 | 72894 |
| North Carolina | 16 |  |  |  | 23742 | 262408 |
| Ohio | 5 |  |  | 1 | 4919 | 100329 |
| Oklahoma |  |  | 1 | 4 | 7468 | 124784 |
| Oregon | 3 | 3 |  | 2 | 10609 | 146043 |
| Pennsylvania | 2 |  |  | 1 | 1192 | 81623 |
| South Carolina | 5 | 4 |  | 2 | 34748 | 395552 |
| Tennessee | 3 | 16 |  |  | 19021 | 50984 |
| Texas |  | 21 |  |  | 29221 | 298599 |
| Virginia | 5 | 1 |  |  | 7824 | 68685 |
| Washington | 3 |  |  | 1 | 13693 | 207002 |
| Wisconsin | 3 | 1 |  |  | 8145 | 81955 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total real estate properties in |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;segments | 110 | 65 | 1 | 26 | 277248 | 3293108 |
| Corporate |  |  |  |  |  | 2632 |
| Other |  |  |  |  | 2504 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total real estate properties |  |  |  |  | $279752 | $3295740 |

---

<sup>1&nbsp;&nbsp;&nbsp;&nbsp;</sup>The total number of properties, as presented in the table above, excludes our corporate office building and one property in the Real Estate Investments segment that was classified as assets held for sale as of December 31, 2025.

<sup>2&nbsp;&nbsp;&nbsp;&nbsp;</sup>The total gross carrying amount, as presented in the table above, excludes $2.6 million related to our corporate office and equipment and $4.8 million related to one property in the Real Estate Investments segment that was classified as assets held for sale as of December 31, 2025.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

A summary of information related to our mortgage and other notes receivable investments as of December 31, 2025 and for the year ended December 31, 2025 follows *($ in thousands)*:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | Number of Properties | Number of Properties | Number of Properties | | |
| | SHOs | SNFs | HOSPs |<br>Interest<br>Income | Gross<br>Carrying<br>Amount |
| Mortgage notes: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Florida | 2 |  | 1 | $2703 | $36942 |
| &nbsp;&nbsp;&nbsp;&nbsp;Illinois | 1 |  |  | 1360 | 14907 |
| &nbsp;&nbsp;&nbsp;&nbsp;Indiana | 1 |  |  | 562 | 6423 |
| &nbsp;&nbsp;&nbsp;&nbsp;Michigan | 2 |  |  | 1547 | 23004 |
| &nbsp;&nbsp;&nbsp;&nbsp;South Carolina | 1 |  |  | 195 | 18750 |
| &nbsp;&nbsp;&nbsp;&nbsp;Texas | 1 | 3 |  | 2525 | 25887 |
| &nbsp;&nbsp;&nbsp;&nbsp;Wisconsin | 1 |  |  | 2513 | 28414 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total mortgage notes receivable | 9 | 3 | 1 | 11405 | 154327 |
| Other notes |  |  |  | 9727 | 64366 |
| Mortgage and other note payoffs |  |  |  | 2684 |  |
| Other interest income |  |  |  | 150 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total mortgage and other notes receivable |  |  |  | $23966 | $218693 |

---

The following table provides information on the expirations of our tenant leases based on the maturities included in the most recent lease agreements or extension periods as of December 31, 2025 *($ in thousands)*:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | | | | Percentage of |
| | Number of | Number of | Annualized | Annualized |
| Year of Maturity | Properties<sup>1</sup> | Beds / Units | Gross Rent<sup>2</sup> | Gross Rent |
| 2026 | 36 | 4849 | $39286 | 14.9% |
| 2027 | 4 | 803 | 15753 | 6.0% |
| 2028 | 12 | 591 | 11948 | 4.5% |
| 2029 | 7 | 836 | 12756 | 4.8% |
| 2030 | 1 | 107 | 4493 | 1.7% |
| 2031 | 13 | 2513 | 57492 | 21.8% |
| 2032 | 2 | 213 | 3958 | 1.5% |
| 2033 | 28 | 1815 | 28297 | 10.7% |
| 2034 | 16 | 984 | 13326 | 5.0% |
| Thereafter | 57 | 5145 | 76645 | 29.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | 176 | 17856 | $263954 | 100.0% |

---

<sup>1&nbsp;&nbsp;&nbsp;&nbsp;</sup>The total number of properties, as presented in the table above, excludes our corporate office building and one property in the Real Estate Investments segment that was classified as assets held for sale as of December 31, 2025.

<sup>2</sup> &nbsp;&nbsp;&nbsp;&nbsp;Annualized gross rent refers to the amount of rental income we would have generated during the year ended December 31, 2025 if all of our tenant leases were in effect for the full calendar year, regardless of the actual commencement dates, maturity dates or renewal periods of the leases.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

As of December 31, 2025, we leased 32 SNFs and three ILFs to NHC, a publicly owned company, under a triple-net master lease which expires in December 2026. The master lease includes two five-year extension options in which the annual lease rate resets at the current fair market value as negotiated between the parties. We have engaged Blueprint Healthcare Real Estate Advisors, a national advisory firm focused on senior housing and skilled nursing facilities, to assist with underwriting, due diligence and market analysis with respect to the master lease renewal.

On September 8, 2025, we provided formal written notice to NHC that it is in default of the triple-net master lease as a result of NHC's failure to remedy its non-compliance with certain non-monetary provisions of the triple-net master lease previously identified by us. NHC had 30 days to cure such default and its failure to do so entitles us to declare an event of default and to pursue any and all remedies available to us under the triple-net master lease. We are currently evaluating potential courses of action.

On October 7, 2025, NHC informed us that it was exercising its option to renew the master lease for one five-year term commencing January 1, 2027. We are currently reviewing the effectiveness and legality of NHC's notice.

**ITEM 3. LEGAL PROCEEDINGS**

From time to time, we are a party to various lawsuits, investigations, claims and other legal and regulatory proceedings arising in connection with our business. Such claims may include, among other things, professional and general liability claims, as well as regulatory proceedings related to our SHOP segment. Further, from time to time, we are a party to certain legal proceedings for which third parties, such as our tenants, managers and borrowers, are contractually obligated to indemnify us from and against various claims, litigation and liabilities arising in connection with their respective businesses. Management believes that the ultimate resolution of all such pending proceedings will have no material adverse effect on our financial condition, results of operations or cash flows.

**ITEM 4. MINE SAFETY DISCLOSURES**

Not applicable

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

**PART II.**

**ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES**

Our charter contains certain provisions which are designed to ensure that our status as a REIT is protected for federal income tax purposes. One of the provisions ensures that any transfers of our common stock which would cause us to be beneficially owned by fewer than 100 persons or which would cause us to be "closely-held" under the Internal Revenue Code would be voided and, subject to certain exceptions, results in no stockholder being allowed to own, either directly or indirectly pursuant to certain tax attribution rules, more than 9.9% of our common stock. If a stockholder's beneficial ownership in us exceeds this limit, then such shares of our common stock over the limit become "Excess Shares", as defined in our charter, and the stockholder loses the right to vote and the right to receive dividends in certain situations. Our charter gives our Board of Directors broad powers to prohibit and rescind any attempted stock transfers in violation of the ownership limits. The purpose of these provisions is to protect our status as a REIT for federal income tax purposes.

In order to qualify for the beneficial tax treatment of a REIT, we must make distributions to holders of our common stock on an annual basis equal to at least 90% of our REIT taxable income, excluding net capital gains and as defined in the Internal Revenue Code. Cash available for distribution to our common stockholders is primarily derived from lease payments received from our tenant leases and interest payments received on our mortgage and other notes receivable. Dividend distributions are made by us, at the discretion of the Board of Directors, and depend on our financial condition, results of operations, cash flows, compliance with debt covenants and other factors deemed relevant by our Board of Directors. Our REIT taxable income is calculated without reference to our cash flows. Therefore, under certain circumstances, our required dividend distribution amounts may exceed our cash available for distribution.

Our common stock is traded on the New York Stock Exchange under the symbol "NHI." As of February 20, 2026, there were 601 holders of record of shares and 61,389 beneficial owners of shares.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

The following graph provides information on our performance related to the cumulative total return to our common stockholders for the previous five years based on a $100 starting investment as of December 31, 2020 in comparison to the cumulative total returns on the MSCI US REIT Index and the Standard and Poor's ("S&P") 500 Stock Index for the same periods. The MSCI US REIT Index is a free float-adjusted market capitalization weighted index that is comprised of equity REIT securities. The MSCI US REIT Index includes securities with exposure to core real estate, such as residential and retail properties, as well as securities with exposure to other types of real estate, such as casinos and theaters.

![549755818537](nhi-20251231_g1.jpg)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | Year Ended December 31, | Year Ended December 31, | Year Ended December 31, | Year Ended December 31, | Year Ended December 31, | Year Ended December 31, |
| | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| NHI | $100.00 | $88.38 | $85.46 | $97.76 | $128.02 | $148.30 |
| MSCI | 100.00 | 143.06 | 108.00 | 122.84 | 133.59 | 137.53 |
| S&P 500 | 100.00 | 128.71 | 105.40 | 133.10 | 166.40 | 196.16 |

---

This graph is not deemed to be "soliciting material" and has been "furnished", and shall not be deemed to be "filed" with the SEC or incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in any such filing.

**Issuer Purchases of Equity Securities**

None.

**ITEM 6. RESERVED**

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

**ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS**

The information set forth below is intended to provide readers with an understanding of our financial condition, changes in financial condition and results of operations. Our discussion and analysis are primarily based on our consolidated financial statements for the years presented and should be read together with the notes thereto contained in this Annual Report. This section generally discusses our results of operations for the year ended December 31, 2025 compared to the year ended December 31, 2024. For a discussion of our results of operations for the year ended December 31, 2024 compared to the year ended December 31, 2023, please refer to "Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations" in our Annual Report for the fiscal year ended December 31, 2024, which we filed with the SEC on February 25, 2025.

The discussion below contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors, including those which are discussed in "Part I, Item 1A. Risk Factors" of this Annual Report. Also, reference "Cautionary Statement Regarding Forward-Looking Statements" preceding Part I of this Annual Report.

**Executive Overview**

National Health Investors, Inc., established in 1991 as a Maryland corporation, is a self-managed REIT. We own, lease, operate and finance the development of high-quality real estate properties, focusing on senior housing communities and medical facilities. We operate through two reportable segments, Real Estate Investments and SHOP. Our investments in senior housing communities, also referred to as SHOs, include ILFs, ALFs, EFCs and SLCs. Our investments in medical facilities include SNFs and HOSPs.

In our Real Estate Investments segment, our revenues primarily relate to triple-net leases with third-party operators at our properties. Additionally, we recognize interest income from financing arrangements we provide to our tenants, operators, or affiliates of our tenants and operators, and other third parties primarily for construction, renovation and expansion projects, funding of working capital or corporate needs and the acquisition of real estate properties. In our SHOP segment, we own and operate senior housing communities and generate revenues from resident fees and services. We utilize third-party managers to operate these properties on our behalf and pay a management fee for their services. Our investments across both segments are funded primarily through (i) operating cash flows, (ii) debt offerings, revolving lines of credit and term loans and (iii) sales of equity securities.

*Real Estate Investments Portfolio*

As of December 31, 2025, our investments comprising the Real Estate Investments segment included real estate properties and financing arrangements involving 189 properties located in 32 states, excluding one property classified as assets held for sale. The aggregate gross carrying value of these owned properties was $2.7 billion, which included 110 SHOs, 65 SNFs and one HOSP leased to 31 tenants. The aggregate gross carrying value of our mortgage and other notes receivable was $218.7 million, excluding $15.4 million of credit loss reserves.

Our tenant leases are typically structured as triple-net leases and relate to single-tenant properties having an initial lease term of 10 to 15 years with one or more five-year extension options. Most of our tenant leases contain annual rent escalators, which may be fixed or variable. Lease payments due to us that are subject to a variable rent escalator are typically determined annually and calculated using a variable index, such as the consumer price index ("CPI") or an index that is dependent on a future date and indeterminable at the inception of the lease.

*Senior Housing Operating Portfolio* 

As of December 31, 2025, our investments included in the SHOP segment consisted of 17 ILFs, six SLCs and three ALFs located in 13 states with a combined total of 3,009 units. The aggregate gross carrying value of these properties was $634.3 million. We have structured the operations at these senior housing communities to comply with the requirements of RIDEA and to utilize our TRS for activities that would otherwise be non-qualifying for REIT purposes.

The properties are operated by third-party managers in exchange for a management fee from us, and as such, we are not directly exposed to the credit risk of the managers in the same manner or to the same extent as we are related to our triple-net tenant leases. However, we rely on the managers' personnel, expertise, technical resources and information systems, proprietary information, good faith and judgment to manage our communities efficiently and effectively. We also rely on the managers to set appropriate resident fees and to operate our communities in compliance with the terms of our management agreements and all applicable laws and regulations.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

*Classifications of Real Estate Properties*

We classify our investments in real estate properties as either SHOs or medical facilities and further classify our SHOs as either need-driven or discretionary properties based on the differing credit risk profiles represented by the underlying revenue sources.

A summary of each of these classifications follows:

*Need-Driven Senior Housing*

Need-driven senior housing properties include ALFs and SLCs which primarily attract private payment for services from residents who require assistance with activities of daily living. Need-driven properties are subject to regulatory oversight.

*Discretionary Senior Housing*

Discretionary senior housing properties include ILFs and EFCs which primarily attract private payment for services from residents who are making the lifestyle choice of living in an age-restricted, multi-family community that offers social programs, meals, housekeeping, and in some cases, access to healthcare services. Discretionary properties are subject to limited regulatory oversight. There is a correlation between demand for this type of community and the strength of the housing market.

*Medical Facilities*

Medical facilities within our Real Estate Investments segment receive payment for services primarily from Medicare, Medicaid and health insurance. These properties include SNFs and HOSPs that attract patients who have a need for acute or complex medical attention, preventative medicine or rehabilitation services. Medical facilities are subject to federal and state regulatory oversight and, in the case of hospitals, Joint Commission accreditation.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

*Investment Portfolio Summary*

The following tables summarize information related to the investment portfolios of our Real Estate Investments and SHOP segments as of and for the year ended December 31, 2025 (*$ in thousands*):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| |<br>Number of<br>Properties<sup>1</sup> |<br>Number of<br>Beds / Units |<br>NOI |% of<br>Total NOI | Gross<br>Carrying<br>Amount<sup>2</sup> |
| Real Estate Investments segment: |  |  |  |  |  |
| &nbsp;&nbsp;Real estate properties: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Senior housing - need-driven: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Assisted living facilities | 86 | 4704 | $87830 | 28.9% | $1065152 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Senior living campuses | 9 | 1073 | 14858 | 5.0% | 179351 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total senior housing - need-driven | 95 | 5777 | 102688 | 33.9% | 1244503 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Senior housing - discretionary: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Independent living facilities | 3 | 273 | 1544 | 0.5% | 9233 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Entrance fee communities | 12 | 3201 | 64663 | 21.3% | 804823 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total senior housing - discretionary | 15 | 3474 | 66207 | 21.8% | 814056 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total senior housing | 110 | 9251 | 168895 | 55.7% | 2058559 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Medical facilities: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Skilled nursing facilities | 65 | 8534 | 86915 | 28.6% | 557996 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Hospitals | 1 | 71 | 4308 | 1.4% | 42298 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total medical facilities | 66 | 8605 | 91223 | 30.0% | 600294 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Properties transitioned to SHOP segment |  |  | (2004) | (0.7)% |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other |  |  | 2504 | 0.8% |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total real estate properties | 176 | 17856 | 260618 | 85.8% | 2658853 |
| &nbsp;&nbsp;Mortgage and other notes receivable: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Senior housing - need-driven | 8 | 591 | 7023 | 2.3% | 101219 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Senior housing - discretionary | 1 | 141 | 39 | —% | 11139 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Skilled nursing facilities | 3 | 367 | 2485 | 0.8% | 14748 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Hospitals | 1 | 36 | 1858 | 0.6% | 27220 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mortgage and note payoffs |  |  | 2684 | 0.9% |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other notes |  |  | 9877 | 3.3% | 64367 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total mortgage and other |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;notes receivable | 13 | 1135 | 23966 | 7.9% | 218693 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Real Estate Investments |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;segment portfolio | 189 | 18991 | 284584 | 93.7% | 2877546 |
| SHOP segment: |  |  |  |  |  |
| &nbsp;&nbsp;Real estate properties: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Independent living facilities | 17 | 1994 | 14607 | 4.8% | 412890 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Senior living campuses | 6 | 738 | 3665 | 1.2% | 172844 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Assisted living facilities | 3 | 277 | 862 | 0.3% | 48521 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total SHOP segment portfolio | 26 | 3009 | 19134 | 6.3% | 634255 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total investments portfolio | 215 | 22000 | $303718 | 100.0% | $3511801 |

---

<sup>1&nbsp;&nbsp;&nbsp;&nbsp;</sup>The total number of properties, as presented in the table above, excludes our corporate office building and one property in the Real Estate Investments segment that was classified as assets held for sale as of December 31, 2025.

<sup>2&nbsp;&nbsp;&nbsp;&nbsp;</sup>The total gross carrying amount, as presented in the table above, excludes $2.6 million related to our corporate office and equipment, $4.8 million related to one property in the Real Estate Investments segment that was classified as assets held for sale as of December 31, 2025 and $15.4 million of credit loss reserves related to our mortgage and other notes receivable investments.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

---

| | | | | |
|:---|:---|:---|:---|:---|
| |<br>Number of<br>Properties<sup>1</sup> |<br>NOI<sup>2</sup> |% of<br>Total NOI | Gross<br>Carrying<br>Amount<sup>2</sup> |
| Portfolio summary by operator type: |  |  |  |  |
| &nbsp;&nbsp;Real Estate Investments segment: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Public | 60 | $75824 | 25.0% | $480022 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;National chain (privately owned) | 10 | 16324 | 5.4% | 242308 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Regional | 111 | 178804 | 58.9% | 2050150 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Small | 8 | 10298 | 3.4% | 105066 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Properties transitioned to SHOP segment |  | (2004) | (0.7)% |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mortgage and note payoffs |  | 2684 | 0.9% |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other |  | 2654 | 0.8% |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Real Estate Investments segment portfolio | 189 | 284584 | 93.7% | 2877546 |
| &nbsp;&nbsp;SHOP segment portfolio | 26 | 19134 | 6.3% | 634255 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total investments portfolio | 215 | $303718 | 100.0% | $3511801 |

---

<sup>1&nbsp;&nbsp;&nbsp;&nbsp;</sup>The total number of properties, as presented in the table above, excludes our corporate office building and one property in the Real Estate Investments segment that was classified as assets held for sale as of December 31, 2025.

<sup>2&nbsp;&nbsp;&nbsp;&nbsp;</sup>The total gross carrying amount, as presented in the table above, excludes $2.6 million related to our corporate office and equipment, $4.8 million related to one property in the Real Estate Investments segment that was classified as assets held for sale as of December 31, 2025 and $15.4 million of credit loss reserves related to our mortgage and other notes receivable investments.

The following table provides a summary of the impact of acquired and transitioned properties on our SHOP segment NOI for the year ended December 31, 2025 *($ in thousands):*

---

| | | | | |
|:---|:---|:---|:---|:---|
| |<br>Number of<br>Properties |<br>Number of<br>Units |<br>NOI | Gross<br>Carrying<br>Amount |
| Properties in SHOP segment as of December 31, 2024 | 15 | 1732 | $13089 | $370118 |
| Acquisitions | 4 | 339 | 1642 | 74495 |
| Transitioned properties | 7 | 938 | 4403 | 189642 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total SHOP segment portfolio | 26 | 3009 | $19134 | $634255 |

---

As of December 31, 2025, our average effective annualized NOI for the leased properties in our Real Estate Investments segment was $13,988 per unit for SLCs, $20,519 per unit for ALFs, $5,536 per unit for ILFs, $21,476 per unit for EFCs, $10,105 per bed for SNFs and $60,574 per bed for the HOSP. As of December 31, 2025, the average effective annualized NOI for our SHOP segment was $9,709 per unit.

*Recent Tax Legislation*

In connection with the passing of the One Big Beautiful Bill Act (the "OBBBA") on July 4, 2025, certain changes to U.S. tax laws were approved that impact us and our stockholders. Among other changes, the OBBBA (i) permanently extended the 20% deduction for "qualified REIT dividends" for individuals and other non-corporate taxpayers under Section 199A of the Internal Revenue Code, (ii) increased the percentage limit under the REIT asset test applicable to TRSs from 20% to 25% for taxable years beginning after December 31, 2025 and (iii) increased the base on which the 30% interest deduction limit under Section 163(j) of the Internal Revenue Code applies by excluding depreciation, amortization and depletion from the definition of "Adjusted Taxable Income" for taxable years beginning after December 31, 2024.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

**Fiscal 2025 Investment Activity**

A summary of our significant investment activity that occurred during the year ended December 31, 2025 follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We funded $325.6 million of acquisitions, which included the settlement of $50.8 million of mortgage and other notes receivable as part of the consideration paid by us.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We funded $71.1 million of mortgage and other note investments.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We transitioned seven properties from our Real Estate Investments segment into our SHOP segment and dissolved the Discovery partnership.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We reclassified $3.6 million of assets as held for sale on our consolidated balance sheet as of December 31, 2025 which related to one real estate property in the Real Estate Investments segment.

*Asset Acquisitions*

During the year ended December 31, 2025, we completed the following asset acquisitions (*$ in thousands*):

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | | | | | Buildings, | |
| | | | | | Building | |
| | | | | | Improvements | |
| | | Number of | Asset | | and Intangible | |
| Operator / Manager | Period | Properties | Class | Land | Assets | Total |
| Real Estate Investments segment: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Generations, LLC | Q1 2025 | 1 | SLC | $3062 | $18138 | $21200 |
| &nbsp;&nbsp;&nbsp;&nbsp;Mainstay Healthcare | Q1 2025 | 1 | ALF | 2864 | 5736 | 8600 |
| &nbsp;&nbsp;&nbsp;&nbsp;Juniper Communities, LLC | Q1 2025 | 1 | ALF | 4154 | 42130 | 46284 |
| &nbsp;&nbsp;&nbsp;&nbsp;Agemark Senior Living | Q2 2025 | 6 | ALF | 7461 | 56039 | 63500 |
| &nbsp;&nbsp;&nbsp;&nbsp;Priority Life Care | Q4 2025 | 1 | ALF | 3539 | 48610 | 52149 |
| &nbsp;&nbsp;&nbsp;&nbsp;William James Group, LLC | Q4 2025 | 1 | ALF | 134 | 6903 | 7037 |
| &nbsp;&nbsp;&nbsp;&nbsp;Senior Living | Q4 2025 | 1 | EFC | 4019 | 48514 | 52533 |
| SHOP segment: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Compass Senior Living | Q4 2025 | 4 | SHO | 5173 | 69171 | 74344 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total asset acquisitions |  |  |  | $30406 | $295241 | $325647 |

---

In January 2025, we acquired a 108-unit SLC located in Colorado. The acquisition price was $21.2 million, including $0.2 million in closing costs. The property is leased pursuant to a 10-year triple-net lease with Generations, LLC, which includes two five-year extension options, an initial annual lease rate of 8.0% and fixed annual escalators of 2.0%.

In February 2025, we acquired an 88-unit ALF located in Florida upon the execution of a deed in lieu of foreclosure agreement initiated by Senior Living Management ("SLM") to settle its $10.0 million non-performing mortgage note with us. We recognized the acquired property at its estimated fair value of $8.6 million, which equaled the net carrying value of the mortgage note. Concurrently, we executed a new lease on this acquired property with the existing operator, Mainstay Healthcare. This lease provides for approximately $0.7 million in annual contractual lease payments.

In March 2025, we acquired a 120-unit ALF located in New Jersey. The acquisition price was $46.3 million, including $0.3 million in closing costs. The property is leased pursuant to a 15-year triple-net lease with Juniper Communities, LLC, which includes two five-year extension options, an initial annual lease rate of 8.0% and fixed annual escalators of 2.0%. The lease includes a $0.8 million development commitment which will be added to the respective lease base, if funded.

In April 2025, we acquired a portfolio of six ALFs located in Nebraska for a total purchase price of $63.5 million, including $0.3 million in closing costs. The portfolio of properties is leased pursuant to a 15-year triple-net master lease with Agemark Senior Living, which includes two five-year extension options, an initial annual lease rate of 8.0% and fixed annual escalators of 2.0%.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

In October 2025, we acquired a portfolio of four SHOs located in Oklahoma and Oregon, consisting of two SLCs and two ALFs, with a combined total of 339 units. The total purchase price of $74.3 million, including $0.5 million in closing costs, was partially funded by the cancellation of a $9.5 million mortgage note with us which had an 8.5% annual interest rate. We recognized a $2.2 million in-place lease intangible asset in connection with this acquisition. This portfolio of properties has been included in our SHOP segment and is being managed by the existing operator, Compass Senior Living, pursuant to a management agreement.

In October 2025, we acquired a 251-unit CCRC located in South Carolina from an affiliate of Senior Living. The acquisition price of $52.5 million was partially funded by the cancellation of a $32.7 million mortgage note on the property. The property is being leased back to the affiliate of Senior Living pursuant to a 15-year triple-net lease with two five-year extension options, an initial annual lease rate of 8.25% and fixed annual escalators of 2.0%. Concurrently with the acquisition, we executed a $1.5 million revolving line of credit with the affiliate of Senior Living which has an initial annual interest rate of 8.25% and matures in October 2040.

In December 2025, we acquired a 107-unit ALF located in Pennsylvania. The acquisition price was $52.1 million, including $1.1 million in closing costs. The property is leased pursuant to a five-year triple-net lease with Priority Life Care, which has an initial annual lease rate of 8.0% plus a revenue participation clause and fixed annual escalators of 2.0%.

In December 2025, we acquired a 56-unit ALF located in Alabama. The acquisition price was $7.0 million, including $0.1 million in closing costs. The property was added to our existing triple-net master lease with William James Group, LLC. As of December 31, 2025, this master lease covers four properties, has an annual lease rate of 8.25%, contains fixed annual escalators of 2.0% and matures in November 2037.

*First Quarter of 2026 Acquisitions and Divestitures*

In January 2026, we sold a 42-unit SLC located in Michigan for $6.7 million in net cash consideration. As of December 31, 2025, the net carrying value of this property was $4.2 million. During each of the years ended December 31, 2025, 2024 and 2023, we recognized $0.5 million of rental income related to this property.

In February 2026, we acquired a portfolio of nine ALFs located in Kentucky, South Carolina and Tennessee with a combined total of 460 units. The total purchase price was $105.5 million, including $1.0 million in closing costs. This portfolio of properties has been included in our SHOP segment and is being managed by Allegro Living Management, an affiliate of Spring Arbor Management, LLC pursuant to a management agreement.

*Discovery Transitions*

Effective August 1, 2025, we terminated a triple-net master lease associated with a portfolio of six SHOs, consisting of four SLCs, one ILF and one ALF, which were held in a consolidated partnership with Discovery Senior Housing Investor XXIV, LLC (the "Discovery partner"). The tenant of the triple-net master lease was a related party of Discovery Senior Living ("Discovery"). In connection with the lease termination, we received net cash consideration of $3.1 million and other non-cash consideration of $0.6 million from the tenant and wrote off the related straight-line rents receivable of $8.9 million on this lease. Each of these amounts was recognized in rental income in our consolidated statement of income for the year ended December 31, 2025. Additionally, on August 1, 2025, we entered into a dissolution agreement with the Discovery partner, which provided for the write-off of the remaining partnership liabilities against the equity in the partnership and the Discovery partner contributing its 2.0% noncontrolling common equity interest to us for nominal consideration.

Concurrently with the activities above, we transitioned the portfolio of six SHOs from our Real Estate Investments segment into our SHOP segment and entered into agreements with an affiliate of Sinceri Senior Living ("Sinceri") to serve as the manager of the properties. As of December 31, 2025, the aggregate net carrying value of this portfolio was $124.9 million. Prior to the transition, we recognized rental income of $3.2 million, $6.1 million and $8.6 million during the years ended December 31, 2025, 2024 and 2023, respectively, related to the triple-net master lease.

Also, effective August 1, 2025, we terminated a triple-net lease with an affiliate of Discovery for an ILF in Oklahoma. In connection with the lease termination, we received $0.8 million in cash consideration and $0.8 million in other non-cash consideration from the tenant and wrote off the related straight-line rent receivable of $3.2 million on this lease. Each of these amounts was recognized in rental income in our consolidated statement of income for the year ended December 31, 2025. Concurrently with the lease termination, we transitioned this property from our Real Estate Investments segment into our SHOP segment by contributing it to an existing consolidated partnership with DSHI NHI Holiday LLC (the "Discovery member"). As of December 31, 2025, the net carrying value of this property was $28.4 million. Prior to the transition, we recognized rental income of $1.6 million, $2.8 million and $2.9 million during the years ended December 31, 2025, 2024 and 2023, respectively. related to the triple-net lease.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

*Mortgage and Other Notes Receivable*

*Vizion Health Loan Amendment -* In March 2025, we amended a mezzanine loan agreement with affiliates of Vizion Health to provide additional funding of $5.4 million and to extend the maturity date to May 2028. The interest rate on the loan escalates on July 1<sup>st</sup> of each year. As of December 31, 2025, the principal amount outstanding on the loan was $16.5 million and the annual interest rate was 9.4%.

*Construction Loan -* In May 2025, we entered into a construction loan agreement to fund up to $28.0 million for the development of an 84-unit ALF located in Michigan which will be operated by Encore Senior Living upon completion. The loan agreement provides for an annual interest rate of 9.0% and a maturity date in April 2030. As of December 31, 2025, the principal amount outstanding on this construction loan was $8.5 million.

*Fellowship Carolina Marsh Mortgage Note* - In November 2025, we funded a new $18.8 million mortgage note secured by a 94-unit SLC located in South Carolina. The five-year loan agreement with Fellowship Senior Living has an annual interest rate of 8.5% with an option to purchase the property upon the satisfaction of certain conditions. The loan matures in November 2030.

*Silver Wave Wichita Falls Mortgage Note* - In December 2025, we funded a new $11.3 million mortgage note secured by a 141-unit ILF located in Texas. The five-year loan agreement with affiliates of Silver Wave Capital has an annual interest rate of 8.75% with an option to purchase the property upon the satisfaction of certain conditions. The loan matures in December 2030.

*Assets Held for Sale*

As of December 31, 2025, we had assets held for sale of $3.6 million related to one real estate property in our Real Estate Investments segment. During the years ended December 31, 2025, 2024 and 2023, we recognized rental income of $0.6 million, $0.6 million and $0.4 million, respectively, related to this property. We did not have any assets held for sale as of December 31, 2024.

*Tenant Purchase and Sale Agreement*

We lease a SLC that is subject to a purchase and sale agreement giving the tenant the option to acquire the property for $39.0 million. The purchase and sale agreement, as amended, is subject to monthly renewals through March 2026 by the tenant upon payment of a non-refundable fee. The property was included in real estate properties, net, on our consolidated balance sheets as of December 31, 2025 and 2024. During the years ended December 31, 2025, 2024 and 2023, we recognized rental income of $2.6 million, $2.8 million and $2.8 million, respectively, related to the existing triple-net lease at this property which expires in July 2027. The property will be reclassified to assets held for sale when the sale becomes probable, including when the tenant demonstrates its ability to obtain sufficient financing to close on the sale of the property within the terms of the purchase and sale agreement. As of December 31, 2025, the net carrying value of this property was $18.4 million.

*Tenant Purchase Options*

Certain of our tenant leases contain a purchase option clause allowing the tenant to acquire the leased property at a fixed base price, a fixed base price plus a specified share in any appreciation of the property or a price based on a specified fixed minimum internal rate of return on our investment. As of December 31, 2025, tenants had purchase options on four of our properties, with an aggregate net carrying value of $74.7 million, which have exercise dates ranging between 2028 and 2031. Rental income from these properties with tenant purchase options was $10.0 million, $8.8 million and $7.2 million for the years ended December 31, 2025, 2024 and 2023, respectively. As of December 31, 2025, we cannot reasonably estimate the probability that any of these tenant purchase options will be exercised in the future.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

**Tenant Concentrations**

The following table presents information related to concentrations of our tenants, or affiliates of tenants, that exceed 10% of our total revenues (*$ in thousands*):

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | December 31, 2025 | December 31, 2025 | Year Ended December 31, | Year Ended December 31, | Year Ended December 31, | Year Ended December 31, | Year Ended December 31, | Year Ended December 31, |
| | | | 2025 | | 2024 | | 2023 | |
| | Real<br>Estate<br>Properties<sup>1</sup> | Mortgage<br>and Other<br>Notes<sup>2</sup> |<br>Revenues<sup>3</sup> | % of<br>Total |<br>Revenues<sup>3</sup> | % of<br>Total |<br>Revenues<sup>3</sup> | % of<br>Total |
| Senior Living | $632253 | $9000 | $55091 | 14.7% | $53570 | 16.0% | $51274 | 16.0% |
| Bickford | 427117 | 15959 | 43185 | 11.5% | 41720 | 12.4% | 38688 | 12.1% |
| NHC | 133770 |  | 40272 | 10.7% | 40016 | 11.9% | 37335 | 11.7% |
| Escrow funds received from tenants |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;for property operating expenses |  |  | 10982 | 2.9% | 11165 | 3.3% | 11513 | 3.6% |
| Other | 1465713 | 193734 | 146036 | 38.9% | 134289 | 40.2% | 132216 | 41.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total tenant concentrations | $2658853 | $218693 | 295566 | 78.7% | 280760 | 83.8% | 271026 | 84.7% |
| Resident fees and services<sup>4</sup> |  |  | 80062 | 21.3% | 54421 | 16.2% | 48809 | 15.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total revenues |  |  | $375628 | 100.0% | $335181 | 100.0% | $319835 | 100.0% |

---

<sup>1&nbsp;&nbsp;&nbsp;&nbsp;</sup>Real estate properties have been stated at their gross carrying amounts. Total real estate properties, as presented in the table above, excludes $2.6 million related to our corporate office and equipment, $4.8 million related to one property in the Real Estate Investments segment that was classified as assets held for sale as of December 31, 2025 and $634.3 million related to the properties in our SHOP segment.

<sup>2&nbsp;&nbsp;&nbsp;&nbsp;</sup>Mortgage and other notes receivable have been stated at their gross carrying amounts. Total mortgage and other notes receivable, as presented in the table above, excludes our total credit loss reserves of $15.4 million as of December 31, 2025.

<sup>3&nbsp;&nbsp;&nbsp;&nbsp;</sup>Revenues related to assets classified as held for sale are included in other revenues in the table above.

<sup>4&nbsp;&nbsp;&nbsp;&nbsp;</sup>There are no concentrations in revenues from resident fees and services because the resident agreements at the senior housing communities are between us and the individual residents.

*Senior Living Leases and Loans*

As of December 31, 2025, we leased 11 SHOs with a combined total of 2,490 units to Senior Living. During the years ended December 31, 2025, 2024 and 2023, we recognized straight-line rent revenue of $(0.6) million, $(0.2) million and $(1.2) million, respectively, related to our leases with Senior Living.

As of December 31, 2025, we had a $15.0 million revolving line of credit with Senior Living which is available for working capital needs and to finance construction projects within Senior Living's portfolio, including projects to build additional residential units at existing facilities. The $15.0 million revolving line of credit matures in December 2031. As of December 31, 2025, the principal amount outstanding on this revolving line of credit was $9.0 million and the annual interest rate was 8.0%. We also had a $1.5 million revolving line of credit with an affiliate of Senior Living which has not been drawn as of December 31, 2025.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

*Bickford Leases and Loans*

As of December 31, 2025, we leased 38 SHOs to Bickford under four master leases. In 2022, we began recognizing rental income from Bickford's leases using the cash basis of accounting for revenue recognition based upon information we obtained from Bickford regarding its financial condition that raised substantial doubt about its ability to continue as a going concern.

We have a fully funded construction loan with Bickford that is secured by a first mortgage lien on substantially all of the related real and personal property as well as a pledge of any and all leases or other agreements which may grant a right of use to the property. Pursuant to the loan agreement, Bickford is required to pay the related property taxes and insurance. The loan agreement contains a fair market value purchase option on the property that is available to us upon stabilization of the underlying operations. As of December 31, 2025, the principal amount outstanding on the construction loan was $14.7 million and the annual interest rate was 9.0%.

We have an unsecured mezzanine loan with Bickford that is classified as a non-performing note. The loan has an annual interest rate of 9.0% and matures in May 2033. As of December 31, 2025, the principal amount outstanding on the mezzanine loan was $1.3 million, which was fully covered by the related credit loss reserve.

*NHC Leases*

As of December 31, 2025, we leased 32 SNFs and three ILFs to NHC, a publicly owned company, under a triple-net master lease which expires in December 2026. The master lease includes two five-year extension options in which the annual lease rate resets at the current fair market value as negotiated between the parties. We have engaged Blueprint Healthcare Real Estate Advisors, a national advisory firm focused on skilled nursing and senior housing facilities, to assist with underwriting, due diligence and market analysis with respect to the master lease renewal.

On September 8, 2025, we provided formal written notice to NHC that it is in default of the triple-net master lease as a result of NHC's failure to remedy its non-compliance with certain non-monetary provisions of the triple-net master lease previously identified by us. NHC had 30 days to cure such default and its failure to do so entitles us to declare an event of default and to pursue any and all remedies available to us under the triple-net master lease. We are currently evaluating potential courses of action.

On October 7, 2025, NHC informed us that it was exercising its option to renew the master lease for one five-year term commencing January 1, 2027. We are currently reviewing the effectiveness and legality of NHC's notice.

**Cash Basis Tenants**

During the year ended December 31, 2025, two of our tenants were on the cash basis of accounting for revenue recognition for their leasing arrangements with us based on our assessment of each tenant's ability to satisfy its contractual obligations under the terms of the respective leases. During the years ended December 31, 2024 and 2023, three of our tenants were on the cash basis of accounting for revenue recognition for their leasing arrangements with us.

A summary of lease payments received by us from cash basis tenants follows (*$ in thousands*):

---

| | | | |
|:---|:---|:---|:---|
| | Year Ended December 31, | Year Ended December 31, | Year Ended December 31, |
| | 2025 | 2024 | 2023 |
| Bickford | $40497 | $38971 | $33352 |
| All others | 6633 | 11010 | 12444 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total lease payments from cash basis tenants | $47130 | $49981 | $45796 |

---

These lease payments from cash basis tenants included $5.9 million, $9.0 million and $2.8 million of rent deferrals granted during the COVID-19 pandemic for the years ended December 31, 2025, 2024 and 2023, respectively.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

*SLM Leases*

SLM was a cash basis tenant from 2022 until January 1, 2025 when the remaining two properties leased from us were transitioned to a new operator who had been serving as the interim manager at the properties. Concurrently with this transition, we executed a 15-year triple-net master lease with a new operator which includes two five-year extension options. The master lease with the new operator provides for approximately $1.1 million in initial annual contractual lease payments with fixed annual escalators of 2.0%. As of December 31, 2025, we had no properties leased to SLM.

**Occupancy**

The following table provides a summary of the average occupancy rates related to properties leased to Senior Living and Bickford for the periods indicated:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | Number of<br>Properties |<br>Q4 2025 |<br>Q3 2025 |<br>Q2 2025 |<br>Q1 2025 |<br>Q4 2024 |
| Senior Living<sup>1</sup> | 10 | 84.9% | 83.9% | 83.9% | 84.3% | 83.8% |
| Senior Living | 11 | 84.9% | 83.9% | 83.8% | 84.2% | 83.8% |
| Bickford<sup>2</sup> | 38 | 83.9% | 86.1% | 85.2% | 85.0% | 87.3% |

---

<sup>1</sup>&nbsp;&nbsp;&nbsp;&nbsp;The occupancy rates exclude a 251-unit CCRC acquired in October 2025.

<sup>2&nbsp;&nbsp;&nbsp;&nbsp;</sup>The number of properties related to Bickford includes one property classified as assets held for sale as of December 31, 2025.

The following table provides a summary of the average occupancy rates related to properties in our SHOP segment for the periods indicated:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| Number of properties at the end of the period | 15 | 15 | 15 | 15 | 15 |
| SHOP segment<sup>1</sup> | 86.4% | 87.9% | 89.1% | 89.2% | 89.4% |
| Number of properties at the end of the period | 26 | 22 | 15 | 15 | 15 |
| Total SHOP segment | 86.9% | 87.2% | 89.1% | 89.2% | 89.4% |

---

<sup>1 &nbsp;&nbsp;&nbsp;&nbsp;</sup>The occupancy rates relate to the 15 real estate properties in the SHOP portfolio as of December 31, 2024.

**Tenant Monitoring**

The operators of our properties in the Real Estate Investments segment report to us the results of their operations on a periodic basis, which we in turn subject to further analysis as a means of monitoring potential credit risks within our portfolio. We have identified EBITDARM, which is calculated as earnings before interest, taxes, depreciation, amortization, rent and management fees, as a primary performance measure for our tenants, based on results they have reported to us. We believe EBITDARM is useful in our most fundamental analyses, as it is a property-level measure of an operator's success, by eliminating the effects of the operator's method of acquiring the use of its assets (interest and rent), its non-cash expenses (depreciation and amortization), and expenses that are dependent on its level of success (income taxes), and also excluding the effect of the operator's payment of its management fees, as typically those fees are contractually subordinate to our lease payments. For operators of our EFCs, our calculation of EBITDARM includes other cash flow adjustments typical of the industry which may include, but are not limited to, net cash flows from entrance fees, amortization of deferred entrance fees, adjustments for tenant rent obligations and management fee true-ups. The eliminations and adjustments reflect covenants in our leases and provide a comparable basis for assessing our various relationships.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

We believe that EBITDARM is a useful way to analyze the cash potential of a group of assets. From EBITDARM, we calculate a coverage ratio (EBITDARM / cash rent) measuring the ability of the operator to meet its monthly obligations. In addition to EBITDARM and the coverage ratio, we rely on a careful balance sheet analysis and other analytical procedures to help us identify potential areas of concern relative to our operators' ability to generate sufficient liquidity to meet their obligations, including their obligations to continue to pay the amount due to us. Typical among our operators is a varying lag in reporting to us the results of their operations. Across our portfolio, however, our operators report their results, typically within either 30 or 45 days and at the latest, within 90 days of month end. For computational purposes, we exclude mortgage and other notes receivable, and development and lease-up properties that have been in operation less than 24 months. For stabilized acquisitions in the portfolio less than 24 months and renewing leases with changes in scheduled rent, we include pro forma cash rent. Same-store portfolio coverage, when presented herein, excludes properties that have transitioned operators in the past 24 months or assets subsequently sold except as noted.

The following table provides a summary of our portfolio and coverage ratios by property type on a trailing 12-month basis as of September 30, 2025 and 2024, the most recent periods available:

**Real Estate Investments Portfolio**<sup>1</sup>

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | Senior | | Medical | | | |
| **Ratios by property type:** | Housing | SNF | Non-SNF | Total |  |  |
| Number of properties | 105 | 68 | 1 | 174 |  |  |
| Q3 2025 coverage | 1.61x | 3.28x | 2.54x | 2.19x |  |  |
| Q3 2025 occupancy | 86.5% | 83.1% | 76.7% | 85.0% |  |  |
| Q3 2024 coverage | 1.52x | 3.06x | 3.02x | 2.08x |  |  |
| Q3 2024 occupancy | 85.7% | 82.8% | 78.5% | 84.2% |  |  |
|  |  |  |  | Discretionary |  |  |
|  |  | Need-Driven |  | (Excluding |  | Medical |
|  | Need- | (Excluding |  | Senior |  | (Excluding |
| **Ratios by property class:** | Driven | Bickford) | Discretionary | Living) | Medical | NHC) |
| Number of properties | 91 | 53 | 14 | 4 | 69 | 34 |
| Q3 2025 coverage | 1.50x | 1.37x | 1.74x | 2.37x | 3.25x | 2.42x |
| Q3 2025 occupancy | 86.3% | 86.6% | 86.8% | 91.6% | 83.0% | 78.7% |
| Q3 2024 coverage | 1.40x | 1.22x | 1.67x | 1.97x | 3.06x | 2.21x |
| Q3 2024 occupancy | 86.0% | 86.2% | 85.4% | 89.6% | 82.7% | 75.9% |
|  | Senior |  |  |  |  |  |
| **Ratios by customer:** | Living<sup>2</sup> | Bickford<sup>3</sup> | NHC<sup>4</sup> |  |  |  |
| Number of properties | 11 | 38 | 35 |  |  |  |
| Q3 2025 coverage | 1.51x | 1.72x | 4.33x |  |  |  |
| Q3 2025 occupancy | 83.9% | 85.9% | 89.3% |  |  |  |
| Q3 2024 coverage | 1.54x | 1.70x | 4.13x |  |  |  |
| Q3 2024 occupancy | 82.9% | 85.6% | 88.5% |  |  |  |

---

<sup>1&nbsp;&nbsp;&nbsp;&nbsp;</sup>The tables are based on trailing 12-month data, excluding (1) transitioned properties of cash basis tenants, (2) mortgage and other notes receivable, (3) development and lease-up properties operating less than 24 months and (4) the impact of security deposits maintained on any tenants. The tables include pro forma cash inflow from rent payments related to acquired properties that have stabilized operations and that have been in the portfolio less than 24 months.

<sup>2&nbsp;&nbsp;&nbsp;&nbsp;</sup>Senior Living's coverage ratios reported in the table above include the impact of our acquisition of a 251-unit CCRC in October 2025 for all periods presented. Senior Living's coverage ratios for the other 10 properties were 1.50x and 1.56x for the trailing 12 months ended September 30, 2025 and 2024.

<sup>3&nbsp;&nbsp;&nbsp;&nbsp;</sup>Bickford's coverage ratios on a pro forma basis, which includes the impact of the April 2024 rent increase, were 1.72x and 1.63x for the trailing 12 months ended September 30, 2025 and 2024, respectively. Bickford's coverage ratios on a pro forma basis, which includes the impact of the April 2024 rent increase and rent deferral repayments made by Bickford during the respective periods, were 1.49x and 1.42x for the trailing 12 months ended September 30, 2025 and 2024, respectively.

<sup>4</sup>&nbsp;&nbsp;&nbsp;&nbsp;NHC's coverage ratios have been reported in the table above at a consolidated level for NHC. The occupancy ratios for SNFs have been reported in the table above using data available in NHC's public filings with the SEC.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

Fluctuations in our portfolio coverage and occupancy ratios primarily result from market and economic trends, local market competition, new or changing regulatory factors and the operational success of our tenants. In addition to the analysis above, we also evaluate and make decisions with respect to our tenants at an individual lease level. Generally, we have security deposits and/or corporate guarantees in place with many of our tenants if lease payment shortfalls materialize. In some instances, we may require a tenant to increase their security deposit with us in an amount equal to the lease payment shortfall until the required tenant lease coverage ratio is met. We monitor economic and financial conditions and also use credit enhancements, such as requiring our tenants to maintain security deposits and corporate guarantees with us, to mitigate the impact of an economic downturn on our business. The metrics presented in the tables above do not reflect the presence of these security deposits.

**Critical Accounting Estimates**

We prepare our consolidated financial statements in conformity with U.S. GAAP, which require us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, we reconsider and evaluate our estimates and assumptions. Management has discussed the development and selection of its critical accounting policies and estimates with the Audit Committee of our Board of Directors.

We consider an accounting estimate or assumption critical if the nature of the estimate or assumption is material due to the levels of subjectivity and judgment necessary to account for highly uncertain matters or the susceptibility of such matters to change and if the impact of the estimate or assumption on financial condition or operating performance is material. We base our estimates on historical experience, current trends and various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. If actual experience differs from the assumptions and other considerations used in estimating amounts reflected in our consolidated financial statements, the resulting changes could have a material adverse effect on our consolidated results of operations, liquidity and/or financial condition.

Our significant accounting policies are discussed in Note 2 to our consolidated financial statements in this Annual Report. We believe the accounting estimates included below are the most critical for fully understanding and evaluating our financial results and require our most difficult, subjective or complex judgments.

*Variable Interest Entities*

Our consolidated financial statements include our wholly owned subsidiaries and partnerships that we control through voting rights or other means. We evaluate our contractual arrangements with other entities to identify those relationships in which control is achieved though means other than voting rights. A variable interest entity ("VIE") is broadly defined as an entity with one or more of the following characteristics: (a) the total equity investment at risk is insufficient to finance the entity's activities without additional subordinated financial support; (b) as a group, the holders of the equity investment at risk lack (i) the ability to make decisions about the entity's activities through voting or similar rights, (ii) the obligation to absorb the expected losses of the entity, or (iii) the right to receive the expected residual returns of the entity; or (c) the equity investors have voting rights that are not proportional to their economic interests, and substantially all of the entity's activities either involve, or are conducted on behalf of, an investor that has disproportionately few voting rights.

We make judgments about which entities are VIEs based on the criteria above and with respect to our level of influence or control of an entity and whether we are the primary beneficiary of a VIE. These considerations include, but are not limited to, our power to direct the activities that most significantly impact the entity's economic performance, the obligation to absorb losses or the right to receive benefits of the VIE that could be significant to the entity, and our ability and the rights of other investors to participate in policy making decisions, replace the manager and/or liquidate the entity. Our ability to correctly determine the primary beneficiary of a VIE at inception of our involvement impacts the presentation of these entities in our consolidated financial statements.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

*Asset Acquisitions*

Our investments in real estate properties are accounted for as asset acquisitions. We allocate the purchase price to the identified tangible and intangible assets at cost based on the relative fair values of the assets as of the acquisition date. The related transaction costs are included in the purchase price allocation. Contingent consideration deemed to be probable at the acquisition date, if any, is also included in the purchase price allocation to the extent that a significant reversal in amounts recognized is not likely to occur and the uncertainty associated with the contingent consideration has been resolved.

The most significant judgments applied in our purchase price allocations are typically related to the determination of the fair values of land, buildings, building improvements and intangible assets. Our estimates of the individual fair values of the assets acquired affect the amounts of depreciation and amortization we recognize over the respective estimated useful lives of the assets or the respective remaining lease term. While we believe our assumptions are reasonable, any changes in these assumptions could have a material impact on our financial results. We do not believe there is a reasonable likelihood that there will be a material change in the future estimates or assumptions we use for our purchase price allocations.

*Impairment of Real Estate Properties*

We evaluate the recoverability of the carrying values of our real estate properties on an individual property basis. We review each property for recoverability when events or circumstances, including any significant physical changes in a property, significant adverse changes in general economic conditions or significant deterioration of the underlying cash flows of a property indicate that the carrying amount of a property may not be recoverable. When indicators of potential impairment are present, we assess whether an impairment charge is needed by comparing the future estimated undiscounted cash flows and eventual disposition of the identified asset to its carrying amount. If recognition of an impairment charge is necessary, it is measured as the amount by which the carrying value of the identified asset exceeds its estimated fair value.

The most significant judgments applied in our analysis of the recoverability of the carrying values of our real estate properties relate to the determination of whether indicators of impairment exist and the determination of the future estimated undiscounted cash flows of the property. There were no material changes in the accounting methodology we used to evaluate the recoverability of our real estate properties during the year ended December 31, 2025.

*Lease Classifications*

Lease accounting standards require that, for purposes of lease classification, we assess whether the lease, by its terms, transfers substantially all of the fair value of the asset under lease to the tenant. This consideration will determine the accounting treatment for the alternative classifications among operating, sales-type, or direct financing types of leases. For classification purposes, we distinguish cash flows that follow under terms of the lease from those that will be derived, subsequent to the lease, from the ultimate disposition or re-deployment of the asset. From this segregation of the sources of cash flow, we are able to establish whether the lease is, in essence, a sale or financing based on it having transferred substantially all of the fair value of the leased asset. Accordingly, management's projected residual values represent significant assumptions in our accounting for leases.

While we do not incorporate residual value guarantees in our lease provisions, the contractual structure of other provisions provides a basis for expectations of realizable value from our properties upon expiration of their lease terms. Additionally, we consider historical, demographic and market trends in developing our estimates. For each new lease, we discount our estimate of unguaranteed residual value and include this amount along with the stream of lease payments (also discounted) called for in the lease. We assess the stream of lease payments and the value deriving from eventual return of our property to establish whether the lease payments themselves comprise a return of substantially all of the fair value of the property under lease. We do not use a "bright line" in considering what constitutes "substantially all of the fair value", but we undertake a more focused assessment when the lease payments approach 90% of the composition of all future cash flows expected from the asset. We do not believe there is a reasonable likelihood that there will be a material change in the future estimates or assumptions we use to assess lease classifications.

*Credit Loss Reserves on Mortgage and Other Notes Receivable*

We evaluate the collectability of our mortgage and other notes receivable and establish reserves for expected credit losses at the inception of these investments and subsequently on a quarterly basis at the end of the period. We take into consideration criteria, such as the borrower's timeliness of required payments, the borrower's current financial condition and the borrower's compliance with other covenants and terms of the loan agreement. If we conclude that a loan has become non-performing, we place it on non-accrual status in the period in which it becomes known and probable that the borrower cannot pay the contractual amounts due to us. A non-performing loan is returned to accrual status if the borrower becomes contractually current on payments and management believes all future principal and interest will be received from the tenant in accordance with the terms of the loan agreement.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

Our models for estimating the future expected credit losses on mortgages and construction loans are calculated on a collective basis for these loan types. Our models for estimating the future expected credit losses on mezzanine loans and revolving credit lines are calculated on an individual loan basis or a borrower-specific basis for these loan types. We use a combination of credit quality indicators in our models including, among others, the current payment status of the loans, the overall financial strength of the borrowers and any guarantors, historical information on any loan write-offs related to our borrowers and the nature, extent and value of underlying collateral on the loans. In addition, we adjust our models using the probability of default method related to any current economic or other conditions occurring or becoming known during the reporting period and any changes in our most recent forecasts that exist as of the end of the reporting period which impact our previous estimates of necessary credit loss reserves. For construction loans, we perform an assessment each period end of the probability that we will acquire any properties in the event of default on any of these loans and, when necessary, reduce the basis of the applicable loans by the amounts that we expect to recover when construction of the applicable properties is complete.

Our most significant judgments in determining whether credit loss reserves are necessary relate to the assumptions we apply in assessing the probability of default or a loss as a result of a default by one or more of our borrowers. We assess all the evidence available to us, including the present value of the expected future discounted cash flows from a mortgage or note, general economic conditions and trends, the duration of a fair value deficiency and other relevant factors. When an economic downturn occurs that has a duration that is expected to span a year or more, we consider projections on the expected economic recovery before we conclude that evidence of impairment exists. While we believe our assumptions are reasonable, any changes in our assumptions may have a material impact on our financial results.

**Other Investment Portfolio Activity**

*Real Estate and Mortgage Write-downs*

In addition to inflation risk and increased interest rates, our tenants and borrowers may experience periods of significant financial pressures and difficulties similar to those encountered by other healthcare providers.

As of December 31, 2025, we had two loans designated as non-performing notes consisting of an unsecured mezzanine loan with a principal balance of $12.0 million due from affiliates of SLM and an unsecured loan due from Bickford with a principal balance of $1.3 million. These loans are fully covered by our credit loss reserves.

As of December 31, 2025, we reduced the carrying value of our mortgage and other notes receivable by a reserve for expected credit losses of $15.4 million and recognized a liability of $0.2 million for estimated credit losses on unfunded loan commitments. During the years ended December 31, 2025, 2024 and 2023, we recognized a provision for (reduction in) expected credit losses of $(3.4) million, $4.6 million and $(0.3) million, respectively.

We had no impairment charges related to long-lived assets during the year ended December 31, 2025. During the year ended December 31, 2024, we recognized an impairment charge of $0.7 million related to one property in our Real Estate Investments segment which was reclassified to assets held for sale in the second quarter of 2024 and sold in the fourth quarter of 2024. During the year ended December 31, 2023, we recognized impairment charges of $1.6 million related to four properties in our Real Estate Investments segment, which included $0.5 million of impairment charges on three of these properties which were either sold or reclassified to assets held for sale during the year ended December 31, 2023.

We believe that the carrying amounts of our real estate properties are recoverable and that mortgage and other notes receivables, net of credit loss reserves, are realizable and supported by the value of the underlying collateral. However, it is possible that future events could require us to make additional significant adjustments to these carrying amounts.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

**Results of Operations**

A summary of our operating results follows (*$ in thousands*):

---

| | | | |
|:---|:---|:---|:---|
| | Year Ended | Year Ended | |
| | December 31, | December 31, |<br>Variance |
| | 2025 | 2024 | $% |
| Revenues |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Rental income: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisitions | $23270 | $3741 | NM |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Discovery transitions | 10346 | 7668 | 34.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All other tenant leases | 237168 | 234337 | 1.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total cash rental income | 270784 | 245746 | 10.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Straight-line rent revenue adjustments | (7265) | 3031 | NM |
| &nbsp;&nbsp;&nbsp;&nbsp;Escrow funds received from tenants for |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;property operating expenses | 10982 | 11165 | (1.6)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of lease incentives | (2901) | (2893) | 0.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total rental income | 271600 | 257049 | 5.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;Resident fees and services | 80062 | 54421 | 47.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest and other income |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Senior Living Management |  | 1143 | (100.0)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Sanders Trust, LLC | 1858 | 128 | NM |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mortgage and other note payoffs | 2684 | 1242 | NM |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All other mortgage and notes receivable | 19274 | 20730 | (7.0)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total interest income | 23816 | 23243 | 2.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other income | 150 | 468 | (67.9)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revenues | 375628 | 335181 | 12.1% |
| Expenses: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisitions | 9733 | 1315 | NM |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All other assets | 71211 | 70128 | 1.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total depreciation and amortization | 80944 | 71443 | 13.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest | 57368 | 59903 | (4.2)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Senior housing operating expenses | 60928 | 42251 | 44.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Legal | 2666 | 1052 | NM |
| &nbsp;&nbsp;&nbsp;&nbsp;Franchise, excise and other taxes | 1080 | 38 | NM |
| &nbsp;&nbsp;&nbsp;&nbsp;Taxes and insurance on leased properties | 10982 | 11165 | (1.6)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Proxy contest and related expenses | 1572 |  | NM |
| &nbsp;&nbsp;&nbsp;&nbsp;Loan and realty (gains) losses, net | (3447) | 5295 | NM |
| &nbsp;&nbsp;&nbsp;&nbsp;Other expenses | 26868 | 20736 | 29.6% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total expenses | 238961 | 211883 | 12.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;Gains on sales of real estate properties, net | 456 | 6678 | (93.2)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Gains from equity method investment | 3664 | 402 | NM |
| &nbsp;&nbsp;&nbsp;&nbsp;Gains on forward equity sales agreements, net |  | 6261 | NM |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income | 140787 | 136639 | 3.0% |
| Add: Net loss attributable to noncontrolling interests | 1390 | 1346 | 3.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income attributable to stockholders | 142177 | 137985 | 3.0% |
| Less: Net income attributable to unvested restricted |  |  |  |
| &nbsp;&nbsp;stock awards | (201) | (118) | 70.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income attributable to common stockholders | $141976 | $137867 | 3.0% |

---

NM - not meaningful

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

Financial highlights for the year ended December 31, 2025, compared to the year ended December 31, 2024, were as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Rental income increased $14.6 million, or 5.7%, primarily due to $19.5 million of increased rental income from real estate properties in our Real Estate Investments segment that were acquired after January 1, 2024. We had a net decrease in rental income of $11.0 million related to the seven properties transitioned into the SHOP segment on August 1, 2025 from the Real Estate Investments segment.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Resident fees and services, less senior housing operating expenses, increased $7.0 million, or 57.2%. We had an increase of $4.4 million resulting from the seven properties transitioned into the SHOP segment on August 1, 2025 and an increase of $1.6 million related to current year acquisitions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Interest income from mortgage and other notes receivable increased $0.6 million, or 2.5%. New investments since January 1, 2024 were mostly offset by mortgage and other notes payoffs since January 1, 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Depreciation and amortization expense increased $9.5 million, or 13.3%, which included an $8.4 million increase as a result of acquisitions since January 1, 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Interest expense decreased $2.5 million, or 4.2%, primarily due to a decrease in interest rates on our variable rate debt.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Legal expense increased $1.6 million primarily from $1.2 million of costs incurred in the current year related to a large SHOP transaction that did not materialize and also the costs incurred in the current period related to the concurrent transactions on August 1, 2025 to terminate leases, transition properties to the SHOP segment and dissolve the Discovery partnership.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Proxy contest and related expenses were $1.6 million for the year ended December 31, 2025 with no comparable costs in the prior year. These expenses consisted of proxy advisory costs related to our response to a proxy campaign associated with our 2025 annual meeting of stockholders.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Loan and realty (gains) losses, net, was a net gain of $3.4 million for the year ended December 31, 2025 compared to a net loss of $5.3 million for the year ended December 31, 2024. The net gain in the current year primarily related to a reduction in our credit loss reserves related to loans that were paid off during the current year. The net loss in the prior year primarily related to an increase in the credit loss reserve on a mezzanine loan due from SLM.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Other expenses increased $6.1 million, or 29.6%, primarily due to higher compensation costs and increases in professional fees and other purchased services.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Gains on sales of real estate properties, net, was $0.5 million in the year ended December 31, 2025 compared to $6.7 million in the year ended December 31, 2024. In the prior year, we sold four real estate properties in our Real Estate Investments segment.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Gains from equity method investment were $3.7 million in the year ended December 31, 2025 compared to $0.4 million in the year ended December 31, 2024. The current period included $1.7 million of gains due to a distribution received from our equity method investment.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Gains from forward equity sales agreements were $6.3 million in the year ended December 31, 2024 with no comparable amount in the year ended December 31, 2025. During the year ended December 31, 2024, we recognized a gain on forward equity sales agreements under our ATM equity program for the period in which these agreements did not qualify for equity treatment under GAAP.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

**Liquidity and Capital Resources**

At December 31, 2025, we had $496.0 million available to draw on our $700.0 million unsecured revolving credit facility ("Credit Facility"), $19.6 million in unrestricted cash and cash equivalents, the ability to access $44.5 million of undrawn net proceeds through ATM forward sales agreements and the ability to access $315.8 million through the issuance of common stock under our ATM equity program. In addition, we maintain an effective automatic shelf registration statement through which capital could be raised through the issuance of additional debt or equity securities.

*Sources and Uses of Funds*

Our primary sources of cash include lease payments from tenants, receipts from residents, principal and interest payments on mortgage and other notes receivable, proceeds from the sales of real estate properties, net proceeds from offerings of debt and equity securities and borrowings from our Credit Facility. Our primary uses of cash include principal and interest payments on our debt, investments in new and existing real estate properties, mortgage and other notes, dividend distributions to our stockholders, operating expenses of our SHOP segment and general corporate overhead expenses.

A summary of our sources and uses of cash, cash equivalents and restricted cash follows (*$ in thousands):*

---

| | | | |
|:---|:---|:---|:---|
| | Year Ended December 31, | Year Ended December 31, | Variance |
| | 2025 | 2024 | $% |
| Cash, cash equivalents and restricted cash |  |  |  |
| &nbsp;&nbsp;at the beginning of the year | $26502 | $24617 | 7.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by operating activities | 236563 | 207768 | 13.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;Net cash used in investing activities | (269149) | (192315) | 40.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by (used in) financing activities | 25708 | (13568) | NM |
| Cash, cash equivalents and restricted cash |  |  |  |
| &nbsp;&nbsp;at the end of the year | $19624 | $26502 | (26.0)% |

---

NM Not meaningful

*Operating Activities –* Net cash provided by operating activities for the year ended December 31, 2025 included the impact of new tenant leases from acquisitions completed during the year, our SHOP segment operations, increased rental income due to rent escalators and interest payments on new loan investments completed during the year.

*Investing Activities –* Net cash used in investing activities for the year ended December 31, 2025 was primarily comprised of $365.1 million of investments in real estate properties, development projects at existing properties and mortgages and other notes, partially offset by the collection of principal amounts due on mortgage and other notes receivable during the year.

*Financing Activities –* Net cash provided by financing activities for the year ended December 31, 2025 included $346.2 million in proceeds received from the issuance of the 2033 Senior Notes and $181.5 million in proceeds received from the issuance of common shares, partially offset by $127.2 million of net paydown on our Credit Facility, $200.8 million of repayments on our term loan and private placement notes and $169.7 million of dividend payments to stockholders.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

*Debt Obligations*

As of December 31, 2025, we had $1.2 billion of outstanding indebtedness. Reference Note 8 to our consolidated financial statements included in this Annual Report for additional information on our debt. Reference "Part II, Item 7A. Quantitative and Qualitative Disclosures About Market Risk" in this Annual Report for more details on the impact of interest rate risk on our business.

*Revolving Credit Facility and Bank Term Loan* - We have a $700.0 million Credit Facility that matures in October 2028, which may be further extended by us pursuant to (i) one or both of the six-month extension options or (ii) one 12-month extension option. In October 2025, we amended the Credit Facility to remove the 0.10% credit spread adjustment applicable to the SOFR interest rates, which resulted in an effective decrease of 0.10% in the applicable interest rates with respect to the Credit Facility. Borrowings under the Credit Facility bear interest, at our election, at one of the following (a) Term SOFR plus a margin ranging from 0.725% to 1.400%, (b) Daily SOFR plus a margin ranging from 0.725% to 1.400% or (c) the base rate plus a margin ranging from 0.000% to 0.400%. In each election, the actual margin is determined according to our credit ratings. The base rate means, for any day, a fluctuating interest rate per annum equal to the highest of (x) the agent's prime rate, (y) the federal funds rate on such day plus 0.50% or (z) the adjusted Term SOFR for a one-month tenor in effect on such day plus 1.0%. In addition, the Credit Facility requires a facility fee equal to 0.125% to 0.300%, based on our credit rating on the $700.0 million committed capacity, without regard to usage.

As of December 31, 2025, we had $496.0 million available to draw on the Credit Facility, subject to usual and customary covenants. Among other stipulations, our Credit Facility requires that we maintain certain financial ratios within limits set by our creditors. As of December 31, 2025, we were in compliance with these covenants.

We have a $200.0 million unsecured bank term loan (the "Bank Term Loan"), which was amended and restated in October 2024 to, among other things, align certain representations, covenants and events of default with the terms of the amended and restated Credit Facility. The Bank Term Loan bears interest at a variable rate which is SOFR-based with a margin determined according to our credit ratings. Concurrently with the most recent amendment of the Credit Facility in October 2025, we also amended the Bank Term Loan to remove the 0.10% credit spread adjustment applicable to the SOFR interest rates, which was also in alignment with the Credit Facility amendment.

During the year ended December 31, 2025, we repaid $75.0 million on the Bank Term Loan and exercised both six-month extension options, which extended the maturity of the Bank Term Loan to June 2026.

Pinnacle Bank is a participating member of our banking group. A member of our Board of Directors, who became the chairman of our Board of Directors effective in January 2025, is also the chairman of the board of directors of Pinnacle Financial Partners, Inc., the holding company for Pinnacle Bank. Our corporate banking transactions are conducted primarily through Pinnacle Bank.

We have provided summary information in the table below on the current SOFR credit spread adjustments and facility fee for our Credit Facility and Bank Term Loan reflecting our ratings compliance based on the applicable margin for SOFR loans with a debt rating of BBB-/Baa3:

---

| | | | |
|:---|:---|:---|:---|
| | SOFR Credit Spread Adjustments | SOFR Credit Spread Adjustments | SOFR Credit Spread Adjustments |
| | Credit | Credit | Bank |
| Debt Ratings | Facility | Facility Fee | Term Loan |
| A-/A3 | 0.725% | 0.125% | 0.850% |
| BBB+/Baa1 | 0.775% | 0.150% | 0.900% |
| BBB/Baa2 | 0.850% | 0.200% | 1.000% |
| BBB-/Baa3 | 1.050% | 0.250% | 1.250% |
| Lower than BBB-/Baa3 | 1.400% | 0.300% | 1.650% |

---

If our credit rating from at least two credit rating agencies is downgraded below "BBB-/Baa3", the debt under our debt agreements will be subject to defined increases in interest rates and fees.

*2031 Senior Notes* - In January 2021, we issued $400.0 million in aggregate principal amount of 3.000% unsecured senior notes that mature in February 2031 (the "2031 Senior Notes") and require semi-annual interest payments. The 2031 Senior Notes are subject to affirmative and negative covenants, including financial covenants. As of December 31, 2025 we were in compliance with these covenants.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

*2033 Senior Notes* - In September 2025, we issued $350.0 million in aggregate principal amount of 5.350% unsecured senior notes that mature in February 2033 (the "2033 Senior Notes"). The 2033 Senior Notes were sold at an issue price of 98.903% of face value, before the underwriters' discounts. Our net proceeds from the 2033 Senior Notes offering, after deducting underwriting discounts and expenses, were $342.5 million. We used the net proceeds to repay existing indebtedness. Interest on the 2033 Senior Notes is due semi-annually beginning in February 2026. The 2033 Senior Notes are subject to affirmative and negative covenants, including financial covenants. As of December 31, 2025 we were in compliance with these covenants.

*Private Placement Notes* - As of December 31, 2025, we had $100.0 million of principal amounts outstanding on our unsecured private placement notes. During the year ended December 31, 2025, we repaid $50.0 million of these notes upon maturity. The remainder of the private placement notes mature in January 2027 and have an annual interest rate of 4.51%.

*Fannie Mae Term Loans -* During the year ended December 31, 2025, we made the final repayment of $75.8 million, including accrued interest.

*Debt Maturities -* Reference Note 8 to the consolidated financial statements included in this Annual Report.

*Credit Ratings -* Moody's Investors Services reaffirmed its credit rating and a senior unsecured debt rating of Baa3 and "Stable" outlook on NHI on September 21, 2025. Fitch Ratings reaffirmed its public issuer credit rating of BBB- and "Stable" outlook on NHI on April 16, 2025 and S&P Global reaffirmed its BBB- rating and "Stable" outlook on NHI on October 6, 2025. Our unsecured private placement notes agreements include a rate increase provision that is effective if any rating agency lowers our credit rating below investment grade and our compliance leverage increases to 50% or more. Any reduction in outlook or downgrade in our credit ratings from the rating agencies could negatively impact our costs of borrowings.

*Debt Metrics -* We believe that our fixed charge coverage ratio, which is the ratio of Adjusted EBITDA (earnings before interest, taxes, depreciation and amortization, excluding impairments of real estate properties and gains on dispositions) to fixed charges (interest expense at contractual rates, net of capitalized interest and principal payments on debt), and the ratio of consolidated net debt (debt less cash and cash equivalents) to Adjusted EBITDA are meaningful measures of our ability to service our debt. We use these two measures as a useful basis to compare the strength of our consolidated balance sheet with those of our peer group. We also believe our consolidated balance sheet gives us a competitive advantage when accessing debt markets.

Our fixed charge ratio was 5.3x for the year ended December 31, 2025. Reference the "Adjusted EBITDA" section below for a table showing the fixed charge ratio calculation. Giving effect to significant acquisitions, financing arrangements, dispositions and note payoffs on an annualized basis, our consolidated net debt to annualized Adjusted EBITDA ratio for the year ended December 31, 2025 was as follows (*$ in thousands*):

---

| | | |
|:---|:---|:---|
| Consolidated Total Debt | $1163814 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Cash and cash equivalents | (19624) |  |
| Consolidated Net Debt | $1144190 |  |
| Adjusted EBITDA | $287650 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Annualized impact of recent investments, dispositions and payoffs | 11149 |  |
| Annualized Adjusted EBITDA | $298799 |  |
| Consolidated Net Debt to Annualized Adjusted EBITDA | 3.8 | x |

---

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

*Supplemental Guarantor Financial Information*

The principal amounts due on each of our debt instruments outstanding as of December 31, 2025 are fully and unconditionally guaranteed on a senior unsecured basis by each of our subsidiaries, except for certain excluded subsidiaries (the "Guarantors"). The Guarantors are either owned or controlled by, or are affiliates of, us.

The following tables present summarized financial information NHI and the Guarantors, on a combined basis after eliminating (i) intercompany transactions and balances among the Guarantors and (ii) equity in earnings from, and any investments in, any subsidiary that is a non-guarantor *($ in thousands)*:

---

| | |
|:---|:---|
| | December 31,<br>2025 |
| Real estate properties, net | $2232633 |
| Other assets, net | 310682 |
| Note receivable due from non-guarantor subsidiary | 81490 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total assets | $2624805 |
| Debt, net | $1163814 |
| Other liabilities | 92246 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | $1256060 |
| Redeemable noncontrolling interest | $10195 |
| Noncontrolling interests | 1241 |

---

---

| | |
|:---|:---|
| | Year Ended<br>December 31,<br>2025 |
| Revenues | $360549 |
| Interest income on a note due from non-guarantor subsidiary | 5767 |
| Expenses | 227734 |
| Gains from equity method investment | 3664 |
| Gains on sales of real estate properties, net | 456 |
| Other non-operating gains, net | 3 |
| Net income | $142705 |
| Net income attributable to NHI and the subsidiary guarantors | $144095 |

---

*Equity and Dividends*

As of December 31, 2025, we had 48,302,944 shares of our common stock outstanding with a market value of $3.7 billion. We had $1.5 billion of total equity on our consolidated balance sheet as of December 31, 2025.

*Dividends* - Our Board of Directors approves a regular quarterly dividend which is reflective of expected taxable income on a recurring basis. Taxable income is determined in accordance with the Internal Revenue Code and differs from net income for financial statement purposes that has been determined in accordance with GAAP. Our Board of Directors has historically directed us towards maintaining a strong consolidated balance sheet. Therefore, we consider the competing interests of short-term and long-term debt interest rates, maturities and other terms versus the higher cost of new equity, and we accept some level of risk associated with leveraging our investments. We intend to continue to make new investments that meet our underwriting criteria and where the credit spread over our costs of equity and debt capital on a leverage neutral basis will generate sufficient returns to our stockholders. We do not expect to utilize borrowings to satisfy the payment of dividends and project that cash flows from operations will be adequate to fund dividends at the current rate.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

We intend to comply with REIT dividend requirements that require us to distribute at least 90% of our annual taxable income for the year ended December 31, 2025 and thereafter. Historically, we have distributed at least 100% of our annual taxable income. Dividends declared for the fourth quarter of each fiscal year that are paid by the end of the following January are treated for federal income tax purposes, with some exceptions, as having been paid in the fiscal year just ended as provided in Section 857(b)(9) of the Internal Revenue Code. To the extent a portion, or all of such dividend, exceeds our current year earnings and profits, the excess is treated as having been received in the year paid for federal income tax purposes.

A summary of our cash distributions paid to common stockholders for federal income tax purposes on a per share basis follows:

---

| | | | |
|:---|:---|:---|:---|
| | Year Ended December 31, | Year Ended December 31, | Year Ended December 31, |
| | 2025 | 2024 | 2023 |
| Ordinary income | $3.16 | $2.84 | $2.41 |
| Capital gains |  |  | 0.25 |
| Return of capital | 0.32 |  | 0.94 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total cash distributions on a per share basis | $3.48 | $2.84 | $3.60 |

---

Pursuant to Section 857(b)(9) of the Internal Revenue Code, the aggregate amount of cash distributions paid to common stockholders for federal income tax purposes is limited to our earnings and profits for the respective year. As a result, the $0.92 per share cash distribution paid by us on January 30, 2026 to stockholders of record as of December 31, 2025 was treated as received by our common stockholders on December 31, 2025 for federal income tax purposes up to the extent of our earnings and profits for the year ended December 31, 2025. The remainder of the $0.92 per share cash distribution received by our common stockholders was recognized in the year ending December 31, 2026 for federal income tax purposes.

During the years ended December 31, 2025, 2024 and 2023, we declared dividends of $3.64 per share, $3.60 per share and $3.60 per share, respectively. On February 17, 2026, the Board of Directors declared a $0.92 per share dividend payable on May 1, 2026 to common stockholders of record on March 31, 2026.

*Shelf Registration Statement -* We have an automatic shelf registration statement on file with the SEC that allows us to offer and sell to the public an unspecified amount of common stock, preferred stock, debt securities, warrants and/or units at prices and on terms to be announced when and if such securities are offered. The details of any future offerings, along with the use of proceeds from any securities offered, will be described in a prospectus supplement or other offering materials at the time of offering. Our shelf registration statement expires in March 2026.

*Forward Equity Sales Agreements* - During the year ended December 31, 2024, we entered into forward equity sales agreements with financial institutions to sell up to an aggregate of 2.8 million shares of common stock, at an initial forward sale price of $68.40 per share, pursuant to which the financial institutions borrowed and sold these shares of common stock in a public offering. We did not receive any proceeds from the sale of the shares of common stock by the forward purchasers at the time of the offering. The net forward sale price that we received upon physical settlement of the forward sales agreements is subject to adjustment for (i) a floating interest rate factor equal to a specified daily rate less a spread and (ii) scheduled dividends during the term of the forward equity sales agreements.

During the year ended December 31, 2024, we partially settled the above forward equity sales agreements by issuing 1.8 million shares of our common stock at a forward price of $68.00 per share for net proceeds of $122.4 million. During the year ended December 31, 2025, we settled the remainder of the above forward equity sales agreements by issuing 1.0 million shares of our common stock at a forward price of $68.21 per share for proceeds of $65.5 million.

*ATM Equity Program -* We maintain an ATM equity program which allows us to sell our common stock directly into the market. This program is governed by an ATM equity sales agreement which includes a forward sales provision that allows us to sell shares of our common stock to forward purchasers at a predetermined price at a future date. Pursuant to this agreement, we are authorized to sell up to $500.0 million of our common stock.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

During the year ended December 31, 2024, we entered into an ATM forward sales agreement with a financial institution to sell shares of our common stock over a forward selling period to be completed by the end of the year. Pursuant to this agreement, we sold 1.0 million shares of our common stock on a forward basis at a weighted average price of $74.99 per share, net of sales agent fees, which totaled $74.2 million. In accordance with Financial Accounting Standards Board's ("FASB") Accounting Standards Codification ("ASC") 815-40, Derivatives and Hedges, Contracts in Entity's Own Equity, we determined the ATM forward sales under this agreement did not qualify for equity classification on our consolidated balance sheet during the forward selling period. Accordingly, we recognized a $6.3 million gain on the forward sales agreement in our consolidated statement of income for the year ended December 31, 2024. We settled a portion of the ATM forward sales agreement during the year ended December 31, 2024 by issuing 0.3 million shares of our common stock for net proceeds of $20.0 million, or $75.22 per share.

During the year ended December 31, 2025, we entered into multiple ATM forward sales agreements with financial institutions to sell shares of our common stock. Pursuant to these agreements, we sold 1.5 million shares of our common stock on a forward basis at a weighted average price of $71.83 per share, net of sales agent fees, which totaled $107.2 million. These ATM forward sales agreements mature in the first and second quarters of 2026 and qualify for equity treatment in accordance with GAAP.

During the year ended December 31, 2025, we partially settled our outstanding ATM forward sales agreements by issuing 1.6 million shares of our common stock at a weighted average forward price of $73.75 for total consideration of $116.0 million, net of sales agent fees.

As of December 31, 2025, we had the ability to access 0.6 million shares of our common stock at a weighted average price of $69.23 per share, net of sales agent fees, under remaining active ATM forward sales agreements, which mature in the second quarter of 2026, and represent $44.5 million of undrawn net proceeds. As of December 31, 2025, we had the ability to access $315.8 million through the issuance of common stock under our ATM equity program.

We use ATM equity program proceeds to rebalance our leverage in response to our acquisitions activity which keeps our alternatives flexible for financing further growth of our business. We have historically used proceeds from the ATM equity program for general corporate purposes, which may include future acquisitions and repayment of indebtedness including borrowings under our Credit Facility. We view our ATM equity program as an effective way to match-fund our smaller acquisitions by exercising control over the timing and size of transactions and achieving a more favorable cost of capital as compared to larger follow-on offerings.

*Material Cash Requirements*

As of January 31, 2026, we had $29.7 million in cash and cash equivalents on hand and $356.0 million of availability under our Credit Facility. Our expected material cash requirements for the 12-months ending December 31, 2026 and thereafter consist of long-term debt maturities, interest payments on our debt and other contractually obligated expenditures. We expect to meet our short-term liquidity needs largely through cash generated from operations, borrowings under our Credit Facility, settlements of ATM forward sales agreements and proceeds from the sale of real estate properties, although we may choose to seek alternative sources of liquidity. Should we have additional liquidity needs, we believe that we could access long-term financing in the debt and equity capital markets.

We believe our current liquidity position, supplemented by our ability to generate positive cash flows from operations in the future, and our low net leverage will be sufficient to meet all of our short-term and long-term financial commitments.

*Contractual Obligations and Contingent Liabilities*

A summary of our contractual obligations as of December 31, 2025 follows *($ in thousands)*:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| |<br>Total | Less than<br>1 Year |<br>1 - 3 Years |<br>3 - 5 Years | More than<br>5 Years |
| Debt, including interest<sup>1</sup> | $1406965 | $174426 | $386287 | $61450 | $784802 |
| Loan commitments | 35858 | 33858 | 2000 |  |  |
| Development commitments | 11515 |  | 11515 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total contractual obligations | $1454338 | $208284 | $399802 | $61450 | $784802 |

---

<sup>1</sup> &nbsp;&nbsp;&nbsp;&nbsp;Interest was calculated based on the weighted average interest rate on the principal amounts outstanding on our debt as of December 31, 2025. The calculation also includes a facility fee of 0.25%.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

A summary of our loan commitments as of December 31, 2025 follows (*$ in thousands*):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | Asset<br>Class | Type of<br>Commitment | Total<br>Commitments |<br>Funded |<br>Remaining |
| &nbsp;&nbsp;&nbsp;&nbsp;Carriage Crossing Senior Living |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Bloomington<sup>1</sup> | SHO | Mortgage | $2000 | $— | $2000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Encore Senior Living | SHO | Construction Loan | 56525 | (37010) | 19515 |
| &nbsp;&nbsp;&nbsp;&nbsp;Mainstay Healthcare | SHO | Revolving Credit | 350 | (350) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Montecito Medical Real Estate | MOB | Mezzanine Loan | 20389 | (20389) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Senior Living | SHO | Revolving Credit | 16500 | (9000) | 7500 |
| &nbsp;&nbsp;&nbsp;&nbsp;Senior Living Hospitality Group<sup>2</sup> | SHO | Working Capital | 5000 | (3476) | 1524 |
| &nbsp;&nbsp;&nbsp;&nbsp;The Sanders Trust, LLC | HOSP | Construction Loan | 27720 | (27401) | 319 |
| &nbsp;&nbsp;&nbsp;&nbsp;Timber Ridge OpCo | SHO | Working Capital | 5000 |  | 5000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Vizion Health | SHO | Mezzanine Loan | 18102 | (18102) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total loan commitments |  |  | $151586 | $(115728) | $35858 |

---

<sup>1 &nbsp;&nbsp;&nbsp;&nbsp;</sup>Funding is contingent upon the operating performance of the respective facility.

<sup>2&nbsp;&nbsp;&nbsp;&nbsp;</sup>This operator was formerly referred to as Watermark Retirement.

As of December 31, 2025, the total credit loss liabilities established for our unfunded loan commitments were $0.2 million. We estimate the amounts we expect to fund using the same methodology as the one applied to provide for credit loss reserves on our mortgage and other notes receivable.

A summary of our outstanding development commitments as of December 31, 2025 follows (*$ in thousands*):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | Asset<br>Class | Type of<br>Commitment | Total<br>Commitments |<br>Funded |<br>Remaining |
| Bickford | SHO | Renovation | $8000 | $(5172) | $2828 |
| Juniper Communities, LLC | SHO | Renovation | 750 |  | 750 |
| Mainstay Healthcare | SHO | Renovation | 250 |  | 250 |
| Navion Senior Solutions | SHO | Renovation | 1000 | (319) | 681 |
| Senior Living | SHO | Renovation | 10000 | (6089) | 3911 |
| Spring Arbor | SHO | Renovation | 3000 |  | 3000 |
| William James Group, LLC | SHO | Renovation | 600 | (505) | 95 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total development commitments |  |  | $23600 | $(12085) | $11515 |

---

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

A summary of our outstanding contingency commitments as of December 31, 2025 follows (*$ in thousands*):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | Asset<br>Class | Type of<br>Contingency | Total<br>Commitments |<br>Funded |<br>Remaining |
| | | Acquisition | | | |
| Compass Senior Living | SHO | consideration | $2750 | $— | $2750 |
|  |  | Lease |  |  |  |
| IntegraCare | SHO | inducement | 750 |  | 750 |
|  |  | Lease |  |  |  |
| Navion Senior Solutions | SHO | inducement | 4850 | (2700) | 2150 |
|  |  | Lease |  |  |  |
| Spring Arbor | SHO | inducement | 10000 |  | 10000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total contingency commitments |  |  | $18350 | $(2700) | $15650 |

---

*Capital Funding Commitments*

Capital expenditures in our Real Estate Investments segment primarily relate to new investments of real estate properties. Our tenant leases typically require the tenant to pay property taxes and insurance, repairs and maintenance costs and a minimum amount of capital expenditures each year. As a result, we do not expect to incur material capital expenditures on our existing properties in the Real Estate Investments segment during the year ending December 31, 2026.

Capital expenditures in our SHOP segment primarily relate to improvements made in our senior housing communities. During the year ending December 31, 2026, we expect to fund approximately $18.4 million of capital expenditures related to existing properties in our SHOP segment from our operating cash flows and other existing liquidity sources.

We expect the capital expenditures of our consolidated partnerships will be funded from the NOI of the respective consolidated partnership and additional capital contributions from the respective partners.

**Litigation**

From time to time, we are party to various lawsuits, investigations, claims and other legal and regulatory proceedings arising in connection with our business. Such claims may include, among other things, professional and general liability claims, as well as regulatory proceedings related to our SHOP segment. Further, from time to time, we are party to certain legal proceedings for which third parties, such as our tenants, managers and borrowers, are contractually obligated to indemnify us from and against various claims, litigation and liabilities arising in connection with their respective businesses. Management believes that the ultimate resolution of all such pending proceedings will have no material adverse effect on our financial condition, results of operations or cash flows.

**Non-GAAP Financial Measures**

The supplemental performance measures described below may not be comparable to similarly titled measures used by other REITs. Consequently, our funds from operations ("FFO"), Normalized FFO and Normalized Funds Available for Distribution ("FAD") may not provide a meaningful measure of our performance as compared to that of other REITs. Since other REITs may not use our definition of these performance measures, caution should be exercised when comparing our FFO, Normalized FFO and Normalized FAD to that of other REITs. These performance measures do not represent cash generated from operating activities in accordance with GAAP as they exclude the changes in operating assets and liabilities, and therefore should not be considered an alternative to net income as an indication of our performance or as an alternative to net cash flows from operating activities as determined in accordance with GAAP as a measure of our liquidity, and are not necessarily indicative of cash available to fund cash needs.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

*Funds From Operations - FFO*

Our FFO per diluted share for the year ended December 31, 2025 increased $0.10 per share, or 2.2%, as compared to the year ended December 31, 2024 primarily due to new investments completed since January 1, 2024, partially offset by dispositions of real estate properties since January 1, 2024. FFO, as defined by the National Association of Real Estate Investment Trusts ("NAREIT") and applied by us, is calculated using the two-class method with net income allocated to common stockholders and holders of unvested restricted stock awards by applying the respective weighted average shares outstanding during each period. The calculation of FFO begins with net income attributable to common stockholders (computed in accordance with GAAP) and excludes gains or losses on sales of real estate properties, impairments of real estate properties, and real estate depreciation and amortization after adjusting for unconsolidated partnerships and joint ventures, if any. FFO per diluted share attributable to common stockholders assumes the exercise of stock options and other potentially dilutive securities.

Our Normalized FFO per diluted share for the year ended December 31, 2025 increased $0.47 per share, or 10.7%, compared to the year ended December 31, 2024 primarily due to $12.4 million of non-cash write-offs of straight-line rents receivable related to the Discovery lease terminations in the year ended December 31, 2025 and $6.3 million of gains on forward equity sales agreements, net, in the year ended December 31, 2024. Normalized FFO excludes from FFO certain items which, due to their infrequent or unpredictable nature, may create some difficulty in comparing FFO for the current period to similar prior periods, and may include, but are not limited to including, impairments of non-real estate assets, gains or losses attributable to the acquisition and disposition of non-real estate assets and liabilities, and recoveries of previous write-downs.

FFO and Normalized FFO are important supplemental measures of operating performance for a REIT. Because the historical cost accounting convention used for real estate assets requires depreciation (except on land), such accounting presentation implies that the realizable value of real estate assets diminishes predictably over time. Since real estate asset values instead have historically risen and fallen with market conditions, presentation of operating results for a REIT that uses historical cost accounting for depreciation could be less informative and should be supplemented with a performance measure such as FFO. The term FFO was designed by the REIT industry to address this issue.

*Funds Available for Distribution - FAD*

Our Normalized FAD for the year ended December 31, 2025 increased $27.9 million, or 13.7%, compared to the year ended December 31, 2024. In addition to the adjustments made to net income attributable to common stockholders that are included in the calculation of Normalized FFO, Normalized FAD excludes the impact of straight-line rent revenue adjustments and the amortization of debt issuance costs and discounts. We also adjust Normalized FAD for the net change in our credit loss reserves, non-cash share-based compensation expense, SHOP capital expenditures, as well as certain non-cash items related to our equity method investment, such as straight-line lease expense and amortization of purchase accounting adjustments. Normalized FAD for the year ended December 31, 2025 includes an adjustment for transaction costs incurred related to a large SHOP transaction that did not materialize. Approximately $0.6 million of this adjustment related to amounts that were capitalized in other assets, net, on our consolidated balance sheet as of December 31, 2024.

Normalized FAD is an important supplemental performance measure for a REIT and a useful measure of liquidity as an indicator of our ability to distribute dividends to our stockholders. GAAP requires a lessor to recognize contractual lease payments as income on a straight-line basis over the expected term of the lease. This straight-line rent adjustment has the effect of reporting rental income that is significantly more or less than the contractual cash flows received pursuant to the terms of our lease agreements. GAAP also requires any discount or premium related to indebtedness and debt issuance costs to be amortized as non-cash adjustments to earnings.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

The following table reconciles our net income attributable to common stockholders, the most directly comparable GAAP financial measure, to NAREIT FFO, Normalized FFO and Normalized FAD and provides supplemental information on basic and diluted earnings per share using these metrics *($ in thousands, except per share amounts)*:

---

| | | | |
|:---|:---|:---|:---|
| | Year Ended December 31, | Year Ended December 31, | Year Ended December 31, |
| | 2025 | 2024 | 2023 |
| Net income attributable to common stockholders | $141976 | $137867 | $135597 |
| &nbsp;&nbsp;&nbsp;&nbsp;Elimination of certain non-cash items in net income: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Real estate depreciation and amortization | 78772 | 70449 | 69436 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Real estate depreciation related to noncontrolling interests | (1629) | (1647) | (1585) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gains on sales of real estate properties, net | (456) | (6678) | (14721) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Impairments of real estate properties |  | 654 | 1642 |
| NAREIT FFO attributable to common stockholders | 218663 | 200645 | 190369 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-cash write-offs of straight-line rents receivable | 12350 | 1452 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-cash rental income related to operations |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;transfers upon early lease terminations | (1375) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other non-cash rental income |  |  | (2500) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proxy contest and related expenses | 1572 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Gains on forward equity sales agreements, net |  | (6261) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on early retirement of debt |  |  | 73 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gains on operations transfers, net |  |  | (20) |
| Normalized FFO attributable to common stockholders | 231210 | 195836 | 187922 |
| &nbsp;&nbsp;&nbsp;&nbsp;Straight-line rent revenue adjustments | (5085) | (4483) | (6961) |
| &nbsp;&nbsp;&nbsp;&nbsp;Straight-line rent revenue adjustments related to noncontrolling interests | (68) | (19) | 58 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of lease incentives | 2901 | 2893 | 2521 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of lease incentives related to noncontrolling interests | (508) | (508) | (434) |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-real estate depreciation | 2172 | 994 | 537 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-real estate depreciation related to noncontrolling interests | (257) | (140) | (49) |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of debt discount | 453 | 322 | 322 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of debt issuance costs | 2974 | 3461 | 2325 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustments related to equity method investment, net | (1219) | (1863) | (1647) |
| &nbsp;&nbsp;&nbsp;&nbsp;Gains from equity method investment | (3664) | (402) | (555) |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity method investment capital expenditures | (671) | (293) | (210) |
| &nbsp;&nbsp;&nbsp;&nbsp;SHOP recurring capital expenditures | (1937) | (1948) | (1845) |
| &nbsp;&nbsp;&nbsp;&nbsp;SHOP recurring capital expenditures related to noncontrolling interests | 216 | 180 | 191 |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity method investment non-refundable fees received | 2339 | 1357 | 1327 |
| &nbsp;&nbsp;&nbsp;&nbsp;Notes receivable credit (benefit) loss expense | (3447) | 4641 | (266) |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-cash share-based compensation expense | 5576 | 4182 | 4605 |
| &nbsp;&nbsp;&nbsp;&nbsp;Transaction costs | 1164 |  |  |
| Normalized FAD attributable to common stockholders | $232149 | $204210 | $187841 |
| Basic: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Weighted average common shares outstanding | 46874691 | 43844771 | 43388794 |
| &nbsp;&nbsp;&nbsp;&nbsp;NAREIT FFO attributable to common stockholders per share | $4.66 | $4.58 | $4.39 |
| &nbsp;&nbsp;&nbsp;&nbsp;Normalized FFO attributable to common stockholders per share | $4.93 | $4.47 | $4.33 |
| Diluted: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Weighted average common shares outstanding | 47051763 | 44102636 | 43389466 |
| &nbsp;&nbsp;&nbsp;&nbsp;NAREIT FFO attributable to common stockholders per share | $4.65 | $4.55 | $4.39 |
| &nbsp;&nbsp;&nbsp;&nbsp;Normalized FFO attributable to common stockholders per share | $4.91 | $4.44 | $4.33 |

---

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

*Adjusted EBITDA*

We consider Adjusted EBITDA to be an important supplemental financial measure because it provides information which we use to evaluate our performance and serves as an indication of our ability to service debt. We define Adjusted EBITDA as consolidated earnings before interest, income taxes, depreciation and amortization, excluding impairments of real estate properties and gains on dispositions and certain items which, due to their infrequent or unpredictable nature, may create some difficulty in comparing Adjusted EBITDA for the current period to similar prior periods. These items include, but are not limited to, impairments of non-real estate assets, gains or losses on disposition of assets and liabilities, and recoveries of previous write-downs on mortgages and other notes. Adjusted EBITDA also includes our proportionate share of an unconsolidated equity method investment presented on a similar basis. Since others may not use our definition of Adjusted EBITDA, caution should be exercised when comparing our Adjusted EBITDA to that of other companies. Adjusted EBITDA reflect GAAP interest expense, which excludes amounts capitalized during the period.

The following table reconciles our net income, the most directly comparable GAAP financial measure, to Adjusted EBITDA (*$ in thousands*):

---

| | | | |
|:---|:---|:---|:---|
| | Year Ended December 31, | Year Ended December 31, | Year Ended December 31, |
| | 2025 | 2024 | 2023 |
| Net income | $140787 | $136639 | $134381 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 80944 | 71443 | 69973 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest | 57368 | 59903 | 58160 |
| &nbsp;&nbsp;&nbsp;&nbsp;Franchise, excise and other taxes | 1080 | 38 | 449 |
| &nbsp;&nbsp;&nbsp;&nbsp;Write-offs of straight-line rents receivable | 12141 | 1452 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-cash rental income related to operations |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;transfers upon early lease terminations | (1375) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Notes receivable credit (benefit) loss expense | (3447) | 4641 | (266) |
| &nbsp;&nbsp;&nbsp;&nbsp;Gains on sales of real estate properties, net | (456) | (6678) | (14721) |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on early retirement of debt |  |  | 73 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gains on forward equity sales agreements, net |  | (6261) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other non-cash rental income |  |  | (2500) |
| &nbsp;&nbsp;&nbsp;&nbsp;Write-offs of transaction costs | 608 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Gains on operations transfers, net |  |  | (20) |
| &nbsp;&nbsp;&nbsp;&nbsp;NHI's share of EBITDA adjustments for |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;unconsolidated subsidiaries |  | 719 | 2432 |
| &nbsp;&nbsp;&nbsp;&nbsp;Impairments of real estate properties |  | 654 | 1642 |
| Adjusted EBITDA | $287650 | $262550 | $249603 |
| Interest expense at contractual rates<sup>1</sup> | $53941 | $56315 | $55603 |
| Principal payments on debt, excluding |  |  |  |
| &nbsp;&nbsp;balloon payments | 222 | 425 | 408 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed charges | $54163 | $56740 | $56011 |
| Fixed charge coverage | 5.3x | 4.6x | 4.5x |

---

<sup>1&nbsp;&nbsp;&nbsp;&nbsp;</sup>Interest expense at contractual rates includes capitalized interest in the table above.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

*Net Operating Income*

NOI is a non-GAAP supplemental financial measure used to evaluate the operating performance of real estate. We define NOI as total revenues, less tenant reimbursements and property operating expenses. We believe NOI provides investors relevant and useful information as it measures the operating performance of real estate assets at the property level on an unleveraged basis. We use NOI to make decisions about resource allocations to our segments and to assess the property level performance of our investment portfolios.

The following table reconciles our net income, the most directly comparable GAAP financial measure, to NOI (*$ in thousands*):

---

| | | | |
|:---|:---|:---|:---|
| | Year Ended December 31, | Year Ended December 31, | Year Ended December 31, |
| | 2025 | 2024 | 2023 |
| Net income | $140787 | $136639 | $134381 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 80944 | 71443 | 69973 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense | 57368 | 59903 | 58160 |
| &nbsp;&nbsp;&nbsp;&nbsp;Legal expense | 2666 | 1052 | 507 |
| &nbsp;&nbsp;&nbsp;&nbsp;Franchise, excise and other taxes | 1080 | 38 | 449 |
| &nbsp;&nbsp;&nbsp;&nbsp;General and administrative expenses | 26868 | 20736 | 19314 |
| &nbsp;&nbsp;&nbsp;&nbsp;Proxy contest and related expenses | 1572 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Loan and realty (gains) losses, net | (3447) | 5295 | 1376 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gains on sales of real estate properties, net | (456) | (6678) | (14721) |
| &nbsp;&nbsp;&nbsp;&nbsp;Gains from equity method investment | (3664) | (402) | (555) |
| &nbsp;&nbsp;&nbsp;&nbsp;Gains on forward equity sales agreements, net |  | (6261) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on early retirement of debt |  |  | 73 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gains on operations transfers, net |  |  | (20) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other income |  |  | (202) |
| NOI | $303718 | $281765 | $268735 |

---

The following table provides a summary of our NOI by segment *($ in thousands)*:

---

| | | | |
|:---|:---|:---|:---|
| | Year Ended December 31, | Year Ended December 31, | Year Ended December 31, |
| | 2025 | 2024 | 2023 |
| Real Estate Investments segment | $284584 | $269127 | $259162 |
| SHOP segment | 19134 | 12170 | 9222 |
| Non-segment / corporate |  | 468 | 351 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total NOI | $303718 | $281765 | $268735 |

---

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

**ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK**

**Interest Rate Risk**

We are exposed to risks related to fluctuations in market interest rates that affect our indebtedness and our mortgage and other notes receivable. As of December 31, 2025, we had $329.0 million of principal amounts outstanding on indebtedness and $496.0 million of availability under our Credit Facility that are subject to variable interest rates.

We have historically used derivative financial instruments in the normal course of our business to mitigate interest rate risk. We do not use derivative financial instruments for speculative or trading purposes. We currently have no derivative financial instruments, but may engage in hedging strategies to manage our exposure to interest rate risk in the future depending on our analysis of the current interest rate environment and the costs and risks of such strategies.

Interest rate fluctuations generally will not affect our future results of operations or cash flows associated with our debt, mortgages and other notes at fixed interest rates unless these financial instruments mature or are otherwise terminated and we are seeking new borrowings or to refinance these borrowings. However, interest rate fluctuations will affect the fair values of our fixed rate financial instruments from period to period. Conversely, changes in interest rates related to our variable rate debt, mortgages and other notes will impact our future results of operations and cash flows but will not significantly affect the fair values of those financial instruments from period to period. Assuming a 50 basis point ("bps") increase or decrease in the interest rates on the principal amounts due on our variable rate debt outstanding as of December 31, 2025 and assuming the amounts outstanding did not change during the period, our interest expense would increase or decrease annually by approximately $1.6 million.

The following table provides a summary of the interest rates on our debt (*$ in thousands*):

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | December 31, 2025 | December 31, 2025 | December 31, 2025 | December 31, 2024 | December 31, 2024 | December 31, 2024 |
| |<br>Principal<br>Amount<br>Outstanding |% of<br>Total<br>Debt | Weighted<br>Average<br>Interest<br>Rate |<br>Principal<br>Amount<br>Outstanding |% of<br>Total<br>Debt | Weighted<br>Average<br>Interest<br>Rate |
| Fixed rate debt: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;2031 Senior Notes - unsecured | $400000 | 33.9% | 3.00% | $400000 | 34.6% | 3.00% |
| &nbsp;&nbsp;&nbsp;&nbsp;2033 Senior Notes - unsecured | 350000 | 29.7% | 5.35% |  | —% | —% |
| &nbsp;&nbsp;&nbsp;&nbsp;Private placement loans - unsecured | 100000 | 8.5% | 4.51% | 150000 | 13.0% | 4.45% |
| &nbsp;&nbsp;&nbsp;&nbsp;Fannie Mae term loans - secured, non-recourse |  | —% | —% | 75815 | 6.6% | 3.96% |
| Variable rate debt: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Revolving credit facility - unsecured | 204000 | 17.3% | 4.71% | 331200 | 28.6% | 5.75% |
| &nbsp;&nbsp;&nbsp;&nbsp;Bank term loan - unsecured | 125000 | 10.6% | 4.91% | 200000 | 17.2% | 5.95% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total principal amounts of debt outstanding | $1179000 | 100.0% | 4.32% | $1157015 | 100.0% | 4.55% |

---

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

The following table provides a summary of the sensitivity of our fixed rate debt as of December 31, 2025 to changes in market interest rates (*$ in thousands*):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | | | Fair Value | Fair Value |
| | Principal<br>Amount<br>Outstanding |<br>Fair<br>Value | After 50 bps<br>Decrease | After 50 bps<br>Increase |
| 2031 Senior notes - unsecured | $400000 | $348467 | $358278 | $341700 |
| 2033 Senior notes - unsecured | 350000 | 347127 | 360295 | 339406 |
| Private placement term loans - unsecured | 100000 | 98638 | 99160 | 98120 |

---

Substantially all of our investments in mortgages and other notes are negotiated at fixed interest rates. As of December 31, 2025, the principal amounts outstanding on these investments totaled $218.7 million and the estimated fair values, discounted for the change in the risk-free interest rate, totaled $201.5 million. A 50 bps increase in market interest rates as of December 31, 2025 would decrease the total estimated fair values of our mortgage and other notes receivable by approximately $74.7 million and a 50 bps decrease in market interest rates would increase the estimated fair values of our mortgage and other notes receivable by approximately $203.6 million.

**Inflation Risk**

Our tenant leases generally provide for annual escalators in contractual rent due to us based on a fixed rate of increase or a variable index, such as CPI. Our tenant leases which are subject to an annual escalator based on CPI may also contain a minimum or maximum cap on the annual increase. Substantially all of our leases include a provision that requires the tenant to pay the operating expenses of the respective property, whether paid directly by the tenant or reimbursed to us. We believe that inflationary increases experienced by us will be at least partially offset by the contractual rent increases and operating expense reimbursements described above.

In addition, inflation, both real and anticipated, as well as any resulting government policies have affected and could continue to adversely affect the costs of labor, goods and services experienced by our operators in the SHOP segment. In periods of inflation, the increases in operating costs experienced by our operators could exceed the corresponding increases in revenues which may adversely affect our operators' and borrowers' ability to make rent and loan payments to us under the terms of the agreements. Additionally, our financial condition and results of operations may be adversely affected by any shortfall experienced by our operators during periods of inflation.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

**ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA**

**Report of Independent Registered Public Accounting Firm**

Stockholders and Board of Directors

National Health Investors, Inc.

Murfreesboro, Tennessee

**Opinion on the Consolidated Financial Statements**

We have audited the accompanying consolidated balance sheets of National Health Investors, Inc. (the "Company") as of December 31, 2025 and 2024, the related consolidated statements of income, equity, and cash flows for each of the three years in the period ended December 31, 2025, and the related notes and financial statement schedules listed in the accompanying index (collectively referred to as the "consolidated financial statements"). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2025 and 2024, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2025, in conformity with accounting principles generally accepted in the United States of America.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2025, based on criteria established in *Internal Control – Integrated Framework (2013)* issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) and our report dated February 26, 2026 expressed an unqualified opinion thereon.

**Basis for Opinion**

These consolidated financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's consolidated financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud.

Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

**Critical Audit Matter**

The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing separate opinions on the critical audit matter or on the accounts or disclosures to which it relates.

*ATM Forward Sale Agreements*

As described in Notes 2 and 11 of the Company's consolidated financial statements, the Company has entered into ATM forward sale agreements relating to shares of its common stock through its at-the-market equity program. The forward sale price that the Company will receive upon settlement of the ATM forward sale agreements will be subject to adjustment for (i) a floating interest rate factor equal to a specified daily rate less a spread adjustment and (ii) scheduled dividends during the term of the ATM forward sale agreements. The ATM forward sale agreements qualified for equity treatment on the consolidated balance sheet as of December 31, 2025.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

We identified the evaluation of the terms and conditions to determine the classification and recognition of certain of the ATM forward sale agreements as a critical audit matter. Auditing the classification and recognition based on the terms and conditions of these ATM forward sale agreements was especially challenging due to the inherent complexities of the agreements and relevant accounting guidance. Auditing these elements required an increased level of audit effort, including the involvement of professionals with specialized skill and knowledge in the relevant technical accounting.

The primary procedures we performed to address this critical audit matter included:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Inspecting certain underlying ATM forward sale agreements to understand the relevant terms.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Utilizing firm personnel with expertise in the relevant technical accounting to assist in evaluating the Company's application of the relevant technical accounting for certain of the ATM forward sale agreements.

/s/ BDO USA, P.C.

We have served as the Company's auditor since 2004.

Nashville, Tennessee

February 26, 2026

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

 **NATIONAL HEALTH INVESTORS, INC.**

**CONSOLIDATED BALANCE SHEETS**

*($ in thousands, except per share amounts)*

---

| | | |
|:---|:---|:---|
| | December 31, | December 31, |
| | 2025 | 2024 |
| Assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Real estate properties: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Land | $221660 | $191909 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Buildings, building improvements and intangible assets | 3055866 | 2751071 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Construction in progress | 18214 | 10568 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total real estate properties | 3295740 | 2953548 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Accumulated depreciation and amortization | (821982) | (742295) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total real estate properties, net | 2473758 | 2211253 |
| &nbsp;&nbsp;&nbsp;&nbsp;Mortgage and other notes receivable, net of credit loss reserves of |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$15,397 and $20,249, respectively | 203296 | 268926 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | 19624 | 24289 |
| &nbsp;&nbsp;&nbsp;&nbsp;Straight-line rents receivable | 78891 | 87150 |
| &nbsp;&nbsp;&nbsp;&nbsp;Assets held for sale, net | 3562 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other assets, net | 17756 | 22753 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets<sup>1</sup> | $2796887 | $2614371 |
| Liabilities and Equity: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Debt, net | $1163814 | $1146041 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and other liabilities | 43734 | 37757 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dividends payable | 44439 | 41119 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income | 4996 | 4277 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities<sup>1</sup> | 1256983 | 1229194 |
| &nbsp;&nbsp;&nbsp;&nbsp;Commitments and contingencies |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Redeemable noncontrolling interest | 10195 | 9790 |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;National Health Investors, Inc. stockholders' equity: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common stock, $0.01 par value per share; 100,000,000 shares authorized;  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;48,302,944 and 45,687,942 shares issued and outstanding, respectively | 483 | 457 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Capital in excess of par value | 1922713 | 1736831 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | 2747006 | 2604829 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cumulative dividends | (3148659) | (2975642) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total National Health Investors, Inc. stockholders' equity | 1521543 | 1366475 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Noncontrolling interests | 8166 | 8912 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total equity | 1529709 | 1375387 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and equity | $2796887 | $2614371 |

---

<sup>1</sup>&nbsp;&nbsp;&nbsp;&nbsp;The consolidated balance sheets included the following amounts related to our consolidated variable interest entities: $403.4 million and $505.9 million of real estate properties, net; $9.1 million and $9.7 million of cash and cash equivalents; $0.6 million and $10.0 million of straight-line rents receivable; $4.2 million and $7.5 million of other assets, net; and $5.5 million and $5.7 million of accounts payable and other liabilities as of December 31, 2025 and 2024, respectively.

*See the accompanying notes to the consolidated financial statements.*

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

**NATIONAL HEALTH INVESTORS, INC.**

**CONSOLIDATED STATEMENTS OF INCOME**

*($ in thousands, except per share amounts)*

---

| | | | |
|:---|:---|:---|:---|
| | Year Ended December 31, | Year Ended December 31, | Year Ended December 31, |
| | 2025 | 2024 | 2023 |
| Revenues: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Rental income | $271600 | $257049 | $249227 |
| &nbsp;&nbsp;&nbsp;&nbsp;Resident fees and services | 80062 | 54421 | 48809 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest and other income | 23966 | 23711 | 21799 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revenues | 375628 | 335181 | 319835 |
| Expenses: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 80944 | 71443 | 69973 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest | 57368 | 59903 | 58160 |
| &nbsp;&nbsp;&nbsp;&nbsp;Senior housing operating expenses | 60928 | 42251 | 39587 |
| &nbsp;&nbsp;&nbsp;&nbsp;Legal | 2666 | 1052 | 507 |
| &nbsp;&nbsp;&nbsp;&nbsp;Franchise, excise and other taxes | 1080 | 38 | 449 |
| &nbsp;&nbsp;&nbsp;&nbsp;General and administrative | 26868 | 20736 | 19314 |
| &nbsp;&nbsp;&nbsp;&nbsp;Proxy contest and related | 1572 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Taxes and insurance on leased properties | 10982 | 11165 | 11513 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loan and realty (gains) losses, net | (3447) | 5295 | 1376 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total expenses | 238961 | 211883 | 200879 |
| Gains on operations transfers, net |  |  | 20 |
| Gains on sales of real estate properties, net | 456 | 6678 | 14721 |
| Gains from equity method investment | 3664 | 402 | 555 |
| Loss on early retirement of debt |  |  | (73) |
| Gains on forward equity sales agreements, net |  | 6261 |  |
| Other income |  |  | 202 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income | 140787 | 136639 | 134381 |
| Add: Net loss attributable to noncontrolling interests | 1390 | 1346 | 1273 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income attributable to stockholders | 142177 | 137985 | 135654 |
| Less: Net income attributable to unvested restricted stock awards | (201) | (118) | (57) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income attributable to common stockholders | $141976 | $137867 | $135597 |
| Weighted average common shares outstanding: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | 46874691 | 43844771 | 43388794 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | 47051763 | 44102636 | 43389466 |
| Earnings per share: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | $3.03 | $3.14 | $3.13 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | $3.02 | $3.13 | $3.13 |

---

*See the accompanying notes to the consolidated financial statements.*

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

**NATIONAL HEALTH INVESTORS, INC.**

**CONSOLIDATED STATEMENTS OF CASH FLOWS**

*($ in thousands*)

---

| | | | |
|:---|:---|:---|:---|
| | Year Ended December 31, | Year Ended December 31, | Year Ended December 31, |
| | 2025 | 2024 | 2023 |
| Cash flows from operating activities: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income | $140787 | $136639 | $134381 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustments to reconcile net income to net cash provided by |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;operating activities: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 80944 | 71443 | 69973 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of lease incentives | 2901 | 2893 | 2521 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of commitment fees and notes receivable discounts | (920) | (116) | (412) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of debt issuance costs and discounts | 3427 | 3783 | 2647 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payments of lease incentives |  |  | (10000) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation expense | 5576 | 4182 | 4605 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-cash rental income related to operations transfers |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;upon early lease terminations | (1375) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other non-cash rental income |  |  | (2500) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-cash changes in straight-line rents receivable | 7265 | (3031) | (6961) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-cash interest income on mortgage and other notes receivable | (1735) | (124) | (1302) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-cash lease incentives recognized as interest and other income |  | (100) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loan and realty (gains) losses, net | (3447) | 5295 | 1376 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gains on sales of real estate properties, net | (456) | (6678) | (14721) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gains from equity method investment | (3664) | (402) | (555) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss on early retirement of debt |  |  | 73 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gains on forward equity sales agreements, net |  | (6261) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other assets, net | 57 | (1900) | (705) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and other liabilities | 5490 | 3285 | 5929 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income | 1713 | (1140) | 101 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by operating activities | 236563 | 207768 | 184450 |
| Cash flows from investing activities: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisitions of real estate properties | (274068) | (138128) | (38081) |
| &nbsp;&nbsp;&nbsp;&nbsp;Investments in existing real estate properties and equipment | (19966) | (19803) | (11475) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sales of real estate properties |  | 6179 | 57031 |
| &nbsp;&nbsp;&nbsp;&nbsp;Investments in mortgage and other notes receivable | (71110) | (60412) | (35625) |
| &nbsp;&nbsp;&nbsp;&nbsp;Payments received on mortgage and other notes receivable | 92331 | 19447 | 13465 |
| &nbsp;&nbsp;&nbsp;&nbsp;Distributions from equity method investment | 3664 | 402 | 3055 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in investing activities | (269149) | (192315) | (11630) |
| Cash flows from financing activities: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from revolving credit facility | 694000 | 449700 | 364000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Repayments of revolving credit facility | (821200) | (363500) | (161000) |
| &nbsp;&nbsp;&nbsp;&nbsp;Borrowings on bank term loan |  |  | 200000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Repayments of bank term loan and private placement notes | (200815) | (75436) | (415427) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from issuance of senior notes | 346161 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Payments of debt issuance costs | (3881) | (3486) | (2747) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from issuance of common shares, net | 181533 | 142394 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Payments of equity issuance costs | (767) | (930) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Capital contributions from noncontrolling interests | 1746 | 1170 | 2973 |
| &nbsp;&nbsp;&nbsp;&nbsp;Distributions paid to noncontrolling interests | (917) | (1151) | (1280) |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividends paid to stockholders | (169696) | (156510) | (156238) |
| &nbsp;&nbsp;&nbsp;&nbsp;Taxes paid related to net settlement of stock incentive awards | (456) | (5819) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by (used in) financing activities | 25708 | (13568) | (169719) |
| (Decrease) increase in cash, cash equivalents and restricted cash | (6878) | 1885 | 3101 |
| Cash, cash equivalents and restricted cash at the beginning of the year | 26502 | 24617 | 21516 |
| Cash, cash equivalents and restricted cash at the end of the year | $19624 | $26502 | $24617 |

---

*See the accompanying notes to the consolidated financial statements.*

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

**NATIONAL HEALTH INVESTORS, INC.**

**CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)**

(*$ in thousands*)

---

| | | | |
|:---|:---|:---|:---|
| | Year Ended December 31, | Year Ended December 31, | Year Ended December 31, |
| | 2025 | 2024 | 2023 |
| Supplemental disclosures of cash flow information: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest paid, net of amounts capitalized | $51497 | $55374 | $51897 |
| Supplemental disclosures of non-cash investing and financing activities: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Real estate properties acquired to settle mortgage notes receivable | 50800 | 22184 | 14200 |
| &nbsp;&nbsp;&nbsp;&nbsp;Increase in liabilities associated with acquisitions of real estate properties | 778 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Assets received upon early lease terminations | 1375 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Right of use assets acquired in exchange for finance lease liabilities | 139 | 344 | 101 |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in other assets related to sales of real estate properties |  |  | 325 |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in accounts payable related to real estate property renovations | (95) | (250) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in accounts payable related to debt issuance costs |  | 189 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in accounts payable related to noncontrolling interest distributions | (241) | 16 | 6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Increases in notes receivable from sales of real estate properties |  | 9000 | 2249 |
| &nbsp;&nbsp;&nbsp;&nbsp;Reclassification of prepaid equity issuance costs to capital in excess of par value |  | 471 | 275 |

---

*See the accompanying notes to the consolidated financial statements.*

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

 **NATIONAL HEALTH INVESTORS, INC.**

**CONSOLIDATED STATEMENTS OF EQUITY**

(*$ in thousands except per share amounts*)

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | Common Stock | Common Stock | | | | | |
| | Shares | Amount | Capital in<br>Excess of<br>Par Value |<br>Retained<br>Earnings |<br>Cumulative<br>Dividends |<br>Noncontrolling<br>Interests |<br>Total<br>Equity |
| Balances at December 31, 2022 | 43388742 | $434 | $1599427 | $2331190 | $(2660826) | $9856 | $1280081 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income (loss), excluding a net loss of $1,091 |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;attributable to redeemable noncontrolling interest |  |  |  | 135654 |  | (182) | 135472 |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity issuance costs |  |  | (275) |  |  |  | (275) |
| &nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation expense |  |  | 4605 |  |  |  | 4605 |
| &nbsp;&nbsp;&nbsp;&nbsp;Grants of restricted stock awards | 21000 |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Shares issued due to stock option exercises | 99 |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Capital contributions from noncontrolling interests, |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;excluding $922 attributable to redeemable |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;noncontrolling interest |  |  |  |  |  | 2051 | 2051 |
| &nbsp;&nbsp;&nbsp;&nbsp;Distributions declared to noncontrolling interests |  |  |  |  |  | (1286) | (1286) |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividends declared, $3.60 per share |  |  |  |  | (156257) |  | (156257) |
| Balances at December 31, 2023 | 43409841 | $434 | $1603757 | $2466844 | $(2817083) | $10439 | $1264391 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income (loss), excluding a net loss of $916 |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;attributable to redeemable noncontrolling interest |  |  |  | 137985 |  | (430) | 137555 |
| &nbsp;&nbsp;&nbsp;&nbsp;Issuance of common shares, net | 2065878 | 21 | 142373 |  |  |  | 142394 |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity issuance costs |  |  | (1401) |  |  |  | (1401) |
| &nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation expense |  |  | 4182 |  |  |  | 4182 |
| &nbsp;&nbsp;&nbsp;&nbsp;Grants of restricted stock awards | 15000 |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Shares issued due to stock options exercised | 197453 | 2 |  |  |  |  | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Taxes paid related to net settlement of stock |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;incentive awards | (230) |  | (5819) |  |  |  | (5819) |
| &nbsp;&nbsp;&nbsp;&nbsp;Reclassification of forward equity sales agreements |  |  | (6261) |  |  |  | (6261) |
| &nbsp;&nbsp;&nbsp;&nbsp;Capital contributions from noncontrolling interests, |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;excluding $1,100 attributable to redeemable |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;noncontrolling interest |  |  |  |  |  | 70 | 70 |
| &nbsp;&nbsp;&nbsp;&nbsp;Distributions declared to noncontrolling interests, |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;excluding $50 attributable to redeemable |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;noncontrolling interest |  |  |  |  |  | (1167) | (1167) |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividends declared, $3.60 per share |  |  |  |  | (158559) |  | (158559) |
| &nbsp;&nbsp;&nbsp;&nbsp;Balances at December 31, 2024 | 45687942 | $457 | $1736831 | $2604829 | $(2975642) | $8912 | $1375387 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income (loss), excluding a net loss of $999 |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;attributable to redeemable noncontrolling interest |  |  |  | 142177 |  | (391) | 141786 |
| &nbsp;&nbsp;&nbsp;&nbsp;Issuance of common shares, net | 2533632 | 25 | 181083 |  |  |  | 181108 |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity issuance costs |  |  | (342) |  |  |  | (342) |
| &nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation expense |  |  | 5576 |  |  |  | 5576 |
| &nbsp;&nbsp;&nbsp;&nbsp;Grants of restricted stock awards | 29500 |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Shares issued due to stock options exercised | 53057 | 1 |  |  |  |  | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Taxes paid related to net settlement of stock |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;incentive awards | (1187) |  | (456) |  |  |  | (456) |
| &nbsp;&nbsp;&nbsp;&nbsp;Capital contributions from noncontrolling interests, |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;excluding $1,440 attributable to redeemable |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;noncontrolling interest |  |  |  |  |  | 306 | 306 |
| &nbsp;&nbsp;&nbsp;&nbsp;Distributions declared to noncontrolling interests, |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;excluding $36 attributable to redeemable |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;noncontrolling interest |  |  |  |  |  | (938) | (938) |
| &nbsp;&nbsp;&nbsp;&nbsp;Reversal of previously declared distributions |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to noncontrolling interest upon liquidation |  |  |  |  |  | 298 | 298 |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchase of noncontrolling interest |  |  | 21 |  |  | (21) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividends declared, $3.64 per share |  |  |  |  | (173017) |  | (173017) |
| Balances at December 31, 2025 | 48302944 | $483 | $1922713 | $2747006 | $(3148659) | $8166 | $1529709 |

---

*See the accompanying notes to the consolidated financial statements.*

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

**NATIONAL HEALTH INVESTORS, INC.**

**NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS**

**Note 1. Description of the Business**

National Health Investors, Inc. ("NHI", the "Company", "we", "us" or "our"), established in 1991 as a Maryland corporation, is a self-managed real estate investment trust ("REIT"). We own, lease, operate and finance the development of high-quality real estate properties, focusing on senior housing communities and medical facilities. We operate through two reportable segments, Real Estate Investments and Senior Housing Operating Portfolio ("SHOP"). Our investments in senior housing communities, also referred to as senior housing properties ("SHO"), include independent living facilities ("ILF"), assisted living facilities ("ALF"), entrance fee communities ("EFC") and senior living campuses ("SLC"). Our investments in medical facilities include skilled nursing facilities ("SNF") and hospitals ("HOSP").

As of December 31, 2025, our Real Estate Investments segment consisted of gross real estate investments of $2.7 billion in 176 properties, excluding one property classified as assets held for sale, which are located in 32 states and leased pursuant primarily to triple-net leases to 31 tenants. These investments included 110 SHOs, 65 SNFs and one HOSP. Additionally, our investments included $218.7 million in principal amounts of mortgage and other notes receivable, excluding $15.4 million of credit loss reserves.

As of December 31, 2025, our SHOP segment consisted of gross real estate investments of $634.3 million in 26 senior housing communities located in 13 states and comprised of 17 ILFs, six SLCs and three ALFs with a combined total of 3,009 units. We outsource the operations at these properties to third-party managers and pay a management fee for these services. As of December 31, 2025, 16 of our senior housing communities were held in consolidated partnerships in which the noncontrolling common equity interests are owned by affiliates of the respective managers.

References in these consolidated financial statements to property, unit and bed counts are outside the scope of our independent registered accounting firm's audit.

**Note 2. Significant Accounting Policies**

*Principles of Consolidation*

Our consolidated financial statements include our wholly owned subsidiaries and partnerships that we control through voting rights or other means. All intercompany transactions and balances are eliminated in consolidation.

We evaluate our contractual arrangements with other entities to identify those relationships in which control is achieved through means other than voting rights. A variable interest entity ("VIE") is broadly defined as an entity with one or more of the following characteristics: (a) the total equity investment at risk is insufficient to finance the entity's activities without additional subordinated financial support; (b) as a group, the holders of the equity investment at risk lack (i) the ability to make decisions about the entity's activities through voting or similar rights, (ii) the obligation to absorb the expected losses of the entity or (iii) the right to receive the expected residual returns of the entity; or (c) the equity investors have voting rights that are not proportional to their economic interests, and substantially all of the entity's activities either involve, or are conducted on behalf of, an investor that has disproportionately few voting rights.

When the VIE criteria have been met, we perform an additional assessment to identify which business enterprise represents the primary beneficiary of the VIE. The primary beneficiary of the VIE is the business enterprise that has both (i) the power to direct the activities of the VIE that most significantly impact the entity's economic performance and (ii) the obligation to absorb losses or the right to receive benefits of the VIE that could be significant to the entity. If we conclude that we are the primary beneficiary of the VIE, we consolidate the entity. The designation of an entity as a VIE is reassessed upon certain events, including but not limited to (i) a change to the contractual arrangements of the entity or in the ability of a party to exercise its participation or kick-out rights, (ii) a change to the capitalization structure of the entity or (iii) acquisitions or sales of interests that constitute a change in control. Reference Note 17 for additional information on our VIEs.

We use the equity method of accounting when we own an interest in an entity over which we can exert significant influence but cannot control the entity's operations. We discontinue the equity method of accounting if our investment in an entity, including our net advances to the entity, is reduced to zero, except in those instances in which we have guaranteed the obligations of the entity or are otherwise committed to provide further financial support to the entity. Reference Note 6 for additional information on our equity method investment.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

*Use of Estimates*

The preparation of consolidated financial statements in conformity with United States ("U.S.") generally accepted accounting principles ("GAAP") requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates.

*Reclassifications*

Certain prior year amounts in the consolidated financial statements and accompanying notes have been reclassified to conform with the current year presentation.

*Segments*

We operate our business through two reportable segments, Real Estate Investments and SHOP. In our Real Estate Investments segment, our investments include (i) the ownership of senior housing and medical facilities which we lease to third-party healthcare operators and (ii) financing arrangements with our tenants, operators, or affiliates of our tenants and operators, and other third parties, primarily mortgages, construction loans, mezzanine loans and revolving lines of credit which fund acquisitions, construction projects and working capital needs associated with healthcare properties. In our SHOP segment, we invest in both the operations and real estate of senior housing communities and utilize third-party managers to operate these properties on our behalf.

*Revenue Recognition*

*Rental Income*

We generate rental income from the properties in our Real Estate Investments segment pursuant to lessor leases between us and the tenants who operate these properties. These leases are typically triple-net operating leases with fixed annual escalators. We recognize the contractual amount of base rental income from a tenant lease using the straight-line method over the initial term of the lease, subject to a collectability assessment. Certain of our leases provide for additional contingent rent based on a percentage of the tenant's revenue in excess of a specified annual or quarterly base amount or other threshold as defined in the lease agreement. We recognize contingent rent as rental income when the actual results reported by the tenant have exceeded the applicable base amount or threshold.

Our leases are primarily triple-net leases in which the tenant pays the related expenses for property taxes and insurance either directly to the third-party vendor or as a reimbursement to us. Upon adoption, we elected the lessor practical expedient within Financial Accounting Standards Board's ("FASB") Accounting Standards Codification ("ASC") 842, Leases ("ASC 842"), which permits us to combine the lease and non-lease components of our tenant leases as the timing and pattern of transfer of the underlying services to the tenant are the same. We determined the lease component is the predominant component within these contracts in accordance with ASC 842 and therefore recognize the revenues from these contracts under ASC 842. As a result, tenant reimbursements of property operating expenses, which may include property taxes and insurance, are recognized as rental income in our consolidated statements of income. The corresponding expenses incurred by us are recognized in taxes and insurance on leased properties in our consolidated statements of income.

At lease inception, we may make certain payments to our tenants that are treated as lease incentives. These amounts are amortized over the respective lease term and recognized as a reduction of rental income in our consolidated statements of income. Certain lease incentives are inducements subject to a contingent event. We recognize contingent lease inducements in the period in which the uncertainty associated with the contingent consideration becomes probable that it will be subsequently resolved and that a significant reversal of amounts recognized in revenues is not likely to occur. We recognize lease incentives in other assets, net, on our consolidated balance sheets.

We assess the collectability of lease payments due from tenants on a regular basis taking into consideration factors, such as a change in the tenant's payment history, the current financial condition of the tenant, other new business or market conditions that may affect the tenant's operations and changes in economic conditions in the geographical areas where the tenant operates. In the event that we determine the future collectability of substantially all lease payments of a tenant are no longer probable, we write off the related accounts receivable and straight-line rents receivable in the period in which this determination becomes known as a reduction of rental income and begin recognizing rental income from the tenant on a cash basis. Any recoveries of previously written-off accounts receivable are recognized as rental income in the period payment is received. Reference the "Cash Basis Tenants" section in Note 5.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

*Resident Fees and Services*

We generate resident fees and services revenues from the senior housing communities in our SHOP segment pursuant to independent agreements for each residential unit at these communities. These revenues include resident room and care charges, community fees and other charges for optional services available to the residents.

Resident agreements generally have terms of 30 days to one year and are cancelable by the resident with 30-day notice. We typically bill residents a fixed monthly fee at the beginning of each month for room fees, community fees and general care services. Certain of the more individualized need-based and optional services are billed to residents monthly in arrears. Upon adoption of ASC 842, we elected the lessor practical expedient which permits us to combine the lease and non-lease components of our resident agreements as the timing and pattern of transfer of the underlying services to the resident are the same. We determined that the non-lease component is the predominant component within these contracts in accordance with ASC 842 and therefore recognize the revenues from these contracts under ASC 606, Revenue Recognition from Contracts with Customers ("ASC 606"). Resident fees and services revenues are recognized as services are provided.

*Interest Income from Mortgage and Other Notes Receivable*

We recognize interest income as earned based on the interest rates and principal amounts outstanding on our mortgage and other notes receivable. Accrued interest on mortgage and other notes receivable is included in other assets, net, on our consolidated balance sheets. We assess the collectability of our mortgage and other notes receivable on a regular basis taking into consideration factors, such as the borrower's timeliness of required payments, the borrower's current financial condition and the borrower's compliance with other covenants and terms of the loan agreement. If we conclude that a loan has become non-performing, we place it on non-accrual status in the period in which it becomes known and probable that the borrower cannot pay the contractual amounts due to us. A non-performing loan is returned to accrual status if the borrower becomes contractually current on payments and management believes all future principal and interest will be received from the borrower in accordance with the terms of the loan agreement. Reference the "Non-Performing Notes" section in Note 4.

*Real Estate Properties*

Our investments in real estate properties are accounted for as asset acquisitions. We allocate the purchase price to the identified tangible and intangible assets based on the relative fair values of the assets as of the acquisition date. The related transaction costs are included in the purchase price allocation. Contingent consideration deemed to be probable at the acquisition date, if any, is also included in the purchase price allocation to the extent that a significant reversal of amounts recognized is not likely to occur and the uncertainty associated with the contingent consideration has been resolved.

We use the straight-line method of depreciation for buildings over their estimated useful lives ranging from 30 to 40 years and building improvements over their estimated useful lives ranging from five to 25 years. Repairs and maintenance costs are expensed as incurred. Our intangible assets consist of in-place leases which are amortized using the straight-line method over the estimated absorption period.

*Impairment of Long-Lived Assets*

We monitor events and changes in circumstances, including investment operating performance and general market conditions, which could indicate that the carrying amounts of our long-lived assets may not be recoverable. When indicators of potential impairment are present, we assess whether an impairment charge is needed by comparing the future estimated undiscounted cash flows and eventual disposition of the identified asset to its carrying amount. If recognition of an impairment charge is necessary, it is measured as the amount by which the carrying value of the identified asset exceeds its estimated fair value. Impairment charges are included in loan and realty (gains) losses, net, in our consolidated statements of income.

*Assets Held for Sale*

We classify real estate properties as assets held for sale on our consolidated balance sheets when the following conditions are met: (i) management commits to a plan to sell the property, (ii) the property is available for immediate sale in its present condition, (iii) an active program to locate a buyer has been initiated, (iv) the property is being marketed for sale at a price that is reasonable given our estimate of its current market value, (v) a sale is highly probable within one year and (vi) it is unlikely that the disposal plan will be significantly modified or discontinued.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

If a real estate property meets the criteria to be classified as an asset held for sale, we remeasure the asset at the lower of the carrying amount and the estimated fair value less cost to sell and upon reclassification, we no longer depreciate the property. We estimate the fair value of a property using a market approach that takes into consideration any recent binding agreements for sales of similar properties, any recent purchase offers we have received for the property and estimates based on broker quotes and third-party valuations. If a property subsequently no longer meets the criteria to be classified as held for sale, it is reclassified as a held and used asset and remeasured at the lower of the original carrying amount before the asset was classified as held for sale, adjusted for any depreciation expense not recognized while it was classified as held for sale and the fair value.

*Mortgage and Other Notes Receivable*

Mortgage and other notes receivable consist of mortgages, construction loans, mezzanine loans and revolving lines of credit investments with certain of our tenants, operators, or affiliates of our tenants and operators, and other third parties. Mortgage and other notes receivable are recognized on our consolidated balance sheets net of any deferred origination fees, discounts, premiums and valuation allowances. We amortize deferred origination fees, discounts and premiums over the contractual life of a loan using the effective interest method. If a loan is repaid prior to its contractual maturity date, we recognize the remaining unamortized balances of deferred origination fees, discounts and premiums in the period the loan is repaid.

*Credit Loss Reserves on Mortgage and Other Notes Receivable*

We evaluate the collectability of our mortgage and other notes receivable and establish reserves for expected credit losses at the inception of these investments and subsequently on a quarterly basis at the end of the period. The calculation of our credit loss reserves is based on our estimate of the total future credit losses we expect to incur over the remaining amortization periods of the loans. As a result, we may recognize some credit loss expense prior to the actual events of default. Credit loss expense is recognized in loan and realty (gains) losses, net, in our consolidated statements of income.

Our models for estimating the future expected credit losses on mortgage and construction loans are calculated on a collective basis for these types of loans. Our models for estimating the future expected credit losses on mezzanine loans and revolving lines of credit are calculated on an individual loan basis or a borrower-specific basis for these types of loans. We use a combination of credit quality indicators in our models including, among others, the current payment status of the loans, the overall financial strength of the borrowers and any guarantors, historical information on any loan write-offs related to our borrowers and the nature, extent and value of underlying collateral on the loans. In addition, we adjust our models using the probability of default method related to any current economic or other conditions occurring or becoming known during the reporting period and any changes in our most recent forecasts that exist as of the end of the reporting period which impact our previous estimates of necessary credit loss reserves. For construction loans, we perform an assessment each reporting period end of the probability that we will acquire any properties in the event of default on any of these loans and, when necessary, reduce the basis of the applicable loans by the amounts that we expect to recover when construction of the applicable properties is complete.

Estimating our credit loss reserves involves significant judgment of our management. We may choose to perform additional qualitative assessments beyond those described above and apply adjustments as necessary in estimating our credit loss reserves. It is possible that our actual credit losses will differ materially from our estimates.

*Fair Value Measurements*

Under GAAP, we are required to measure certain financial instruments at fair value on a recurring basis. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The GAAP fair value framework uses a three-tiered hierarchy approach which requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs.

The three levels of inputs used to measure fair value in the GAAP hierarchy are as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 1 measurements include inputs based on quoted prices in active markets for identical assets or liabilities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 2 measurements include observable inputs, other than quoted prices described in Level 1 of the hierarchy, such as quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active and other inputs that can be corroborated by observable market data.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 3 measurements include unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities including, but not limited to, pricing models, discounted cash flow methodologies and other similar techniques.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

If the fair value measurement is based on inputs from different levels of the hierarchy, the level within which the entire fair value measurement falls is the lowest level input that is significant to the fair value measurement in its entirety. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and consideration of factors specific to the asset or liability. When an event or circumstance alters our assessment of the observability and thus the appropriate classification of an input to a fair value measurement which we deem to be significant to the fair value measurement in its entirety, we disclose the transfer of the fair value measurement to the appropriate level within the hierarchy.

*Concentrations of Credit Risks*

We have credit risks related to our tenants, borrowers and managers. Our investments portfolio, consisting of real estate properties and mortgage and other notes receivable, subjects us to the possibility of incurring losses that may result from the failure of other parties to perform according to their contractual obligations with us or may result from a decline in market prices which may make our investments less valuable. Our mortgage and other notes receivable primarily consist of secured loans on healthcare facilities. We require collateral and other protective rights from our borrowers which we continually monitor to reduce our potential risks of incurring losses on these investments. Our management performs periodic reviews of our investments on an individual basis to assess for necessary reserves for potential losses.

We also have credit risks related to our cash and cash equivalents, which are primarily held in bank accounts and overnight investments. We maintain our bank deposit accounts with large financial institutions in amounts that may exceed federally insured limits. We have not experienced any losses related to these accounts.

*Cash, Cash Equivalents and Restricted Cash*

Our cash equivalents consist of all highly liquid investments with original maturities of three months or less. Our restricted cash includes amounts required to be held on deposit or subject to an agreement.

The following table provides a reconciliation of cash, cash equivalents and restricted cash from our consolidated statements of cash flows to the amounts included on our consolidated balance sheets (*$ in thousands*):

---

| | | |
|:---|:---|:---|
| | December 31, | December 31, |
| | 2025 | 2024 |
| Balances at the beginning of the year: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $24289 | $22347 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restricted cash<sup>1</sup> | 2213 | 2270 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total cash, cash equivalents and restricted cash | $26502 | $24617 |
| Balances at the end of the year: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $19624 | $24289 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restricted cash<sup>1</sup> |  | 2213 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total cash, cash equivalents and restricted cash | $19624 | $26502 |

---

<sup>1&nbsp;&nbsp;&nbsp;&nbsp;</sup>Restricted cash is included in other assets, net, on our consolidated balance sheets.

*Deferred Income*

Deferred income primarily includes rents received in advance from tenants and residents and non-refundable commitment fees received by us, which are amortized into income over the expected period of the related loan or lease. In the event that our financing commitment to a potential borrower or tenant expires, the related commitment fees are recognized into income immediately. Commitment fees may be charged based on the terms of the contracts and the creditworthiness of the parties.

*Deferred Financing Costs*

Deferred financing costs include capitalized debt issuance costs, discounts and premiums incurred in connection with the issuance, assumption or modification of debt instruments. We amortize debt issuance costs, discounts and premiums separately by debt instrument over the maturity period of the related debt instrument using the straight-line method, which approximates the effective interest method. Deferred financing costs are recognized as a reduction to debt, net, on our consolidated balance sheets.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

*Leases - Lessee*

We evaluate our leases in which we are the lessee at inception to determine whether the lease meets the criteria for classification as an operating lease or a finance lease. Right-of-use ("ROU") assets and lease liabilities are initially recognized based on the present value of lease payments over the lease term calculated using our incremental borrowing rate unless the implicit rate of the lease is readily determinable. Our incremental borrowing rate is the interest rate we would have to pay to borrow on a collateralized basis over a similar term in a similar economic environment. Our ROU assets also include any upfront lease payments made and exclude lease incentives. We include any options to extend or terminate a lease in the lease term when it is reasonably certain that those options will be exercised. We elected the short-term lease recognition exemption and the practical expedient to not separate lease and non-lease components.

ROU assets and lease liabilities are recognized in real estate properties, net, and accounts payable and other liabilities, respectively, on our consolidated balance sheets. We recognize the amortization of ROU assets related to operating leases on a straight-line basis in general and administrative expenses in our consolidated statements of income. We recognize the amortization of ROU assets for finance leases on a straight-line basis in depreciation and amortization expense. Rent expense is recognized on a straight-line basis in general and administrative expenses.

*Noncontrolling Interests*

We assess our arrangements with noncontrolling interest holders to determine the appropriate balance sheet classification based on the redemption rights and other rights held by the noncontrolling interest holders. Contingently redeemable noncontrolling interests are initially recognized at the greater of the initial carrying value or the redemption value and subsequently adjusted to reflect contributions and distributions of the noncontrolling interest and its share of the partnership's net income or loss each period. In the period in which the contingencies for redemption of the noncontrolling interest's shares are met or become probable of being met at a future date, we accrete the carrying value to the redemption value over the expected redemption period with an offsetting adjustment to capital in excess of par value.

*Forward Equity Sales Transactions*

We have entered into, and may continue to enter into, forward equity sales agreements relating to shares of our common stock, either through our at-the-market ("ATM") equity program or through underwritten public offerings. These agreements may be physically settled in our common stock, settled in cash or net share settled at our election. The forward sales price that we will receive upon physical settlement of a forward equity sales agreement will be subject to adjustment for (i) a floating interest rate factor equal to a specified daily rate less a spread adjustment and (ii) scheduled dividends during the term of the forward equity sales agreements. To the extent a forward equity sales agreement does not meet all the criteria to qualify for equity treatment on our consolidated balance sheets under ASC 815, Derivatives and Hedging ("ASC 815"), we recognize the change in its fair value during the period in net income in our consolidated statements of income. As of December 31, 2025, our forward equity sales agreements met the criteria to be classified as equity on our consolidated balance sheet.

Shares issuable under a forward equity sales agreement are reflected in our diluted earnings per share calculations using the treasury stock method. Under this method, the number of common shares used in calculating our diluted earnings per share for each period is deemed to be increased by the excess, if any, of the number of common shares that would be issued upon full physical settlement of the forward equity sales agreements over the number of common shares that could be purchased by us in the market, as determined based on the average market price during the period, using the proceeds receivable upon full physical settlement, as determined based on the weighted average forward price during the period.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

*Management Fees*

Management fees paid to the third-party operators of the real estate properties in our SHOP segment are recognized as expense over the period of the management contract with us. Generally, our management fee structure includes a base management fee of 5.0% of net revenue and may also include a real estate services fee of 5.0% of real estate costs incurred during any calendar year that exceed a threshold. Incentive management fees, if any, are recognized as expense beginning in the calendar year period in which the applicable threshold is met.

*Share-Based Compensation Expense*

We measure and recognize share-based compensation expense upon issuing stock incentive awards based on the grant date fair value of the award which is amortized over the requisite service period in accordance with the terms of each agreement. The fair values of stock options are estimated on the respective grant dates using the Black-Scholes option pricing model. The fair values of restricted stock awards are determined based on the closing market price of our common stock on the individual dates of grant. We recognize forfeitures of awards as a reduction to share-based compensation expense in the periods in which they occur. Share-based compensation expense is recognized in general and administrative expenses in our consolidated statements of income. Share-based compensation expense for awards with performance-based vesting conditions is recognized based on our estimate of the ultimate value of the awards after considering our expectations of future performance.

*Income Taxes*

We intend at all times to qualify as a REIT in accordance with the Internal Revenue Code. We will generally not be subject to U.S. federal income taxes provided that we continue to meet the necessary qualifications of a REIT. A failure to qualify with the applicable REIT rules and regulations would have a material adverse impact on our consolidated financial position, results of operations and cash flows.

Certain activities that we undertake may be conducted by subsidiary entities that have elected to be treated as taxable REIT subsidiaries ("TRS"). TRSs are subject to federal, state and local income taxes. Accordingly, we include a provision for federal, state and local income taxes in our consolidated financial statements, when applicable. The One Big Beautiful Bill Act, which passed on July 4, 2025, contains legislation increasing the percentage limit under the REIT asset test applicable to TRSs from 20% to 25%. This change applies to taxable years beginning after December 31, 2025.

We account for deferred income taxes using the asset and liability method and recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in our consolidated financial statements or tax returns. Under this method, we determine deferred tax assets and liabilities based on the differences between the financial reporting and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Any increase or decrease in the deferred tax liability that results from a change in circumstances, and that causes a change in our judgment about expected future tax consequences of events, is included in our income tax provision in the period such change occurs. Deferred tax assets also reflect net operating loss and tax credit carryforwards. A valuation allowance is provided if we believe it is more likely than not that all or some portion of a deferred tax asset will not be realized. Any increase or decrease in the valuation allowance that results from a change in circumstances, and that causes a change in our judgment about the realizability of the related deferred tax asset, is included in our income tax provision in the period such change occurs.

We classify interest and penalties related to uncertain tax positions, if any, in our consolidated statements of income as a component of income tax expense. Earnings and profits, which determine the taxability of dividends to our stockholders, differ from our net income for financial reporting purposes primarily due to differences in the basis of assets, the estimated useful lives used to compute depreciation and amortization of real property, gains on sales of real estate properties, non-cash compensation expense and the recognition of commitment fees.

We are subject to state and local income taxes in certain states where we operate. State and local income taxes are included in franchise, excise and other taxes in our consolidated statements of income. Certain of our tenant leases include a provision requiring the tenant to reimburse us for certain taxes. Tenant reimbursements are recognized on a gross basis in our consolidated statements of income in rental income and taxes and insurance on leased properties

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

*Earnings Per Share*

Our unvested restricted stock awards contain non-forfeitable rights to dividends and accordingly, these awards are deemed to be participating securities. As a result, we apply the two-class method to calculate basic and diluted earnings per share. Under the two-class method, we allocate net income to common stockholders and the holders of unvested restricted stock awards using the weighted average shares outstanding for each class and based on their respective participation rights to dividends declared and undistributed earnings. The computation of diluted earnings per share also includes the effect of potentially dilutive securities issued.

*Recent Accounting Pronouncements Not Yet Adopted*

In November 2024, FASB issued Accounting Standards Update ("ASU") 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses which requires public entities to enhance transparency of income statement disclosures on an interim and annual basis by providing additional disaggregated information related to certain costs and expenses. This guidance is effective for annual periods beginning after December 15, 2026 and interim periods beginning after December 15, 2027 with early adoption permitted. We are currently evaluating the potential impact of this accounting standard on our consolidated financial statements and related disclosures.

*Recently Adopted Accounting Pronouncements*

In December 2023, FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures which includes amendments to existing guidance that further enhance income tax disclosures, primarily through standardization of income tax rate reconciliation categories and requiring disaggregation of income taxes paid by jurisdiction. We adopted ASU 2023-09 effective December 31, 2025.

**Note 3. Real Estate Properties**

*Asset Acquisitions*

*2025 Acquisitions*

During the year ended December 31, 2025, we completed the following acquisitions of real estate properties (*$ in thousands*):

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | | | | | Buildings, | |
| | | | | | Building | |
| | | | | | Improvements | |
| | | Number of | Asset | | and Intangible | |
| Operator / Manager | Period | Properties | Class | Land | Assets | Total |
| Real Estate Investments segment: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Generations, LLC | Q1 2025 | 1 | SLC | $3062 | $18138 | $21200 |
| &nbsp;&nbsp;&nbsp;&nbsp;Mainstay Healthcare | Q1 2025 | 1 | ALF | 2864 | 5736 | 8600 |
| &nbsp;&nbsp;&nbsp;&nbsp;Juniper Communities, LLC | Q1 2025 | 1 | ALF | 4154 | 42130 | 46284 |
| &nbsp;&nbsp;&nbsp;&nbsp;Agemark Senior Living | Q2 2025 | 6 | ALF | 7461 | 56039 | 63500 |
| &nbsp;&nbsp;&nbsp;&nbsp;Priority Life Care | Q4 2025 | 1 | ALF | 3539 | 48610 | 52149 |
| &nbsp;&nbsp;&nbsp;&nbsp;William James Group, LLC | Q4 2025 | 1 | ALF | 134 | 6903 | 7037 |
| &nbsp;&nbsp;&nbsp;&nbsp;Senior Living Communities, |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;LLC ("Senior Living") | Q4 2025 | 1 | EFC | 4019 | 48514 | 52533 |
| SHOP segment: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Compass Senior Living | Q4 2025 | 4 | SHO | 5173 | 69171 | 74344 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total asset acquisitions |  |  |  | $30406 | $295241 | $325647 |

---

In January 2025, we acquired a 108-unit SLC located in Colorado. The acquisition price was $21.2 million, including $0.2 million in closing costs. The property is leased pursuant to a 10-year triple-net lease with Generations, LLC, which includes two five-year extension options, an initial annual lease rate of 8.0% and fixed annual escalators of 2.0%.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

In February 2025, we acquired an 88-unit ALF located in Florida upon the execution of a deed in lieu of foreclosure agreement initiated by Senior Living Management ("SLM") to settle its $10.0 million non-performing mortgage note with us. We recognized the acquired property at its estimated fair value of $8.6 million, which equaled the net carrying value of the mortgage note. Concurrently, we executed a new lease on this acquired property with the existing operator, Mainstay Healthcare. This lease provides for approximately $0.7 million in annual contractual lease payments.

In March 2025, we acquired a 120-unit ALF located in New Jersey. The acquisition price was $46.3 million, including $0.3 million in closing costs. The property is leased pursuant to a 15-year triple-net lease with Juniper Communities, LLC, which includes two five-year extension options, an initial annual lease rate of 8.0% and fixed annual escalators of 2.0%. The lease includes a $0.8 million development commitment which will be added to the respective lease base if funded.

In April 2025, we acquired a portfolio of six ALFs located in Nebraska for a total purchase price of $63.5 million, including $0.3 million in closing costs. The portfolio of properties is leased pursuant to a 15-year triple-net master lease with Agemark Senior Living, which includes two five-year extension options, an initial annual lease rate of 8.0% and fixed annual escalators of 2.0%.

In October 2025, we acquired a portfolio of four SHOs located in Oklahoma and Oregon, consisting of two SLCs and two ALFs, with a combined total of 339 units. The total purchase price of $74.3 million, including $0.5 million in closing costs, was partially funded by the cancellation of a $9.5 million mortgage note with us which had an 8.5% annual interest rate. We recognized a $2.2 million in-place lease intangible asset in connection with this acquisition. This portfolio of properties has been included in our SHOP segment and is being managed by the existing operator, Compass Senior Living, pursuant to a management agreement.

In October 2025, we acquired a 251-unit continuing care retirement community ("CCRC") located in South Carolina from an affiliate of Senior Living. The acquisition price of $52.5 million was partially funded by the cancellation of a $32.7 million mortgage note on the property. The property is being leased back to the affiliate of Senior Living pursuant to a 15-year triple-net lease with two five-year extension options, an initial annual lease rate of 8.25% and fixed annual escalators of 2.0%. Concurrently with the acquisition, we executed a $1.5 million revolving line of credit with the affiliate of Senior Living which has an initial annual interest rate of 8.25% and matures in October 2040. Reference the "Senior Living Loans" section in Note 4 for additional information on the canceled mortgage note.

In December 2025, we acquired a 107-unit ALF located in Pennsylvania. The acquisition price was $52.1 million, including $1.1 million in closing costs. The property is leased pursuant to a five-year triple-net lease with Priority Life Care, which has an initial annual lease rate of 8.0% plus a revenue participation clause and fixed annual escalators of 2.0%.

In December 2025, we acquired a 56-unit ALF located in Alabama. The acquisition price was $7.0 million, including $0.1 million in closing costs. The property was added to our existing triple-net master lease with William James Group, LLC. As of December 31, 2025, this master lease covers four properties, has an annual lease rate of 8.25%, contains fixed annual escalators of 2.0% and matures in November 2037.

*2024 Acquisitions*

During the year ended December 31, 2024, we completed the following acquisitions of real estate properties (*$ in thousands*):

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | | | | | Buildings, | |
| | | | | | Building | |
| | | | | | Improvements | |
| | | Number of | Asset | | and Intangible | |
| Operator | Period | Properties | Class | Land | Assets | Total |
| Real Estate Investments segment: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Encore Senior Living | Q2 2024 | 1 | ALF | $1329 | $30721 | $32050 |
| &nbsp;&nbsp;&nbsp;&nbsp;Spring Arbor | Q4 2024 | 10 | ALF | 10284 | 111038 | 121322 |
| &nbsp;&nbsp;&nbsp;&nbsp;William James Group, LLC | Q4 2024 | 1 | ALF | 452 | 6488 | 6940 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total asset acquisitions |  |  |  | $12065 | $148247 | $160312 |

---

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

In June 2024, we acquired a 110-unit ALF located in Wisconsin. The acquisition price of $32.1 million, including $0.1 million in closing costs, was partially funded by the cancellation of a construction loan with us which had an outstanding balance of $22.2 million, including accrued interest. The property was added to our existing triple-net master lease with Encore Senior Living for a term of 15 years at an initial annual lease rate of 8.25% and fixed annual escalators of 2.2%.

In October 2024, we acquired a portfolio of 10 ALFs located in North Carolina for a total purchase price of $121.0 million, excluding $0.3 million in closing costs. The properties are leased pursuant to a 15-year triple-net master lease, which includes two five-year extension options, an initial annual lease rate of 8.25% and fixed annual escalators of 2.0%. The master lease also provides for a $10.0 million lease incentive which will be added to the respective lease base if funded.

In December 2024, we acquired an ALF located in Georgia. The acquisition price was $6.9 million, including $0.1 million in closing costs. The property was added to our existing 10-year triple-net master lease with William James Group, LLC, which includes two five-year extension options, an annual lease rate of 8.5% and fixed annual escalators of 2.0%.

*First Quarter of 2026 Acquisitions*

In February 2026, we acquired a portfolio of nine ALFs located in Kentucky, South Carolina and Tennessee with a combined total of 460 units. The total purchase price was $105.5 million, including $1.0 million in closing costs. This portfolio of properties has been included in our SHOP segment and is being managed by Allegro Living Management, an affiliate of Spring Arbor Management, LLC pursuant to a management agreement.

*Discovery Transitions*

Effective August 1, 2025, we terminated a triple-net master lease associated with a portfolio of six SHOs, consisting of four SLCs, one ILF and one ALF, which were held in a consolidated partnership with Discovery Senior Housing Investor XXIV, LLC (the "Discovery partner"). The tenant of the triple-net master lease was a related party of Discovery Senior Living ("Discovery"). In connection with the lease termination, we received net cash consideration of $3.1 million and other non-cash consideration of $0.6 million from the tenant and wrote off the related straight-line rents receivable of $8.9 million on this lease. Each of these amounts was recognized in rental income in our consolidated statement of income for the year ended December 31, 2025. Additionally, on August 1, 2025, we entered into a dissolution agreement with the Discovery partner, which provided for the write-off of the remaining partnership liabilities against the equity in the partnership and the Discovery partner contributing its 2.0% noncontrolling common equity interest to us for nominal consideration.

Concurrently with the activities above, we transitioned the portfolio of six SHOs from our Real Estate Investments segment into our SHOP segment and entered into agreements with an affiliate of Sinceri Senior Living ("Sinceri") to serve as the manager of the properties. As of December 31, 2025, the aggregate net carrying value of this portfolio was $124.9 million. Prior to the transition, we recognized rental income of $3.2 million, $6.1 million and $8.6 million during the years ended December 31, 2025, 2024 and 2023, respectively, related to the triple-net master lease.

Also, effective August 1, 2025, we terminated a triple-net lease with an affiliate of Discovery related to an ILF in Oklahoma. In connection with the lease termination, we received $0.8 million in cash consideration and $0.8 million in other non-cash consideration from the tenant and wrote off the related straight-line rents receivable of $3.2 million on this lease. Each of these amounts was recognized in rental income in our consolidated statement of income for the year ended December 31, 2025. Concurrently with the lease termination, we transitioned this property from our Real Estate Investments segment into our SHOP segment by contributing it to an existing consolidated partnership with DSHI NHI Holiday LLC (the "Discovery member"). As of December 31, 2025, the net carrying value of this property was $28.4 million. Prior to the transition, we recognized rental income of $1.6 million, $2.8 million and $2.9 million during the years ended December 31, 2025, 2024 and 2023, respectively. related to the triple-net lease.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

*Dispositions*

*2025 Dispositions*

During the year ended December 31, 2025, we had no asset dispositions.

*2024 Dispositions*

During the year ended December 31, 2024, we completed the following dispositions of real estate properties (*$ in thousands*):

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | | Number of | Asset | Net | Net Carrying | Gain (Loss) |
| Operator | Period | Properties | Class | Proceeds | Amount | on Sale |
| Real Estate Investments segment: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;SLM | Q2 2024 | 2 | ALF | $4658 | $3240 | $1418 |
| &nbsp;&nbsp;&nbsp;&nbsp;Bickford Senior Living ("Bickford")<sup>1</sup> | Q4 2024 | 1 | ALF | 790 | 665 | 125 |
| &nbsp;&nbsp;&nbsp;&nbsp;SLM<sup>2</sup> | Q4 2024 | 1 | ALF | 9731 | 5004 | 4727 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total dispositions |  |  |  | $15179 | $8909 | $6270 |

---

<sup>1&nbsp;&nbsp;&nbsp;&nbsp;</sup>We recognized impairment of $0.7 million and $1.2 million on this property during the years ended December 31, 2024 and 2023, respectively.

<sup>2&nbsp;&nbsp;&nbsp;&nbsp;</sup>We entered into a note receivable with the buyer of this property for $9.4 million, net of discount, which has been included in the net proceeds amount in the table above.

During the years ended December 31, 2024 and 2023, we recognized rental income of $1.3 million and $2.6 million, respectively, related to these property dispositions.

*First Quarter of 2026 Dispositions*

In January 2026, we sold a 42-unit SLC located in Michigan for $6.7 million in net cash consideration. As of December 31, 2025, the net carrying value of this property was $4.2 million. During each of the years ended December 31, 2025, 2024 and 2023, we recognized $0.5 million of rental income related to this property.

*Impairments of Long-Lived Assets*

We had no impairment charges related to long-lived assets during the year ended December 31, 2025.

During the year ended December 31, 2024, we recognized an impairment charge of $0.7 million related to one property in our Real Estate Investments segment which was reclassified to assets held for sale in the second quarter of 2024. This property was subsequently sold in the fourth quarter of 2024.

During the year ended December 31, 2023, we recognized impairment charges of $1.6 million related to four properties in our Real Estate Investments segment, which included $0.5 million of impairment charges on three of these properties which were either sold or reclassified to assets held for sale during the year ended December 31, 2023.

*Assets Held for Sale*

As of December 31, 2025, we had assets held for sale of $3.6 million related to one property in our Real Estate Investments segment. During the years ended December 31, 2025, 2024 and 2023, we recognized rental income of $0.6 million, $0.6 million and $0.4 million, respectively, related to this property. We did not have any assets held for sale as of December 31, 2024.

*Intangible Assets, Net*

In connection with the October 2025 acquisition of a portfolio of four SHOs in our SHOP segment, we recognized a $2.2 million intangible asset related to the fair value of in-place leases at the date of acquisition. This intangible asset is being amortized over the estimated absorption period of one year. During the year ended December 31, 2025, we recognized $0.6 million of amortization expense related to this intangible asset. We had no other intangible assets related to our real estate properties as of December 31, 2025 and 2024.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

**Note 4. Mortgage and Other Notes Receivable** 

We enter into financing arrangements with our tenants, operators, or affiliates of our tenants and operators, and other third parties primarily for construction, renovation and expansion projects, funding of working capital or other corporate needs and the acquisition of real estate properties. These investments are primarily secured loans guaranteed by significant parties to the notes or by cross-collateralization of properties with the same owner. Mortgage and other notes receivable are included in the Real Estate Investments segment. As of December 31, 2025, the principal amounts of our mortgage notes receivable totaled $154.3 million and the principal amounts of our other notes receivable totaled $64.4 million. As of December 31, 2024, the principal amounts of our mortgage and other notes receivable totaled $175.8 million and $113.4 million, respectively. We had credit loss reserves of $15.4 million and $20.2 million as of December 31, 2025 and 2024, respectively, on these investments.

*2025 Investments*

*Vizion Health Loan Amendment*

In March 2025, we amended a mezzanine loan agreement with affiliates of Vizion Health to provide additional funding of $5.4 million and to extend the maturity date to May 2028. The interest rate on the loan escalates on July 1<sup>st</sup> of each year. As of December 31, 2025, the principal amount outstanding on the loan was $16.5 million and the annual interest rate was 9.4%.

*Construction Loan* 

In May 2025, we entered into a construction loan agreement to fund up to $28.0 million for the development of an 84-unit ALF located in Michigan which will be operated by Encore Senior Living upon completion. The loan agreement provides for an annual interest rate of 9.0% and a maturity date in April 2030. As of December 31, 2025, the principal amount outstanding on this construction loan was $8.5 million.

*Fellowship Carolina Marsh Mortgage Note*

In November 2025, we funded a new $18.8 million mortgage note secured by a 94-unit SLC located in South Carolina. The five-year loan agreement with Fellowship Senior Living has an annual interest rate of 8.5% with an option to purchase the property upon the satisfaction of certain conditions. The loan matures in November 2030.

*Silver Wave Wichita Falls Mortgage Note*

In December 2025, we funded a new $11.3 million mortgage note secured by a 141-unit ILF located in Texas. The five-year loan agreement with affiliates of Silver Wave Capital has an annual interest rate of 8.75% with an option to purchase the property upon the satisfaction of certain conditions. The loan matures in December 2030.

*2024 Investments*

*Carriage Crossing Senior Living Bloomington Mortgage Note*

In February 2024, we funded a $15.0 million mortgage note with Carriage Crossing Senior Living Bloomington, which included an additional $2.0 million of available funding contingent upon the operating performance of the facility through March 2027. The five-year loan agreement provides for an annual interest rate of 8.75% and two one-year extensions with an option for us to purchase the facility after February 2026.

*Compass Senior Living Mortgage Note*

In June 2024, we funded a $9.5 million mortgage note with Compass Senior Living that was secured by two facilities. The five-year loan agreement provided for an annual interest rate of 8.5% with an option for us to purchase one or both facilities after July 2026. In October 2025, this loan was fully settled in connection with the acquisition of both properties. Reference the "2025 Acquisitions" section in Note 3.

*The Sanders Trust, LLC Construction Loan*

In August 2024, we entered into a construction loan agreement with TST Lake City IRF, LLC to fund up to $27.7 million for the development of an in-patient rehabilitation facility located in Florida. The four-year loan agreement provides for an annual interest rate of 9.0% and two one-year extensions. As of December 31, 2025, the principal amount outstanding on the loan was $27.4 million.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

*Capital Funding Group, Inc. Loan Extension*

In November 2024, we amended a mezzanine loan agreement with Capital Funding Group, Inc. Pursuant to the terms of the related amended loan agreement, the principal amount outstanding on the loan increased from $25.0 million to $50.0 million and the annual interest rate on the loan increased to 10.0%. The loan matures in December 2028. As of December 31, 2025, the principal amount outstanding on the loan was $9.8 million.

*Other Activity*

*Bickford Construction Loans and Mortgage Notes*

We have a fully funded construction loan with Bickford that is secured by a first mortgage lien on substantially all of the related real and personal property as well as a pledge of any and all leases or other agreements which may grant a right of use to the property. Pursuant to the loan agreement, Bickford is required to pay the related property taxes and insurance. The loan agreement contains a fair market value purchase option on the property that is available to us upon stabilization of the underlying operations. As of December 31, 2025, the principal amount outstanding on the construction loan was $14.7 million and the annual interest rate was 9.0%.

As of December 31, 2025, we held an $11.8 million second mortgage note as a component of the purchase price consideration in connection with the sale of six properties to Bickford in 2021. This second mortgage note bears a 10.0% annual interest rate and matures in April 2026. We did not include this mortgage note receivable in the determination of the initial gain recognized on the sale of this portfolio and the mortgage note is not reflected in mortgage and other notes receivable, net, on our consolidated balance sheets as of December 31, 2025 and 2024. During the years ended December 31, 2025, 2024 and 2023, we received and recognized interest income of $1.2 million, $1.3 million and $1.2 million, respectively, related to this mortgage note. During the years ended December 31, 2025, 2024 and 2023, Bickford repaid $0.5 million, $0.4 million and $0.3 million, respectively, of principal amounts due on this mortgage note which is included in gains on sales of real estate properties, net, in our consolidated statements of income.

Reference the "Non-Performing Notes" section below related to Bickford non-performing notes.

*Senior Living Loans*

In October 2025, the outstanding principal on a $32.7 million mortgage note with Senior Living was fully settled as part of the consideration paid by us when we acquired the underlying property. Concurrently with this acquisition, we executed a 15-year triple-net lease with an affiliate of Senior Living and provided a new $1.5 million revolving line of credit to the affiliate of Senior Living which bears an initial annual interest rate of 8.25%. The revolving line of credit matures in October 2040. As of December 31, 2025, there was no outstanding balance on this revolving line of credit.

As of December 31, 2025, we had an additional $15.0 million revolving line of credit with Senior Living that matures in December 2031. As of December 31, 2025, the principal amount outstanding on this revolving line of credit was $9.0 million and the annual interest rate was 8.0%.

*Non-Performing Notes*

As of December 31, 2025, we had two loans designated as non-performing notes consisting of an unsecured mezzanine loan with a principal balance of $12.0 million due from affiliates of SLM and an unsecured loan due from Bickford with a principal balance of $1.3 million. As of December 31, 2024, the principal amount due to us on the SLM mezzanine loan was $14.5 million and the principal amount due to us on the Bickford loan was $1.4 million. Reference the "SLM Leases" section in Note 5 for information on the $10.0 million SLM mortgage note settlement in February 2025, which was also a non-performing note as of December 31, 2024.

During the year ended December 31, 2025 we received $2.5 million as a partial repayment of the unsecured mezzanine loan due from affiliates of SLM that is classified as non-performing. This repayment resulted in a $1.3 million reduction of the credit loss reserve and related credit loss expense on this loan in the year ended December 31, 2025. As of December 31, 2025, the principal amount outstanding on this loan was $12.0 million, which was fully covered by the related credit loss reserve.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

During the year ended December 31, 2024, we received $0.7 million as a partial repayment upon the sale of the underlying property securing a $2.1 million non-performing mortgage note due from Bickford. We executed a new unsecured mezzanine loan with Bickford for the remaining $1.4 million principal balance due on the existing mortgage note and recognized a credit loss reserve for the entire balance. The new loan bears interest at an annual interest rate of 9.0% and matures in May 2033. As of December 31, 2025, the principal amount outstanding on the mezzanine loan was $1.3 million, which was fully covered by the related credit loss reserve.

During the years ended December 31, 2025, 2024 and 2023, we recognized interest income on a cash basis from non-performing notes of $0.2 million, $1.3 million and $1.8 million, respectively. Credit loss reserves related to non-performing notes totaled $13.3 million and $16.1 million as of December 31, 2025 and 2024 respectively. This decrease in our credit loss reserves related to non-performing notes primarily related to the settlement of the SLM mortgage note in February 2025.

*Credit Loss Reserves*

Our principal measures of credit quality related to our mortgage and other notes receivable, except for construction loans, are debt service coverage for amortizing loans and interest or fixed charge coverage for non-amortizing loans (collectively, "Coverage"). A Coverage ratio provides a measure of the borrower's ability to make scheduled principal and interest payments. The Coverage ratios presented in the table below have been calculated utilizing the most recent date for which data is available, September 30, 2025, using EBITDARM (earnings before interest, taxes, depreciation, amortization, rent and management fees) and the requisite debt service, interest service or fixed charges, as defined in the applicable loan agreement. We categorize Coverage into three levels: (i) more than 1.5x, (ii) between 1.0x and 1.5x and (iii) below 1.0x. We update our calculations of Coverage on a quarterly basis. Coverage is not a meaningful credit quality indicator for construction loans as these developments are typically not generating any operating income or they have insufficient operating income because occupancy levels necessary to stabilize the properties have not yet been achieved. We measure credit quality for these mortgages by considering the construction and stabilization timelines and the financial condition of the borrower, as well as economic and market conditions. We consider the accounting guidance in ASC 310-20, Receivables - Nonrefundable Fees and Other Costs when determining whether a modification, extension or renewal constitutes a current period origination.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

The following table summarizes the credit quality indicators related to the principal amounts outstanding on mortgage and other notes receivable as of December 31, 2025 (*$ in thousands*):

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | Year of Loan Origination | Year of Loan Origination | Year of Loan Origination | Year of Loan Origination | Year of Loan Origination | Year of Loan Origination | Year of Loan Origination |
| | 2025 | 2024 | 2023 | 2022 | 2021 | Prior<br>Years |<br>Total |
| Mortgage notes: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;More than 1.5x | $8304 | $51127 | $722 | $14748 | $— | $— | $74901 |
| &nbsp;&nbsp;&nbsp;&nbsp;Between 1.0x and 1.5x | 11139 |  |  |  |  | 14700 | 25839 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less than 1.0x | 18750 |  |  | 28414 |  | 6423 | 53587 |
|  | 38193 | 51127 | 722 | 43162 |  | 21123 | 154327 |
| Mezzanine loans: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;More than 1.5x |  |  |  |  | 19546 |  | 19546 |
| &nbsp;&nbsp;&nbsp;&nbsp;Between 1.0x and 1.5x | 1512 |  | 789 |  | 6640 |  | 8941 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less than 1.0x |  |  |  |  |  | 9795 | 9795 |
|  | 1512 |  | 789 |  | 26186 | 9795 | 38282 |
| Non-performing notes: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;More than 1.5x |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Between 1.0x and 1.5x |  | 1259 |  |  |  |  | 1259 |
| &nbsp;&nbsp;&nbsp;&nbsp;No coverage available |  |  |  |  |  | 12000 | 12000 |
|  |  | 1259 |  |  |  | 12000 | 13259 |
| Revolving lines of credit: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;More than 1.5x |  |  |  |  |  |  | 12825 |
| Credit loss reserves |  |  |  |  |  |  | (15397) |
| Total mortgage and other notes |  |  |  |  |  |  |  |
| &nbsp;&nbsp;receivable, net |  |  |  |  |  |  | $203296 |

---

Our methodology for estimating credit loss reserves on non-performing notes incorporates considerations of the sufficiency of the underlying collateral, current economic conditions and forecasts of future economic conditions that may impact the collectability of these loans, including qualitative factors, which may differ from conditions existing in historical periods. Due to the continuing challenges in the U.S. financial markets and the potential impact on the collectability of our mortgage and other notes receivable, we forecasted a 20.0% increase in the probability of a default and a 20.0% increase in the amount of estimated loss from a default on all loans, other than those designated as non-performing notes, resulting in an effective adjustment of 4.4% as of December 31, 2025.

The following table provides a summary of the changes in our credit loss reserves during the year ended December 31, 2025 (*$ in thousands*):

---

| | |
|:---|:---|
| Balance at the beginning of the year | $20249 |
| &nbsp;&nbsp;&nbsp;&nbsp;Reduction in expected credit losses, net | (3452) |
| &nbsp;&nbsp;&nbsp;&nbsp;Write-offs | (1400) |
| Balance at the end of the year | $15397 |

---

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

**Note 5. Leases**

*Leases - Lessor*

Our tenant leases are typically structured as triple-net leases and relate to single-tenant properties having an initial lease term of 10 to 15 years with one or more five-year extension options. Most of our tenant leases contain annual rent escalators, which may be fixed or variable. Lease payments due to us that are subject to a variable rent escalator are typically determined annually and calculated using a variable index, such as the consumer price index, or an index that is dependent on a future date and indeterminable at the inception of the lease.

A summary of our rental income with information on our lease payments received that were subject to fixed and variable rent escalators follows *($ in thousands*):

---

| | | | |
|:---|:---|:---|:---|
| | Year Ended December 31, | Year Ended December 31, | Year Ended December 31, |
| | 2025 | 2024 | 2023 |
| Lease payments based on fixed rent escalators | $247495 | $234672 | $225565 |
| Lease payments based on variable rent escalators<sup>1</sup> | 23289 | 11074 | 7709 |
| Straight-line rent revenue adjustments, net of write-offs<sup>2</sup> | (7265) | 3031 | 6961 |
| Escrow funds received from tenants for property operating expenses | 10982 | 11165 | 11513 |
| Amortization of lease incentives | (2901) | (2893) | (2521) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total rental income | $271600 | $257049 | $249227 |

---

<sup>1&nbsp;&nbsp;&nbsp;&nbsp;</sup>Cash and non-cash consideration received by us as a result of the early lease terminations described in the "Discovery Transitions" section in Note 3 have been included in lease payments based on variable rent escalators for the year ended December 31, 2025.

<sup>2</sup>&nbsp;&nbsp;&nbsp;&nbsp;The amount presented for the year ended December 31, 2025 included $12.1 million of write-offs of straight-line rents receivable as a result of the early lease terminations described in the "Discovery Transitions" section in Note 3.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

*Tenant Concentrations*

The following table presents information related to concentrations of our tenants, or affiliates of our tenants, that exceeded 10% of our total revenues (*$ in thousands*):

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | December 31, 2025 | December 31, 2025 | Year Ended December 31, | Year Ended December 31, | Year Ended December 31, | Year Ended December 31, | Year Ended December 31, | Year Ended December 31, |
| | | | 2025 | | 2024 | | 2023 | |
| | Real<br>Estate<br>Properties<sup>1</sup> | Mortgage<br>and Other<br>Notes<sup>2</sup> |<br>Revenues<sup>3</sup> | % of<br>Total |<br>Revenues<sup>3</sup> | % of<br>Total |<br>Revenues<sup>3</sup> | % of<br>Total |
| Senior Living | $632253 | $9000 | $55091 | 14.7% | $53570 | 16.0% | $51274 | 16.0% |
| Bickford | 427117 | 15959 | 43185 | 11.5% | 41720 | 12.4% | 38688 | 12.1% |
| National Healthcare |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Corporation ("NHC") | 133770 |  | 40272 | 10.7% | 40016 | 11.9% | 37335 | 11.7% |
| Escrow funds received from tenants |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;for property operating expenses |  |  | 10982 | 2.9% | 11165 | 3.3% | 11513 | 3.6% |
| Other | 1465713 | 193734 | 146036 | 38.9% | 134289 | 40.2% | 132216 | 41.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total tenant concentrations | $2658853 | $218693 | 295566 | 78.7% | 280760 | 83.8% | 271026 | 84.7% |
| Resident fees and services<sup>4</sup> |  |  | 80062 | 21.3% | 54421 | 16.2% | 48809 | 15.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total revenues |  |  | $375628 | 100.0% | $335181 | 100.0% | $319835 | 100.0% |

---

<sup>1&nbsp;&nbsp;&nbsp;&nbsp;</sup>Real estate properties have been stated at their gross carrying amounts. Total real estate properties, as presented in the table above, excludes $2.6 million related to our corporate office and equipment, $4.8 million related to one property in the Real Estate Investments segment that was classified as assets held for sale as of December 31, 2025 and $634.3 million related to the properties in our SHOP segment.

<sup>2&nbsp;&nbsp;&nbsp;&nbsp;</sup>Mortgage and other notes receivable have been stated at their gross carrying amounts. Total mortgage and other notes receivable, as presented in the table above, excludes our total credit loss reserves of $15.4 million as of December 31, 2025.

<sup>3&nbsp;&nbsp;&nbsp;&nbsp;</sup>Revenues related to assets classified as held for sale are included in other revenues in the table above.

<sup>4&nbsp;&nbsp;&nbsp;&nbsp;</sup>There are no concentrations in revenues from resident fees and services because the resident agreements at the senior housing communities are between us and the individual residents.

As of December 31, 2025, our real estate properties in South Carolina represented 12.0% of our total real estate properties, net, on our consolidated balance sheet. As of December 31, 2024, our real estate properties in South Carolina and Texas represented 11.6% and 10.1%, respectively, of our total real estate properties, net. There were no other states where our concentration of real estate properties was 10% or greater as of December 31, 2025 and 2024.

*Senior Living Leases*

As of December 31, 2025, we leased 11 SHOs with a combined total of 2,490 units to Senior Living. During the years ended December 31, 2025, 2024 and 2023, we recognized straight-line rent revenue of $(0.6) million, $(0.2) million and $(1.2) million, respectively, related to our leases with Senior Living.

During the year ended December 31, 2024, our tenant leases with Senior Living were amended to extend the maturity dates by two years and to provide up to $10.0 million of capital improvements on various properties in the Senior Living portfolio. Rental income will increase at an annual lease rate of 8.5% applied to the amount expended.

*Bickford Leases*

As of December 31, 2025, we leased 38 SHOs to Bickford under four master leases. In 2022, we began recognizing rental income from Bickford's leases using the cash basis of accounting for revenue recognition based upon information we obtained from Bickford regarding its financial condition that raised substantial doubt about its ability to continue as a going concern.

In April 2024, the combined rent for the Bickford lease portfolio with us was reset to $34.5 million per year with nominal increases through April 2026, at which time the rent will be reset to fair market value, as defined in the amended lease agreements. In connection with these lease amendments, we entered into an agreement with Bickford to fund up to $8.0 million of capital improvements on various properties in the Bickford portfolio. Rental income will increase at an annual lease rate of 8.0% applied to the amount expended.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

During the years ended December 31, 2025, 2024 and 2023, Bickford repaid $5.3 million, $5.1 million and $2.3 million of its outstanding rent deferrals, respectively. These repayments excluded $2.5 million of rental income recognized during the year ended December 31, 2023 which related to rent deferrals settled in connection with the acquisition of one ALF located in Virginia from Bickford. As of December 31, 2025, Bickford's outstanding rent deferrals were $7.6 million.

In November 2024, we sold an ALF from the Bickford portfolio that is located in Indiana. Reference the "2024 Dispositions" section in Note 3.

*NHC Leases*

As of December 31, 2025, we leased 32 SNFs and three ILFs to NHC, a publicly owned company, under a triple-net master lease which expires in December 2026. The master lease includes two five-year extension options in which the annual lease rate resets at the current fair market value as negotiated between the parties. Four of these properties have been subleased to other third parties pursuant to leases in which NHC serves as a guarantor. The triple-net master lease provides for a contingent rent clause that requires NHC to pay additional rent based on 4.0% of the excess, if any, in the annual revenues of the facilities it leases from us over a base amount specified in each lease. During the years ended December 31, 2025, 2024 and 2023, we recognized straight-line rent revenue of $0.6 million, $0.2 million and $(1.2) million, respectively, related to NHC.

A summary of the portion of our rental income from NHC that was attributable to contingent rent follows (*$ in thousands*):

---

| | | | |
|:---|:---|:---|:---|
| | Year Ended December 31, | Year Ended December 31, | Year Ended December 31, |
| | 2025 | 2024 | 2023 |
| Current year | $6474 | $5518 | $3862 |
| Prior year final certifications<sup>1</sup> | 956 | 1656 | 630 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total contingent rental income from NHC | $7430 | $7174 | $4492 |

---

<sup>1 &nbsp;&nbsp;&nbsp;&nbsp;</sup>NHC certifies the annual revenue of its facilities leased from us by March 31<sup>st</sup> of the following year.

One of the members of our Board of Directors is also the chairperson of NHC's board of directors. This director has announced his resignation to be effective as of our 2026 annual meeting of stockholders. As of December 31, 2025, NHC owned 1,630,642 shares of our common stock.

*Cash Basis Tenants*

During the year ended December 31, 2025, two of our tenants were on the cash basis of accounting for revenue recognition for their leasing arrangements with us based on our assessment of each tenant's ability to satisfy its contractual obligations under the terms of the respective leases. During the years ended December 31, 2024 and 2023, three of our tenants were on the cash basis of accounting for revenue recognition for their leasing arrangements with us.

A summary of lease payments received by us from cash basis tenants follows (*$ in thousands*):

---

| | | | |
|:---|:---|:---|:---|
| | Year Ended December 31, | Year Ended December 31, | Year Ended December 31, |
| | 2025 | 2024 | 2023 |
| Bickford | $40497 | $38971 | $33352 |
| All others | 6633 | 11010 | 12444 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total lease payments from cash basis tenants | $47130 | $49981 | $45796 |

---

These lease payments from cash basis tenants included $5.9 million, $9.0 million and $2.8 million of rent deferrals granted during the COVID-19 pandemic for the years ended December 31, 2025, 2024 and 2023, respectively.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

*SLM Leases*

In 2022, we began recognizing our tenant leases with SLM, which related to four properties, using the cash basis of accounting for revenue recognition. In September 2024, SLM notified us that ongoing liquidity constraints were continuing to raise substantial doubts about its ability to continue operations and pay contractual rent and interest obligations prospectively. In the fourth quarter of 2024, we entered into an agreement with SLM to transition one of the existing leased properties to a new operator under a new lease agreement. Additionally, we reclassified one of the properties to assets held for sale during the year ended December 31, 2024. This property was sold in the fourth quarter of 2024. On January 1, 2025, the remaining two properties leased to SLM were transitioned to a new operator who had been serving as the interim manager at each of the properties. Concurrently with this transition, we executed a 15-year triple-net master lease, which includes two five-year extension options, with the new operator. The master lease with the new operator provides for approximately $1.1 million in initial annual contractual lease payments with fixed annual escalators of 2.0%. As of December 31, 2025, we had no properties leased to SLM.

During the years ended December 31, 2025, 2024 and 2023, we received lease payments of $0.7 million, $2.7 million and $5.4 million, respectively, from SLM.

*Lease Terminations*

Reference the "Discovery Transitions" section in Note 3 for information on the Discovery lease terminations during the year ended December 31, 2025.

During the year ended December 31, 2024, we transitioned an SNF located in Wisconsin and an ALF located in Alabama to new operators. In connection with these transitions, we wrote off straight-line rents receivable of $1.6 million related to the early termination of the leases with the previous operators.

We did not transition any properties to new operators during the year ended December 31, 2023.

*Tenant Purchase and Sale Agreement*

We lease a SLC that is subject to a purchase and sale agreement giving the tenant the option to acquire the property for $39.0 million. The purchase and sale agreement, as amended, is subject to monthly renewals through March 2026 by the tenant upon payment of a non-refundable fee. The property was included in real estate properties, net, on our consolidated balance sheets as of December 31, 2025 and 2024. During the years ended December 31, 2025, 2024 and 2023, we recognized rental income of $2.6 million, $2.8 million and $2.8 million, respectively, related to the existing triple-net lease at this property which expires in July 2027. The property will be reclassified to assets held for sale when the sale becomes probable, including when the tenant demonstrates its ability to obtain sufficient financing to close on the sale of the property within the terms of the purchase and sale agreement. As of December 31, 2025, the net carrying value of this property was $18.4 million.

*Tenant Purchase Options*

Certain of our tenant leases contain a purchase option clause allowing the tenant to acquire the leased property at a fixed base price, a fixed base price plus a specified share in any appreciation of the property or a price based on a specified fixed minimum internal rate of return on our investment. As of December 31, 2025, tenants had purchase options on four of our properties, with an aggregate net carrying value of $74.7 million, which have exercise dates ranging between 2028 and 2031. Rental income from these properties with tenant purchase options was $10.0 million, $8.8 million and $7.2 million for the years ended December 31, 2025, 2024 and 2023, respectively. As of December 31, 2025, we cannot reasonably estimate the probability that any of these tenant purchase options will be exercised in the future.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

*Future Minimum Lease Payments*

The fixed amounts of future minimum lease payments due to us under our existing tenant leases as of December 31, 2025 were as follows *($ in thousands*):

---

| | |
|:---|:---|
| 2026 | $269940 |
| 2027 | 220708 |
| 2028 | 215439 |
| 2029 | 204290 |
| 2030 | 203941 |
| Thereafter | 833620 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $1947938 |

---

*Leases - Lessee*

We have a ground lease related to an ALF located in Ohio that is classified as an operating lease. As of each of December 31, 2025 and 2024, the ROU asset related to this operating lease was $1.5 million and the operating lease liability was $1.7 million. During each of the years ended December 31, 2025, 2024 and 2023, we recognized lease expense of $0.1 million related to this lease. As of December 31, 2025, the future minimum lease payments due from us under this lease were $0.1 million annually for 2026 through 2030 and $2.0 million for the aggregate years thereafter. Imputed interest on these future minimum lease payments was $1.1 million.

**Note 6. Equity Method Investment**

Concurrently with the acquisition of a CCRC in January 2020 from LCS-Westminster Partnership III, LLP ("Timber Ridge CCRC"), we invested $0.9 million in the operating company, Timber Ridge OpCo, LLC ("Timber Ridge OpCo"), which represented a 25.0% equity interest. This investment is held by our TRS to be compliant with the provisions of RIDEA. As part of our initial investment, we provided Timber Ridge OpCo with a revolving credit facility that has a maximum borrowing capacity of $5.0 million. As of December 31, 2025, no amounts have been drawn on this revolving credit facility.

We account for our investment in Timber Ridge OpCo under the equity method of accounting and decrease the carrying value of our investment for operating losses in the entity and distributions to us for cumulative amounts up to and including our basis plus any guaranteed or implied commitments to fund operations. In February 2023, we received $2.5 million from Timber Ridge OpCo, representing our proportionate share of a lease incentive earned based on our equity interest in the entity. Our guaranteed and implied commitments are currently limited to the additional $5.0 million of availability under the revolving credit facility and the $2.5 million lease incentive distribution received. As of December 31, 2025 and 2024, we have recognized our share of Timber Ridge OpCo's operating losses in excess of our initial investment. These cumulative losses of $5.0 million in excess of our original basis and the $2.5 million lease incentive distribution received are included in accounts payable and other liabilities on our consolidated balance sheets as of December 31, 2025 and 2024. During the years ended December 31, 2025, 2024 and 2023, excess unrecognized equity method losses for this investment were $2.1 million, $2.7 million and $2.7 million respectively. As of December 31, 2025, our cumulative unrecognized losses for this investment were $18.0 million. During the years ended December 31, 2025, 2024 and 2023, we recognized gains from equity method investment in our consolidated statements of income of $3.7 million, $0.4 million and $0.6 million, respectively, related to cash distributions received from this investment.

The Timber Ridge OpCo property is subject to early resident mortgages secured by a Deed of Trust and Indenture of Trust (the "Deed and Indenture"). As part of our acquisition, NHI-LCS JV I, LLC ("Timber Ridge PropCo") acquired the Timber Ridge CCRC property and a subordination agreement was entered into pursuant to which the trustee acknowledged and confirmed that the security interests created under the Deed and Indenture were subordinate to any security interests granted in connection with the $81.0 million loan made by us to Timber Ridge PropCo, which is eliminated in our consolidated financial statements. In addition, under the terms of the resident loan assumption agreements, during the term of the seven-year lease to Timber Ridge Opco, which includes two five-year extension options, Timber Ridge OpCo is required to indemnify Timber Ridge PropCo for any repayment by Timber Ridge PropCo of these early resident mortgage liabilities under the guarantee. As a result of the subordination agreement and the resident loan assumption agreements, we have not recorded any liabilities as of December 31, 2025 and 2024. As of December 31, 2025, the balance secured by the Deed and Indenture was $7.7 million.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

**Note 7. Other Assets, Net**

Other assets, net, consisted of the following (*$ in thousands*):

---

| | | |
|:---|:---|:---|
| | December 31, | December 31, |
| | 2025 | 2024 |
| Real Estate Investments segment accounts receivable and other assets | $3435 | $4223 |
| SHOP segment accounts receivable, net of allowances of $309 and $494, respectively, |  |  |
| &nbsp;&nbsp;and other assets | 3137 | 2232 |
| Lease incentives, net | 4976 | 7877 |
| Regulatory escrows | 6208 | 6208 |
| Restricted cash |  | 2213 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total other assets, net | $17756 | $22753 |

---

During the year ended December 31, 2025, we recognized $1.2 million of transaction costs in legal expense in our consolidated statement of income related to an acquisition in our SHOP segment that did not materialize. We had $0.6 million of these costs capitalized in SHOP segment other assets as of December 31, 2024.

Lease incentives, net of accumulated amortization, primarily consist of a $10.0 million lease incentive paid to Timber Ridge Opco in February 2023 related to the Timber Ridge CCRC. This lease incentive is being amortized on a straight-line basis through the remaining initial lease term ending in January 2027.

Regulatory escrows consist of required amounts held on deposit related to our EFCs located in Connecticut.

**Note 8. Debt, Net**

Debt, net consisted of the following (*$ in thousands*):

---

| | | |
|:---|:---|:---|
| | December 31, | December 31, |
| | 2025 | 2024 |
| Revolving credit facility - unsecured | $204000 | $331200 |
| Bank term loan - unsecured | 125000 | 200000 |
| 2031 Senior Notes - unsecured, net of discount of $1,635 and $1,956, respectively | 398365 | 398044 |
| 2033 Senior Notes - unsecured, net of discount of $3,707 | 346293 |  |
| Private placement notes - unsecured | 100000 | 150000 |
| Fannie Mae term loans - secured, non-recourse |  | 75815 |
| Unamortized debt issuance costs | (9844) | (9018) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total debt, net | $1163814 | $1146041 |

---

A summary of the aggregate principal maturities of our outstanding debt as of December 31, 2025 follows (*$ in thousands*):

---

| | |
|:---|:---|
| 2026 | $125000 |
| 2027 | 100000 |
| 2028 | 204000 |
| 2029 |  |
| 2030 |  |
| Thereafter | 750000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total principal amounts of debt outstanding | 1179000 |
| Less: Unamortized debt issuance costs and discounts | (15186) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total debt, net | $1163814 |

---

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

*Revolving Credit Facility and Bank Term Loan*

We have a $700.0 million unsecured revolving credit facility (the "Credit Facility") that matures in October 2028, which may be further extended by us pursuant to (i) one or both of the six-month extension options or (ii) one 12-month extension option. In October 2025, we amended the Credit Facility to remove the 0.10% credit spread adjustment applicable to the Secured Overnight Financing Rate ("SOFR") interest rates, which resulted in an effective decrease of 0.10% in the applicable interest rates with respect to the Credit Facility. Borrowings under the Credit Facility bear interest, at our election, at one of the following (a) Term SOFR plus a margin ranging from 0.725% to 1.400%, (b) Daily SOFR plus a margin ranging from 0.725% to 1.400% or (c) the base rate plus a margin ranging from 0.000% to 0.400%. In each election, the actual margin is determined according to our credit ratings. The base rate means, for any day, a fluctuating interest rate per annum equal to the highest of (x) the agent's prime rate, (y) the federal funds rate on such day plus 0.50% or (z) the adjusted Term SOFR for a one-month tenor in effect on such day plus 1.0%. In addition, the Credit Facility requires a facility fee equal to 0.125% to 0.300%, based on our credit rating on the $700.0 million committed capacity, without regard to usage.

As of December 31, 2025, we had $496.0 million available to draw on the Credit Facility, subject to usual and customary covenants. Among other stipulations, our Credit Facility requires that we maintain certain financial ratios within limits set by our creditors. As of December 31, 2025, we were in compliance with these covenants.

We have a $200.0 million unsecured bank term loan (the "Bank Term Loan"), which was amended and restated in October 2024 to, among other things, align certain representations, covenants and events of default with the terms of the amended and restated Credit Facility. The Bank Term Loan bears interest at a variable rate which is SOFR-based with a margin determined according to our credit ratings. Concurrently with the most recent amendment of the Credit Facility in October 2025, we also amended the Bank Term Loan to remove the 0.10% credit spread adjustment applicable to the SOFR interest rates, which was in alignment with the Credit Facility amendment.

During the year ended December 31, 2025, we repaid $75.0 million on the Bank Term Loan and exercised both six-month extension options, which extended the maturity of the Bank Term Loan to June 2026.

Pinnacle Bank is a participating member of our banking group. A member of our Board of Directors who became the chairman of our Board of Directors effective in January 2025, is also the chairman of the board of directors of Pinnacle Financial Partners, Inc., the holding company for Pinnacle Bank. Our corporate banking transactions are conducted primarily through Pinnacle Bank.

*2031 Senior Notes*

In January 2021, we issued $400.0 million in aggregate principal amount of 3.000% senior notes that mature in February 2031 (the "2031 Senior Notes") and require semi-annual interest payments. The 2031 Senior Notes were sold at an issue price of 99.196% of face value before the underwriters' discounts. Our net proceeds from the 2031 Senior Notes offering, after deducting underwriting discounts and expenses, were $392.3 million. The 2031 Senior Notes are subject to affirmative and negative covenants, including financial covenants. As of December 31, 2025, we were in compliance with these covenants.

*2033 Senior Notes*

In September 2025, we issued $350.0 million in aggregate principal amount of 5.350% unsecured senior notes that mature in February 2033 (the "2033 Senior Notes"). The 2033 Senior Notes were sold at an issue price of 98.903% of face value before the underwriters' discount. Our net proceeds from the 2033 Senior Notes offering, after deducting underwriting discounts and expenses, were $342.5 million. We used the net proceeds to repay existing indebtedness. Interest on the 2033 Senior Notes is due semi-annually beginning in February 2026. The 2033 Senior Notes are subject to affirmative and negative covenants, including financial covenants. As of December 31, 2025, we were in compliance with these covenants.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

*Private Placement Notes*

Our private placement notes have a fixed interest rate and require interest only payments up to the respective maturity dates. Covenants pertaining to the private placement notes are generally conformed with those governing our Credit Facility, except for specific debt coverage ratios that are more restrictive. Our private placement notes include a provision that increases the fixed interest rate if any rating agency lowers the credit rating on our unsecured senior debt below investment grade and our compliance leverage increases to 50.0% or more.

During the years ended December 31, 2025, 2024 and 2023, we repaid $50.0 million, $75.0 million and $175.0 million, respectively, of our private placement notes upon maturity. As of December 31, 2025, we had $100.0 million of principal amounts outstanding on our private placement notes which bore interest at 4.51% and mature in January 2027.

*Fannie Mae Term Loans*

During the year ended December 31, 2025, we made the final repayment of $75.8 million, including accrued interest.

*Interest Expense*

A summary of the components of interest expense follows *($ in thousands*):

---

| | | | |
|:---|:---|:---|:---|
| | Year Ended December 31, | Year Ended December 31, | Year Ended December 31, |
| | 2025 | 2024 | 2023 |
| Interest expense at contractual rates | $53941 | $56313 | $55603 |
| Capitalized interest |  | (193) | (90) |
| Amortization of debt issuance costs and discounts | 3427 | 3783 | 2647 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total interest expense | $57368 | $59903 | $58160 |

---

**Note 9. Commitments, Contingencies and Uncertainties**

In the normal course of business, we enter into a variety of commitments, typically consisting of funding construction loans, mezzanine loans and revolving lines of credit with our tenants, operators, or affiliates of our tenants and operators, and other third parties. In our leasing operations, we may offer our tenants and the sellers of properties we acquire certain inducements that originate contractually as contingencies, but which may become commitments upon the satisfaction of the contingent event. Any contingent payments made by us are included in the respective lease base when funded.

As of December 31, 2025, we had loan commitments with nine operators or borrowers totaling $151.6 million of which we had funded $115.7 million toward these commitments. We also had development commitments with seven tenants totaling $23.6 million of which we had funded $12.1 million toward these commitments. Additionally, we had remaining contingency commitments totaling $15.7 million, which included lease inducement contingencies with three tenants and contingent consideration related to an acquisition in our SHOP segment. Each of these contingency commitments is based on the respective facility operating performance over a specified period.

We provide for expected credit loss liabilities on our unfunded loan commitments based on the estimated amounts we expect to fund using the same methodology as the one applied to provide for credit loss reserves on our mortgage and other notes receivable. The liabilities for expected credit losses on our unfunded loan commitments are included in accounts payable and other liabilities on our consolidated balance sheets. Reference the "Credit Loss Reserves" section in Note 4 for additional information.

The following table provides a summary of the changes in our expected credit loss liabilities for the year ended December 31, 2025 (*$ in thousands*):

---

| | |
|:---|:---|
| Balance at the beginning of the year | $147 |
| &nbsp;&nbsp;&nbsp;&nbsp;Provision for expected credit losses | 5 |
| Balance at the end of the year | $152 |

---

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

*Bickford Contingent Note Arrangement*

Related to the sale of six properties to Bickford in 2021, we reached an agreement with Bickford whereby Bickford would owe us up to $4.5 million under a contingent note arrangement. We have the one-time option to determine fair market value of the portfolio through April 30, 2026, at which time the amount owed under the contingent note arrangement, if any, will be determined as the lesser of (i) the difference between the fair market value of the portfolio and $52.1 million, which amount represents the purchase consideration for the portfolio of $52.9 million less $0.8 million in mortgage debt repayment fees previously paid by us associated with this portfolio and (ii) $4.5 million. Any amount due on the contingent note arrangement will accrue interest at an annual rate of 10.0% and will be due in five years from the determination date.

*Litigation*

From time to time, we are party to various lawsuits, investigations, claims and other legal and regulatory proceedings arising in connection with our business. Such claims may include, among other things, professional and general liability claims, as well as regulatory proceedings related to our SHOP segment. Further, from time to time, we are a party to certain legal proceedings for which third parties, such as our tenants, managers and borrowers, are contractually obligated to indemnify us from and against various claims, litigation and liabilities arising in connection with their respective businesses. Management believes that the ultimate resolution of all such pending proceedings will have no material adverse effect on our financial condition, results of operations or cash flows.

**Note 10. Noncontrolling Interests**

*Redeemable Noncontrolling Interest*

As of December 31, 2025, we had a portfolio of six ILFs located in California and Washington that are held in a consolidated partnership with Merrill Gardens, LLC. ("Merrill"), which owns a 20% common equity interest in the partnership. We own 100% of the preferred equity interest and 80% of the common equity interest in the partnership. The operating agreement for the partnership provides for contingent distributions to the members based on the attainment of certain yields on the investment calculated on an annual basis. The Merrill consolidated partnership is included in our SHOP segment.

Certain provisions in the operating agreement related to the Merrill consolidated partnership in our SHOP segment entitle Merrill to put rights upon certain contingent events that are not solely within our control as the majority equity interest owner. As a result, Merrill's noncontrolling interest in the partnership was deemed to be contingently redeemable and has been classified in the mezzanine section between liabilities and equity on our consolidated balance sheets as of December 31, 2025 and 2024. We are required to remeasure the carrying value of the noncontrolling interest to its redemption value in the period it becomes known that a triggering event is probable to occur. As of December 31, 2025 and 2024, we concluded that the redemption criteria were not met. The operating agreement of the partnership provides for contingent distributions to the members based on the attainment of certain yields on the investment calculated on an annual basis.

The following table provides a summary of the activity related to the redeemable noncontrolling interest (*$ in thousands*):

---

| | | |
|:---|:---|:---|
| | Year Ended December 31, | Year Ended December 31, |
| | 2025 | 2024 |
| Balance at the beginning of the year | $9790 | $9656 |
| &nbsp;&nbsp;&nbsp;&nbsp;Contributions | 1440 | 1100 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss attributable to redeemable noncontrolling interest | (999) | (916) |
| &nbsp;&nbsp;&nbsp;&nbsp;Distributions declared to redeemable noncontrolling interest | (36) | (50) |
| Balance at the end of the year | $10195 | $9790 |

---

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

*Noncontrolling Interests Classified as Equity*

In our Real Estate Investments segment, we own an 80.0% common equity interest in a partnership with LCS Timber Ridge LLC ("LCS"), which owns and leases a CCRC in Washington. LCS owns the remaining 20.0% common equity interest in the partnership.

Prior to the Discovery transitions on August 1, 2025, we had a portfolio of six SHOs in a consolidated partnership in which we owned a 98.0% common equity interest and the Discovery partner owned a 2.0% common equity interest in the partnership. On August 1, 2025, we entered into a dissolution agreement with the Discovery partner, which provided for the write-off of the remaining partnership liabilities against the equity in the partnership and the Discovery partner contributing its 2.0% noncontrolling common equity interest to us for nominal consideration. This partnership was included in our Real Estate Investments segment prior to its dissolution on August 1, 2025.

As of December 31, 2025, we had a portfolio of 10 ILFs located in Arkansas, Georgia, Ohio, Oklahoma, New Jersey and South Carolina that are held in a consolidated partnership with the Discovery member, a related party of Discovery. This partnership is included in our SHOP segment. We own 100.0% of the preferred equity interest and 98.0% of the common equity interest in the partnership and the Discovery member owns 2.0% of the common equity in the partnership. During the years ended December 31, 2025, 2024 and 2023, the members contributed $2.8 million, $3.5 million and $2.6 million respectively to the partnership to fund additional capital expenditures, which included contributions in cash from the Discovery member of $0.3 million, $0.1 million and $0.1 million, respectively in accordance with its common equity interest in the partnership. On August 1, 2025, we transitioned a property in Oklahoma from our Real Estate Investments segment into this portfolio. The operating agreement of the partnership provides for contingent distributions to the members based on the attainment of certain yields on the investment calculated on an annual basis.

**Note 11. Equity and Dividends**

*Forward Equity Sales Agreements*

During the year ended December 31, 2024, we entered into forward equity sales agreements with financial institutions to sell up to an aggregate of 2.8 million shares of our common stock, at an initial forward sale price of $68.40 per share, pursuant to which the financial institutions borrowed and sold these shares of common stock in a public offering. We did not receive any proceeds from the sale of the shares of common stock by the forward purchasers at the time of the offering. The net forward sale price that we received upon physical settlement of the forward sales agreements is subject to adjustment for (i) a floating interest rate factor equal to a specified daily rate less a spread and (ii) scheduled dividends during the term of the forward equity sales agreements.

During the year ended December 31, 2024, we partially settled the above forward equity sales agreements by issuing 1.8 million shares of our common stock at a forward price of $68.00 per share for net proceeds of $122.4 million. During the year ended December 31, 2025, we settled the remainder of the above forward equity sales agreements by issuing 1.0 million shares of our common stock at a forward price of $68.21 per share for proceeds of $65.5 million.

*ATM Equity Program*

We maintain an ATM equity program which allows us to sell our common stock directly into the market. This program is governed by an ATM equity sales agreement which includes a forward sales provision that allows us to sell shares of our common stock to forward purchasers at a predetermined price at a future date. Pursuant to this agreement, we are authorized to sell up to $500.0 million of our common stock.

During the year ended December 31, 2024, we entered into an ATM forward sales agreement with a financial institution to sell shares of our common stock over a forward selling period to be completed by the end of the year. Pursuant to this agreement, we sold 1.0 million shares of our common stock on a forward basis at a weighted average price of $74.99 per share, net of sales agent fees, which totaled $74.2 million. In accordance with ASC 815-40, Derivatives and Hedges, Contracts in Entity's Own Equity, we determined the ATM forward sales under this agreement did not qualify for equity classification on our consolidated balance sheet during the forward selling period. Accordingly, we recognized a $6.3 million gain on the ATM forward sales agreement in our consolidated statement of income for the year ended December 31, 2024. We settled a portion of the ATM forward sales agreement during the year ended December 31, 2024 by issuing 0.3 million shares of our common stock for net proceeds of $20.0 million, or $75.22 per share.

During the year ended December 31, 2025, we entered into multiple ATM forward sales agreements with financial institutions to sell shares of our common stock. Pursuant to these agreements, we sold 1.5 million shares of our common stock on a forward basis at a weighted average price of $71.83 per share, net of sales agent fees, which totaled $107.2 million. These ATM forward sales agreements mature in the first and second quarters of 2026 and qualify for equity treatment in accordance with GAAP.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

During the year ended December 31, 2025, we partially settled our outstanding ATM forward sales agreements by issuing 1.6 million shares of our common stock at a weighted average forward price of $73.75 per share for total consideration of $116.0 million, net of sales agent fees.

As of December 31, 2025, we had the ability to access 0.6 million shares of our common stock at a weighted average price of $69.23 per share, net of sales agent fees, under remaining active ATM forward sales agreements, which mature in the second quarter of 2026, and represent $44.5 million of undrawn net proceeds. As of December 31, 2025, we had the ability to access $315.8 million through the issuance of common stock under our ATM equity program.

*Dividends*

During the years ended December 31, 2025, 2024 and 2023, we declared dividends of $3.64 per share, $3.60 per share and $3.60 per share, respectively. On February 17, 2026, the Board of Directors declared a $0.92 per share dividend payable on May 1, 2026 to common stockholders of record on March 31, 2026.

**Note 12. Share-Based Compensation**

Our outstanding stock incentive awards have been granted under the 2012 Stock Incentive Plan and the 2019 Stock Incentive Plan, as amended and restated (the "2019 Plan"). As of December 31, 2025, all outstanding awards under the 2012 Stock Incentive Plan have vested. No further grants are permitted under this plan.

The Compensation Committee of our Board of Directors has authorized issuance of up to 6.0 million shares of our common stock under the 2019 Plan. Awards may be in the form of options, restricted stock or restricted stock units, subject to certain conditions and restrictions as specified in the 2019 Plan. Under the terms of the 2019 Plan, the Compensation Committee has the authority to select participants, to designate whether an award granted is an incentive stock option ("ISO"), a non-qualified option or a stock appreciation right, to establish the number of shares of common stock issued upon exercise of an option and to establish the vesting provisions and terms of awards. Individual awards may vest over periods up to five years and the term of an award may not exceed 10 years from the grant date. The exercise price of any ISOs granted may not be less than 100.0% of the fair market value of a share of our common stock on the grant date. The exercise price of non-qualified options may not be less than 100.0% of the fair market value of a share of our common stock on the grant date unless it is approved by the Compensation Committee. As of December 31, 2025, we had 3,385,671 shares of common stock available for future grants under the 2019 Plan.

*Share-Based Compensation Expense*

A summary of share-based compensation expense, net of forfeitures, by award type follows *($ in thousands)*:

---

| | | | |
|:---|:---|:---|:---|
| | Year Ended December 31, | Year Ended December 31, | Year Ended December 31, |
| | 2025 | 2024 | 2023 |
| Stock options | $4310 | $3506 | $4295 |
| Restricted stock awards | 1266 | 676 | 310 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total share-based compensation expense | $5576 | $4182 | $4605 |

---

As of December 31, 2025, we had unrecognized share-based compensation expense of $3.1 million that is expected to be recognized over the following years: 2026 - $2.0 million, 2027 - $0.7 million, 2028 - $0.3 million and 2029 - $0.1 million.

*Restricted Stock Awards*

Restricted stock awards vest over five years, with 20.0% vesting on each anniversary of the grant date beginning with the grant date, and certain of the awards are subject to a one-year post-vesting hold. The holders of restricted stock awards have a non-forfeitable right to dividends or dividend equivalents during the vesting periods.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

During the years ended December 31, 2025, 2024 and 2023, we granted 29,500, 15,000 and 21,000 restricted stock awards, respectively, with weighted average grant date fair values of $73.34, $57.76 and $49.30, respectively, to our executive officers under the 2019 Plan. During the years ended December 31, 2025 and 2024, 7,200 and 3,970 restricted stock awards, respectively, vested with weighted average grant date fair values of $52.83 and $49.30, respectively. We had no vestings of restricted stock awards during the year ended December 31, 2023. Additionally, we did not have any forfeitures during each of the years ended December 31, 2025, 2024 and 2023. As of December 31, 2025 and 2024, 54,100 and 31,800 restricted stock awards, respectively, were outstanding with weighted average grant date fair values of $64.29 and $53.29, respectively. As of December 31, 2025 the weighted average remaining vesting period of restricted stock awards was 3.5 years.

*Stock Options*

The following assumptions were used to estimate the fair value of our stock options at the respective grant dates:

---

| | | | |
|:---|:---|:---|:---|
| | Year Ended December 31, | Year Ended December 31, | Year Ended December 31, |
| | 2025 | 2024 | 2023 |
| Risk-free interest rate | 3.94% | 4.49% | 4.56% |
| Expected volatility | 24.0% | 26.1% | 39.0% |
| Dividend yield | 5.2% | 6.4% | 6.9% |
| Expected lives | 2.9 years | 2.9 years | 2.9 years |

---

A summary of the activity related to our stock options follows:

---

| | | | |
|:---|:---|:---|:---|
| |<br><br>Number<br>of Options |<br>Weighted<br>Average<br>Exercise Price<br>Per Share | Weighted<br>Average<br>Remaining<br>Contractual<br>Life (Years) |
| Options outstanding at December 31, 2022 | 2216175 | $70.97 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Granted | 385500 | 54.73 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Exercised | (5166) | 53.41 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Forfeited | (61168) | 66.44 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Expired | (88170) | 64.33 |  |
| Options outstanding at December 31, 2023 | 2447171 | 68.80 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Granted | 431000 | 57.76 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Exercised | (1065119) | 58.24 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Forfeited | (95000) | 68.00 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Expired | (301837) | 79.96 |  |
| Options outstanding at December 31, 2024 | 1416215 | 71.06 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Granted | 579500 | 73.43 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Exercised | (309713) | 62.58 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Forfeited | (70503) | 64.79 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Expired | (491000) | 90.79 |  |
| Options outstanding at December 31, 2025 | 1124499 | 66.39 | 2.9 |
| Options exercisable at December 31, 2025 | 719311 | 64.60 | 2.3 |

---

During the years ended December 31, 2025, 2024 and 2023, the weighted average fair value of options granted was $9.34, $7.36 and $10.56, respectively. The aggregate intrinsic value of stock options exercised during the years ended December 31, 2025, 2024 and 2023 was $4.4 million, $11.8 million and less than $0.1 million, respectively. As of December 31, 2025, the aggregate intrinsic values of our stock options outstanding and exercisable were $11.2 million and $8.5 million, respectively.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

A summary of activity related to our non-vested stock options for the year ended December 31, 2025 follows:

---

| | | |
|:---|:---|:---|
| |<br><br>Number of<br>Options | Weighted<br>Average<br>Grant Date<br>Fair Value<br>Per Share |
| Non-vested options outstanding at the beginning of the year | 340694 | $8.71 |
| &nbsp;&nbsp;&nbsp;&nbsp;Granted | 579500 | 9.34 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-vested options forfeited | (70503) | 8.86 |
| &nbsp;&nbsp;&nbsp;&nbsp;Vested | (444503) | 9.28 |
| Non-vested options outstanding at the end of the year | 405188 | 8.95 |

---

**Note 13. Earnings Per Share**

The following table presents the calculations of basic and diluted earnings per share (*$ in thousands, except per share amounts*):

---

| | | | |
|:---|:---|:---|:---|
| | Year Ended December 31, | Year Ended December 31, | Year Ended December 31, |
| | 2025 | 2024 | 2023 |
| Net income attributable to common stockholders - basic and diluted | $141976 | $137867 | $135597 |
| Weighted average common shares outstanding - basic | 46874691 | 43844771 | 43388794 |
| &nbsp;&nbsp;&nbsp;&nbsp;Effect of dilutive securities: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock options | 132982 | 184416 | 672 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Forward equity sales agreements | 44090 | 73449 |  |
| Weighted average common shares outstanding - diluted | 47051763 | 44102636 | 43389466 |
| Earnings per share: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | $3.03 | $3.14 | $3.13 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | $3.02 | $3.13 | $3.13 |
| Anti-dilutive stock options excluded from above | 41377 | 235344 | 802506 |
| Dividends declared per share | $3.64 | $3.60 | $3.60 |

---

**Note 14. Fair Value of Financial Instruments**

The carrying amounts of cash and cash equivalents, restricted cash, straight-line rents receivable, accounts receivable, accounts payable, other liabilities. dividends payable and deferred income on our consolidated balance sheets as of December 31, 2025 and 2024 approximate their fair values due to the short-term nature of these financial instruments.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

The following table includes the carrying amounts and fair values of certain of our financial instruments (*$ in thousands*):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Carrying Amount | Carrying Amount | Fair Value | Fair Value |
| | December 31, | December 31, | December 31, | December 31, |
| | 2025 | 2024 | 2025 | 2024 |
| Level 2: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed rate debt | $838764 | $620864 | $794233 | $548339 |
| &nbsp;&nbsp;&nbsp;&nbsp;Variable rate debt | 325050 | 525177 | 329000 | 531200 |
| Level 3: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Mortgage and other notes receivable, net | 203296 | 268926 | 201490 | 261708 |

---

We classify fixed rate debt as a Level 2 measurement. We determine the fair values of these debt instruments based on quoted prices for similar instruments or calculations utilizing model derived valuations in which significant inputs are observable in active markets.

We classify variable rate debt as a Level 2 measurement. We estimate the fair values of our borrowings under our Credit Facility and Bank Term Loan at their notional amounts due to the predominance of floating interest rates, which generally reflect market conditions.

We classify mortgage and other notes receivable, net, as Level 3 measurements. We estimate the fair values of these financial instruments using projected payoff valuations based on the expected future cash flows and credit risk of the borrower. If the repayment of a loan is expected to be provided solely from the collateral, we estimate the projected payoff of the loan based on the estimated fair value of the collateral, net of selling cost.

Our real estate properties and intangible assets are remeasured at fair value on a non-recurring basis. We classify these assets as Level 3 measurements. When indicators of potential impairment exists, we estimate the fair value of the identified asset or group of assets using the income approach and unobservable data, such as expected future cash flows, estimated capitalization and discounts rates. We also consider national, regional and local industry market data, including comparable sales information, and may engage an external third-party appraiser to assist us in our estimations of fair value. We estimate the fair value of assets held for sale based on our current sales price expectation, net of selling cost.

We did not remeasure the fair values of our real estate properties and intangible assets December 31, 2025 and 2024, except for the property reclassified to assets held for sale as of December 31, 2025, which was remeasured using the Level 3 measurements described above.

**Note 15. Income Taxes**

Beginning with our inception in 1991, we elected to be taxed as a REIT under Sections 856 through 860 of the Internal Revenue Code commencing with our first taxable year. To qualify as a REIT for federal income tax purposes, at least 90% of taxable income (excluding 100% of net capital gains) must be distributed to stockholders. REITs that do not distribute a certain amount of taxable income in the current year are also subject to a 4% federal excise tax. Undistributed net income for federal income tax purposes differs from undistributed net income for financial statement purposes primarily due to the recognition of straight-line rent revenue for financial reporting purposes, differences in the basis of acquisitions, recording of impairments, differing useful lives and depreciation and amortization methods for real property and the provision for loan losses for financial reporting purposes versus bad debt expense for federal income tax purposes.

During the years ended December 31, 2025, 2024 and 2023, we recognized $0.2 million, $0.1 million and $0.1 million, respectively, of state current income tax expense in our consolidated statements of income. We made state income tax payments of $0.2 million, $0.2 million and $0.2 million, respectively, during the years ended December 31, 2025, 2024 and 2023. We had no federal income taxes in these years.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

A summary of our deferred tax assets and liabilities follows:

---

| | | |
|:---|:---|:---|
| | December 31, | December 31, |
| | 2025 | 2024 |
| Deferred tax assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Federal net operating loss carryforwards | $4201 | $2925 |
| &nbsp;&nbsp;&nbsp;&nbsp;State net operating loss carryforwards | 279 | 75 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred income | 234 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | 12 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total deferred tax assets | 4726 | 3000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Valuation allowance | (277) | (920) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total deferred tax assets, net of valuation allowance | 4449 | 2080 |
| Deferred tax liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Partnership differences | (3899) | (2080) |
| &nbsp;&nbsp;&nbsp;&nbsp;Real estate properties | (550) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total deferred tax liabilities | (4449) | (2080) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total deferred tax assets, net | $— | $— |

---

As of December 31, 2025, we had $20.0 million of federal net operating loss carryforwards of which $0.9 million expires in 2035 through 2036 and the remainder has no expiration. We had $5.9 million of state net operating loss carryforwards as of December 31, 2025 of which $1.0 million expires in 2035 and the remainder has no expiration.

A summary of our cash distributions paid to common stockholders for federal income tax purposes on a per share basis were as follows (*unaudited*):

---

| | | | |
|:---|:---|:---|:---|
| | Year Ended December 31, | Year Ended December 31, | Year Ended December 31, |
| | 2025 | 2024 | 2023 |
| Ordinary income | $3.16 | $2.84 | $2.41 |
| Capital gains |  |  | 0.25 |
| Return of capital | 0.32 |  | 0.94 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total cash distributions on a per share basis | $3.48 | $2.84 | $3.60 |

---

Our income tax returns are generally subject to examination by the Internal Revenue Service or state and local taxing authorities for the year ended December 31, 2022 and subsequent years. The statutes of limitations for state and local examinations may vary across the states in which we operate.

**Note 16. Segment Reporting**

We evaluate our business and make resource allocations based on two operating segments: Real Estate Investments and SHOP. The Real Estate Investments segment consists of our investments in acquiring SHOs and medical facilities and providing financing arrangements to our tenants, operators, or affiliates of our tenants and operators, and other third parties primarily for construction, renovation and expansion projects, funding of working capital or other corporate needs and the acquisition of real estate properties. We lease these properties primarily under triple-net leases and do not have involvement in the operations at the properties. The types of properties we acquire or finance include ILFs, ALFs, EFCs, SLCs, SNFs and HOSPs. Our SHOP segment consists of senior housing communities we own, which are operated on our behalf by third-party managers in exchange for a management fee.

Our President and Chief Executive Officer serves as our Chief Operating Decision Maker ("CODM"). Our CODM reviews financial and other performance information quarterly based upon segment net operating income ("NOI"). We define NOI as total revenues less tenant reimbursements and property operating expenses. Our CODM evaluates NOI to make decisions about resource allocations to the segments and to assess the property level performance of our investment portfolios. The CODM evaluates revenues and operating expenses on a comparative basis for each segment, both sequentially and year-over-year, and also evaluates budget-to-actual variances on a quarterly basis. For our SHOP segment, the CODM reviews additional key performance indicators based on the revenues and operating expenses per occupied or available resident unit and based on revenues and functional expenses by resident.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

We do not allocate non-property expenses to our operating segments in determining NOI. Our non-segment / corporate assets primarily include cash and cash equivalents, the corporate office and certain equipment.

On August 1, 2025, we entered into a series of concurrent transactions that included the transition of seven properties from the Real Estate Investments segment to the SHOP segment. The operating results of these properties have been reflected in the Real Estate Investments segment prior to August 1, 2025 and the SHOP segment from August 1, 2025 through December 31, 2025. There were no real estate property transitions in the years ended December 31, 2024 and 2023. We do not have any other inter-segment transactions. Reference the "Discovery Transitions" section in Note 3 for additional information on the transitioned properties.

The following tables provide information on our operating segments (*$ in thousands*):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Year Ended December 31, 2025 | Year Ended December 31, 2025 | Year Ended December 31, 2025 | Year Ended December 31, 2025 |
| | Real Estate<br>Investments |<br>SHOP | Non-Segment /<br>Corporate |<br>Total |
| Rental income | $271600 | $— | $— | $271600 |
| Resident fees and services |  | 80062 |  | 80062 |
| Interest and other income | 23966 |  |  | 23966 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total revenues | 295566 | 80062 |  | 375628 |
| Utilities |  | 5573 |  | 5573 |
| Dietary |  | 5736 |  | 5736 |
| Labor |  | 27532 |  | 27532 |
| Taxes and insurance | 10982 | 7817 |  | 18799 |
| Management fees |  | 3997 |  | 3997 |
| Other senior housing operating expenses<sup>1</sup> |  | 10273 |  | 10273 |
| &nbsp;&nbsp;&nbsp;&nbsp;NOI | 284584 | 19134 |  | 303718 |
| Depreciation and amortization | 66035 | 14859 | 50 | 80944 |
| Interest expense | 929 |  | 56439 | 57368 |
| Legal expense |  |  | 2666 | 2666 |
| Franchise, excise and other taxes |  |  | 1080 | 1080 |
| General and administrative expenses |  |  | 26868 | 26868 |
| Proxy contest and related expenses |  |  | 1572 | 1572 |
| Loan and realty gains, net | (3447) |  |  | (3447) |
| Gains on sales of real estate properties, net | (456) |  |  | (456) |
| Gains from equity method investment | (3664) |  |  | (3664) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) | $225187 | $4275 | $(88675) | $140787 |
| Capital expenditures | $259496 | $87486 | $49 | $347031 |

---

<sup>1&nbsp;&nbsp;&nbsp;&nbsp;</sup>Amount primarily includes general and administrative costs and marketing expenses.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Year Ended December 31, 2024 | Year Ended December 31, 2024 | Year Ended December 31, 2024 | Year Ended December 31, 2024 |
| | Real Estate<br>Investments |<br>SHOP | Non-Segment /<br>Corporate |<br>Total |
| Rental income | $257049 | $— | $— | $257049 |
| Resident fees and services |  | 54421 |  | 54421 |
| Interest and other income | 23243 |  | 468 | 23711 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total revenues | 280292 | 54421 | 468 | 335181 |
| Utilities |  | 3887 |  | 3887 |
| Dietary |  | 4287 |  | 4287 |
| Labor |  | 17166 |  | 17166 |
| Taxes and insurance | 11165 | 6412 |  | 17577 |
| Management fees |  | 2685 |  | 2685 |
| Other senior housing operating expenses<sup>1</sup> |  | 7814 |  | 7814 |
| &nbsp;&nbsp;&nbsp;&nbsp;NOI | 269127 | 12170 | 468 | 281765 |
| Depreciation and amortization | 61249 | 10157 | 37 | 71443 |
| Interest expense | 3060 |  | 56843 | 59903 |
| Legal expense |  |  | 1052 | 1052 |
| Franchise, excise and other taxes |  |  | 38 | 38 |
| General and administrative expenses |  |  | 20736 | 20736 |
| Loan and realty losses, net | 5295 |  |  | 5295 |
| Gains on sales of real estate properties, net | (6678) |  |  | (6678) |
| Gains from equity method investment | (402) |  |  | (402) |
| Gains on forward equity sales agreements, net |  |  | (6261) | (6261) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) | $206603 | $2013 | $(71977) | $136639 |
| Capital expenditures | $169225 | $10984 | $— | $180209 |

---

<sup>1&nbsp;&nbsp;&nbsp;&nbsp;</sup>Amount primarily includes general and administrative costs and marketing expenses.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Year Ended December 31, 2023 | Year Ended December 31, 2023 | Year Ended December 31, 2023 | Year Ended December 31, 2023 |
| | Real Estate<br>Investments |<br>SHOP | Non-Segment /<br>Corporate |<br>Total |
| Rental income | $249227 | $— | $— | $249227 |
| Resident fees and services |  | 48809 |  | 48809 |
| Interest and other income | 21448 |  | 351 | 21799 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total revenues | 270675 | 48809 | 351 | 319835 |
| Utilities |  | 3537 |  | 3537 |
| Dietary |  | 3763 |  | 3763 |
| Labor |  | 16165 |  | 16165 |
| Taxes and insurance | 11513 | 5889 |  | 17402 |
| Management fees |  | 2434 |  | 2434 |
| Other senior housing operating expenses<sup>1</sup> |  | 7799 |  | 7799 |
| &nbsp;&nbsp;&nbsp;&nbsp;NOI | 259162 | 9222 | 351 | 268735 |
| Depreciation and amortization | 60764 | 9158 | 51 | 69973 |
| Interest expense | 3071 |  | 55089 | 58160 |
| Legal expense |  |  | 507 | 507 |
| Franchise, excise and other taxes |  |  | 449 | 449 |
| General and administrative expenses |  |  | 19314 | 19314 |
| Loan and realty losses, net | 1376 |  |  | 1376 |
| Gains on operations transfers, net | (20) |  |  | (20) |
| Gains on sales of real estate properties, net | (14721) |  |  | (14721) |
| Gains from equity method investment | (555) |  |  | (555) |
| Loss on early retirement of debt |  |  | 73 | 73 |
| Other income | (202) |  |  | (202) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) | $209449 | $64 | $(75132) | $134381 |
| Capital expenditures | $56928 | $9328 | $— | $66256 |

---

<sup>1&nbsp;&nbsp;&nbsp;&nbsp;</sup>Amount primarily includes general and administrative costs and marketing expenses.

The following table provides a summary of our total assets by segment *($ in thousands)*:

---

| | | |
|:---|:---|:---|
| | December 31, | December 31, |
| | 2025 | 2024 |
| Real Estate Investments segment | $2282128 | $2325269 |
| SHOP segment | 503201 | 270273 |
| Non-segment / corporate | 11558 | 18829 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total assets | $2796887 | $2614371 |

---

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

**Note 17. Variable Interest Entities**

*Consolidated Variable Interest Entities*

We are the controlling equity partner in certain entities that we have deemed to be VIEs. For each of these partnerships, we determined whether either the members as a group lack the characteristics of a controlling financial interest or the total equity at risk in the individual partnership is insufficient to finance the activities of the partnership without additional subordinated financial support. We are deemed the primary beneficiary of these VIEs because we have the ability to direct the activities that most significantly impact the economic performance of these partnerships and also have the obligation to absorb the losses of the partnership or have the right to receive benefits arising from the partnership, subject to limited protective rights extended to our partners for specified business decisions. Reference the "Discovery Transitions" section in Note 3 for information on the dissolution of a partnership which was a consolidated VIE through August 1, 2025.

The following table provides information on the assets and liabilities of our consolidated VIEs *($ in thousands)*:

---

| | | |
|:---|:---|:---|
| | December 31, | December 31, |
| | 2025 | 2024 |
| Real Estate Investments segment: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Real estate properties, net | $112717 | $244337 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | 1020 | 3185 |
| &nbsp;&nbsp;&nbsp;&nbsp;Straight-line rents receivable | 554 | 10025 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other assets, net | 2751 | 5291 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and other liabilities |  | (26) |
| SHOP segment: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Real estate properties, net | 290691 | 261561 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | 8121 | 6480 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other assets, net | 1457 | 2232 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and other liabilities | (5473) | (5689) |

---

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

*Unconsolidated Variable Interest Entities*

In our Real Estate Investments segment, we have concluded that we are not the primary beneficiary for certain investments where we lack either directly or through related parties the power to direct the activities that most significantly impact the economic performance of these entities. We do not have any unconsolidated VIEs in our SHOP segment.

The following table provides a summary of our relationships and sources of exposure related to our unconsolidated VIEs as of December 31, 2025 (*$ in thousands*):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| Year |  |  |  | Maximum |  |
| of Initial |  | Source of | Carrying | Exposure | Note |
| Involvement | Name | Exposure | Amount | to Loss | References |
|  |  | Notes and straight-line |  |  |  |
| 2014 | Senior Living | rents receivable | $48243 | $55743 | Notes 4, 5 |
| 2016 | SLM | Note | 12000 | 12000 | Note 4 |
| 2018 | Bickford | Notes | 16073 | 27864 | Note 4 |
| 2019 | Encore Senior Living | Various<sup>1</sup> | 43967 | 63481 | Notes 3, 4 |
| 2020 | Timber Ridge OpCo | Various<sup>2</sup> | (4195) | 805 | Notes 6, 7 |
|  | Senior Living Hospitality | Notes and straight-line |  |  |  |
| 2020 | &nbsp;&nbsp;Group<sup>3</sup> | rents receivable | 12396 | 13920 | N/A |
|  | Montecito Medical |  |  |  |  |
| 2021 | &nbsp;&nbsp;Real Estate | Notes | 6640 | 6640 | N/A |
|  |  | Note and straight-line |  |  |  |
| 2021 | Vizion Health | rents receivable | 18924 | 18924 | Note 4 |
| 2021 | Navion Senior Solutions | Various<sup>4</sup> | 7310 | 9460 | N/A |
| 2023 | Kindcare Senior Living | Notes<sup>5</sup> | 820 | 820 | N/A |
| 2024 | Mainstay Healthcare | Note | 9066 | 9066 | N/A |

---

<sup>1&nbsp;&nbsp;&nbsp;&nbsp;</sup>Notes, straight-line rents receivable and interest receivable

<sup>2&nbsp;&nbsp;&nbsp;&nbsp;</sup>Loan commitment, equity method investment, straight-line rents receivable and unamortized lease incentive

<sup>3&nbsp;&nbsp;&nbsp;&nbsp;</sup>Formerly referred to as Watermark Retirement

<sup>4&nbsp;&nbsp;&nbsp;&nbsp;</sup>Note, straight-line rents receivable and unamortized lease incentive

<sup>5&nbsp;&nbsp;&nbsp;&nbsp;</sup>Represents two mezzanine loans originating from the sales of real estate properties

We are not obligated to provide support beyond our stated commitments to these tenants and borrowers whom we classify as VIEs and accordingly, our maximum exposure to loss as a result of these relationships is limited to the amount of our commitments. Our risk of economic loss on a tenant lease in excess of what is presented in the table above is limited to any future non-payments of rent before we are able to take effective remedial action, as well as any costs incurred to secure a new lease at the property. The potential extent of such losses at a future date would depend upon facts and circumstances unique to each tenant and the related lease and therefore are not included in the table above.

In the future, we may be deemed the primary beneficiary of the operations if the tenants or borrowers do not have adequate liquidity to accept the risks and rewards as the tenants and operators of the properties and we may be required to consolidate the financial position and results of operations of the tenants or borrowers.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

**ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE**

None.

**ITEM 9A. CONTROLS AND PROCEDURES**

***Evaluation of Disclosure Control and Procedures -*** As of December 31, 2025, an evaluation was performed under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of management's disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) to ensure information required to be disclosed in our filings under the Exchange Act, is (i) recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC; and (ii) accumulated and communicated to our management, including the Chief Executive Officer and the Chief Financial Officer, as appropriate, to allow for timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can only provide reasonable assurance of achieving desired control objectives, and management is necessarily required to apply its judgment when evaluating the cost-benefit relationship of potential controls and procedures. Based upon the evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that the design and operation of these disclosure controls and procedures were effective as of December 31, 2025.

There were no significant changes in our internal controls or in other factors that could significantly affect these controls subsequent to the date of their evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

***Changes in Internal Control over Financial Reporting -*** There were no changes in our internal control over financial reporting identified in management's evaluation during the quarter ended December 31, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

**MANAGEMENT'S ANNUAL REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING**

The management of National Health Investors, Inc. is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934, as amended. The Company's internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles in the United States. The Company's internal control over financial reporting includes those policies and procedures that: (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles in the United States, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company's assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Management assessed the effectiveness of the Company's internal control over financial reporting as of December 31, 2025 using the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission ("COSO") in Internal Control-Integrated Framework (2013). Based on that assessment, management concluded that the Company's internal control over financial reporting was effective as of December 31, 2025.

On October 1, 2025, the Company acquired the real estate and related operations of four senior housing communities in Oklahoma and Oregon. As permitted by guidance issued by the SEC staff, we have excluded this acquisition from our assessment of internal control over financial reporting as of December 31, 2025. This acquisition constituted 2.7% and 1.6% of total assets and total revenues, respectively, as of and for the year ended December 31, 2025.

The Company's independent registered public accounting firm, BDO USA, P.C., has issued an attestation report on the effectiveness of the Company's internal control over financial reporting included herein.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

**Report of Independent Registered Public Accounting Firm** 

Stockholders and Board of Directors

National Health Investors, Inc.

Murfreesboro, Tennessee

**Opinion on Internal Control over Financial Reporting**

We have audited National Health Investors, Inc.'s (the "Company's") internal control over financial reporting as of December 31, 2025, based on criteria established in *Internal Control – Integrated Framework (2013)* issued by the Committee of Sponsoring Organizations of the Treadway Commission (the "COSO criteria"). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2025, based on the COSO criteria*.* 

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) ("PCAOB"), the consolidated balance sheets of the Company as of December 31, 2025 and 2024, the related consolidated statements of income, equity, and cash flows for each of the three years in the period ended December 31, 2025, and the related notes and financial statement schedules and our report dated February 26, 2026 expressed an unqualified opinion thereon.

**Basis for Opinion**

The Company's management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Item 9A, Management's Annual Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company's internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit of internal control over financial reporting in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

As indicated in the accompanying Item 9A, Management's Annual Report on Internal Control Over Financial Reporting, management's assessment of and conclusion on the effectiveness of internal control over financial reporting did not include the internal controls of four senior housing communities in Oklahoma and Oregon, which were acquired on October 1, 2025, and are included in the consolidated balance sheet of the Company as of December 31, 2025, and the related consolidated statements of income, equity, and cash flows for the year then ended. This acquisition constituted 2.7% of total assets and 1.6% of total revenues as of and for the year ended December 31, 2025. Management did not assess the effectiveness of internal control over financial reporting of these acquired properties. Our audit of internal control over financial reporting of the Company also did not include an evaluation of the internal control over financial reporting of these acquired properties.

**Definition and Limitations of Internal Control over Financial Reporting**

A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ BDO USA, P.C.

Nashville, Tennessee

February 26, 2026

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

**ITEM 9B. OTHER INFORMATION**

None of our directors or officers adopted, modified, or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement during our fiscal quarter ended December 31, 2025.

**ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS**

Not applicable.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

**PART III.**

**ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE**

Incorporated by reference from the information in our definitive proxy statement for the 2026 annual meeting of stockholders, which we will file within 120 days of the end of the fiscal year to which this Annual Report relates.

**ITEM 11. EXECUTIVE COMPENSATION**

Incorporated by reference from the information in our definitive proxy statement for the 2026 annual meeting of stockholders, which we will file within 120 days of the end of the fiscal year to which this Annual Report relates.

**ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS**

Incorporated by reference from the information in our definitive proxy statement for the 2026 annual meeting of stockholders, which we will file within 120 days of the end of the fiscal year to which this Annual Report relates.

**ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE**

Incorporated by reference from the information in our definitive proxy statement for the 2026 annual meeting of stockholders, which we will file within 120 days of the end of the fiscal year to which this Annual Report relates.

**ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES**

Incorporated by reference from the information in our definitive proxy statement for the 2026 annual meeting of stockholders, which we will file within 120 days of the end of the fiscal year to which this Annual Report relates.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

**PART IV.**

**ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES**

(a)&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;&nbsp;&nbsp;&nbsp;Financial Statements

The following financial statements are included in "Part II, Item 8. "Financial Statements and Supplementary Data" of this Annual Report:

Report of Independent Registered Public Accounting Firm (BDO USA, P.C.; Nashville, TN; PCAOB ID # 243)

Consolidated Balance Sheets - December 31, 2025 and 2024

Consolidated Statements of Income - Years ended December 31, 2025, 2024 and 2023

Consolidated Statements of Cash Flows - Years ended December 31, 2025, 2024 and 2023

Consolidated Statements of Equity - Years ended December 31, 2025, 2024 and 2023

Notes to the Consolidated Financial Statements

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;&nbsp;&nbsp;&nbsp;Financial Statement Schedules

The following financial statement schedules are included in this Annual Report following the signature page:

Schedule III - Real Estate and Accumulated Depreciation

Schedule IV - Mortgage Loans on Real Estate

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;&nbsp;&nbsp;&nbsp;Exhibits

Exhibits required as part of this Annual Report are listed in the Exhibit Index.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

**EXHIBIT INDEX**

---

| | |
|:---|:---|
| Item |  |
| Number | Exhibit Description |
| 3.1 | <u>[Articles of Incorporation](https://www.sec.gov/Archives/edgar/data/877860/000087786013000105/exhibit31articlesofincorp.htm)</u> (incorporated by reference to Exhibit 3.1 to Form S-3 Registration Statement No. 333-192322) |
| 3.2 | <u>[Articles of Amendment to Articles of Incorporation of National Health Investors, Inc.](https://www.sec.gov/Archives/edgar/data/877860/000119312514104291/d692366dex32.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000119312514104291/d692366dex32.htm)[dated](https://www.sec.gov/Archives/edgar/data/877860/000119312514104291/d692366dex32.htm)[June 8, 1994](https://www.sec.gov/Archives/edgar/data/877860/000119312514104291/d692366dex32.htm)</u> (incorporated by reference to Exhibit 3.2 to Form S-3 Registration Statement No. 333-194653) |
| 3.3 | <u>[Amendment to Articles of Incorporation](https://www.sec.gov/Archives/edgar/data/877860/000087786009000005/f2008nhiannualproxyfinal.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786009000005/f2008nhiannualproxyfinal.htm)[dated](https://www.sec.gov/Archives/edgar/data/877860/000087786009000005/f2008nhiannualproxyfinal.htm)[May 1, 2009](https://www.sec.gov/Archives/edgar/data/877860/000087786009000005/f2008nhiannualproxyfinal.htm)</u> (incorporated by reference to Exhibit A to Definitive Proxy Statement filed March 23, 2009) |
| 3.4 | <u>[Amendment to Articles of Incorporation approved by stockholders on May 2, 2014](https://www.sec.gov/Archives/edgar/data/877860/000087786014000058/nhi-6302014x10qex33.htm)</u> (incorporated by reference to Exhibit 3.3 to Form 10-Q filed August 4, 2014) |
| 3.5 | <u>[Amendment to Articles of Incorporation approved by stockholders on May 6, 2020](https://www.sec.gov/Archives/edgar/data/877860/000087786020000091/amendmenttoarticlesofi.htm)</u> (incorporated by reference to Exhibit 3.6 to Form 10-Q filed August 10, 2020) |
| 3.6 | <u>[Amendment to Articles of Incorporation approved by stockholders on May 21, 2025](https://www.sec.gov/Archives/edgar/data/877860/000087786025000135/nhi-6302025xex36nhiamendme.htm)</u> (incorporated by reference to Exhibit 3.6 to Form 10-Q filed August 6, 2025) |
| 3.7 | <u>[Amended and Restated Bylaws](https://www.sec.gov/Archives/edgar/data/877860/000087786023000066/nhiamendedandrestatedbylaws.htm)[as approved February 17, 2023, as amended April 27, 2023](https://www.sec.gov/Archives/edgar/data/877860/000087786023000066/nhiamendedandrestatedbylaws.htm)</u> (incorporated by reference to Exhibit 3.5 to Form 10-Q filed May 9, 2023) |
| 4.1 | Form of Common Stock Certificate (incorporated by reference to Exhibit 39 to Form S-11 Registration Statement No. 33-41863, filed in paper - hyperlink is not required pursuant to Rule 105 of Regulation S-T) |
| 4.2 | <u>[Indenture](https://www.sec.gov/Archives/edgar/data/877860/000119312521017853/d253368dex41.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000119312521017853/d253368dex41.htm)[dated](https://www.sec.gov/Archives/edgar/data/877860/000119312521017853/d253368dex41.htm)[as of](https://www.sec.gov/Archives/edgar/data/877860/000119312521017853/d253368dex41.htm)[January 26, 2021, among National Health Investors, Inc. and Regions Bank, as trustee](https://www.sec.gov/Archives/edgar/data/877860/000119312521017853/d253368dex41.htm)</u>(incorporated by reference to Exhibit 4.1 to Form 8-K filed January 26, 2021) |
| 4.3 | <u>[First Supplemental Indenture](https://www.sec.gov/Archives/edgar/data/877860/000119312521017853/d253368dex42.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000119312521017853/d253368dex42.htm)[dated](https://www.sec.gov/Archives/edgar/data/877860/000119312521017853/d253368dex42.htm)[as of](https://www.sec.gov/Archives/edgar/data/877860/000119312521017853/d253368dex42.htm)[January 26, 2021, among National Health Investors, Inc., Regions Bank, as trustee, and the subsidiary guarantors set forth therein](https://www.sec.gov/Archives/edgar/data/877860/000119312521017853/d253368dex42.htm)</u> (incorporated by reference to Exhibit 4.2 to Form 8-K filed January 26, 2021) |
| 4.4 | <u>[Second Supplemental Indenture, dated](https://www.sec.gov/Archives/edgar/data/877860/000087786022000041/secondsupplementalindentur.htm)[as of](https://www.sec.gov/Archives/edgar/data/877860/000087786022000041/secondsupplementalindentur.htm)[March 31, 2022, among National Health Investors, Inc., Regions Bank, as trustee, and the subsidiary guarantors set forth therein](https://www.sec.gov/Archives/edgar/data/877860/000087786022000041/secondsupplementalindentur.htm)</u>(incorporated by reference to Exhibit 4.6 to Form 10-Q filed May 9, 2022) |
| 4.5 | <u>[Third Supplemental Indenture, dated](https://www.sec.gov/Archives/edgar/data/877860/000087786025000135/nhi-6302025xex41nhithirdsu.htm)[as of](https://www.sec.gov/Archives/edgar/data/877860/000087786025000135/nhi-6302025xex41nhithirdsu.htm)[July 7, 2025, among National Health Investors, Inc., Regions Bank, as trustee, and the subsidiary guarantors set forth therein](https://www.sec.gov/Archives/edgar/data/877860/000087786025000135/nhi-6302025xex41nhithirdsu.htm)</u> (incorporated by reference to Exhibit 4.1 to Form 10-Q filed August 6, 2025) |
| 4.6 | <u>[Fourth Supplemental Indenture, dated](https://www.sec.gov/Archives/edgar/data/877860/000119312525220487/d41665dex42.htm)[as of](https://www.sec.gov/Archives/edgar/data/877860/000119312525220487/d41665dex42.htm)[September 26, 2025, among National Health Investors, Inc., Regions Bank, as trustee, and the subsidiary guarantors set forth therein](https://www.sec.gov/Archives/edgar/data/877860/000119312525220487/d41665dex42.htm)</u> (incorporated by reference to Exhibit 4.2 to Form 8-K filed September 26, 2025) |
| 4.7 | <u>[Fifth Supplemental Indenture, dated](https://www.sec.gov/Archives/edgar/data/877860/000087786025000183/exhibit42nhififthsupplemen.htm)[as of](https://www.sec.gov/Archives/edgar/data/877860/000087786025000183/exhibit42nhififthsupplemen.htm)[October 10, 2025, among National Health Investors, Inc., Regions Bank, as trustee, and the subsidiary guarantors set forth therein](https://www.sec.gov/Archives/edgar/data/877860/000087786025000183/exhibit42nhififthsupplemen.htm)</u> (incorporated by reference to Exhibit 4.2 to Form 10-Q filed November 6, 2025) |
| 4.8 | <u>[Description of Securities](ex48-descriptionofsecuriti.htm)</u>(filed herewith) |
| 10.1 | <u>[Master Agreement to Lease](https://www.sec.gov/Archives/edgar/data/877860/000087786020000018/nhi-12312019x101exhibi.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786020000018/nhi-12312019x101exhibi.htm)[dated](https://www.sec.gov/Archives/edgar/data/877860/000087786020000018/nhi-12312019x101exhibi.htm)[October 17, 1991](https://www.sec.gov/Archives/edgar/data/877860/000087786020000018/nhi-12312019x101exhibi.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786020000018/nhi-12312019x101exhibi.htm)[by and between National Health Investors, Inc. and National HealthCorp, L.P. including amendments No. 1 through 4](https://www.sec.gov/Archives/edgar/data/877860/000087786020000018/nhi-12312019x101exhibi.htm)</u> (incorporated by reference to Exhibit 10.1 to Form 10-K filed February 22, 2020) |
| 10.2 | <u>[Amendment No. 5 to the Company's Master Agreement to Lease with NHC](https://www.sec.gov/Archives/edgar/data/877860/000095014406002071/g00130exv10w2.txt)</u> (incorporated by reference to Exhibit 10.2 to Form 10-K filed March 10, 2006) |
| 10.3 | <u>[Amendment No. 6 to the Company's Master Agreement to Lease with NHC](https://www.sec.gov/Archives/edgar/data/877860/000087786013000101/nhi-9302013x10qex101.htm)</u> (incorporated by reference to Exhibit 10.1 to Form 10-Q filed November 4, 2013) |
| 10.4 | <u>[Amended and Restated Amendment No. 6 to the Company's Master Agreement to Lease with NHC](https://www.sec.gov/Archives/edgar/data/877860/000087786014000012/nhi-12312013x10kex10_4.htm)</u> (incorporated by reference to Exhibit 10.4 to Form 10-K filed February 18, 2014) |
| 10.5 | <u>[Extension of Master Agreement to Lease](https://www.sec.gov/Archives/edgar/data/877860/000087786013000017/nhi-12312012x10kex1022.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786013000017/nhi-12312012x10kex1022.htm)[dated December 28, 2012](https://www.sec.gov/Archives/edgar/data/877860/000087786013000017/nhi-12312012x10kex1022.htm)</u> (incorporated by reference to Exhibit 10.22 to Form 10-K filed February 15, 2013) |
| \*10.6 | <u>[National Health Investors, Inc. 2](https://www.sec.gov/Archives/edgar/data/877860/000087786012000018/fdef1412012.htm)[012 Stock Option Plan](https://www.sec.gov/Archives/edgar/data/877860/000087786012000018/fdef1412012.htm)</u> (incorporated by reference to Appendix A to Definitive Proxy Statement filed March 23, 2012) |
| 10.9 | <u>[Membership Interest Purchase Agreement](https://www.sec.gov/Archives/edgar/data/877860/000087786013000076/nhi-6302013x10qex101.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786013000076/nhi-6302013x10qex101.htm)[dated](https://www.sec.gov/Archives/edgar/data/877860/000087786013000076/nhi-6302013x10qex101.htm)[as of](https://www.sec.gov/Archives/edgar/data/877860/000087786013000076/nhi-6302013x10qex101.htm)[June 24, 2013](https://www.sec.gov/Archives/edgar/data/877860/000087786013000076/nhi-6302013x10qex101.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786013000076/nhi-6302013x10qex101.htm)[among Care Investment Trust Inc., Care YBE Subsidiary LLC and NHI-Bickford RE, LLC](https://www.sec.gov/Archives/edgar/data/877860/000087786013000076/nhi-6302013x10qex101.htm)</u> (incorporated by reference to Exhibit 10.1 to Form 10-Q filed August 6, 2013) |
| 10.10 | <u>[Master Lease](https://www.sec.gov/Archives/edgar/data/877860/000087786013000122/exhibit102masterlease.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786013000122/exhibit102masterlease.htm)[dated](https://www.sec.gov/Archives/edgar/data/877860/000087786013000122/exhibit102masterlease.htm)[December 23, 2013](https://www.sec.gov/Archives/edgar/data/877860/000087786013000122/exhibit102masterlease.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786013000122/exhibit102masterlease.htm)[between NHI-](https://www.sec.gov/Archives/edgar/data/877860/000087786013000122/exhibit102masterlease.htm)[REIT of Next House, LLC, Myrtle Beach Retirement Residence LLC and Voorhees Retirement Residence LLC, individually and collectively as Landlord, and NH Master Tenant LLC, as Tenant](https://www.sec.gov/Archives/edgar/data/877860/000087786013000122/exhibit102masterlease.htm)</u> (incorporated by reference to Exhibit 10.2 to Form 8-K filed December 24, 2013) |

---

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

---

| | |
|:---|:---|
| Item |  |
| Number | Exhibit Description |
| 10.11 | <u>[Guarantee of Lease Agreement](https://www.sec.gov/Archives/edgar/data/877860/000087786013000122/exhibit103guarantyoflease.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786013000122/exhibit103guarantyoflease.htm)[dated](https://www.sec.gov/Archives/edgar/data/877860/000087786013000122/exhibit103guarantyoflease.htm)[December 23, 2013](https://www.sec.gov/Archives/edgar/data/877860/000087786013000122/exhibit103guarantyoflease.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786013000122/exhibit103guarantyoflease.htm)[between NHI-REIT of Next House, LLC, Myrtle Beach Retirement Residence LLC and Voorhees Retirement Residence LLC, individually and collectively as Landlord, and Holiday AL Holdings, LP](https://www.sec.gov/Archives/edgar/data/877860/000087786013000122/exhibit103guarantyoflease.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786013000122/exhibit103guarantyoflease.htm)[as Guarantor](https://www.sec.gov/Archives/edgar/data/877860/000087786013000122/exhibit103guarantyoflease.htm)</u> (incorporated by reference to Exhibit 10.3 to Form 8-K filed December 24, 2013) |
| 10.12 | <u>[Amendment No. 7 to Master Agreement to Lease with NHC](https://www.sec.gov/Archives/edgar/data/877860/000087786014000012/nhi-21312013x10kex1032.htm)</u> (incorporated by reference to Exhibit 10.32 to Form 10-K filed February 18, 2014) |
| 10.13 | <u>[$225 million Note Purchase Agreement](https://www.sec.gov/Archives/edgar/data/877860/000087786015000008/nhi-12312014x10kex1032.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786015000008/nhi-12312014x10kex1032.htm)[dated January 13, 2015](https://www.sec.gov/Archives/edgar/data/877860/000087786015000008/nhi-12312014x10kex1032.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786015000008/nhi-12312014x10kex1032.htm)[with Prudential Capital Group and certain of its affiliates](https://www.sec.gov/Archives/edgar/data/877860/000087786015000008/nhi-12312014x10kex1032.htm)</u> (incorporated by reference to Exhibit 10.32 to Form 10-K filed February 17, 2015) |
| \*10.14 | <u>[First](https://www.sec.gov/Archives/edgar/data/877860/000087786015000022/a2015def14a.htm)[A](https://www.sec.gov/Archives/edgar/data/877860/000087786015000022/a2015def14a.htm)[mendment to](https://www.sec.gov/Archives/edgar/data/877860/000087786015000022/a2015def14a.htm)[National Health Investors, Inc.](https://www.sec.gov/Archives/edgar/data/877860/000087786015000022/a2015def14a.htm)[2012 Stock Incentive Plan](https://www.sec.gov/Archives/edgar/data/877860/000087786015000022/a2015def14a.htm)</u> (incorporated by reference to Appendix A to Definitive Proxy Statement filed March 20, 2015) |
| 10.15 | <u>[Construction and Term Loan Agreement](https://www.sec.gov/Archives/edgar/data/877860/000087786018000013/nhi-12312017x10kex1021.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786018000013/nhi-12312017x10kex1021.htm)[dated February 10, 2015](https://www.sec.gov/Archives/edgar/data/877860/000087786018000013/nhi-12312017x10kex1021.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786018000013/nhi-12312017x10kex1021.htm)[between the Company and LCS-Westminster Partnershi](https://www.sec.gov/Archives/edgar/data/877860/000087786018000013/nhi-12312017x10kex1021.htm)[p](https://www.sec.gov/Archives/edgar/data/877860/000087786018000013/nhi-12312017x10kex1021.htm)[III LLP](https://www.sec.gov/Archives/edgar/data/877860/000087786018000013/nhi-12312017x10kex1021.htm)</u> (incorporated by reference to Exhibit 10.21 to Form 10-K filed February 16, 2018) |
| 10.16 | <u>[Multifamily Loan and Security Agreement for Urbandale Bickford Cottage by and between Care YBE Subsidiary LLC, a Delaware limited liability company, and KeyBank National Association, a national banking association](https://www.sec.gov/Archives/edgar/data/877860/000087786015000029/exhibit103formofmultifamil.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786015000029/exhibit103formofmultifamil.htm)[with Appendix 1 identifying substantially identical agreements and setting forth the material details in which such agreements differ from this agreement](https://www.sec.gov/Archives/edgar/data/877860/000087786015000029/exhibit103formofmultifamil.htm)</u> (incorporated by reference to Exhibit 10.3 to Form 10-Q filed May 7, 2015) |
| 10.17 | <u>[Multifamily Loan and Security Agreement for Omaha II Bickford Cottage by and between Care YBE Subsidiary LLC, a Delaware limited liability company, and KeyBank National Association, a national banking association](https://www.sec.gov/Archives/edgar/data/877860/000087786015000029/exhibit104formofmultifamil.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786015000029/exhibit104formofmultifamil.htm)[with Appendix 1 identifying substantially identical agreements and setting forth the material details in which such agreements differ from this agreement](https://www.sec.gov/Archives/edgar/data/877860/000087786015000029/exhibit104formofmultifamil.htm)</u> (incorporated by reference to Exhibit 10.4 to Form 10-Q filed May 7, 2015) |
| 10.18 | <u>[Second Amendment to Note Purchase Agreement](https://www.sec.gov/Archives/edgar/data/877860/000087786015000064/nhi-6302015x10qex102pruamd.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786015000064/nhi-6302015x10qex102pruamd.htm)[dated](https://www.sec.gov/Archives/edgar/data/877860/000087786015000064/nhi-6302015x10qex102pruamd.htm)[as of](https://www.sec.gov/Archives/edgar/data/877860/000087786015000064/nhi-6302015x10qex102pruamd.htm)[June 30,](https://www.sec.gov/Archives/edgar/data/877860/000087786015000064/nhi-6302015x10qex102pruamd.htm)[2015](https://www.sec.gov/Archives/edgar/data/877860/000087786015000064/nhi-6302015x10qex102pruamd.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786015000064/nhi-6302015x10qex102pruamd.htm)[among the Corporation, The Prudential Insurance Company of America and the other Purchasers named therein](https://www.sec.gov/Archives/edgar/data/877860/000087786015000064/nhi-6302015x10qex102pruamd.htm)</u> (incorporated by reference to Exhibit 10.2 to Form 10-Q filed August 5, 2015) |
| \*10.19 | <u>[Amended and Restated Employment Agreement, dated](https://www.sec.gov/Archives/edgar/data/877860/000087786019000015/ex10_1x2019comp-01.htm)[as of](https://www.sec.gov/Archives/edgar/data/877860/000087786019000015/ex10_1x2019comp-01.htm)[February 15, 2019, by and between National Health Investors, Inc. and D. Eric Mendelsohn](https://www.sec.gov/Archives/edgar/data/877860/000087786019000015/ex10_1x2019comp-01.htm)</u> (incorporated by reference to Exhibit 10.1 to Form 8-K filed February 22, 2019) |
| 10.20 | <u>[NHI PropCo, LLC Membership Interest Purchase Agreement](https://www.sec.gov/Archives/edgar/data/877860/000087786016000169/nhi-9302016x10qex101.htm)</u> (incorporated by reference to Exhibit 10.1 to Form 10-Q filed November 7, 2016) |
| 10.21 | <u>[Fifth Amendment to Note Purchase Agreement](https://www.sec.gov/Archives/edgar/data/877860/000087786017000070/exhbit992nhi-fifthamendmen.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786017000070/exhbit992nhi-fifthamendmen.htm)[dated January 13, 2015, made and entered into as of August 8, 2017](https://www.sec.gov/Archives/edgar/data/877860/000087786017000070/exhbit992nhi-fifthamendmen.htm)</u> (incorporated by reference to Exhibit 99.2 to Form 8-K filed August 14, 2017) |
| 10.22 | <u>[Second Amendment to](https://www.sec.gov/Archives/edgar/data/877860/000087786018000029/a2018def14a.htm)[National Health Investors, Inc.](https://www.sec.gov/Archives/edgar/data/877860/000087786018000029/a2018def14a.htm)[2012 Stock Incentive Plan](https://www.sec.gov/Archives/edgar/data/877860/000087786018000029/a2018def14a.htm)</u> (incorporated by reference to Appendix A to Definitive Proxy Statement filed March 20, 2018) |
| 10.23 | <u>[Amendment to Master Lease and Termination of Guaranty](https://www.sec.gov/Archives/edgar/data/877860/000087786018000081/exhibit99_2amendmentx1.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786018000081/exhibit99_2amendmentx1.htm)[dated](https://www.sec.gov/Archives/edgar/data/877860/000087786018000081/exhibit99_2amendmentx1.htm)[as of](https://www.sec.gov/Archives/edgar/data/877860/000087786018000081/exhibit99_2amendmentx1.htm)[November 5, 2018, by and among NHI-REIT of Next House, LLC, Myrtle Beach Retirement Residence LLC, Voorhees Retirement Residence LLC, NH Master Tenant LLC](https://www.sec.gov/Archives/edgar/data/877860/000087786018000081/exhibit99_2amendmentx1.htm)[and Holiday AL Holdings LP](https://www.sec.gov/Archives/edgar/data/877860/000087786018000081/exhibit99_2amendmentx1.htm)</u> (incorporated by reference to Exhibit 99.2 to Form 8-K filed November 6, 2018) |
| 10.24 | <u>[Construction and Term Loan Agreement](https://www.sec.gov/Archives/edgar/data/877860/000087786019000006/nhi-12312018x10kex1036.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786019000006/nhi-12312018x10kex1036.htm)[dated](https://www.sec.gov/Archives/edgar/data/877860/000087786019000006/nhi-12312018x10kex1036.htm)[December 21, 2018](https://www.sec.gov/Archives/edgar/data/877860/000087786019000006/nhi-12312018x10kex1036.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786019000006/nhi-12312018x10kex1036.htm)[between the Company and LCS-Westminster Partnership IV, LLP](https://www.sec.gov/Archives/edgar/data/877860/000087786019000006/nhi-12312018x10kex1036.htm)</u> (incorporated by reference to Exhibit 10.36 to Form 10-K filed February 19, 2019) |
| \*10.25 | <u>[National Health Investors, Inc. 2019 Stock Incentive Plan](https://www.sec.gov/Archives/edgar/data/877860/000087786019000024/a2019def14a.htm)</u> (incorporated by reference to Appendix A to Definitive Proxy Statement filed March 19, 2019) |
| 10.26 | <u>[Composite Note Purchase Agreement Reflecting: First Amendment](https://www.sec.gov/Archives/edgar/data/877860/000087786020000035/ex101compositeagreement.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786020000035/ex101compositeagreement.htm)[dated](https://www.sec.gov/Archives/edgar/data/877860/000087786020000035/ex101compositeagreement.htm)[March 20,](https://www.sec.gov/Archives/edgar/data/877860/000087786020000035/ex101compositeagreement.htm)[2015; Second Amendment](https://www.sec.gov/Archives/edgar/data/877860/000087786020000035/ex101compositeagreement.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786020000035/ex101compositeagreement.htm)[dated](https://www.sec.gov/Archives/edgar/data/877860/000087786020000035/ex101compositeagreement.htm)[June 30, 2015; Third Amendment to Note Purchase Agreement](https://www.sec.gov/Archives/edgar/data/877860/000087786020000035/ex101compositeagreement.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786020000035/ex101compositeagreement.htm)[dated](https://www.sec.gov/Archives/edgar/data/877860/000087786020000035/ex101compositeagreement.htm)[November 3, 2015; Fourth Amendment to Note Purchase Agreement](https://www.sec.gov/Archives/edgar/data/877860/000087786020000035/ex101compositeagreement.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786020000035/ex101compositeagreement.htm)[dated](https://www.sec.gov/Archives/edgar/data/877860/000087786020000035/ex101compositeagreement.htm)[August 15, 2016; and Fifth Amendment to Note Purchase Agreement](https://www.sec.gov/Archives/edgar/data/877860/000087786020000035/ex101compositeagreement.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786020000035/ex101compositeagreement.htm)[dated](https://www.sec.gov/Archives/edgar/data/877860/000087786020000035/ex101compositeagreement.htm)[August 8, 2017, in HTML format](https://www.sec.gov/Archives/edgar/data/877860/000087786020000035/ex101compositeagreement.htm)</u> (incorporated by reference to Exhibit 10.1 to Form 8-K filed March 19, 2020) |
| 10.27 | <u>[Settlement Agreement](https://www.sec.gov/Archives/edgar/data/877860/000087786022000041/settlementagreementdatedma.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786022000041/settlementagreementdatedma.htm)[dated March 31, 2022](https://www.sec.gov/Archives/edgar/data/877860/000087786022000041/settlementagreementdatedma.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786022000041/settlementagreementdatedma.htm)[by and among National Health Investors, Inc. and Welltower, Inc., Welltower Victory II TRS LLC](https://www.sec.gov/Archives/edgar/data/877860/000087786022000041/settlementagreementdatedma.htm)[and WELL Churchill Leasehold Owner LLC](https://www.sec.gov/Archives/edgar/data/877860/000087786022000041/settlementagreementdatedma.htm)</u> (incorporated by reference to Exhibit 10.2 to Form 10-Q filed May 9, 2022) |
| 10.28 | <u>[Sixth Amendment](https://www.sec.gov/Archives/edgar/data/877860/000087786022000051/sixthamendmentdatedjune292.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786022000051/sixthamendmentdatedjune292.htm)[dated June 29, 2022](https://www.sec.gov/Archives/edgar/data/877860/000087786022000051/sixthamendmentdatedjune292.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786022000051/sixthamendmentdatedjune292.htm)[to Note Purchase Agreement](https://www.sec.gov/Archives/edgar/data/877860/000087786022000051/sixthamendmentdatedjune292.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786022000051/sixthamendmentdatedjune292.htm)[dated January 13, 2015](https://www.sec.gov/Archives/edgar/data/877860/000087786022000051/sixthamendmentdatedjune292.htm)</u> (incorporated by reference to Exhibit 10.4 to Form 10-Q filed August 8, 2022) |
| 10.29 | <u>[Amendment No. 8 to Master Lease Agreement to Lease with NHC](https://www.sec.gov/Archives/edgar/data/877860/000087786023000015/amendmentno8tomasterleasea.htm)</u> (incorporated by reference to Exhibit 10.38 to Form 10-K filed February 21, 2023) |
| 10.30 | <u>[Amendment No. 9 to Master Lease Agreement to Lease with NHC](https://www.sec.gov/Archives/edgar/data/877860/000087786023000015/amendmentno9tomasterleasea.htm)</u> (incorporated by reference to Exhibit 10.39 to Form 10-K filed February 21, 2023) |
| 10.31 | <u>[Amendment No. 10 to Master Lease Agreement to Lease with NHC](https://www.sec.gov/Archives/edgar/data/877860/000087786022000064/exhibit101nhi-nhcmasterlea.htm)</u>) (incorporated by reference to Exhibit 10.1 to Form 8-K filed September 8, 2022) |
| \*10.32 | <u>[Amended and Restated National Health Investors, Inc. 2019 Stock Incentive Plan](https://www.sec.gov/Archives/edgar/data/877860/000087786023000027/nhi-20230322.htm)</u> (incorporated by reference to Appendix A to Definitive Proxy Statement filed March 23, 2023) |

---

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

---

| | |
|:---|:---|
| Item |  |
| Number | Exhibit Description |
| 10.33 | <u>[Term Loan Agreement](https://www.sec.gov/Archives/edgar/data/877860/000087786023000076/exhibit101.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786023000076/exhibit101.htm)[dated](https://www.sec.gov/Archives/edgar/data/877860/000087786023000076/exhibit101.htm)[as of](https://www.sec.gov/Archives/edgar/data/877860/000087786023000076/exhibit101.htm)[June 16, 2023, by and among National Health Investors, Inc.](https://www.sec.gov/Archives/edgar/data/877860/000087786023000076/exhibit101.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786023000076/exhibit101.htm)[the lenders party thereto and Wells Fargo Bank, National Association, as administrative agent](https://www.sec.gov/Archives/edgar/data/877860/000087786023000076/exhibit101.htm)</u> (incorporated by reference to Exhibit 10.1 to Form 8-K filed June 20, 2023) |
| \*10.34 | <u>[Amended and Restated Ch](https://www.sec.gov/Archives/edgar/data/877860/000087786025000198/ex101severanceagreementem1.htm)[ange in Control Severance Agreement, dated December 15, 2025, by and between National Health Investors, Inc. and D. Eric Mendelsohn](https://www.sec.gov/Archives/edgar/data/877860/000087786025000198/ex101severanceagreementem1.htm)</u> (incorporated by reference to Exhibit 10.1 to Form 8-K filed December 19, 2025) |
| \*10.35 | <u>[Amended and Restated Ch](https://www.sec.gov/Archives/edgar/data/877860/000087786025000198/ex102severanceagreementkg1.htm)[ange in Control Severance Agreement, dated December 15, 2025, by and between National Health Investors, Inc. and Kristin S. Gaines](https://www.sec.gov/Archives/edgar/data/877860/000087786025000198/ex102severanceagreementkg1.htm)</u>(incorporated by reference to Exhibit 10.2 to Form 8-K filed December 19, 2025) |
| \*10.36 | <u>[Amended and Restated Ch](https://www.sec.gov/Archives/edgar/data/877860/000087786025000198/ex103severanceagreementkpa.htm)[ange in Control Severance Agreement, dated December 15, 2025, by and between National Health Investors, Inc. and Kevin C. Pascoe](https://www.sec.gov/Archives/edgar/data/877860/000087786025000198/ex103severanceagreementkpa.htm)</u>(incorporated by reference to Exhibit 10.3 to Form 8-K filed December 19, 2025) |
| \*10.37 | <u>[Amended and Restated Ch](https://www.sec.gov/Archives/edgar/data/877860/000087786025000198/ex104severanceagreementjs1.htm)[ange in Control Severance Agreement, dated December 15, 2025, by and between National Health Investors, Inc. and John L. Spaid](https://www.sec.gov/Archives/edgar/data/877860/000087786025000198/ex104severanceagreementjs1.htm)</u> (incorporated by reference to Exhibit 10.4 to Form 8-K filed December 19, 2025) |
| \*10.38 | <u>[Amended and Restated Ch](https://www.sec.gov/Archives/edgar/data/877860/000087786025000198/ex105severanceagreementdt1.htm)[ange in Control Severance Agreement, dated December 15, 2025, by and between National Health Investors, Inc. and David L. Travis](https://www.sec.gov/Archives/edgar/data/877860/000087786025000198/ex105severanceagreementdt1.htm)</u>(incorporated by reference to Exhibit 10.5 to Form 8-K filed December 19, 2025) |
| 10.39 | <u>[Amended and Restated Credit Agreement](https://www.sec.gov/Archives/edgar/data/877860/000087786025000027/a2024amendedandrestatedcre.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786025000027/a2024amendedandrestatedcre.htm)[dated](https://www.sec.gov/Archives/edgar/data/877860/000087786025000027/a2024amendedandrestatedcre.htm)[as of](https://www.sec.gov/Archives/edgar/data/877860/000087786025000027/a2024amendedandrestatedcre.htm)[October 24, 2024](https://www.sec.gov/Archives/edgar/data/877860/000087786025000027/a2024amendedandrestatedcre.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786025000027/a2024amendedandrestatedcre.htm)[by and among National Health Investors, Inc.](https://www.sec.gov/Archives/edgar/data/877860/000087786025000027/a2024amendedandrestatedcre.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786025000027/a2024amendedandrestatedcre.htm)[Wells Fargo](https://www.sec.gov/Archives/edgar/data/877860/000087786025000027/a2024amendedandrestatedcre.htm)[Bank](https://www.sec.gov/Archives/edgar/data/877860/000087786025000027/a2024amendedandrestatedcre.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786025000027/a2024amendedandrestatedcre.htm)[National Association](https://www.sec.gov/Archives/edgar/data/877860/000087786025000027/a2024amendedandrestatedcre.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786025000027/a2024amendedandrestatedcre.htm)[as administrative agent](https://www.sec.gov/Archives/edgar/data/877860/000087786025000027/a2024amendedandrestatedcre.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786025000027/a2024amendedandrestatedcre.htm)[and the financial institutions party thereto](https://www.sec.gov/Archives/edgar/data/877860/000087786025000027/a2024amendedandrestatedcre.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786025000027/a2024amendedandrestatedcre.htm)[as lenders and agents](https://www.sec.gov/Archives/edgar/data/877860/000087786025000027/a2024amendedandrestatedcre.htm)</u> (incorporated by reference to Exhibit 10.48 to Form 10-K filed February 25, 2025) |
| 10.40 | <u>[Amendment No. 1](https://www.sec.gov/Archives/edgar/data/877860/000087786025000027/firstamendmentto2023termlo.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786025000027/firstamendmentto2023termlo.htm)[dated](https://www.sec.gov/Archives/edgar/data/877860/000087786025000027/firstamendmentto2023termlo.htm)[as of](https://www.sec.gov/Archives/edgar/data/877860/000087786025000027/firstamendmentto2023termlo.htm)[October 24, 2024](https://www.sec.gov/Archives/edgar/data/877860/000087786025000027/firstamendmentto2023termlo.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786025000027/firstamendmentto2023termlo.htm)[to](https://www.sec.gov/Archives/edgar/data/877860/000087786025000027/firstamendmentto2023termlo.htm)[Term Loan Agreement](https://www.sec.gov/Archives/edgar/data/877860/000087786025000027/firstamendmentto2023termlo.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786025000027/firstamendmentto2023termlo.htm)[dated June 16, 2023](https://www.sec.gov/Archives/edgar/data/877860/000087786025000027/firstamendmentto2023termlo.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786025000027/firstamendmentto2023termlo.htm)[with Wells Fargo Bank](https://www.sec.gov/Archives/edgar/data/877860/000087786025000027/firstamendmentto2023termlo.htm)[,](https://www.sec.gov/Archives/edgar/data/877860/000087786025000027/firstamendmentto2023termlo.htm)[National Association, as administrative agent, and the lenders party thereto](https://www.sec.gov/Archives/edgar/data/877860/000087786025000027/firstamendmentto2023termlo.htm)</u> (incorporated by reference to Exhibit 10.49 Form 10-K filed February 25, 2025) |
| 10.41 | <u>[Amendment No. 2 to Term Loan Agreement, dated](https://www.sec.gov/Archives/edgar/data/877860/000087786025000183/ex102nhitermloanamendment.htm)[as of](https://www.sec.gov/Archives/edgar/data/877860/000087786025000183/ex102nhitermloanamendment.htm)[October 31, 2025, by and among National Health Investors, Inc., the lenders party thereto](https://www.sec.gov/Archives/edgar/data/877860/000087786025000183/ex102nhitermloanamendment.htm)[and Wells Fargo Bank, National Association, as administrative agent](https://www.sec.gov/Archives/edgar/data/877860/000087786025000183/ex102nhitermloanamendment.htm)</u>(incorporated by reference to Exhibit 10.2 to Form 10-Q filed November 6, 2025) |
| 10.42 | <u>[Amendment No. 1 to Amended and Restated Credit Agreement, dated](https://www.sec.gov/Archives/edgar/data/877860/000087786025000183/ex101nhicreditagreementame.htm)[as of](https://www.sec.gov/Archives/edgar/data/877860/000087786025000183/ex101nhicreditagreementame.htm)[October 31, 2025, by and among National Health Investors, Inc., the lenders party thereto](https://www.sec.gov/Archives/edgar/data/877860/000087786025000183/ex101nhicreditagreementame.htm)[and Wells Fargo Bank, National Association, as administrative agent](https://www.sec.gov/Archives/edgar/data/877860/000087786025000183/ex101nhicreditagreementame.htm)</u> (incorporated by reference to Exhibit 10.1 to Form 10-Q filed November 6, 2025) |
| 19 | <u>[NHI's Insider Trading Policy](ex19-nhiinsidertradingpoli.htm)</u> (filed herewith) |
| 21 | <u>[Subsidiaries](ex21-subsidiaryentitylist.htm)</u>(filed herewith) |
| 23.1 | <u>[Consent of Independent Registered Public Accounting Firm](ex231-consentofindependent.htm)</u> (filed herewith) |
| 31.1 | <u>[Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](ex311q4202510-k.htm)</u> (filed herewith) |
| 31.2 | <u>[Certification of Principal Financial Officer pursuant to 18 U.S.C Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](ex312q4202510-k.htm)</u> (filed herewith) |
| 32 | <u>[Certification of Chief Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](ex32q4202510-k.htm)</u> (filed herewith) |
| 97 | <u>[National Health Investors, Inc. Incentive Compensation Recovery Policy](https://www.sec.gov/Archives/edgar/data/877860/000087786024000010/nationalhealthinvestorsinc.htm)</u> (incorporated by reference to Exhibit 97 to Form 10-K filed February 20, 2024) |
| 101.INS | Inline XBRL Instance Document |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document and contained in Exhibit 101) |

---

\*&nbsp;&nbsp;&nbsp;&nbsp;Indicates management contract or compensatory plan or arrangement

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

**ITEM 16. SUMMARY**

None.

------

<u>[**Table of Contents**](#i5eab276dbf9543dcafb4a7f5846ad360_7)</u>

**SIGNATURES**

Pursuant to the requirements of Section 13 or 15(d) of the Exchange Act, the Registrant has duly caused this Annual Report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | | <u>NATIONAL HEALTH INVESTORS, INC.</u> |
| | | (Registrant) |
| Date: | February 26, 2026 | /s/ D. Eric Mendelsohn |
| | | D. Eric Mendelsohn |
| | | President, Chief Executive Officer and Director |
| | | (duly authorized officer) |

---

---

| | | |
|:---|:---|:---|
| Signature | Title | Date |
| /s/ D. Eric Mendelsohn | President, Chief Executive Officer and Director | February 26, 2026 |
| D. Eric Mendelsohn | (Principal Executive Officer) |  |
| /s/ John L. Spaid | Chief Financial Officer | February 26, 2026 |
| John L. Spaid | (Principal Financial Officer) |  |
| /s/ David L. Travis | Chief Accounting Officer | February 26, 2026 |
| David L. Travis | (Principal Accounting Officer) |  |
| /s/ Robert A. McCabe, Jr. | Chairman of the Board | February 26, 2026 |
| Robert A. McCabe, Jr. |  |  |
| /s/ Robert G. Adams | Director | February 26, 2026 |
| Robert G. Adams |  |  |
| /s/ Robert W. Chapin, Jr. | Director | February 26, 2026 |
| Robert W. Chapin, Jr. |  |  |
| /s/ Tracy M. J. Colden | Director | February 26, 2026 |
| Tracy M. J. Colden |  |  |
| /s/ James R. Jobe | Director | February 26, 2026 |
| James R. Jobe |  |  |
| /s/ Charlotte A. Swafford | Director | February 26, 2026 |
| Charlotte A. Swafford |  |  |
| /s/ Candice W. Todd | Director | February 26, 2026 |
| Candice W. Todd |  |  |

---

------

**NATIONAL HEALTH INVESTORS, INC.**

**SCHEDULE III - REAL ESTATE AND ACCUMULATED DEPRECIATION**

**December 31, 2025**

*($ in thousands)*

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | Initial Cost to Company | Initial Cost to Company | | Gross Carrying Amount | Gross Carrying Amount | Gross Carrying Amount | | |
| | | Buildings, | | | Buildings, | | | |
| | | Building | Costs | | Building | | Accumulated | Date |
| | | Improvements | Capitalized | | Improvements | | Depreciation | Acquired or |
| | | and Intangible | Subsequent to | | and Intangible | | and | Construction |
| Real Estate Properties | Land | Assets | Acquisition | Land | Assets | Total<sup>1</sup> | Amortization<sup>2</sup> | Completed |
| Real Estate Investments segment: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Skilled nursing facilities: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Anniston, AL | $70 | $4477 | $— | $70 | $4477 | $4547 | $3925 | 10/17/1991 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Moulton, AL | 25 | 688 |  | 25 | 688 | 713 | 688 | 10/17/1991 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Avondale, AZ | 453 | 6678 |  | 453 | 6678 | 7131 | 4949 | 08/13/1996 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Brooksville, FL | 1217 | 16166 |  | 1217 | 16166 | 17383 | 6433 | 02/01/2010 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Crystal River, FL | 912 | 12117 |  | 912 | 12117 | 13029 | 4822 | 02/01/2010 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dade City, FL | 605 | 8042 |  | 605 | 8042 | 8647 | 3200 | 02/01/2010 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Hudson, FL | 1290 | 22392 |  | 1290 | 22392 | 23682 | 14290 | Various |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Merritt Island, FL | 701 | 8869 |  | 701 | 8869 | 9570 | 8052 | 10/17/1991 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;New Port Richey, FL | 228 | 3023 |  | 228 | 3023 | 3251 | 1203 | 02/01/2010 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Plant City, FL | 405 | 8777 |  | 405 | 8777 | 9182 | 7915 | 10/17/1991 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stuart, FL | 787 | 9048 |  | 787 | 9048 | 9835 | 8367 | 10/17/1991 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Trenton, FL | 851 | 11312 |  | 851 | 11312 | 12163 | 4501 | 09/29/2000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Glasgow, KY | 33 | 2110 |  | 33 | 2110 | 2143 | 2075 | 10/17/1991 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Desloge, MO | 178 | 3804 |  | 178 | 3804 | 3982 | 3804 | 10/17/1991 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Joplin, MO | 175 | 4034 |  | 175 | 4034 | 4209 | 3576 | 10/17/1991 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Kennett, MO | 180 | 4928 |  | 180 | 4928 | 5108 | 4844 | 10/17/1991 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Maryland Heights, MO | 150 | 4790 |  | 150 | 4790 | 4940 | 4693 | 10/17/1991 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;St. Charles, MO | 420 | 5512 |  | 420 | 5512 | 5932 | 5512 | 10/17/1991 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Albany, OR | 190 | 10415 |  | 190 | 10415 | 10605 | 3476 | 03/31/2014 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Creswell, OR | 470 | 8946 |  | 470 | 8946 | 9416 | 2886 | 03/31/2014 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Forest Grove, OR | 540 | 11848 |  | 540 | 11848 | 12388 | 3895 | 03/31/2014 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Anderson, SC | 308 | 4643 |  | 308 | 4643 | 4951 | 4524 | 10/17/1991 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Greenwood, SC | 174 | 3457 |  | 174 | 3457 | 3631 | 3337 | 10/17/1991 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Laurens, SC | 42 | 3426 |  | 42 | 3426 | 3468 | 3257 | 10/17/1991 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Orangeburg, SC | 300 | 3714 |  | 300 | 3714 | 4014 | 1659 | 09/25/2008 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Athens, TN | 38 | 1463 |  | 38 | 1463 | 1501 | 1389 | 10/17/1991 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chattanooga, TN | 143 | 2309 |  | 143 | 2309 | 2452 | 2304 | 10/17/1991 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dickson, TN | 90 | 3541 |  | 90 | 3541 | 3631 | 3374 | 10/17/1991 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dunlap, TN | 35 | 3679 |  | 35 | 3679 | 3714 | 3252 | 10/17/1991 |

---

------

**NATIONAL HEALTH INVESTORS, INC.**

**SCHEDULE III - REAL ESTATE AND ACCUMULATED DEPRECIATION (CONTINUED)**

*($ in thousands)*

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | Initial Cost to Company | Initial Cost to Company | | Gross Carrying Amount | Gross Carrying Amount | Gross Carrying Amount | | |
| | | Buildings, | | | Buildings, | | | |
| | | Building | Costs | | Building | | Accumulated | Date |
| | | Improvements | Capitalized | | Improvements | | Depreciation | Acquired or |
| | | and Intangible | Subsequent to | | and Intangible | | and | Construction |
| Real Estate Properties | Land | Assets | Acquisition | Land | Assets | Total<sup>1</sup> | Amortization<sup>2</sup> | Completed |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Franklin, TN | 47 | 1130 |  | 47 | 1130 | 1177 | 1130 | 10/17/1991 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Hendersonville, TN | 363 | 3837 |  | 363 | 3837 | 4200 | 3592 | 10/17/1991 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Johnson City, TN | 85 | 1918 |  | 85 | 1918 | 2003 | 1918 | 10/17/1991 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lawrenceburg, TN | 98 | 2900 |  | 98 | 2900 | 2998 | 2587 | 10/17/1991 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lewisburg, TN | 46 | 994 |  | 46 | 994 | 1040 | 995 | 10/17/1991 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;McMinnville, TN | 73 | 3618 |  | 73 | 3618 | 3691 | 3380 | 10/17/1991 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Milan, TN | 41 | 1826 |  | 41 | 1826 | 1867 | 1728 | 10/17/1991 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pulaski, TN | 53 | 3921 |  | 53 | 3921 | 3974 | 3607 | 10/17/1991 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Smithville, TN | 35 | 3816 |  | 35 | 3816 | 3851 | 3452 | 10/18/1991 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Somerville, TN | 26 | 677 |  | 26 | 677 | 703 | 678 | 10/19/1991 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sparta, TN | 80 | 1602 |  | 80 | 1602 | 1682 | 1570 | 10/20/1991 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Austin, TX | 606 | 9895 |  | 606 | 9895 | 10501 | 2748 | 04/01/2016 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Canton, TX | 420 | 12330 |  | 420 | 12330 | 12750 | 4641 | 04/18/2013 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Corinth, TX | 1075 | 13935 |  | 1075 | 13935 | 15010 | 5435 | 04/18/2013 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ennis, TX | 986 | 9025 |  | 986 | 9025 | 10011 | 3716 | 10/31/2011 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Euless, TX | 1241 | 12629 |  | 1241 | 12629 | 13870 | 3718 | 04/01/2016 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fort Worth, TX | 1380 | 14370 |  | 1380 | 14370 | 15750 | 3625 | 05/10/2018 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Garland, TX | 1440 | 14310 |  | 1440 | 14310 | 15750 | 3602 | 05/10/2018 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gladewater, TX | 70 | 17840 |  | 70 | 17840 | 17910 | 4749 | 04/01/2016 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Greenville, TX | 1800 | 13948 |  | 1800 | 13948 | 15748 | 5571 | 10/31/2011 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Houston, TX | 2808 | 42511 |  | 2808 | 42511 | 45319 | 17509 | Various |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Katy, TX | 610 | 13893 |  | 610 | 13893 | 14503 | 3869 | 04/01/2016 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Kyle, TX | 1096 | 12279 |  | 1096 | 12279 | 13375 | 4924 | 06/11/2012 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Marble Falls, TX | 480 | 14989 |  | 480 | 14989 | 15469 | 4107 | 04/01/2016 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;McAllen, TX | 1175 | 8259 |  | 1175 | 8259 | 9434 | 2473 | 04/01/2016 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;New Braunfels, TX | 1430 | 13666 |  | 1430 | 13666 | 15096 | 3898 | 02/24/2017 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;San Antonio, TX | 2370 | 40054 |  | 2370 | 40054 | 42424 | 13733 | Various |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Waxahachie, TX | 1330 | 14349 |  | 1330 | 14349 | 15679 | 3733 | 01/17/2018 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Bristol, VA | 176 | 2511 |  | 176 | 2511 | 2687 | 2511 | 10/17/1991 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Oak Creek, WI | 2000 | 14903 | 7403 | 2000 | 22306 | 24306 | 4708 | 12/07/2018 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total skilled nursing facilities | 34450 | 516143 | 7403 | 34450 | 523546 | 557996 | 250109 |  |

---

------

**NATIONAL HEALTH INVESTORS, INC.**

**SCHEDULE III - REAL ESTATE AND ACCUMULATED DEPRECIATION (CONTINUED)**

*($ in thousands)*

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | Initial Cost to Company | Initial Cost to Company | | Gross Carrying Amount | Gross Carrying Amount | Gross Carrying Amount | | |
| | | Buildings, | | | Buildings, | | | |
| | | Building | Costs | | Building | | Accumulated | Date |
| | | Improvements | Capitalized | | Improvements | | Depreciation | Acquired or |
| | | and Intangible | Subsequent to | | and Intangible | | and | Construction |
| Real Estate Properties | Land | Assets | Acquisition | Land | Assets | Total<sup>1</sup> | Amortization<sup>2</sup> | Completed |
| &nbsp;&nbsp;&nbsp;&nbsp;Assisted living facilities: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Anniston, AL | 134 | 6903 |  | 134 | 6903 | 7037 | 28 | 12/01/2025 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sacramento, CA | 660 | 10840 |  | 660 | 10840 | 11500 | 3522 | 06/01/2014 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pueblo West, CO | 169 | 7431 |  | 169 | 7431 | 7600 | 1430 | 07/23/2019 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Oviedo, FL | 2864 | 5736 |  | 2864 | 5736 | 8600 | 412 | 02/07/2025 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Statham, GA | 452 | 6487 |  | 452 | 6487 | 6939 | 283 | 12/05/2024 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ames, IA | 360 | 4670 | 335 | 360 | 5005 | 5365 | 1627 | 06/28/2013 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Burlington, IA | 200 | 8374 | 468 | 200 | 8842 | 9042 | 2930 | 06/28/2013 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cedar Falls, IA | 260 | 4700 | 30 | 260 | 4730 | 4990 | 1678 | 06/28/2013 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ft. Dodge, IA | 100 | 7208 |  | 100 | 7208 | 7308 | 2475 | 06/28/2013 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Iowa City, IA | 297 | 2725 | 33 | 297 | 2758 | 3055 | 1169 | 06/30/2010 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Marshalltown, IA | 240 | 6208 |  | 240 | 6208 | 6448 | 2167 | 06/28/2013 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Urbandale, IA | 540 | 4292 | 342 | 540 | 4634 | 5174 | 1532 | 06/28/2013 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Caldwell, ID | 320 | 9353 |  | 320 | 9353 | 9673 | 3054 | 03/31/2014 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Aurora, IL | 1195 | 11713 |  | 1195 | 11713 | 12908 | 3391 | 05/09/2017 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Bolingbrook, IL | 1290 | 14677 |  | 1290 | 14677 | 15967 | 3552 | 03/16/2017 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Bourbonnais, IL | 170 | 16594 | 526 | 170 | 17120 | 17290 | 5602 | 06/28/2013 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Crystal Lake, IL | 1060 | 30043 | 170 | 1060 | 30213 | 31273 | 7482 | Various |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gurnee, IL | 1244 | 13856 |  | 1244 | 13856 | 15100 | 2603 | 09/10/2019 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Moline, IL | 250 | 5630 |  | 250 | 5630 | 5880 | 1980 | 06/28/2013 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Oswego, IL | 390 | 20957 | 212 | 390 | 21169 | 21559 | 5334 | 06/01/2016 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Quincy, IL | 360 | 12403 |  | 360 | 12403 | 12763 | 4268 | 06/28/2013 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Rockford, IL | 390 | 12575 | 522 | 390 | 13097 | 13487 | 4313 | 06/28/2013 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;South Barrington, IL | 1610 | 13456 |  | 1610 | 13456 | 15066 | 3313 | 03/16/2017 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;St. Charles, IL | 820 | 22188 | 252 | 820 | 22440 | 23260 | 5694 | 06/01/2016 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tinley Park, IL | 1622 | 11354 |  | 1622 | 11354 | 12976 | 3351 | 06/23/2016 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Attica, IN | 284 | 7891 |  | 284 | 7891 | 8175 | 1351 | 05/01/2020 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Carmel, IN | 463 | 7055 | 342 | 463 | 7397 | 7860 | 2704 | 11/12/2014 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Crown Point, IN | 574 | 7336 | 698 | 574 | 8034 | 8608 | 2885 | 10/30/2013 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Greenwood, IN | 791 | 7020 | 573 | 791 | 7593 | 8384 | 2775 | 11/07/2013 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Linton, IN | 60 | 6015 |  | 60 | 6015 | 6075 | 1032 | 05/01/2020 |

---

------

**NATIONAL HEALTH INVESTORS, INC.**

**SCHEDULE III - REAL ESTATE AND ACCUMULATED DEPRECIATION (CONTINUED)**

*($ in thousands)*

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | Initial Cost to Company | Initial Cost to Company | | Gross Carrying Amount | Gross Carrying Amount | Gross Carrying Amount | | |
| | | Buildings, | | | Buildings, | | | |
| | | Building | Costs | | Building | | Accumulated | Date |
| | | Improvements | Capitalized | | Improvements | | Depreciation | Acquired or |
| | | and Intangible | Subsequent to | | and Intangible | | and | Construction |
| Real Estate Properties | Land | Assets | Acquisition | Land | Assets | Total<sup>1</sup> | Amortization<sup>2</sup> | Completed |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Bossier City, LA | 500 | 3344 |  | 500 | 3344 | 3844 | 1384 | 04/30/2011 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;West Monroe, LA | 770 | 5627 |  | 770 | 5627 | 6397 | 2222 | 04/30/2011 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Frederick, MD | 1942 | 17415 |  | 1942 | 17415 | 19357 | 1545 | 02/04/2023 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Battle Creek, MI | 398 | 3093 | 197 | 398 | 3290 | 3688 | 1512 | 10/19/2009 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lansing, MI | 1020 | 9684 | 174 | 1020 | 9858 | 10878 | 2567 | 10/19/2009 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Okemos, MI | 340 | 8082 |  | 340 | 8082 | 8422 | 3522 | 11/19/2009 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shelby, MI | 1588 | 13512 |  | 1588 | 13512 | 15100 | 2433 | 01/27/2020 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Champlin, MN | 980 | 4475 |  | 980 | 4475 | 5455 | 1886 | 03/10/2010 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Hugo, MN | 400 | 3945 | 113 | 400 | 4058 | 4458 | 1674 | 03/10/2010 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mahtomedi, MN | 515 | 8825 |  | 515 | 8825 | 9340 | 1499 | 12/27/2019 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Maplewood, MN | 1700 | 6544 |  | 1700 | 6544 | 8244 | 2756 | 03/10/2010 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;North Branch, MN | 595 | 3053 |  | 595 | 3053 | 3648 | 1316 | 03/10/2010 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Albermarle, NC | 870 | 4872 |  | 870 | 4872 | 5742 | 182 | 10/09/2024 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Apex, NC | 1042 | 15831 |  | 1042 | 15831 | 16873 | 559 | 10/09/2024 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cary, NC | 1366 | 20805 |  | 1366 | 20805 | 22171 | 729 | 10/09/2024 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Charlotte, NC | 650 | 17663 | 2000 | 650 | 19663 | 20313 | 5809 | 07/01/2015 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Durham, NC | 860 | 7752 | 2681 | 860 | 10433 | 11293 | 1710 | 12/15/2017 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Greensboro, NC | 1426 | 20550 |  | 1426 | 20550 | 21976 | 755 | 10/09/2024 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Greenville, NC | 797 | 10612 |  | 797 | 10612 | 11409 | 416 | 10/09/2024 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Hendersonville, NC | 3120 | 12980 | 128 | 3120 | 13108 | 16228 | 3346 | Various |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Kinston, NC | 798 | 3958 |  | 798 | 3958 | 4756 | 157 | 10/09/2024 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Kill Devil Hills, NC | 1276 | 9471 |  | 1276 | 9471 | 10747 | 336 | 10/09/2024 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Rocky Mount, NC | 990 | 8114 |  | 990 | 8114 | 9104 | 414 | 10/09/2024 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Wilmington, NC | 843 | 7313 |  | 843 | 7313 | 8156 | 295 | 10/09/2024 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Wilson, NC | 876 | 9512 |  | 876 | 9512 | 10388 | 381 | 10/09/2024 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Elkhorn, NE | 1579 | 9875 |  | 1579 | 9875 | 11454 | 216 | 04/01/2025 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Kearney, NE | 1193 | 9362 |  | 1193 | 9362 | 10555 | 243 | 04/01/2025 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lincoln, NE | 3944 | 39789 | 405 | 3944 | 40194 | 44138 | 4369 | Various |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Omaha, NE | 2235 | 23354 | 1197 | 2235 | 24551 | 26786 | 5187 | Various |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Bloomfield, NJ | 4154 | 42130 |  | 4154 | 42130 | 46284 | 1146 | 03/14/2025 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Las Vegas, NV | 1951 | 16184 |  | 1951 | 16184 | 18135 | 1421 | 02/14/2023 |

---

------

**NATIONAL HEALTH INVESTORS, INC.**

**SCHEDULE III - REAL ESTATE AND ACCUMULATED DEPRECIATION (CONTINUED)**

*($ in thousands)*

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | Initial Cost to Company | Initial Cost to Company | | Gross Carrying Amount | Gross Carrying Amount | Gross Carrying Amount | | |
| | | Buildings, | | | Buildings, | | | |
| | | Building | Costs | | Building | | Accumulated | Date |
| | | Improvements | Capitalized | | Improvements | | Depreciation | Acquired or |
| | | and Intangible | Subsequent to | | and Intangible | | and | Construction |
| Real Estate Properties | Land | Assets | Acquisition | Land | Assets | Total<sup>1</sup> | Amortization<sup>2</sup> | Completed |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Arlington, OH | 570 | 7917 |  | 570 | 7917 | 8487 | 2466 | 04/30/2018 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Columbus, OH | 530 | 6776 |  | 530 | 6776 | 7306 | 2180 | 04/30/2018 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lancaster, OH | 530 | 20530 | 675 | 530 | 21205 | 21735 | 6334 | 07/31/2015 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Middletown, OH | 940 | 15548 | 522 | 940 | 16070 | 17010 | 4878 | 10/31/2014 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Worthington, OH |  | 18869 | 1476 |  | 20345 | 20345 | 5391 | 04/30/2018 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;McMinnville, OR | 384 | 9183 |  | 384 | 9183 | 9567 | 2427 | 08/31/2016 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Portland, OR | 930 | 25270 |  | 930 | 25270 | 26200 | 5938 | 08/31/2015 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Jamison, PA | 3539 | 48610 |  | 3539 | 48610 | 52149 |  | 12/18/2025 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Wexford, PA | 1030 | 15206 | 976 | 1030 | 16182 | 17212 | 3504 | 04/30/2018 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Manchester, TN | 534 | 6068 | 191 | 534 | 6259 | 6793 | 926 | 06/03/2021 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chesapeake, VA | 1746 | 15542 |  | 1746 | 15542 | 17288 | 1389 | 02/09/2023 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fredericksburg, VA | 1615 | 9271 |  | 1615 | 9271 | 10886 | 2693 | 09/20/2016 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Midlothian, VA | 1646 | 8635 |  | 1646 | 8635 | 10281 | 2603 | 10/31/2016 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Suffolk, VA | 1022 | 9320 |  | 1022 | 9320 | 10342 | 2576 | 03/25/2016 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Virginia Beach, VA | 2052 | 15148 |  | 2052 | 15148 | 17200 | 1282 | 11/10/2022 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Bellevue, WI | 504 | 11796 |  | 504 | 11796 | 12300 | 1925 | 09/30/2020 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Oshkosh, WI | 542 | 12758 |  | 542 | 12758 | 13300 | 1338 | 04/29/2022 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sussex, WI | 1329 | 30721 |  | 1329 | 30721 | 32050 | 1345 | 06/21/2024 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assisted living facilities | 79330 | 970584 | 15238 | 79330 | 985822 | 1065152 | 185119 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Independent living facilities: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;St. Charles, MO | 344 | 3181 |  | 344 | 3181 | 3525 | 2888 | 10/17/1991 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chattanooga, TN | 9 | 1567 |  | 9 | 1567 | 1576 | 1546 | 10/17/1991 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Johnson City, TN | 55 | 4077 |  | 55 | 4077 | 4132 | 3537 | 10/17/1991 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total independent living facilities | 408 | 8825 |  | 408 | 8825 | 9233 | 7971 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Senior living campuses: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Rainbow City, AL | 670 | 11330 |  | 670 | 11330 | 12000 | 3775 | 10/31/2013 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Montrose, CO | 3062 | 18138 |  | 3062 | 18138 | 21200 | 736 | Various |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Greensboro, GA | 672 | 4849 | 1135 | 672 | 5984 | 6656 | 1967 | 09/15/2011 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Needham, MA | 5500 | 45157 | 1451 | 5500 | 46608 | 52108 | 10291 | 01/15/2019 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Roscommon, MI | 45 | 6005 | 1 | 45 | 6006 | 6051 | 1860 | 08/31/2015 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mt. Airy, NC | 1370 | 7470 | 432 | 1370 | 7902 | 9272 | 2392 | 12/17/2014 |

---

------

**NATIONAL HEALTH INVESTORS, INC.**

**SCHEDULE III - REAL ESTATE AND ACCUMULATED DEPRECIATION (CONTINUED)**

*($ in thousands)*

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | Initial Cost to Company | Initial Cost to Company | | Gross Carrying Amount | Gross Carrying Amount | Gross Carrying Amount | | |
| | | Buildings, | | | Buildings, | | | |
| | | Building | Costs | | Building | | Accumulated | Date |
| | | Improvements | Capitalized | | Improvements | | Depreciation | Acquired or |
| | | and Intangible | Subsequent to | | and Intangible | | and | Construction |
| Real Estate Properties | Land | Assets | Acquisition | Land | Assets | Total<sup>1</sup> | Amortization<sup>2</sup> | Completed |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;McMinnville, OR | 410 | 26667 |  | 410 | 26667 | 27077 | 6739 | 08/31/2016 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Auburn, WA | 1980 | 7710 | 7520 | 1980 | 15230 | 17210 | 3567 | 01/15/2016 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Silverdale, WA | 1750 | 23860 | 2167 | 1750 | 26027 | 27777 | 9327 | 08/16/2012 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total senior living campuses | 15459 | 151186 | 12706 | 15459 | 163892 | 179351 | 40654 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Entrance fee communities: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Bridgeport, CT | 4320 | 23494 | 5809 | 4320 | 29303 | 33623 | 8406 | 06/02/2016 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;North Branford, CT | 7724 | 64430 | 301 | 7724 | 64731 | 72455 | 16659 | 11/03/2016 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Southbury, CT | 10320 | 17143 | 6178 | 10320 | 23321 | 33641 | 6084 | 06/02/2016 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fernandina Beach, FL | 1430 | 63420 | 2084 | 1430 | 65504 | 66934 | 19854 | 12/17/2014 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;St. Simons Island, GA | 8770 | 38070 | 1783 | 8770 | 39853 | 48623 | 12013 | 12/17/2014 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Winston-Salem, NC | 8700 | 73920 | 1358 | 8700 | 75278 | 83978 | 22456 | 12/17/2014 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Columbia, SC | 4019 | 48514 |  | 4019 | 48514 | 52533 | 320 | 10/31/2025 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Greenville, SC | 5850 | 90760 | 1364 | 5850 | 92124 | 97974 | 26895 | 12/17/2014 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Myrtle Beach, SC | 3910 | 82140 | 1143 | 3910 | 83283 | 87193 | 25041 | 12/17/2014 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pawleys Island, SC | 1480 | 38620 | 898 | 1480 | 39518 | 40998 | 12119 | 12/17/2014 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Spartanburg, SC | 900 | 49190 | 1889 | 900 | 51079 | 51979 | 15281 | 12/17/2014 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Issaquah, WA | 4370 | 130522 |  | 4370 | 130522 | 134892 | 22175 | 01/31/2020 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total entrance fee communities | 61793 | 720223 | 22807 | 61793 | 743030 | 804823 | 187303 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Hospitals: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tulsa, OK | 1470 | 38780 | 2048 | 1470 | 40828 | 42298 | 4840 | 05/28/2021 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total hospitals | 1470 | 38780 | 2048 | 1470 | 40828 | 42298 | 4840 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Real Estate Investments segment | 192910 | 2405741 | 60202 | 192910 | 2465943 | 2658853 | 675996 |  |
| SHOP segment: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Independent living facilities: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fort Smith, AR | 590 | 22447 | 1591 | 590 | 24038 | 24628 | 7520 | 04/01/2022 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Rogers, AR | 1470 | 25282 | 2551 | 1470 | 27833 | 29303 | 8609 | 04/01/2022 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fresno, CA | 420 | 10899 | 1539 | 420 | 12438 | 12858 | 3788 | 04/01/2022 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Modesto, CA | 1170 | 22673 | 2135 | 1170 | 24808 | 25978 | 7457 | 04/01/2022 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pinole, CA | 1020 | 18066 | 2374 | 1020 | 20440 | 21460 | 5988 | 04/01/2022 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Roseville, CA | 630 | 31343 | 2937 | 630 | 34280 | 34910 | 10248 | 04/01/2022 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;West Covina, CA | 940 | 20280 | 2848 | 940 | 23128 | 24068 | 6978 | 04/01/2022 |

---

------

**NATIONAL HEALTH INVESTORS, INC.**

**SCHEDULE III - REAL ESTATE AND ACCUMULATED DEPRECIATION (CONTINUED)**

*($ in thousands)*

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | Initial Cost to Company | Initial Cost to Company | | Gross Carrying Amount | Gross Carrying Amount | Gross Carrying Amount | | |
| | | Buildings, | | | Buildings, | | | |
| | | Building | Costs | | Building | | Accumulated | Date |
| | | Improvements | Capitalized | | Improvements | | Depreciation | Acquired or |
| | | and Intangible | Subsequent to | | and Intangible | | and | Construction |
| Real Estate Properties | Land | Assets | Acquisition | Land | Assets | Total<sup>1</sup> | Amortization<sup>2</sup> | Completed |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Athens, GA | 910 | 31940 | 2800 | 910 | 34740 | 35650 | 10785 | 04/01/2022 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Columbus, GA | 570 | 8639 | 1534 | 570 | 10173 | 10743 | 3295 | 04/01/2022 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Voorhees, NJ | 670 | 23710 | 2230 | 670 | 25940 | 26610 | 8102 | 04/01/2022 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gahanna, OH | 920 | 22919 | 1608 | 920 | 24527 | 25447 | 7692 | 04/01/2022 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Broken Arrow, OK | 2660 | 18477 | 1393 | 2660 | 19870 | 22530 | 6264 | 04/01/2022 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Greenville, SC | 560 | 16547 | 1677 | 560 | 18224 | 18784 | 5776 | 04/01/2022 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Myrtle Beach, SC | 1310 | 26229 | 2486 | 1310 | 28715 | 30025 | 9101 | 04/01/2022 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Vancouver, WA | 1030 | 19183 | 6912 | 1030 | 26095 | 27125 | 6548 | 04/01/2022 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Columbus, IN | 348 | 6124 | 48 | 348 | 6172 | 6520 | 1168 | 05/31/2019 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tulsa, OK | 1980 | 32620 | 1651 | 1980 | 34271 | 36251 | 7527 | 12/01/2017 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total independent living facilities | 17198 | 357378 | 38314 | 17198 | 395692 | 412890 | 116846 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Senior living campuses: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Vero Beach, FL | 550 | 37450 | 3388 | 550 | 40838 | 41388 | 7950 | 02/01/2019 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Michigan City, IN | 974 | 22667 | 136 | 974 | 22803 | 23777 | 4274 | 05/31/2019 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Portage, IN | 661 | 21959 | 97 | 661 | 22056 | 22717 | 4152 | 05/31/2019 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Salisbury, MD | 1876 | 44084 | 766 | 1876 | 44850 | 46726 | 8748 | 05/31/2019 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Broken Arrow, OK | 944 | 5551 | 94 | 944 | 5645 | 6589 | 151 | 10/01/2025 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Redmont, OR | 1465 | 30171 | 11 | 1465 | 30182 | 31647 | 430 | 10/01/2025 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total senior living campuses | 6470 | 161882 | 4492 | 6470 | 166374 | 172844 | 25705 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Assisted living facilities: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Reading, PA | 1027 | 11179 | 57 | 1027 | 11236 | 12263 | 2210 | 05/31/2019 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Central Point, OR | 1070 | 18055 | 18 | 1070 | 18073 | 19143 | 282 | 10/01/2025 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tulsa, OK | 1694 | 15394 | 27 | 1694 | 15421 | 17115 | 379 | 10/01/2025 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assisted living facilities | 3791 | 44628 | 102 | 3791 | 44730 | 48521 | 2871 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total SHOP segment | 27459 | 563888 | 42908 | 27459 | 606796 | 634255 | 145422 |  |
| Corporate office | 1291 | 677 | 664 | 1291 | 1341 | 2632 | 564 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total real estate properties | $221660 | $2970306 | $103774 | $221660 | $3074080 | $3295740 | $821982 |  |

---

<sup>1&nbsp;&nbsp;&nbsp;&nbsp;</sup>These amounts include construction in progress costs.

<sup>2&nbsp;&nbsp;&nbsp;&nbsp;</sup>As of December 31, 2025, the tax basis of our real estate properties, net, was $2.7 billion.

------

**NATIONAL HEALTH INVESTORS, INC.**

**SCHEDULE III - REAL ESTATE AND ACCUMULATED DEPRECIATION (CONTINUED)**

*($ in thousands)*

---

| | | | |
|:---|:---|:---|:---|
| | Year Ended December 31, | Year Ended December 31, | Year Ended December 31, |
| | 2025 | 2024 | 2023 |
| Real estate properties: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at the beginning of the year | $2953548 | $2780358 | $2729898 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisitions and investments in existing real estate properties and equipment | 294034 | 157931 | 49556 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in accounts payable related to real estate property renovations | (95) | (250) | 325 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in other assets related to investments in real estate properties |  |  | 454 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Right of use assets acquired in exchange for financing lease liabilities | 139 | 344 | 101 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Assets received upon early lease terminations | 1375 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Real estate acquired in exchange for non-cash rental income |  |  | 2500 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Real estate properties acquired to settle mortgage notes receivable | 50800 | 22184 | 14200 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Increase in liabilities associated with acquisitions of real estate properties | 778 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sales of real estate properties |  | (4758) | (19326) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Real estate properties reclassified as assets held for sale | (4839) | (2261) | (11970) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Real estate properties reclassified as assets held for use |  |  | 15793 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Impairments of real estate properties |  |  | (1173) |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at the end of the year | $3295740 | $2953548 | $2780358 |
| Accumulated depreciation: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at the beginning of the year | $742295 | $673276 | $611688 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 80944 | 71443 | 69973 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of right-of-use assets | 20 | 36 | 38 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dispositions |  | (1518) | (4851) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Real estate properties reclassified as assets held for sale | (1277) | (942) | (6965) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Real estate properties reclassified as assets held for use |  |  | 3393 |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at the end of the year | $821982 | $742295 | $673276 |

---

------

**NATIONAL HEALTH INVESTORS, INC.**

**SCHEDULE IV - MORTGAGE LOANS ON REAL ESTATE**

**December 31, 2025**

*($ in thousands)*

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| |<br><br>Interest<br>Rate |<br><br>Maturity<br>Date |<br><br>Monthly<br>Payment<br>Terms |<br><br>Prior<br>Liens |<br><br>Principal<br>Amount<br>Outstanding |<br><br>Gross<br>Carrying<br>Amount | Principal<br>Amount of<br>Loans Subject<br>to Delinquent<br>Principal<br>or Interest |
| First mortgage notes: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Maitland, FL | 8.50% | 12/31/2027 | Interest Only | $— | $9000 | $9000 | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;Indianapolis, IA | 9.00% | 06/30/2026 | Interest Only |  | 6423 | 6423 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Bloomington, IL | 8.75% | 02/28/2029 | Interest Only |  | 15000 | 14907 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Mount Pleasant, SC | 8.50% | 11/30/2030 | Interest Only |  | 18750 | 18750 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Austin / San Antonio, TX | 7.25% | 11/30/2027 | Interest Only |  | 14731 | 14748 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Wichita Falls, TX | 8.75% | 12/31/2030 | Interest Only |  | 11250 | 11139 |  |
| Second mortgage notes: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Winter Park, FL | 12.00% | 10/31/2026 | Interest Only |  | 725 | 722 |  |
| Construction loans: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Lake City, FL | 9.00% | 08/31/2028 | Interest Only |  | 27401 | 27220 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Canton, MI | 9.00% | 07/31/2026 | Interest Only |  | 14700 | 14700 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Wyoming, MI | 9.00% | 04/30/2030 | Interest Only |  | 8547 | 8304 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Fitchburg, WI | 8.50% | 01/28/2027 | Interest Only |  | 28462 | 28414 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total mortgage loans on real estate |  |  |  | $— | $154989 | $154327 | $— |

---

As of December 31, 2025, the tax basis of our mortgage notes was $166.8 million. Balloon payments on our interest only mortgage notes are equivalent to the carrying amounts listed above except for unamortized commitment fees of $0.7 million.

Reference Note 4 to our consolidated financial statements included in this Annual Report on Form 10-K for more information on our mortgage notes receivable.

------

**NATIONAL HEALTH INVESTORS, INC.**

**SCHEDULE IV - MORTGAGE LOANS ON REAL ESTATE (CONTINUED)**

*($ in thousands)*

---

| | | | |
|:---|:---|:---|:---|
| | Year Ended December 31, | Year Ended December 31, | Year Ended December 31, |
| | 2025 | 2024 | 2023 |
| Balance at the beginning of the year | $175830 | $162433 | $164576 |
| &nbsp;&nbsp;&nbsp;&nbsp;Additions: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;New mortgage notes | 58532 | 41718 | 15083 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of commitment fees and discounts | 435 | 471 | 428 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total additions | 58967 | 42189 | 15511 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deductions: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Commitment fees received | 458 | 885 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Extension and exit fees received | 43 | 82 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Real estate properties acquired to settle mortgage notes receivable | 50800 | 22184 | 14200 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Write-offs of mortgage and other notes receivable | 1400 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Principal payments received, less recoveries of amounts previously written down | 27769 | 5641 | 3454 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total deductions | 80470 | 28792 | 17654 |
| Balance at the end of the year | $154327 | $175830 | $162433 |

---

## Exhibit 4.8

**Exhibit 4.8**

**DESCRIPTION OF SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934**

The following description of the capital stock of National Health Investors, Inc. (the "Company," "us," "our" or "we") is a summary of the rights of our common stock and certain provisions of Maryland General Corporation Law and our articles of incorporation, as amended (our "articles") and amended and restated bylaws (our "bylaws"), as currently in effect. This description is a summary, does not purport to be complete and is qualified in its entirety by reference to the provisions of our articles and bylaws, copies of which are filed as exhibits to our Annual Report on Form 10-K and are incorporated by reference herein, and to the applicable provisions of Maryland law. We encourage you to read our articles and bylaws, and the applicable provisions of Maryland law for additional information.

**Authorized Capital**

Our articles authorize us to issue up to 110,000,000 shares of capital stock, consisting of 100,000,000 shares of common stock, par value $0.01 per share, and 10,000,000 shares of preferred stock, par value $0.01 per share.

*Voting Rights*. With respect to all matters upon which stockholders are entitled to vote, except as required by applicable law, the holders of our common stock will be entitled to one vote in person or by proxy for each share of our common stock outstanding in the name of such stockholder on the record of stockholders. The holders of our outstanding common stock do not have the right to cumulate their votes with respect to the election of directors or any other matters. Generally, all matters to be voted on by our stockholders must be approved by a majority of the votes cast on such matter (or by a plurality of the votes cast in the case of an election of directors where the number of candidates nominated for election exceeds the number of directors to be elected) at a meeting of stockholders at which a quorum is present.

*Dividends*. Subject to applicable law and rights, if any, of the holders of any outstanding class or series of preferred stock having a preference over our common stock with respect to the payment of dividends, dividends may be declared and paid on our common stock from time to time and in amounts as our board of directors may determine.

*Liquidation Rights*. Upon our liquidation or dissolution or the winding up of our business, whether voluntarily or involuntarily, the holders of our common stock will be entitled to share ratably in all assets available for distribution after payment or provision for the payment of our debt and liabilities and to holders of preferred stock then outstanding of any amount required to be paid to them.

*Other Provisions*. The holders of our common stock will not be entitled to any preemptive, subscription or redemption rights, and will not be entitled to the benefit of any sinking fund. All outstanding shares of our common stock are fully paid and nonassessable.

*Miscellaneous.* The transfer agent and registrar for our common stock is Computershare Trust Company, N.A. Our common stock is listed on the New York Stock Exchange under the symbol "NHI."

**Preferred Stock**

Our board of directors is authorized to issue preferred stock in one or more series and, with respect to each series, to determine the number of shares constituting any series, and the preferences, conversion and other rights, voting powers, restrictions and limitations as to dividends, qualifications and terms and conditions of redemption. No shares of preferred stock are currently issued or outstanding.

Preferred stock and the variety of characteristics available for it offers us flexibility in financing and acquisition transactions. An issuance of stock could dilute the book value or adversely affect the relative voting power of our common stock. The issuance of such shares could be used to discourage unsolicited business combinations, for example, by providing for class voting rights which would enable the holder to block such a transaction. Although our board of directors is required when issuing such stock to act based on its judgment as to the best interests of our stockholders, our board of

------

directors could act in a manner which would discourage or prevent a transaction some stockholders might believe is in the Company's best interests or in which stockholders could or would receive a premium for their shares over the market price. Our board of directors has authority to classify or reclassify authorized but unissued shares of stock by setting or changing the preferences, conversion and other rights, voting powers, restrictions and limitations as to dividends, qualifications, and terms and conditions of redemption of stock.

**Restrictions on Ownership and Transfer**

Our articles contain certain limitations on the number of shares of our stock that any one stockholder may own, which limitations are designed to ensure that the Company maintains its status as a real estate investment trust, or REIT. Our articles provide that any transfer that would cause the Company to be beneficially owned by fewer than 100 persons or would cause the Company to be "closely held" under the Internal Revenue Code of 1986, as amended (the "Code") would be void. In addition, our articles provide that no person (as defined in the Code) may own directly or indirectly 9.9% or more of our common stock (as adjusted downward in accordance with our articles to take into account shares beneficially owned by "Excepted Holders" (as such term is defined in our articles)). These limitations are referred to below as the "ownership limits." For purposes of the ownership limits, shares are beneficially owned by the person who is the actual owner or who is treated as the owner of such shares, directly, indirectly or constructively under the Code. The beneficial ownership of shares of common or preferred stock in excess of the ownership limits and any attempted transfer in violation of the ownership limits is void.

Our board of directors has broad powers to prohibit and rescind any attempted transfer in violation of the ownership limits. Our articles provide that any shares owned in violation of the ownership limits will be automatically converted into shares of Excess Stock (as defined in our articles) effective as of the day before the transaction giving rise to the conversion. Upon conversion, shares of Excess Stock will be deemed to be contributed into a trust held for the sole benefit of a tax exempt charitable organization designated by our board of directors. Shares of Excess Stock will carry the same voting rights and rights to distributions and dividends as the shares from which they were converted. However, any distributions or dividends paid on the shares of Excess Stock will be held in the trust and all voting rights with respect to the shares of Excess Stock may be exercised only by the trustee. The trustee may sell shares of Excess Stock provided that any such sale would not result in a violation of the ownership limits. From the proceeds of such sale, the trustee is required to distribute to the record owner of such shares the lesser of (i) the price paid by the record owner for such shares (or, if no consideration was paid by such record owner, the average closing price for such shares for the ten trading days immediately preceding the date the record owner acquired such shares) or (ii) the proceeds receive by the trustee. All remaining proceeds will be distributed to the charitable beneficiary.

Our board of directors has the power to permit persons to own shares in excess of the ownership limits described above (thereby causing such persons to become Excepted Holders) provided that our board of directors believes that our REIT status will not be jeopardized and any such persons enter into Excepted Holder agreements with the Company. The ownership limit with respect to each Excepted Holder will be as set forth in such Excepted Holder's agreement with the Company.

There are currently no outstanding Excepted Holder agreements. As a result, the ownership limit of our outstanding common stock is 9.9%. This ownership limit may change if we enter into Excepted Holder agreements in the future. Our articles give our board of directors broad powers to prohibit and rescind any attempted transfer in violation of the ownership limit.

Upon demand of the Company, each stockholder must disclose to the Company such information with respect to direct and indirect ownership of stock owned (or deemed to be owned after applying the rules applicable to REITs under the Code) as our board of directors deems reasonably necessary in order that the Company may fully comply with the REIT provisions of the Code. Proposed transferees of stock must also satisfy our board of directors, upon demand, that such transferees will not cause the Company to fall out of compliance with such provisions.

------

**Anti-Takeover Effect of Certain Provisions of our Articles and Bylaws**

*Meetings of stockholders*. Under our bylaws, annual meetings of stockholders are to be held on the date and at the time determined by our board of directors. Special meetings of stockholders may be called by a majority of the directors then in office, the chairperson of our board of directors or our president. Additionally, subject to the provisions of our bylaws, special meetings of the stockholders will be called by our secretary upon the written request of stockholders entitled to cast not less than 25% of the votes entitled to be cast at such meeting. Only matters set forth in the notice of the special meeting may be considered and acted upon at such a meeting. Our bylaws provide and Maryland law permits that any action required or permitted to be taken at a meeting of stockholders may be taken without a meeting by unanimous written consent, if that consent sets forth such action and is provided by each stockholder entitled to vote on the matter.

*Filling of board vacancies*. Vacancies on our board of directors and newly created directorships resulting from any increase in the authorized number of directors may be filled by a vote of the entire board of directors. Each person so appointed will hold office until the next annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier resignation, removal or disqualification.

*Amendment of the bylaws*. To the fullest extent permitted by the Maryland General Corporation Law, our board of directors has the power at any annual, regular or special meeting (with appropriate notice), to amend, alter or repeal any of our bylaws and to make new bylaws. Our stockholders have the power at any annual or special meeting (with appropriate notice), with the approval of holders of at least a majority of the votes cast at such meeting, to amend, alter or repeal any bylaws of the Company and to make new bylaws.

*Advance notice of director nominations and other stockholder proposals.* Our bylaws include advance notice provisions specifying procedures, informational requirements and time limitations with respect to stockholder proposals and stockholder nominations of individuals for election to our board of directors at a meeting of stockholders. Failure to comply with these advance notice provisions can result in a stockholder's director nomination or proposal of other business to not be considered at a meeting of stockholders.

Our bylaws provide that, with respect to an annual meeting of stockholders, nominations of individuals for election to our board of directors and the proposal of other business to be considered by stockholders may be made only (i) pursuant to our notice of the meeting, (ii) by or at the direction of our board of directors or (iii) by a stockholder who is a stockholder of record on the date of the giving of notice required by our bylaws through the date of the meeting, who is entitled to vote at the meeting in the election of each individual so nominated or on such other business and who has complied with the advance notice provisions set forth in our bylaws.

With respect to a special meeting of stockholders, only the business specified in our notice of meeting may be brought before the meeting. Nominations of individuals for election to our board of directors may be made only at a special meeting of stockholders at which directors are to be elected pursuant to our notice of meeting (i) by or at the direction of our board of directors or (ii) by a stockholder who is a stockholder of record on the date of the giving of notice required by our bylaws through the date of the meeting, who is entitled to vote at the meeting in such election and who has complied with the advance notice provisions set forth in our bylaws.

The purpose of these advance notice procedures is to afford our board of directors a meaningful opportunity to consider the qualifications of the proposed nominees and the advisability of any other proposed business and, to the extent considered necessary by our board of directors, to inform stockholders and make recommendations regarding the nominations or business, as well as to permit a more orderly procedure for conducting our stockholder meetings. Although our bylaws do not give our board of directors the power to disapprove timely stockholder nominations for the election of directors or proposals recommending certain action, they may have the effect of precluding a contest for the election of directors or the consideration of stockholder proposals if the proper procedures are not followed, and of discouraging or deterring a third party from conducting a solicitation of proxies to elect its own slate of directors to our board of directors or to approve its own proposal without regard to whether consideration of such nominees or proposals might be harmful or beneficial to us and our stockholders.

------

*Ownership limitations.* Primarily to protect us against the risk of losing our status as a REIT, our articles contain provisions that limit the ownership by any person of shares of any class or series of our capital stock. These provisions may have the effect of inhibiting or impeding a change in control.

**Anti-Takeover Effect of Maryland Law**

In addition to certain provisions of our articles and bylaws discussed above, Maryland has adopted a series of statutes which can have an anti-takeover effect and may delay or prevent a takeover attempt that a stockholder might consider in its best interest, including those attempts that might result in a premium over the market price for our capital stock.

*The Maryland General Corporation Law.* The Maryland General Corporation Law applies to all Maryland corporations. It imposes a five-year standstill on transactions such as mergers, share exchanges, sales of assets, liquidations and other interested party transactions between Maryland corporations and "interested stockholders" and their associates or affiliates, unless the business combination is approved by the board of directors before the interested stockholder goes above a 10% ownership threshold. Thereafter, the transaction either requires a two-thirds vote of the stockholders other than the interested stockholder and an 80% vote of all stockholders or satisfaction of minimum price standards. Our articles provide that any shares of our stock held by a person identified by our board of directors as a "Current Excepted Holder" and their affiliates are not deemed to be "interested stockholders" for purposes of the Maryland General Corporation Law.

*Control Share Acquisitions.* The provisions of the Maryland Control Share Acquisition Act provide that a holder of control shares of a Maryland corporation acquired in a control share acquisition has no voting rights with respect to those shares except to the extent approved by a vote of two-thirds of the votes entitled to be cast on the matter. Shares owned by the acquiror, by officers or by directors who are employees of the corporation are excluded from shares entitled to vote on the matter. Control shares are voting shares of stock which, if aggregated with all other shares of stock owned by the acquiror or in respect of which the acquiror is able to exercise or direct the exercise of voting power (except solely by virtue of a revocable proxy), would entitle the acquiror to exercise voting power in electing directors within one of the following ranges of voting power:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• one-tenth or more but less than one-third;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• one-third or more but less than a majority; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• majority or more of all voting power.

Control shares do not include shares that the acquiring person is then entitled to vote as a result of having previously obtained stockholder approval or shares acquired directly from the corporation. A control share acquisition means, subject to certain exceptions, the acquisition of issued and outstanding control shares.

A person who has made or proposes to make a control share acquisition may compel the board of directors of the corporation to call a special meeting of stockholders to be held within 50 days of demand to consider the voting rights of the shares. The right to compel the calling of a special meeting is subject to the satisfaction of certain conditions, including an undertaking to pay the expenses of the meeting. If no request for a meeting is made, the corporation may itself present the question at any stockholders' meeting.

If voting rights are not approved at the meeting or if the acquiring person does not deliver an acquiring person statement as required by the statute, then the corporation may redeem for fair value any or all of the control shares, except those for which voting rights have previously been approved. The right of the corporation to redeem control shares is subject to certain conditions and limitations. Fair value is determined, without regard to the absence of voting rights for the control shares, as of the date of the last control share acquisition by the acquiror or, if a meeting of stockholders at which the voting rights of the shares are considered and not approved, as of the date of that meeting. If voting rights for control shares are approved at a stockholders' meeting and the acquiror becomes entitled to vote a majority of the shares entitled to vote, all other stockholders may exercise appraisal rights. The fair value of the shares as determined for purposes of appraisal rights may not be less than the highest price per share paid by the acquiror in the control share acquisition.

------

The control share acquisition statute does not apply to (i) shares acquired in a merger, consolidation or share exchange if the corporation is a party to the transaction or (ii) acquisitions approved or exempted by the articles or bylaws of the corporation. Our articles provide that the voting rights of shares of our stock held by a person identified by our board of directors as a "Current Excepted Holder" and their affiliates are not be governed by the control share provisions of the Maryland General Corporation Law.

## Ex-19

Exhibit 19

**NATIONAL HEALTH INVESTORS, INC.** 

**INSIDE INFORMATION AND INSIDER TRADING POLICY** 

Under federal and state securities laws, it is illegal to purchase or sell securities of National Health Investors, Inc. (the "**Company**") while in possession of material nonpublic information related to, affecting or regarding the Company or its subsidiaries (such information, "**Inside Information**"), or to disclose Inside Information to others who then trade in the securities of the Company. Insider trading violations are pursued vigorously by the Securities and Exchange Commission (the "**SEC**") and other governmental agencies and can result in severe penalties. While the regulatory authorities usually concentrate their efforts on the individuals who trade, or who tip Inside Information to others who trade, the federal securities laws also impose potential liability on companies and other "controlling persons" if they fail to take reasonable steps to prevent insider trading by Company personnel.

The Board of Directors of the Company has adopted this Inside Information and Insider Trading Policy (this "**Policy**") both to satisfy the Company's obligation to prevent insider trading and to help the Company's personnel avoid violating insider trading laws.

**<u>Persons Subject to this Policy</u>**

This Policy applies to (i) all members of the Company's Board of Directors, (ii) all officers of the Company and its subsidiaries, and (iii) all employees of the Company and its subsidiaries (collectively, "**Covered Persons**").

This Policy also applies to family members who reside with Covered Persons (including a spouse, a child, a child away at college, stepchildren, grandchildren, parents, stepparents, grandparents, siblings and in-laws), anyone else who lives in a Covered Person's household, and any family members who do not live in a Covered Person's household but whose transactions in Company Securities (defined below) are directed by a Covered Person or are subject to a Covered Person's influence or control, such as parents or children who consult with a Covered Person before they trade in Company Securities (collectively referred to as "**Family Members**"). Each Covered Person should make his or her Family Members aware of the need to confer with such Covered Person before they trade in Company Securities. This Policy does not, however, apply to personal securities transactions of Family Members where the purchase or sale decision is made by a third party not controlled by, influenced by or related to a Covered Person or his or her Family Members.

This Policy also applies to any entities that a Covered Person influences or controls, including any corporations, partnerships or trusts (collectively referred to as "**Controlled Entities**"), and transactions by these Controlled Entities should be treated for the purposes of this Policy and applicable securities laws as if they were for the Covered Person's own account.

All consultants and outside advisors assisting the Company on sensitive matters are expected to abide by this Policy, although the Company assumes no responsibility with respect to the actions of persons who are not under its direct control.

**<u>Transactions Subject to this Policy</u>**

This Policy applies to all transactions in the Company's securities (collectively referred to in this Policy as "**Company Securities**"), including the Company's common stock, any securities that are exercisable for, or convertible or exchangeable into, shares of common stock, and any other type of securities that the Company may issue from time to time, including (but not limited to) preferred stock, notes, convertible

-- 1-

------

debt and warrants, as well as derivative securities that are not issued by the Company, such as exchange-traded put or call options or swaps relating to the Company's Securities.

**<u>Statement of Policy</u>**

It is the policy of the Company that no Covered Person (or any other person designated as subject to this Policy) who is aware of Inside Information may, directly, or indirectly through Family Members, Controlled Entities or other persons or entities:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• engage in transactions in Company Securities, except as otherwise specified in this Policy under the headings "Transactions Not Subject to Trading Restrictions" and "Rule 10b5-1 Plans";

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• recommend the purchase or sale of any Company Securities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• disclose Inside Information to persons within the Company whose jobs do not require them to have that information, or outside of the Company to other persons; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• assist anyone engaged in the above activities.

In addition, it is the policy of the Company that no Covered Person (or any other person designated as subject to this Policy) who, in the course of working for the Company, learns of material nonpublic information about a company with which the Company does business, including a customer or supplier of the Company, may trade in that company's securities until the information becomes public or is no longer material.

There are no exceptions to this Policy, except as specifically noted herein. Transactions that may be necessary or justifiable for independent reasons (such as the need to raise money for an emergency expenditure), or small transactions, are not exempted from this Policy. The securities laws do not recognize any mitigating circumstances, and, in any event, even the appearance of an improper transaction must be avoided to preserve the Company's reputation for adhering to the highest standards of conduct.

**<u>Administration of this Policy</u>**

The Vice President, HR/Benefits and Compliance, of the Company shall serve as the Compliance Officer for the purposes of this Policy, and in his or her absence, another employee designated by the Compliance Officer shall be responsible for administration of this Policy. All determinations and interpretations by the Compliance Officer shall be final and not subject to further review.

When in doubt about a matter covered by this Policy, or if you have questions, please contact the Compliance Officer before engaging in any transaction involving Company Securities. See "Personal Responsibility; Assistance" below.

**<u>Material Nonpublic Information</u>**

***Material Information***

Information is material if there is a substantial likelihood that a reasonable investor would consider it important in deciding whether to buy, hold or sell a security. Therefore, any information that could

------

reasonably be expected to affect the price of the security is material. While it is not possible to compile an exhaustive list of circumstances involving material information, common examples include:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Annual or quarterly financial results, or the need to restate such financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Unpublished financial or operating results.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Projections of future earnings or losses or other earnings guidance.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Earnings that are inconsistent with the consensus expectations of the investment community.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• A pending or proposed merger, acquisition, reorganization or tender offer or an acquisition or disposition of significant assets.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• A change in management or control.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Major events regarding Company Securities, including the declaration of a stock split or the offering of additional securities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Changes in the Company's independent registered public accounting firm.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Financial liquidity problems.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Significant cybersecurity incidents or potential significant cybersecurity incidents.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Gain or loss of a significant customer or business partner.

Both positive and negative information can be material. Because trading that receives scrutiny will be evaluated after the fact with the benefit of hindsight, questions concerning the materiality of particular information should be resolved in favor of materiality, and trading should be avoided.

***Inside Information***

Inside Information is material information about the Company that is not generally known or available to the public. Information is considered to be available to the public only when it has been disclosed by the Company or third parties to the marketplace (such as by a press release, other authorized public statement or an SEC filing) and the investing public has had time to absorb the information fully. As a general rule, information is considered nonpublic until the second business day after the information is released. For example, if the Company announces financial earnings before trading begins on a Tuesday, the first time you can buy or sell Company Securities is the opening of the market on Thursday. However, if the Company announces earnings after trading begins on the Tuesday, the first time you can buy or sell Company Securities is the opening of the market on Friday.

**<u>Transactions Not Subject to Trading Restrictions</u>**

For purposes of this Policy, the Company considers transactions between Covered Persons with respect to grants under the Company's Amended and Restated 2019 Stock Incentive Plan or other equity incentive plans (or, to the extent applicable, granted outside such plan) to be exempt from this Policy. Such transactions include, without limitation, the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the exercise of stock options for cash;

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the exercise of options on a "net exercise" basis pursuant to which an optionee either (i) delivers outstanding shares of common stock to the Company or (ii) authorizes the Company to withhold from issuance shares of common stock issuable upon exercise of the option, in either case, having a fair market value on the date of exercise equal to the aggregate exercise price;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the forfeiture to the Company of restricted shares of common stock or share units to cover withholding tax obligations; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• purchases of Company Securities in any 401(k) plan maintained by the Company resulting from your periodic contribution of money to the plan pursuant to your payroll deduction election.

However, transactions with parties other than the Company involving Company equity awards, including sales of shares underlying vested awards and broker-assisted sales of shares to cover withholding taxes, are subject to this Policy.

*Bona fide* gifts of securities (including transfers of Company Securities made to trusts for estate planning purposes) are also not subject to this Policy, unless the person making the gift is aware of Inside Information at the time the gift is made and has reason to believe that the recipient intends to sell the Company's securities while the person making the gift continues to be aware of such Inside Information; provided, however, that Covered Persons must still pre-clear and report gift transfers as described in "Pre-clearance Procedures" below.

Finally, transactions in mutual funds that are invested in Company Securities are not transactions subject to this Policy.

**<u>Special and Prohibited Transactions</u>**

The Company has determined that there is a heightened legal risk and/or the appearance of improper or inappropriate conduct if the persons subject to this Policy engage in certain types of transactions. Therefore, it is the Company's policy that any persons covered by this Policy may not engage in any of the following transactions, or should otherwise consider the Company's preferences as described below:

***Short-Term Speculative Transactions***

The Company considers it improper and inappropriate for those employed by or associated with the Company to engage in short-term or speculative transactions in Company Securities. It therefore is the Company's policy that Covered Persons may not engage in any of the following transactions:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• short-term trading involving purchases and sales (or sales and purchases) of Company Securities within six months of each other (note that Section 16(b) of the Securities Exchange Act of 1934, as amended (the "**Exchange Act**") already removes the incentive for officers or directors to engage in short-term trading in Company Securities);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• short sales of Company Securities (note that Section 16(c) of the Exchange Act prohibits officers and directors from engaging in short sales); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• transactions in publicly traded options, such as puts, calls and other derivative securities, on an exchange or in any other organized market.

------

***Margin Accounts and Pledged Securities***

Securities held in a margin account as collateral for a margin loan may be sold by the broker or lender without the customer's consent if the customer fails to meet a margin call. Similarly, securities pledged (or hypothecated) as collateral for a loan may be sold in foreclosure if the borrower defaults on the loan. Because a margin sale or foreclosure sale may occur at a time when the pledgor is aware of Inside Information or otherwise is not permitted to trade in Company Securities, Covered Persons are prohibited from holding Company Securities in a margin account or otherwise pledging Company Securities as collateral for a loan. An exception to this prohibition is hereby granted for any Company Securities held in a margin account or otherwise pledged as collateral for a loan on January 30, 2025, the date the Company adopted this prohibition. However, no new or additional shares of Company Securities may be deposited in such margin account or otherwise pledged after January 30, 2025. In addition, employees should exercise caution in considering pledging Company Securities for a margin loan.

***Hedging Transactions***

Certain forms of hedging or monetization transactions, such as zero-cost collars and forward sale contracts, allow a person to lock in much of the value of his or her stock holdings, often in exchange for all or part of the potential for upside appreciation in the stock. Covered Persons may not engage in any hedging or monetization transactions with respect to Company Securities, including, but not limited to, through the use of financial instruments such as exchange funds, prepaid variable forward contracts, equity swaps, puts, calls, collars, forwards and other derivative instruments.

***Standing and Limit Orders***

Placing a standing or limit order is discouraged. Standing and limit orders with respect to Company Securities (except standing and limit orders under approved Trading Plans (as defined below)) create heightened risks for insider trading violations similar to the use of margin accounts. There is no control over the timing of purchases or sales that result from standing instructions to a broker, and as a result the broker could execute a transaction when a Covered Person is in possession of Inside Information. If a Covered Person determines that he or she must use a standing order or limit order with respect to Company Securities, the order should be limited to short duration and should otherwise comply with the restrictions and pre-clearance procedures outlined in this Policy. Any such orders must be cancelled for the duration of any applicable black-out period.

***Post-Termination Transactions***

If a Covered Person is aware of Inside Information when he or she terminates service as a director, officer or other employee of the Company, such Covered Person may not trade in Company Securities until that Inside Information has become public or is no longer material. In all other respects, the procedures set forth in this Policy will cease to apply to such Covered Person's transactions in Company Securities upon the expiration of any blackout period that is applicable to such Covered Person's transactions at the time of his or her termination of service.

**<u>Additional Procedures</u>**

The Company has established additional procedures in order to assist the Company in the administration of this Policy, to facilitate compliance with laws prohibiting insider trading while in possession of material nonpublic information, and to avoid the appearance of any impropriety. These additional procedures are applicable only to those individuals described below.

------

***Pre-Clearance Procedures***

To help prevent inadvertent violations of the federal securities laws and to avoid even the appearance of trading on Inside Information, all directors, executive officers and other personnel of the Company and its subsidiaries who are subject to the reporting and "short-swing profit" liability provisions of Section 16 of the Exchange Act and any other persons designated by the Compliance Officer as being subject to these procedures, as well as the Family Members and Controlled Entities of such persons (all of the foregoing are referred to as "**Restricted Persons**"), may not engage in any transaction involving Company Securities without first obtaining pre-clearance of the transaction from the Compliance Officer, regardless of whether a black-out period is then in effect, and such Restricted Person must certify that he or she is not in possession of any Inside Information at that time. A request for pre-clearance must be submitted to the Compliance Officer by email in advance of the proposed transaction. If, upon requesting pre-clearance, a Restricted Person is advised that Company Securities may be traded, such Restricted Person may buy or sell Company Securities within five business days thereafter unless advised by the Compliance Officer otherwise. If for any reason the trade is not completed within the five business days, pre-clearance must be obtained again before Company Securities may be traded. The Compliance Officer is under no obligation to approve a trade submitted for pre-clearance and may determine not to permit the trade. Pre-clearance does not, in any circumstance, relieve a Restricted Person of their legal obligation to refrain from trading while in possession of Inside Information. In other words, even if pre-clearance is received, if a Restricted Person becomes aware of Inside Information or becomes subject to a black-out period, the transaction may not be completed. If pre-clearance is denied, the fact of such denial must be kept confidential by the Restricted Person requesting such pre-clearance. Restricted Persons do not need to receive pre-clearance for trades pursuant to an approved Trading Plan, but they must receive prior approval before implementing such a Trading Plan by the Compliance Officer.

***Post-Transaction Notice***

Restricted Persons who have a reporting obligation under Section 16 of the Exchange Act must notify the Company's Vice President, HR/Benefits and Compliance of the occurrence of any purchase, sale or other acquisition or disposition or gift of Company Securities as soon as possible following the transaction, but in any event within one business day after the transaction. Such notification may be oral or in writing (including by email) and should include the identity of the Restricted Person, the type of transaction, the date of the transaction, the number of Company Securities involved and the purchase or sale price (if applicable).

For both the "Pre-Clearance Procedures" section above and this "Post-Transaction Notice" section, a purchase, sale or other acquisition or disposition or gift shall be deemed to occur at the time the person or entity becomes irrevocably committed to it (for example, in the case of an open market purchase or sale, this occurs when the trade is executed, not when it settles).

***Black-Out Periods***

*Quarterly Black-Out Periods*

The Company's announcement of its quarterly financial results almost always has the potential to have a material effect on the market for Company Securities. Restricted Persons are prohibited from trading in Company Securities during the period beginning on the close of market on the last day of each fiscal quarter and ending after the second full business day following the Company's issuance of its earnings release for that quarter or the full year. Trading may resume the morning of the third business day following the applicable earnings release.

------

*Interim Guidance and Event-Specific Black-Out Periods*

The Company may on occasion issue interim earnings guidance or other potentially material information by means of a press release, SEC filing on Form 8-K or other means designed to achieve widespread dissemination of the information. Restricted Persons should anticipate that trades are unlikely to be pre-cleared while the Company is in the process of assembling the information to be released and until the information has been released and fully absorbed by the market.

In addition, from time to time, the Company may impose event-specific black-out periods on Restricted Persons and other employees of the Company if, in the judgement of the Compliance Officer, it is likely that such person or persons have become aware of significant corporate developments that have not yet been disclosed to the public, even when trading otherwise may be permitted. In the event that certain Restricted Persons or other employees of the Company become subject to a special black-out period, such persons are prohibited from (i) trading in Company Securities and (ii) disclosing to others the fact they are subject to such event-specific black-out period. These event-specific black-out periods may vary in length or may not be broadly communicated to Covered Persons. The failure of the Compliance Officer to designate a person as being subject to an event-specific black-out period will not relieve that person of the obligation not to trade while aware of Inside Information.

***Tipping***

Restricted Persons may not disclose, convey or "tip" Inside Information to any person by providing them with Inside Information other than to disclose on a "need to know" basis to officers and employees of the Company or outside advisors in the course of performing their duties for the Company. Unlawful tipping includes passing on Inside Information to friends, Family Members or acquaintances under circumstances that suggest that persons subject to this Policy were trying to help the recipients of such information to make a profit or avoid a loss by trading in Company Securities based on such information. 

**<u>Rule 10b5-1 Plans</u>**

Notwithstanding the prohibition against insider trading, Rule 10b5-1 under the Exchange Act ("**Rule 10b5-1**") and this Policy permit Restricted Persons to trade in Company Securities regardless of their awareness of Inside Information if the transaction is made pursuant to a pre-arranged trading plan (a "**Trading Plan**") that (i) meets the requirements set forth in Rule 10b5-1, (ii) was entered into outside of a black-out period and when the Restricted Person was not in possession of Inside Information, and (iii) is operated in good faith. All Trading Plans, including any amendment, modification or termination, or any cancellation of scheduled transactions, must be approved in writing in advance by the Compliance Officer.

A Trading Plan must be written, and either specify (including by formula) the amount, pricing and timing of transactions in advance or delegate discretion on these matters to an independent third party, such as a broker. Once a Trading Plan is adopted, a Restricted Person must not exercise any influence over the amount of securities to be traded, the price at which they are to be traded, or the date of the trade.

A Trading Plan must comply with and be operated in accordance with the conditions of Rule 10b5-1, including the following:

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• trades under the Trading Plan, and in certain circumstances, an amended Trading Plan, may not commence until expiration of the "cooling-off period" set forth in Rule 10b5-1<sup>1</sup>;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the Trading Plan must include representations that (i) the person is not aware of material nonpublic information about the Company or its securities; and (ii) the person is adopting, or in certain cases amending, the Trading Plan in good faith and not as part of a plan or scheme to evade the prohibitions of Rule 10b5-1;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• no person may have more than one Trading Plan outstanding at any given time, unless otherwise permitted by the limited exceptions of Rule 10b5-1 (such as plans relating to "sell to cover" arrangements intended to satisfy tax withholding obligations upon the vesting of equity awards); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• no person may have more than one single-trade Trading Plan (a plan designed to effect the open-market purchase or sale of the total amount of securities covered by the plan in a single transaction) within any consecutive 12-month period, unless otherwise permitted by the limited exceptions of Rule 10b5-1.

A Restricted Person who wishes to enter into, amend or terminate (other than by expiration) a Trading Plan must submit the Trading Plan, or the amendment or notice of termination of the Trading Plan, to the Compliance Officer for approval prior to the adoption, amendment or termination of the Trading Plan. Subject to prior approval by the Compliance Officer, a Restricted Person may amend or replace his or her Trading Plan only during periods when trading is permitted in accordance with this Policy and when the Restricted Person was not in possession of Inside Information.

The SEC rules regarding trading plans are complex and must be complied with completely to be effective. The description of Trading Plans provided above is only a summary, and the Company strongly advises that each Restricted Person consult with his or her personal legal advisor if he or she intends to adopt a Trading Plan. While such plans are subject to review and approval by the Compliance Officer, the Restricted Person adopting the Trading Plan is ultimately responsible for compliance with Rule 10b5-1 and ensuring that the Trading Plan complies with this Policy.

**<u>Consequences of Violation</u>**

***Insider trading is a crime.*** Violations are pursued vigorously by the SEC, U.S. Attorneys and state enforcement authorities and foreign jurisdictions. Violations can result in severe penalties including significant fines and imprisonment.

Failure to comply with this Policy may also subject an employee to Company-imposed sanctions, including dismissal for cause, whether or not the employee's failure to comply results in a violation of law. Any sanctions imposed upon or liabilities incurred by an employee for insider trading will be the sole responsibility of the employee. The Company will not cover or indemnify the employee for these costs.

**<u>Personal Responsibility; Assistance</u>**

Persons subject to this Policy have ethical and legal obligations to maintain the confidentiality of information about the Company and to not engage in transactions in Company Securities while in possession of Inside Information. Persons subject to this Policy must not engage in illegal trading and

<sup>1</sup> For directors and Section 16 officers, such cooling-off period is generally the later of (i) 90 days after execution of the Trading Plan or (ii) two business days following the filing of the Form 10-K or Form 10-Q for the reporting period in which the Trading Plan was executed; for all other insiders, such cooling-off period is 30 days after execution of the Trading Plan.

------

must avoid the appearance of improper trading. Each individual is responsible for making sure that he or she complies with this Policy, and that any Family Member or Controlled Entity whose transactions are subject to this Policy, as discussed above, also comply with this Policy. In all cases, the responsibility for determining whether an individual is in possession of Inside Information rests with that individual, and any action on the part of the Company, the Compliance Officer or any other employee or director pursuant to this Policy (or otherwise) does not in any way constitute legal advice or insulate an individual from liability under applicable securities laws. **You could be subject to severe legal penalties and disciplinary action by the Company for any conduct prohibited by this Policy or applicable securities laws.** 

Any person who has a question about this Policy or its application to any proposed transaction may obtain additional guidance from the Compliance Officer, the Chief Financial Officer or the Chief Executive Officer.

**<u>Certification</u>**

You must sign, date and return the attached Acknowledgement and Certification (or such other certification as the Compliance Officer may deem appropriate) stating that you have received, read, understand and agree to comply with the Company's Inside Information and Insider Trading Policy. The Company may require you to sign such an Acknowledgment and Certification on an annual basis, which Acknowledgment and Certification may be in electronic format.

Revised: November 5, 2025.

------

• **NATIONAL HEALTH INVESTORS, INC.**

&nbsp;&nbsp;&nbsp;&nbsp;• **INSIDE INFORMATION AND INSIDER TRADING POLICY**

&nbsp;&nbsp;&nbsp;&nbsp;• **ACKNOWLEDGMENT AND CERTIFICATION**

• I hereby acknowledge and certify that I have received, read, understand and will comply with National Health Investors, Inc.'s Inside Information and Insider Trading Policy.

• I understand that my agreement to comply with the Inside Information and Insider Trading Policy does not constitute a contract of employment.

---

| | |
|:---|:---|
| • Please sign here:  | • |
| • | • |
| • Print name: | • |
| • | • |
| • Date:  | • |
| • | • |

---

• • - 10-

## Ex-21

**Exhibit 21**

**NATIONAL HEALTH INVESTORS, INC.**

**SUBSIDIARY ENTITY LIST**

---

| | | |
|:---|:---|:---|
| **Entity Name** | **Ownership**<sup>1</sup> | **Tax Treatment** |
| NHI/REIT, Inc. | 100% | DE |
| Florida Holdings IV, LLC | 100% | DE |
| Inchin Along, LLC | 100% | DE |
| NHI REIT of Alabama, L.P. | 100% | DE |
| NHI-REIT of California, LP | 100% | DE |
| NHI/REIT of Florida, L.P. | 100% | DE |
| NHI-REIT of Georgia, L.P. | 100% | DE |
| NHI-REIT of Idaho, L.P. | 100% | DE |
| NHI-REIT of Missouri, LP | 100% | DE |
| NHI-REIT of South Carolina, L.P. | 100% | DE |
| NHI-REIT of Virginia, L.P. | 100% | DE |
| NHI/Anderson, LLC | 100% | DE |
| NHI/Laurens, LLC | 100% | DE |
| Texas NHI Investors, LLC | 100% | DE |
| NHI-REIT of Oregon, LLC | 100% | DE |
| NHI-REIT of Florida, LLC | 100% | DE |
| NHI-REIT of Maryland, LLC | 100% | DE |
| NHI-REIT of Minnesota, LLC | 100% | DE |
| NHI-REIT of Tennessee, LLC | 100% | DE |
| NHI Selah Properties, LLC | 100% | DE |
| NHI-REIT of Northeast, LLC | 100% | DE |
| NHI-REIT of Wisconsin, LLC | 100% | DE |
| NHI-REIT of NC Springs, LLC | 100% | DE |
| NHI-REIT of Washington, LLC | 100% | DE |
| NHI-REIT of Next House, LLC | 80% | Partnership |
| NHI-SS TRS, LLC | 100% | Corporation |
| NHI-Bickford RE, LLC | 100% | DE |
| Care YBE Subsidiary LLC | 100% | DE |
| Myrtle Beach Retirement Residence LLC | 98% | DE |
| Voorhees Retirement Residence LLC | 98% | DE |
| NHI-REIT of Axel, LLC | 100% | DE |
| NHI-REIT of Michigan, LLC | 100% | DE |
| NHI-REIT of Seaside, LLC | 100% | DE |
| NHI-REIT of Bickford, LLC | 100% | DE |
| NHI-REIT of Evergreen, LLC | 100% | DE |
| NHI-REIT of North Carolina, LLC | 100% | DE |
| NHI-REIT of TX-IL, LLC | 100% | DE |
| NHI-REIT of CCWH, LLC | 98% | DE |
| NHI-REIT of Colorado, LLC | 100% | DE |
| NHI-LCS JV I LLC | 80% | Partnership |
| NHI-LCS TRS LLC | 100% | DE |
| NHI-REIT of Indiana, LLC | 100% | DE |
| Timber Ridge OpCo, LLC | 25% | Partnership |
| NHI-REIT of Oklahoma, LLC | 100% | DE |

---

------

**Exhibit 21**

---

| | | |
|:---|:---|:---|
| **Entity Name** | **Ownership**<sup>1</sup> | **Tax Treatment** |
| NHI PropCo Member LLC | 100% of common; 80.8% of preferred | REIT |
| NHI-REIT of DSL PropCo II, LLC | 98% | Partnership |
| NHI-Discovery I TRS, LLC | 100% | Corporation |
| NHI-Merrill I TRS, LLC | 100% | DE |
| NHI-Sub REIT of Colorado, LLC | 100% | DE |
| NHI-REIT of PropCo I, LLC | 100% | DE |
| NHI-REIT of PropCo II, LLC | 100% | DE |
| NHI-REIT of PropCo III, LLC | 100% | DE |
| NHI-REIT of PropCo IV, LLC | 100% | DE |
| NHI-REIT of PropCo V, LLC | 100% | DE |
| NHI SH PropCo 1, LLC | 100% | DE |
| NHI SH OpCo 1, LLC | 100% | DE |
| NHI OpCo Columbus IN, LLC | 100% | DE |
| NHI OpCo Michigan City IN, LLC | 100% | DE |
| NHI OpCo Portage IN, LLC | 100% | DE |
| NHI OpCo Vero Beach FL, LLC | 100% | DE |
| NHI OpCo Salisbury MD, LLC | 100% | DE |
| NHI OpCo Reading PA, LLC | 100% | DE |
| NHI SH PropCo 2, LLC | 100% | DE |
| NHI PropCo Redmond OR, LLC | 100% | DE |
| NHI PropCo Central Point OR, LLC | 100% | DE |
| NHI PropCo Tulsa OK, LLC | 100% | DE |
| NHI PropCo Broken Arrow OK, LLC | 100% | DE |
| NHI SH OpCo 2, LLC | 100% | DE |
| NHI OpCo Redmond OR, LLC | 100% | DE |
| NHI OpCo Central Point OR, LLC | 100% | DE |
| NHI OpCo Tulsa OK, LLC | 100% | DE |
| NHI OpCo Broken Arrow OK, LLC | 100% | DE |
| NHI SH PropCo 3, LLC | 100% | DE |
| NHI PropCo Jamison PA, LLC | 100% | DE |
| NHI OpCo Jamison PA, LLC | 100% | DE |
| NHI SH PropCo 4, LLC | 100% | DE |
| NHI PropCo Athens TN, LLC | 100% | DE |
| NHI PropCo Bristol TN, LLC | 100% | DE |
| NHI PropCo Crossville TN, LLC | 100% | DE |
| NHI PropCo Sevierville TN, LLC | 100% | DE |
| NHI PropCo Maryville TN, LLC | 100% | DE |
| NHI PropCo Anderson SC, LLC | 100% | DE |
| NHI PropCo Frankfurt KY, LLC | 100% | DE |
| NHI PropCo Florence KY, LLC | 100% | DE |
| NHI PropCo Richmond KY, LLC | 100% | DE |
| NHI SH OpCo 4, LLC | 100% | DE |
| NHI OpCo Athens TN, LLC | 100% | DE |
| NHI OpCo Bristol TN, LLC | 100% | DE |
| NHI OpCo Crossville TN, LLC | 100% | DE |
| NHI OpCo Sevierville TN, LLC | 100% | DE |

---

------

**Exhibit 21**

---

| | | |
|:---|:---|:---|
| **Entity Name** | **Ownership**<sup>1</sup> | **Tax Treatment** |
| NHI OpCo Maryville TN, LLC | 100% | DE |
| NHI OpCo Anderson SC, LLC | 100% | DE |
| NHI OpCo Frankfurt KY, LLC | 100% | DE |
| NHI OpCo Florence KY, LLC | 100% | DE |
| NHI OpCo Richmond KY, LLC | 100% | DE |
| NHI SH PropCo 5, LLC | 100% | DE |
| NHI PropCo Torino Fort Collins CO, LLC | 100% | DE |
| NHI PropCo 900 Centre Fort Collins CO, LLC | 100% | DE |
| NHI PropCo 909 Centre Fort Collins CO, LLC | 100% | DE |
| NHI PropCo 900 Worthington |  |  |
| Fort Collins CO, LLC | 100% | DE |
| NHI PropCo 1422 West 29 Loveland CO, LLC | 100% | DE |
| NHI PropCo 1385 Main Windsor CO, LLC | 100% | DE |
| NHI PropCo 14th Main Windsor CO, LLC | 100% | DE |
| NHI SH OpCo 5, LLC | 100% | DE |
| NHI ManCo CO, LLC | 100% | DE |
| NHI OpCo 900 Centre Fort Collins CO, LLC | 100% | DE |
| NHI OpCo 1422 West 29 Loveland CO, LLC | 100% | DE |

---

<sup>1&nbsp;&nbsp;&nbsp;&nbsp;</sup>Ownership of 100% means that National Health Investors, Inc. owns the reflected percentage of the entity through itself or its subsidiaries.

## Exhibit 23.1

**Exhibit 23.1**

**CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-270557) and Form S-8 (Nos. 333-206273, 333-226629, 333-233129 and 333-273831) of National Health Investors, Inc. (the Company) of our reports dated February 26, 2026, relating to the consolidated financial statements and financial statement schedules, and the effectiveness of the Company's internal control over financial reporting, which appear in this Annual Report on Form 10-K.

/s/ BDO USA, P.C.

Nashville, Tennessee

February 26, 2026

## Exhibit 31.1

**Exhibit 31.1** 

**CERTIFICATION PURSUANT TO**

**SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, D. Eric Mendelsohn, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this annual report on Form 10-K of the registrant, National Health Investors, Inc., for the period ended December 31, 2025 as filed with the Securities and Exchange Commission on the date hereof;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | | |
|:---|:---|:---|:---|
| Date: | February 26, 2026 | /s/ D. Eric Mendelsohn | /s/ D. Eric Mendelsohn |
| | | Name: | D. Eric Mendelsohn |
| | | Title: | President, Chief Executive Officer and Director |
| | | | (Principal Executive Officer) |

---

## Exhibit 31.2

**Exhibit 31.2** 

**CERTIFICATION PURSUANT TO**

**SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, John L. Spaid, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this annual report on Form 10-K of the registrant, National Health Investors, Inc., for the period ended December 31, 2025 as filed with the Securities and Exchange Commission on the date hereof;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;&nbsp;&nbsp;&nbsp;The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | | |
|:---|:---|:---|:---|
| Date: | February 26, 2026 | /s/ John L. Spaid | /s/ John L. Spaid |
| | | Name: | John L. Spaid |
| | | Title: | Chief Financial Officer |
| | | | (Principal Financial Officer) |

---

## Ex-32

**Exhibit 32**

**CERTIFICATION** 

**PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

The undersigned hereby certify, pursuant to 18 U.S.C. Section 1350, as added by Section 906 of the Sarbanes-Oxley Act of 2002, that, to the undersigned's best knowledge and belief, the following related to the annual report on Form 10- K for National Health Investors, Inc. ("Issuer") for the period ended December 31, 2025 as filed with the Securities and Exchange Commission on the date hereof (the "Report"):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Issuer.

---

| | | | |
|:---|:---|:---|:---|
| Date: | February 26, 2026 | /s/ D. Eric Mendelsohn | /s/ D. Eric Mendelsohn |
|  |  | Name: | D. Eric Mendelsohn |
|  |  | Title: | President, Chief Executive Officer and Director |
|  |  |  | (Principal Executive Officer) |
| Date: | February 26, 2026 | /s/ John L. Spaid | /s/ John L. Spaid |
|  |  | Name: | John L. Spaid |
|  |  | Title: | Chief Financial Officer |
|  |  |  | (Principal Financial Officer) |

---

<br>